CHEBI ONTOLOGY - ANNOTATIONS |
|
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
| Term: | sodium channel blocker |
|
| Accession: | CHEBI:38633
|
browse the term
|
| Definition: | An agent that inhibits sodium influx through cell membranes. |
| Synonyms: | related_synonym: | Na channel blocker; sodium channel blockers |
|
|
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
5-(N,N-hexamethylene)amiloride results in increased expression of DDIT3 mRNA
|
CTD |
PMID:19302589 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
affects expression
|
ISO
|
5-(N,N-hexamethylene)amiloride affects the expression of HSP90B1 mRNA
|
CTD |
PMID:19302589 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
affects expression
|
ISO
|
5-(N,N-hexamethylene)amiloride affects the expression of HSPA5 mRNA
|
CTD |
PMID:19302589 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
5-(N,N-hexamethylene)amiloride results in increased expression of PPP1R15A mRNA
|
CTD |
PMID:19302589 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression
|
ISO
|
5-(N,N-hexamethylene)amiloride results in increased expression of PTGS2 mRNA
|
CTD |
PMID:19302589 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Serpinb1a
|
serpin family B member 1A
|
multiple interactions
|
ISO
|
5-(N,N-hexamethylene)amiloride results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form
|
CTD |
PMID:25447644 |
|
NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166
|
|
|
|
| G
|
Acan
|
aggrecan
|
affects expression
|
EXP
|
Amiloride affects the expression of ACAN mRNA
|
CTD |
PMID:20454829 |
|
NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779
|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions increases expression
|
EXP ISO
|
Amiloride inhibits the reaction [AGT protein results in increased expression of ATP1A1 mRNA] Amiloride results in increased expression of AGT protein modified form
|
CTD |
PMID:7357812 PMID:14630723 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
Amiloride results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alb
|
albumin
|
multiple interactions
|
EXP
|
Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein]
|
CTD |
PMID:11340305 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aoc1
|
amine oxidase, copper containing 1
|
affects binding multiple interactions decreases activity
|
ISO EXP
|
Amiloride binds to AOC1 protein Amiloride inhibits the reaction [Phenylamil binds to Aoc1 protein] Amiloride binds to Aoc1 protein Amiloride inhibits the reaction [AOC1 protein results in increased degradation of Putrescine] Amiloride results in decreased activity of AOC1 protein
|
CTD RGD |
PMID:2217167 PMID:8144586 PMID:8375402 PMID:8375402 |
RGD:724757, RGD:724757 |
NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:79,143,126...79,162,704
|
|
| G
|
Asic3
|
acid sensing ion channel subunit 3
|
affects response to substance
|
ISO
|
ASIC3 protein affects the susceptibility to Amiloride
|
CTD |
PMID:12037186 |
|
NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
multiple interactions
|
EXP
|
Amiloride inhibits the reaction [AGT protein results in increased expression of ATP1A1 mRNA]
|
CTD |
PMID:14630723 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp6v1b1
|
ATPase H+ transporting V1 subunit B1
|
multiple interactions
|
EXP
|
[Furosemide co-treated with Amiloride] results in increased expression of ATP6V1B1 protein
|
CTD |
PMID:17311909 |
|
NCBI chr 4:117,781,444...117,800,103
Ensembl chr 4:117,781,444...117,800,103
|
|
| G
|
Cacna1h
|
calcium voltage-gated channel subunit alpha1 H
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium]
|
CTD |
PMID:9930755 PMID:11897840 |
|
NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Acids results in increased secretion of CALCA protein]
|
CTD |
PMID:20100279 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO EXP
|
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein] Amiloride inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]
|
CTD |
PMID:15607733 PMID:16059913 PMID:34656704 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]
|
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein]
|
CTD |
PMID:16059913 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions decreases expression
|
ISO EXP
|
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] Amiloride results in decreased expression of CCL2 mRNA; Amiloride results in decreased expression of CCL2 protein Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein]; Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA]; Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein]
|
CTD |
PMID:11340305 PMID:12107048 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]
|
CTD |
PMID:11420121 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression
|
ISO
|
Amiloride results in decreased expression of CCNB1 protein
|
CTD |
PMID:9458082 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
increases activity
|
ISO EXP
|
Amiloride results in increased activity of CFTR protein Amiloride increases activity of Cftr protein in nasal cavity epithelium
|
CTD RGD |
PMID:15246976 PMID:31942562 |
RGD:126928119 |
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Col2a1
|
collagen type II alpha 1 chain
|
affects expression
|
EXP
|
Amiloride affects the expression of COL2A1 mRNA
|
CTD |
PMID:20454829 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL2 protein]
|
CTD |
PMID:11420121 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
ISO
|
Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein]
|
CTD |
PMID:15607733 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
Amiloride results in decreased activity of CYP1A1 protein
|
CTD |
PMID:33814510 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases activity
|
ISO
|
Amiloride results in decreased activity of CYP1B1 protein
|
CTD |
PMID:33814510 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Tunicamycin results in increased expression of DDIT3]
|
CTD |
PMID:20015086 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Dysf
|
dysferlin
|
decreases expression
|
ISO
|
Amiloride results in decreased expression of DYSF mRNA
|
CTD |
PMID:15535137 |
|
NCBI chr 4:118,048,460...118,248,273
Ensembl chr 4:118,047,989...118,248,273
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
increases phosphorylation
|
ISO
|
Amiloride results in increased phosphorylation of EIF2A protein
|
CTD |
PMID:20015086 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
decreases phosphorylation
|
ISO
|
Amiloride results in decreased phosphorylation of ERBB2 protein
|
CTD |
PMID:16059913 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein]
|
CTD |
PMID:20015086 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
ISO
|
Amiloride results in increased expression of FOS mRNA Amiloride inhibits the reaction [Acids results in increased expression of and results in increased localization of FOS protein]
|
CTD |
PMID:12730611 PMID:16769263 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Grip1
|
glutamate receptor interacting protein 1
|
affects response to substance
|
ISO
|
GRIP1 gene SNP affects the susceptibility to Amiloride
|
CTD |
PMID:25622337 |
|
NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]
|
CTD |
PMID:20015086 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA] Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein]
|
CTD |
PMID:11420121 PMID:12070711 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Il12b
|
interleukin 12B
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein]
|
CTD |
PMID:11420121 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Amiloride inhibits the reaction [IL1B protein results in increased expression of SELE protein]; Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Amiloride inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]
|
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Itgal
|
integrin subunit alpha L
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL protein]
|
CTD |
PMID:10198263 |
|
NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:191,348,542...191,386,225
|
|
| G
|
Klk1
|
kallikrein 1
|
multiple interactions increases response to substance
|
ISO
|
KLK1 protein affects the susceptibility to [Amiloride results in increased secretion of Sodium] KLK1 protein results in increased susceptibility to Amiloride
|
CTD |
PMID:18086683 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:12065299 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:12065299 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein]
|
CTD |
PMID:19815690 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein]
|
CTD |
PMID:19815690 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Myf5
|
myogenic factor 5
|
increases expression
|
ISO
|
Amiloride results in increased expression of MYF5 mRNA
|
CTD |
PMID:15535137 |
|
NCBI chr 7:44,689,407...44,692,638
Ensembl chr 7:44,689,407...44,692,638
|
|
| G
|
Myl12b
|
myosin light chain 12B
|
decreases phosphorylation
|
ISO
|
Amiloride results in decreased phosphorylation of MRLC2 protein
|
CTD |
PMID:11078707 |
|
NCBI chr 9:118,320,479...118,334,810
Ensembl chr 9:118,320,489...118,324,418
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein]
|
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased degradation of and results in decreased expression of NFKBIA protein]
|
CTD |
PMID:12107048 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
Lipopolysaccharides inhibits the reaction [Amiloride results in increased expression of NOS2]
|
CTD |
PMID:21356098 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]
|
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1
|
decreases phosphorylation
|
ISO
|
Amiloride results in decreased phosphorylation of PDPK1 protein
|
CTD |
PMID:16059913 |
|
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
|
|
| G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
decreases uptake
|
ISO
|
Amiloride results in decreased uptake of PDX1 protein
|
CTD |
PMID:16405074 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
| G
|
Pkd2
|
polycystin 2, transient receptor potential cation channel
|
multiple interactions
|
ISO
|
Amiloride results in decreased activity of [PKD2 protein binds to PKD2 protein]; Amiloride results in decreased activity of [PKD2 protein binds to TRPC1 protein]
|
CTD |
PMID:19193631 |
|
NCBI chr14:5,541,821...5,585,140
Ensembl chr14:5,495,401...5,587,594
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
multiple interactions decreases activity
|
ISO
|
Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein] Amiloride results in decreased activity of PLAU protein
|
CTD |
PMID:8921802 PMID:11454671 PMID:14644129 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IFNA2 protein results in increased expression of PLAUR mRNA]; Amiloride inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA]
|
CTD |
PMID:12070711 |
|
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Plg
|
plasminogen
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein]
|
CTD |
PMID:14644129 |
|
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320
|
|
| G
|
Ppp1ca
|
protein phosphatase 1 catalytic subunit alpha
|
decreases phosphorylation multiple interactions
|
ISO
|
Amiloride results in decreased phosphorylation of PPP1CA protein Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of PPP1CA protein]
|
CTD |
PMID:16059913 |
|
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO EXP
|
Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Amiloride inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein]
|
CTD |
PMID:17237260 PMID:34656704 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO EXP
|
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein] Amiloride inhibits the reaction [Doxorubicin results in increased expression of RELA protein]
|
CTD |
PMID:12065299 PMID:12107048 PMID:34656704 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Scnn1a
|
sodium channel epithelial 1 subunit alpha
|
multiple interactions affects activity
|
ISO EXP
|
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] [farglitazar co-treated with Amiloride] results in increased expression of SCNN1A mRNA Amiloride affects the activity of SCNN1A protein
|
CTD |
PMID:8617496 PMID:15475592 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405
|
|
| G
|
Scnn1b
|
sodium channel epithelial 1 subunit beta
|
multiple interactions affects activity
|
ISO
|
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] Amiloride affects the activity of SCNN1B protein
|
CTD |
PMID:8617496 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049
|
|
| G
|
Scnn1g
|
sodium channel epithelial 1 subunit gamma
|
affects activity multiple interactions
|
ISO
|
Amiloride affects the activity of SCNN1G protein Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein]
|
CTD |
PMID:8617496 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 1:185,736,225...185,770,099
Ensembl chr 1:185,736,191...185,770,097
|
|
| G
|
Sele
|
selectin E
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [IL1B protein results in increased expression of SELE protein]
|
CTD |
PMID:12107048 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Slc12a4
|
solute carrier family 12 member 4
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [SLC12A4 protein results in increased transport of Potassium]
|
CTD |
PMID:11703599 |
|
NCBI chr19:50,748,268...50,770,217
Ensembl chr19:50,748,279...50,770,259
|
|
| G
|
Slc22a2
|
solute carrier family 22 member 2
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
|
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
|
|
| G
|
Slc26a4
|
solute carrier family 26 member 4
|
multiple interactions
|
EXP
|
[Furosemide co-treated with Amiloride] affects the localization of SLC26A4 protein
|
CTD |
PMID:17311909 |
|
NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:53,835,110...53,873,216
|
|
| G
|
Slc31a1
|
solute carrier family 31 member 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein]
|
CTD |
PMID:17108132 |
|
NCBI chr 5:80,830,574...80,859,810
Ensembl chr 5:80,830,389...80,859,809
|
|
| G
|
Slc47a1
|
solute carrier family 47 member 1
|
decreases activity multiple interactions
|
ISO
|
Amiloride results in decreased activity of SLC47A1 protein Amiloride inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:16928787 PMID:22419765 |
|
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,533,583...46,587,096
|
|
| G
|
Slc47a2
|
solute carrier family 47 member 2
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:22419765 |
|
NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425
|
|
| G
|
Slc52a3
|
solute carrier family 52 member 3
|
multiple interactions
|
EXP
|
Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
|
CTD |
PMID:19122205 |
|
NCBI chr 3:160,959,233...160,976,170
Ensembl chr 3:160,965,302...160,974,692
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
multiple interactions
|
EXP
|
Amiloride inhibits the reaction [Doxorubicin results in increased expression of SLC9A1 protein]
|
CTD |
PMID:34656704 |
|
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Slc9a2
|
solute carrier family 9 member A2
|
multiple interactions
|
EXP
|
[Amiloride results in decreased activity of SLC9A2 protein] which results in decreased transport of Chlorides; [Amiloride results in decreased activity of SLC9A2 protein] which results in decreased transport of Sodium
|
CTD |
PMID:10958346 |
|
NCBI chr 9:50,427,612...50,510,043
Ensembl chr 9:50,426,798...50,510,040
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO EXP
|
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL protein]; Lipopolysaccharides inhibits the reaction [Amiloride results in increased expression of TNF] Amiloride inhibits the reaction [Doxorubicin results in increased expression of TNF protein]
|
CTD |
PMID:10198263 PMID:21356098 PMID:34656704 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions
|
ISO
|
Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]
|
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Trpa1
|
transient receptor potential cation channel, subfamily A, member 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]
|
CTD |
PMID:15843607 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:9,163,060...9,217,325
|
|
| G
|
Trpc1
|
transient receptor potential cation channel, subfamily C, member 1
|
multiple interactions
|
ISO
|
Amiloride results in decreased activity of [PKD2 protein binds to TRPC1 protein]
|
CTD |
PMID:19193631 |
|
NCBI chr 8:105,142,931...105,193,842
Ensembl chr 8:105,142,931...105,193,826
|
|
| G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
decreases activity
|
ISO
|
Amiloride results in decreased activity of TRPC6 protein
|
CTD |
PMID:11179201 |
|
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
decreases expression
|
ISO
|
Amiloride results in decreased expression of VEGFA mRNA; Amiloride results in decreased expression of VEGFA protein
|
CTD |
PMID:16884771 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
multiple interactions
|
ISO
|
Amiloride inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]
|
CTD |
PMID:20015086 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
multiple interactions increases expression increases response to substance
|
ISO
|
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein]; [Capsaicin results in increased expression of ABCA1 protein] which results in decreased uptake of Cholesterol; [Capsaicin results in increased expression of ABCA1 protein] which results in increased secretion of Cholesterol; APOE affects the reaction [Capsaicin results in increased expression of ABCA1 protein]; Cyclosporine affects the reaction [Capsaicin results in increased expression of ABCA1 protein]; KT 5720 inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein] ABCA1 results in increased susceptibility to Capsaicin
|
CTD |
PMID:21908651 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of ABCB1 mRNA; Capsaicin results in increased expression of ABCB1 protein Capsaicin results in decreased expression of ABCB1A mRNA Capsaicin affects the reaction [ABCB1 protein results in increased export of Digoxin]
|
CTD |
PMID:16674925 PMID:24013073 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of ABCB1B mRNA
|
CTD |
PMID:24013073 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Abl1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ABL1 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846
|
|
| G
|
Acacb
|
acetyl-CoA carboxylase beta
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of ACACB mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ACOX1 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of ACSL3 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
increases secretion increases expression
|
ISO
|
Capsaicin results in increased secretion of ADIPOQ protein Capsaicin results in increased expression of ADIPOQ mRNA; Capsaicin results in increased expression of ADIPOQ protein
|
CTD |
PMID:17295509 PMID:17719033 PMID:19798065 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adra1a
|
adrenoceptor alpha 1A
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ADRA1A mRNA; Capsaicin results in increased expression of ADRA1A protein
|
CTD |
PMID:39800145 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
|
|
| G
|
Adra2a
|
adrenoceptor alpha 2A
|
decreases response to substance decreases expression
|
ISO
|
ADRA2A results in decreased susceptibility to Capsaicin Capsaicin results in decreased expression of ADRA2A mRNA
|
CTD |
PMID:15220790 PMID:39800145 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ADRB1 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ADRB2 mRNA; Capsaicin results in increased expression of ADRB2 protein
|
CTD |
PMID:39800145 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Adrb3
|
adrenoceptor beta 3
|
affects expression increases expression multiple interactions
|
ISO
|
Capsaicin affects the expression of ADRB3 mRNA Capsaicin results in increased expression of ADRB3 mRNA; Capsaicin results in increased expression of ADRB3 protein [BRL 37344 co-treated with Capsaicin] results in increased expression of ADRB3 protein; [N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide co-treated with Capsaicin] results in decreased expression of ADRB3 protein
|
CTD |
PMID:39800145 |
|
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
| G
|
Aga
|
aspartylglucosaminidase
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of AGA mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
increases expression
|
EXP
|
Capsaicin results in increased expression of AGTR1A mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Methylcholanthrene results in increased activity of and results in increased localization of AHR protein]
|
CTD |
PMID:21250977 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
affects localization
|
ISO
|
Capsaicin affects the localization of AIFM1 protein
|
CTD |
PMID:20925121 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Akirin2
|
akirin 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of AKIRIN2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 5:53,897,792...53,918,873
Ensembl chr 5:53,904,285...53,918,934
|
|
| G
|
Akr1a1
|
aldo-keto reductase family 1 member A1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of AKR1A1 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035
|
|
| G
|
Akr7a3
|
aldo-keto reductase family 7 member A3
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of AKR7A3 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases expression increases phosphorylation increases activity multiple interactions
|
EXP ISO
|
Capsaicin results in increased expression of AKT1 protein modified form Capsaicin results in increased phosphorylation of AKT1 protein Capsaicin results in increased activity of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Capsaicin co-treated with Oxygen deficiency co-treated with Oxygen] results in increased phosphorylation of AKT1 protein]; [Capsaicin co-treated with Oxygen deficiency co-treated with Oxygen] results in increased phosphorylation of AKT1 protein [Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of AKT1 protein; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of AKT1 protein]; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein]; wortmannin inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:16360265 PMID:17084039 PMID:17979524 PMID:19011674 PMID:19059400 PMID:19139269 PMID:20619260 PMID:20660715 PMID:21462327 PMID:21474332 PMID:22226932 More...
|
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alb
|
albumin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ALB protein
|
CTD |
PMID:9537786 PMID:18991268 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldh3a1
|
aldehyde dehydrogenase 3 family, member A1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of ALDH3A1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
multiple interactions decreases activity
|
EXP
|
[Capsaicin co-treated with Curcumin] results in decreased activity of ALOX5 protein Capsaicin results in decreased activity of ALOX5 protein
|
CTD |
PMID:16956363 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Amhr2
|
anti-Mullerian hormone receptor type 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of AMHR2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104
|
|
| G
|
Amn
|
amnion associated transmembrane protein
|
multiple interactions increases expression
|
EXP
|
AMN protein inhibits the reaction [Capsaicin results in increased expression of SST protein]; AMN protein inhibits the reaction [Capsaicin results in increased expression of TAC1 protein] Capsaicin results in increased expression of AMN protein
|
CTD |
PMID:16938409 |
|
NCBI chr 6:136,132,567...136,140,008
Ensembl chr 6:136,132,567...136,140,008
|
|
| G
|
Amy2a3
|
amylase 2a3
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Melatonin results in increased secretion of AMY2A3 protein]
|
CTD |
PMID:15009505 |
|
NCBI chr 2:204,005,840...204,014,412
Ensembl chr 2:204,005,840...204,014,413
|
|
| G
|
Angpt1
|
angiopoietin 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ANGPT1 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Angpt2
|
angiopoietin 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ANGPT2 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of APAF1 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apob
|
apolipoprotein B
|
increases expression
|
EXP
|
Capsaicin results in increased expression of APOB mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoc1
|
apolipoprotein C1
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of APOC1 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155
|
|
| G
|
Apoe
|
apolipoprotein E
|
multiple interactions
|
ISO
|
APOE affects the reaction [Capsaicin results in decreased expression of LRP1 protein]; APOE affects the reaction [Capsaicin results in increased expression of ABCA1 protein]; Capsaicin inhibits the reaction [[APOE affects the susceptibility to Dietary Fats] which affects the abundance of Cholesterol]; Capsaicin inhibits the reaction [[APOE affects the susceptibility to Dietary Fats] which affects the abundance of Triglycerides]
|
CTD |
PMID:21908651 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Aqp1
|
aquaporin 1
|
increases response to substance
|
ISO
|
AQP1 results in increased susceptibility to Capsaicin
|
CTD |
PMID:20018876 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
| G
|
Ar
|
androgen receptor
|
increases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of AR protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of AR protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of AR protein]; Capsaicin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Capsaicin inhibits the reaction [Dihydrotestosterone results in increased expression of AR protein]; capsazepine inhibits the reaction [Capsaicin results in increased expression of AR protein]; iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of AR protein]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [Capsaicin results in increased expression of AR protein]
|
CTD |
PMID:16540674 PMID:19059400 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Areg
|
amphiregulin
|
multiple interactions
|
ISO
|
[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of AREG mRNA; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of AREG mRNA]
|
CTD |
PMID:20660715 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
| G
|
Arpp19
|
cAMP-regulated phosphoprotein 19
|
increases expression
|
EXP
|
Capsaicin results in increased expression of ARPP19 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385 Ensembl chr 8:119,691,942...119,692,385
|
|
| G
|
Arrdc4
|
arrestin domain containing 4
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of ARRDC4 mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
|
|
| G
|
Atf2
|
activating transcription factor 2
|
increases phosphorylation increases expression
|
ISO
|
Capsaicin results in increased phosphorylation of ATF2 protein Capsaicin results in increased expression of ATF2 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745
|
|
| G
|
Atf3
|
activating transcription factor 3
|
multiple interactions
|
ISO
|
ATF3 mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]; Capsaicin promotes the reaction [CEBPB protein binds to ATF3 protein binds to GSK3B protein]
|
CTD |
PMID:20110283 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
multiple interactions affects localization increases expression
|
ISO
|
Cycloheximide inhibits the reaction [Capsaicin results in increased expression of ATF4 protein] Capsaicin affects the localization of ATF4 protein
|
CTD |
PMID:18533110 PMID:19139269 PMID:20925121 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atg16l1
|
autophagy related 16-like 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of ATG16L1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 9:95,869,839...95,905,354
Ensembl chr 9:95,869,865...95,905,357
|
|
| G
|
Atg5
|
autophagy related 5
|
multiple interactions increases expression
|
ISO
|
ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein]; ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein] Capsaicin results in increased expression of ATG5 protein
|
CTD |
PMID:22226932 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
increases activity multiple interactions increases phosphorylation increases expression
|
ISO
|
Capsaicin results in increased activity of ATM protein 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein]; ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein]; Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein Capsaicin results in increased phosphorylation of ATM protein Capsaicin results in increased expression of ATM mRNA
|
CTD |
PMID:19502594 PMID:22226932 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atp2a1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
|
increases expression multiple interactions affects expression
|
ISO
|
Capsaicin results in increased expression of ATP2A1 mRNA; Capsaicin results in increased expression of ATP2A1 protein [BRL 37344 co-treated with Capsaicin] results in increased expression of ATP2A1 protein Capsaicin affects the expression of ATP2A1 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
affects metabolic processing multiple interactions affects expression increases expression decreases expression
|
EXP ISO
|
Capsaicin affects the metabolism of ATP2A2 protein [BRL 37344 co-treated with Capsaicin] results in increased expression of ATP2A2 protein Capsaicin affects the expression of ATP2A2 mRNA Capsaicin results in increased expression of ATP2A2 mRNA; Capsaicin results in increased expression of ATP2A2 protein Capsaicin results in decreased expression of ATP2A2 protein modified form
|
CTD |
PMID:18037908 PMID:39800145 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ATP5B protein
|
CTD |
PMID:39800145 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Atp6ap1
|
ATPase H+ transporting accessory protein 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of ATP6AP1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr X:157,231,243...157,238,323
Ensembl chr X:157,225,327...157,238,323
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BAD mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BAG3 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
increases activity increases expression
|
ISO
|
Capsaicin results in increased activity of BAK1 protein Capsaicin results in increased expression of BAK1 mRNA
|
CTD |
PMID:17295509 PMID:19502594 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions affects expression increases expression affects localization increases activity
|
ISO
|
TP53 protein promotes the reaction [Capsaicin results in increased expression of BAX protein]; TRPV6 protein promotes the reaction [Capsaicin results in increased expression of BAX protein] Capsaicin affects the expression of BAX protein Capsaicin results in increased expression of BAX; Capsaicin results in increased expression of BAX mRNA; Capsaicin results in increased expression of BAX protein Capsaicin affects the localization of BAX protein Capsaicin results in increased activity of BAX protein
|
CTD |
PMID:16540674 PMID:17292493 PMID:17295509 PMID:19002586 PMID:19331147 PMID:20069556 PMID:34939720 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcan
|
brevican
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of BCAN mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314
|
|
| G
|
Bcl10
|
BCL10, immune signaling adaptor
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BCL10 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases response to substance affects expression increases expression decreases expression
|
ISO
|
BCL2 protein results in decreased susceptibility to Capsaicin Capsaicin affects the expression of BCL2 protein Capsaicin results in increased expression of BCL2 mRNA Capsaicin results in decreased expression of BCL2 protein Capsaicin results in decreased expression of BCL2; Capsaicin results in decreased expression of BCL2 protein
|
CTD |
PMID:9580328 PMID:11275362 PMID:15595419 PMID:17295509 PMID:17306913 PMID:17505005 PMID:18405923 PMID:18991268 PMID:19002586 PMID:19331147 PMID:19502594 PMID:21310942 PMID:22230393 PMID:34939720 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression increases expression
|
ISO
|
Capsaicin results in decreased expression of BCL2L1 protein Capsaicin results in increased expression of BCL2L1 mRNA
|
CTD |
PMID:17505005 PMID:19502594 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bclaf1
|
BCL2-associated transcription factor 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BCLAF1 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
multiple interactions increases expression
|
EXP
|
Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA]; capsazepine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA]
|
CTD |
PMID:22264228 |
|
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Bdkrb2
|
bradykinin receptor B2
|
multiple interactions
|
EXP ISO
|
Capsaicin inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] BDKRB2 affects the reaction [Capsaicin results in increased activity of TRPV1 protein]; BDKRB2 affects the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]]
|
CTD |
PMID:15363968 PMID:17347322 |
|
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions affects expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of BDNF protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of BDNF protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of BECN1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
increases cleavage multiple interactions increases expression
|
ISO
|
Capsaicin results in increased cleavage of BID protein Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of BID protein] Capsaicin results in increased expression of BID mRNA
|
CTD |
PMID:19502594 PMID:22200406 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BIRC2 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
decreases expression multiple interactions
|
ISO
|
Capsaicin results in decreased expression of BIRC5; Capsaicin results in decreased expression of BIRC5 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in decreased expression of BIRC5 protein]; BIRC5 results in decreased activity of [Capsaicin co-treated with TNFSF10 protein]
|
CTD |
PMID:17505005 PMID:19002586 PMID:19939880 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Bnip2
|
BCL2 interacting protein 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of BNIP2 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
decreases expression increases expression
|
ISO
|
Capsaicin results in decreased expression of BNIP3 mRNA Capsaicin results in increased expression of BNIP3 mRNA
|
CTD |
PMID:19502594 PMID:36044967 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
decreases expression increases expression
|
ISO
|
Capsaicin results in decreased expression of BNIP3L mRNA Capsaicin results in increased expression of BNIP3L mRNA
|
CTD |
PMID:19502594 PMID:36044967 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Cacng3
|
calcium voltage-gated channel auxiliary subunit gamma 3
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of CACNG3 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:186,632,334...186,728,220
Ensembl chr 1:186,632,323...186,728,214
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
increases expression increases secretion decreases expression multiple interactions affects response to substance
|
ISO EXP
|
Capsaicin results in increased expression of CALCA mRNA; Capsaicin results in increased expression of CALCA protein Capsaicin results in increased secretion of CALCA protein Capsaicin results in decreased expression of CALCA mRNA; Capsaicin results in decreased expression of CALCA protein 3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; [Capsaicin co-treated with Calcium] results in increased secretion of CALCA protein; [Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein; [Capsaicin results in decreased susceptibility to safranal] which results in decreased secretion of CALCA protein; botulinum toxin type D inhibits the reaction [[Capsaicin co-treated with Calcium] results in increased secretion of CALCA protein]; butaprost promotes the reaction [Capsaicin results in increased secretion of CALCA protein]; Calcium affects the reaction [Capsaicin inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]; Calcium affects the reaction [Capsaicin inhibits the reaction [mustard oil results in increased secretion of CALCA protein]]; Calcium affects the reaction [mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]; Capsaicin inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Capsaicin inhibits the reaction [Freund's Adjuvant results in increased expression of CALCA mRNA]; Capsaicin inhibits the reaction [monophosphoryl lipid A results in increased expression of CALCA mRNA]; Capsaicin inhibits the reaction [mustard oil results in increased secretion of CALCA protein]; Capsaicin inhibits the reaction [Nitroglycerin results in increased expression of CALCA mRNA]; Capsaicin promotes the reaction [Phenol results in decreased expression of CALCA protein]; Capsaicin results in increased secretion of [CALCA protein co-treated with CALCB protein]; capsazepine inhibits the reaction [Capsaicin results in increased expression of CALCA protein]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of [CALCA protein co-treated with CALCB protein]]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; chelerythrine inhibits the reaction [Capsaicin results in increased expression of CALCA protein]; Dinoprostone promotes the reaction [Capsaicin results in increased secretion of CALCA protein]; Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; epothilone B affects the reaction [[Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein]; iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of CALCA protein]; mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Nefopam inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; neuropeptide Y, Leu(31)-Pro(34)- inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; NGF protein promotes the reaction [Capsaicin results in increased expression of CALCA protein]; nociceptin (1-13) amide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; OPRL1 protein promotes the reaction [nociceptin (1-13) amide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]; Paclitaxel inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Plant Extracts inhibits the reaction [Capsaicin results in decreased expression of CALCA protein]; Plant Extracts inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Polyphenols inhibits the reaction [Capsaicin results in decreased expression of CALCA protein]; Polyphenols inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; PPP3CA protein affects the reaction [mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]; TRPV1 protein affects the reaction [Capsaicin results in increased secretion of CALCA protein] CALCA protein alternative form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; capsazepine inhibits the reaction [Capsaicin results in increased expression of CALCA mRNA] CALCA protein affects the susceptibility to Capsaicin [Capsaicin co-treated with Ethanol] results in increased expression of CALCA protein; CALCA protein affects the reaction [Capsaicin results in decreased susceptibility to Ethanol]; CALCA protein affects the reaction [Capsaicin results in increased expression of IGF1 mRNA]; CALCA protein affects the reaction [Capsaicin results in increased expression of IGF1 protein]; CALCA protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin]; CNR1 protein affects the reaction [Capsaicin results in increased secretion of CALCA protein]; rimabotulinumtoxinB inhibits the reaction [[Capsaicin co-treated with Calcium] results in increased secretion of CALCA protein]
|
CTD |
PMID:2462184 PMID:3412491 PMID:7473211 PMID:8971780 PMID:11738242 PMID:11919648 PMID:14764656 PMID:15120475 PMID:15615864 PMID:16777323 PMID:16996168 PMID:17434803 PMID:17569567 PMID:17590514 PMID:17635592 PMID:17640294 PMID:17666428 PMID:17693108 PMID:17828286 PMID:17997062 PMID:18052948 PMID:18054007 PMID:18178321 PMID:18203709 PMID:18296611 PMID:18311519 PMID:18508045 PMID:18584893 PMID:18752301 PMID:18809208 PMID:18809749 PMID:18987195 PMID:19096234 PMID:19878665 PMID:26762784 PMID:26883566 PMID:30636360 More...
|
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Calcb
|
calcitonin-related polypeptide, beta
|
increases expression decreases activity multiple interactions increases secretion
|
ISO EXP
|
Capsaicin results in increased expression of CALCB mRNA CALCB protein alternative form results in decreased activity of Capsaicin Capsaicin results in increased secretion of [CALCA protein co-treated with CALCB protein]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of [CALCA protein co-treated with CALCB protein]] capsazepine inhibits the reaction [Capsaicin results in increased expression of CALCB mRNA] Capsaicin results in increased secretion of CALCB protein
|
CTD |
PMID:9932722 PMID:14764656 PMID:17434803 PMID:18584893 |
|
NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654
|
|
| G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
multiple interactions
|
EXP
|
Capsaicin results in increased phosphorylation of and results in increased expression of CAMK2A protein
|
CTD |
PMID:12019337 |
|
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
increases expression
|
ISO
|
Capsaicin results in increased expression of CAMK2B mRNA; Capsaicin results in increased expression of CAMK2B protein
|
CTD |
PMID:39800145 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camp
|
cathelicidin antimicrobial peptide
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CAMP protein Glyoxal promotes the reaction [Capsaicin results in increased expression of CAMP protein]
|
CTD |
PMID:29496360 |
|
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998
|
|
| G
|
Casp2
|
caspase 2
|
multiple interactions
|
ISO
|
[Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP2 protein
|
CTD |
PMID:19939880 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
| G
|
Casp3
|
caspase 3
|
increases expression affects cleavage affects activity increases activity multiple interactions increases cleavage affects expression
|
ISO EXP
|
Capsaicin results in increased expression of CASP3 protein Capsaicin affects the cleavage of CASP3 protein Capsaicin affects the activity of CASP3 protein Capsaicin results in increased activity of CASP3 protein Capsaicin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein] Capsaicin results in increased cleavage of CASP3 protein [ND1 gene mutant form results in increased susceptibility to Capsaicin] which results in increased activity of CASP3 protein; Capsaicin promotes the reaction [resveratrol results in increased activity of CASP3 protein]; Capsaicin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP3 protein]; Capsaicin promotes the reaction [TRPV1 protein results in increased activity of CASP3 protein]; Capsaicin results in increased cleavage of and results in increased activity of CASP3 protein; capsazepine inhibits the reaction [Capsaicin results in increased cleavage of and results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [Capsaicin results in increased cleavage of CASP3 protein]; EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP3 protein]; resveratrol promotes the reaction [Capsaicin results in increased activity of CASP3 protein] Capsaicin affects the expression of CASP3 protein
|
CTD |
PMID:11275362 PMID:16125681 PMID:16477149 PMID:17295509 PMID:17306913 PMID:17442041 PMID:17505005 PMID:18405923 PMID:18456414 PMID:18991268 PMID:19002586 PMID:19011674 PMID:19139269 PMID:19331147 PMID:19381455 PMID:19502594 PMID:19846903 PMID:19855437 PMID:19939880 PMID:20925121 PMID:21647434 PMID:21745629 PMID:21859781 PMID:22200406 PMID:25603234 PMID:29991444 PMID:34939720 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
increases activity multiple interactions increases expression
|
ISO EXP
|
Capsaicin results in increased activity of CASP4 protein Capsaicin results in increased cleavage of and results in increased activity of CASP4 protein Capsaicin results in increased expression of CASP4 mRNA
|
CTD |
PMID:19139269 PMID:19699254 PMID:20349343 PMID:20371669 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp6
|
caspase 6
|
multiple interactions
|
ISO
|
[Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP6 protein
|
CTD |
PMID:19939880 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp7
|
caspase 7
|
multiple interactions increases activity
|
ISO
|
[Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP7 protein Capsaicin results in increased activity of CASP7 protein
|
CTD |
PMID:19139269 PMID:19699254 PMID:19855437 PMID:19939880 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
increases activity decreases expression multiple interactions increases expression
|
ISO
|
Capsaicin results in increased activity of CASP8 protein Capsaicin results in decreased expression of CASP8 protein [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein; Capsaicin promotes the reaction [resveratrol results in decreased expression of CASP8 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP8 protein]; resveratrol promotes the reaction [Capsaicin results in decreased expression of CASP8 protein] Capsaicin results in increased expression of CASP8 mRNA
|
CTD |
PMID:19502594 PMID:19846903 PMID:19939880 PMID:22200406 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
increases cleavage increases activity multiple interactions increases expression affects expression
|
ISO EXP
|
Capsaicin results in increased cleavage of CASP9 protein Capsaicin results in increased activity of CASP9 protein [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP9 protein]; CAT protein inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein]; EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein] Capsaicin results in increased expression of CASP9 protein Capsaicin affects the expression of CASP9 protein Capsaicin results in increased expression of CASP9 mRNA
|
CTD |
PMID:16125681 PMID:16477149 PMID:19502594 PMID:19699254 PMID:19855437 PMID:19939880 PMID:20925121 PMID:21647434 PMID:21859781 PMID:22200406 More...
|
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
CAT protein inhibits the reaction [Capsaicin results in increased cleavage of CASP3 protein]; CAT protein inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein]; CAT protein inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein] Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased expression of CAT]
|
CTD |
PMID:14871840 PMID:18023135 PMID:18338764 PMID:21647434 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cck
|
cholecystokinin
|
multiple interactions
|
ISO EXP
|
[Capsaicin co-treated with CCK protein alternative form] results in increased expression of TAC1 protein; Capsaicin inhibits the reaction [CCK protein alternative form results in decreased expression of NGF mRNA]; Capsaicin promotes the reaction [CCK protein alternative form results in increased expression of NGF protein] Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK1 protein]; Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:10683199 PMID:22508518 |
|
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686
|
|
| G
|
Ccl19
|
C-C motif chemokine ligand 19
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CCL19 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions decreases expression decreases secretion increases expression
|
EXP ISO
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of CCL2 protein] Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] Capsaicin results in decreased expression of CCL2 mRNA; Capsaicin results in decreased expression of CCL2 protein Capsaicin results in decreased secretion of CCL2 protein capsazepine inhibits the reaction [Capsaicin results in decreased secretion of CCL2 protein]; troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] Capsaicin results in increased expression of CCL2 mRNA; Capsaicin results in increased expression of CCL2 protein
|
CTD |
PMID:17719033 PMID:19798065 PMID:20349343 PMID:22150557 PMID:30244119 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CCL20 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
| G
|
Ccl22
|
C-C motif chemokine ligand 22
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
multiple interactions increases expression
|
ISO EXP
|
Capsaicin inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [Capsaicin inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]] [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]
|
CTD |
PMID:21745629 PMID:22150557 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccna2
|
cyclin A2
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of CCNA2 protein
|
CTD |
PMID:19939880 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of CCNB1 protein
|
CTD |
PMID:19939880 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of CCND1 protein
|
CTD |
PMID:17505005 PMID:19855437 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnl1
|
cyclin L1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CCNL1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468
|
|
| G
|
Ccr4
|
C-C motif chemokine receptor 4
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CCR4 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642
|
|
| G
|
Cd46
|
CD46 molecule
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CD46 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr13:109,104,122...109,134,903
|
|
| G
|
Cd68
|
Cd68 molecule
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of CD68 mRNA
|
CTD |
PMID:19798065 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Cd80
|
Cd80 molecule
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CD80 protein [Naproxen co-treated with Sumatriptan] affects the reaction [Capsaicin results in increased expression of CD80 protein]; Naproxen affects the reaction [Capsaicin results in increased expression of CD80 protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of CD80 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
| G
|
Cd8b
|
CD8 subunit beta
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CD8B mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868
|
|
| G
|
Cdc14a
|
cell division cycle 14A
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CDC14A mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 2:206,910,475...207,070,537
Ensembl chr 2:206,910,475...207,091,722
|
|
| G
|
Cdh1
|
cadherin 1
|
increases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of CDH1 protein acadesine promotes the reaction [Capsaicin results in increased expression of CDH1 protein]; bafilomycin A1 inhibits the reaction [Capsaicin results in increased expression of CDH1 protein]; dorsomorphin inhibits the reaction [Capsaicin results in increased expression of CDH1 protein]
|
CTD |
PMID:36044967 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh2
|
cadherin 2
|
multiple interactions decreases expression
|
ISO
|
acadesine promotes the reaction [Capsaicin results in decreased expression of CDH2 protein]; bafilomycin A1 inhibits the reaction [Capsaicin results in decreased expression of CDH2 protein]; dorsomorphin inhibits the reaction [Capsaicin results in decreased expression of CDH2 protein]
|
CTD |
PMID:36044967 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CDK1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of CDK2 protein
|
CTD |
PMID:20646592 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of CDK4 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression decreases expression
|
ISO
|
Capsaicin results in increased expression of CDKN1A mRNA; Capsaicin results in increased expression of CDKN1A protein Capsaicin results in decreased expression of CDKN1A protein
|
CTD |
PMID:16540674 PMID:19502594 PMID:20646592 PMID:22226932 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
increases expression decreases expression
|
ISO
|
Capsaicin results in increased expression of CDKN1B Capsaicin results in increased expression of CDKN1B protein Capsaicin results in decreased expression of CDKN1B protein
|
CTD |
PMID:19855437 PMID:20069556 PMID:22226932 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
increases expression
|
ISO
|
Capsaicin results in increased expression of CDKN2A mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
decreases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of CEBPA protein Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA]
|
CTD |
PMID:17295509 PMID:20359164 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions increases activity
|
ISO
|
[CEBPB protein binds to GDF15 promoter] promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA]; Capsaicin promotes the reaction [CEBPB protein binds to ATF3 protein binds to GSK3B protein]; CEBPB mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]; CEBPB protein promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA] Capsaicin results in increased activity of CEBPB protein [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]
|
CTD |
PMID:20110283 PMID:21250977 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cfl1
|
cofilin 1
|
multiple interactions
|
ISO
|
[Capsaicin results in decreased phosphorylation of and results in increased activity of CFL1 protein] which results in increased import of Calcium; Capsaicin results in decreased phosphorylation of and results in increased activity of CFL1 protein; Egtazic Acid inhibits the reaction [Capsaicin results in decreased phosphorylation of and results in increased activity of CFL1 protein]
|
CTD |
PMID:17303079 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
increases expression decreases expression
|
ISO
|
Capsaicin results in increased expression of CFLAR mRNA Capsaicin results in decreased expression of CFLAR protein alternative form
|
CTD |
PMID:19502594 PMID:19939880 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
increases activity
|
ISO
|
Capsaicin results in increased activity of CFTR protein; Capsaicin results in increased activity of CFTR protein mutant form
|
CTD |
PMID:15155835 |
|
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Chek2
|
checkpoint kinase 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of CHEK2 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
|
|
| G
|
Ciita
|
class II, major histocompatibility complex, transactivator
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA]
|
CTD |
PMID:19825429 |
|
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342
|
|
| G
|
Cilk1
|
ciliogenesis associated kinase 1
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CILK1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 8:87,868,294...87,922,995
Ensembl chr 8:87,868,156...87,922,995
|
|
| G
|
Ckb
|
creatine kinase B
|
increases expression
|
ISO
|
Capsaicin results in increased expression of CKB mRNA; Capsaicin results in increased expression of CKB protein
|
CTD |
PMID:39800145 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckmt2
|
creatine kinase, mitochondrial 2
|
multiple interactions increases expression
|
ISO
|
[BRL 37344 co-treated with Capsaicin] results in increased expression of CKMT2 protein; [N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide co-treated with Capsaicin] results in decreased expression of CKMT2 protein Capsaicin results in increased expression of CKMT2 mRNA; Capsaicin results in increased expression of CKMT2 protein
|
CTD |
PMID:39800145 |
|
NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511
|
|
| G
|
Cldn1
|
claudin 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CLDN1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
| G
|
Clec2d
|
C-type lectin domain family 2, member D
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of CLEC2D mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587
|
|
| G
|
Clk1
|
CDC-like kinase 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CLK1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
multiple interactions increases activity affects response to substance
|
ISO EXP
|
CNR1 protein affects the reaction [Capsaicin results in increased secretion of CALCA protein] Capsaicin results in increased activity of CNR1 protein CNR1 protein affects the susceptibility to Capsaicin
|
CTD |
PMID:11408034 PMID:18987195 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cntf
|
ciliary neurotrophic factor
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CNTF protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTF protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 1:219,312,512...219,314,535
Ensembl chr 1:219,312,512...219,314,488
|
|
| G
|
Cntfr
|
ciliary neurotrophic factor receptor
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:61,619,326...61,657,359
Ensembl chr 5:61,619,326...61,645,795
|
|
| G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
increases expression
|
ISO
|
Capsaicin results in increased expression of COL18A1 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression
|
EXP
|
Capsaicin results in increased expression of COL1A1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
increases expression
|
EXP
|
Capsaicin results in increased expression of COL3A1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of COX4I1 protein
|
CTD |
PMID:18079164 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
increases expression
|
ISO
|
Capsaicin results in increased expression of COX5A protein
|
CTD |
PMID:18991268 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
| G
|
Cox6a1
|
cytochrome c oxidase subunit 6A1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of COX6A1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions increases expression
|
ISO EXP
|
Capsaicin promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA] Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CPT1A mRNA] Capsaicin results in increased expression of CPT1A mRNA
|
CTD |
PMID:20359164 PMID:21745629 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions increases phosphorylation
|
EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; KN 93 inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; NPC 15437 inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; Ro 31-8425 inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]
|
CTD |
PMID:15385614 PMID:15631885 PMID:16159392 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Csf2
|
colony stimulating factor 2
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CSF2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
increases phosphorylation
|
ISO
|
Capsaicin results in increased phosphorylation of CSNK2A1 protein
|
CTD |
PMID:20510015 |
|
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Csnk2b
|
casein kinase 2 beta
|
increases phosphorylation
|
ISO
|
Capsaicin results in increased phosphorylation of CSNK2B protein
|
CTD |
PMID:20510015 |
|
NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CTNNB1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
affects expression multiple interactions
|
EXP
|
Capsaicin affects the expression of CX3CL1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CXCL10 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CXCL2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CXCR4 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
multiple interactions
|
ISO EXP
|
CYBB protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin] CYBB mutant form inhibits the reaction [Capsaicin results in increased expression of STAT1 protein]
|
CTD |
PMID:18203709 PMID:20712533 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions affects expression
|
ISO
|
[Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Capsaicin affects the expression of and affects the activity of CYP1A1 protein; Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Capsaicin inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Capsaicin inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] Capsaicin affects the expression of CYP1A1 mRNA
|
CTD |
PMID:19449198 PMID:21250977 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
Capsaicin results in decreased activity of CYP1A2 protein
|
CTD |
PMID:22375877 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2a2
|
cytochrome P450, family 2, subfamily a, polypeptide 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of CYP2A2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:91,391,492...91,417,158
Ensembl chr 1:91,391,502...91,417,158
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases activity
|
ISO
|
Capsaicin results in decreased activity of CYP2C19 protein
|
CTD |
PMID:22375877 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity
|
ISO
|
Capsaicin results in decreased activity of CYP2D6 protein
|
CTD |
PMID:22375877 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of CYP2E1
|
CTD |
PMID:22375877 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases expression decreases activity
|
EXP ISO
|
Capsaicin results in decreased expression of CYP3A2 mRNA; Capsaicin results in decreased expression of CYP3A2 protein Capsaicin results in decreased activity of CYP3A4 protein
|
CTD |
PMID:20388821 PMID:24013073 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of CYP3A23-3A1 mRNA; Capsaicin results in decreased expression of CYP3A23-3A1 protein
|
CTD |
PMID:24013073 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Dap
|
death-associated protein
|
increases expression
|
ISO
|
Capsaicin results in increased expression of DAP mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:83,910,060...83,962,673
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression affects localization
|
EXP ISO
|
Capsaicin results in increased expression of DDIT3 protein Capsaicin affects the localization of DDIT3 protein Capsaicin analog results in increased expression of DDIT3 mRNA; Capsaicin results in increased expression of DDIT3; Capsaicin results in increased expression of DDIT3 mRNA; Capsaicin results in increased expression of DDIT3 protein
|
CTD |
PMID:18533110 PMID:19139269 PMID:19285962 PMID:19331147 PMID:19699254 PMID:19939880 PMID:20925121 PMID:21343315 PMID:21859781 PMID:36044967 More...
|
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Defb2
|
defensin beta 2
|
multiple interactions increases expression
|
EXP
|
Glyoxal promotes the reaction [Capsaicin results in increased expression of DEFB2 protein]
|
CTD |
PMID:29496360 |
|
NCBI chr16:76,934,341...76,948,284
Ensembl chr16:76,934,337...76,948,299
|
|
| G
|
Depp1
|
DEPP autophagy regulator 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of DEPP1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
|
|
| G
|
Dffa
|
DNA fragmentation factor subunit alpha
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of DFFA
|
CTD |
PMID:16188123 |
|
NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728
|
|
| G
|
Dpp3
|
dipeptidylpeptidase 3
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of DPP3 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 1:211,634,067...211,657,898
Ensembl chr 1:211,634,068...211,658,310
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
multiple interactions
|
ISO
|
[NFKB1 mutant form inhibits the reaction [Capsaicin results in increased expression of PRKCD protein]] which results in increased expression of DUSP1 protein; DUSP1 mutant form promotes the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; DUSP1 mutant form promotes the reaction [Capsaicin results in increased secretion of CXCL8 protein]; DUSP1 mutant form promotes the reaction [Capsaicin results in increased secretion of IL6 protein]
|
CTD |
PMID:22171160 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of E2F1 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
Edn1
|
endothelin 1
|
decreases activity multiple interactions
|
ISO
|
EDN1 protein results in decreased activity of Capsaicin EDN1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; FR 139317 inhibits the reaction [EDN1 protein results in decreased activity of Capsaicin]
|
CTD |
PMID:9932722 PMID:19429182 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of EEF2 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Egf
|
epidermal growth factor
|
multiple interactions decreases expression decreases activity
|
ISO EXP
|
Capsaicin inhibits the reaction [EGF results in increased activity of MMP2 protein]; Capsaicin inhibits the reaction [EGF results in increased activity of MMP9 protein]; Capsaicin inhibits the reaction [EGF results in increased expression of MMP14]; Capsaicin inhibits the reaction [EGF results in increased expression of MMP2]; Capsaicin inhibits the reaction [EGF results in increased expression of MMP9]; Capsaicin inhibits the reaction [EGF results in increased localization of FOS protein]; Capsaicin inhibits the reaction [EGF results in increased localization of JUN protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of AKT1 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of EGFR protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK1 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK3 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK8 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK9 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of PTK2 protein] Capsaicin results in decreased expression of EGF protein Capsaicin results in decreased activity of EGF protein
|
CTD |
PMID:9324159 PMID:14521749 PMID:21462327 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions decreases expression increases phosphorylation
|
ISO EXP
|
AG 1879 inhibits the reaction [Capsaicin results in increased phosphorylation of EGFR protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of EGFR protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Capsaicin results in increased phosphorylation of EGFR protein]; RTKI cpd inhibits the reaction [Capsaicin results in increased phosphorylation of EGFR protein] Capsaicin results in decreased expression of EGFR protein [Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of EGFR protein; AG 1879 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of EGFR protein]; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of AREG mRNA]; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of AKT1 protein]; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein]; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein]; EGFR gene mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]]; EGFR gene mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]]; EGFR gene mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; RTKI cpd inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of EGFR protein]
|
CTD |
PMID:14521749 PMID:19855437 PMID:20619260 PMID:20660715 PMID:21462327 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of EGR1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
increases phosphorylation
|
ISO EXP
|
Capsaicin results in increased phosphorylation of EIF2A protein
|
CTD |
PMID:18533110 PMID:19285962 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases phosphorylation
|
ISO
|
Capsaicin results in increased phosphorylation of EIF2S1 protein
|
CTD |
PMID:19139269 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eln
|
elastin
|
increases expression
|
EXP
|
Capsaicin results in increased expression of ELN mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
| G
|
Eno2
|
enolase 2
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein]
|
CTD |
PMID:19449198 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Enox2
|
ecto-NOX disulfide-thiol exchanger 2
|
increases response to substance
|
ISO
|
ENOX2 results in increased susceptibility to Capsaicin
|
CTD |
PMID:15706060 |
|
NCBI chr X:133,148,813...133,470,914
Ensembl chr X:133,148,813...133,470,891
|
|
| G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
multiple interactions
|
ISO
|
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; 3-(2-methoxybenzylamino)-2-phenylpiperidine inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; [[Capsaicin results in increased chemical synthesis of Lysophosphatidylcholines] which results in increased secretion of Lysophosphatidylcholines] promotes the reaction [ENPP2 results in increased chemical synthesis of lysophosphatidic acid]; [ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid; arachidonyltrifluoromethane inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; bisindolylmaleimide I inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; Dizocilpine Maleate inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; U 0126 inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; xestospongin C inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]
|
CTD |
PMID:19014389 |
|
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957
|
|
| G
|
Epor
|
erythropoietin receptor
|
increases expression
|
ISO
|
Capsaicin results in increased expression of EPOR mRNA; Capsaicin results in increased expression of EPOR protein
|
CTD |
PMID:17603282 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
affects expression decreases expression
|
ISO
|
Capsaicin affects the expression of ERBB2 mRNA Capsaicin results in decreased expression of ERBB2 protein
|
CTD |
PMID:19502594 PMID:19855437 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ERN1 protein
|
CTD |
PMID:19139269 PMID:19699254 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Etfa
|
electron transfer flavoprotein subunit alpha
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of ETFA protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080
|
|
| G
|
Exosc8
|
exosome component 8
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of EXOSC8 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
affects expression
|
EXP
|
Capsaicin affects the expression of F2 protein
|
CTD |
PMID:8285224 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
F2rl1
|
F2R like trypsin receptor 1
|
multiple interactions
|
ISO
|
F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]; PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]]
|
CTD |
PMID:16793902 |
|
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
decreases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of FABP4 mRNA Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of FABP4 mRNA]; Capsaicin inhibits the reaction [Dietary Fats results in increased expression of FABP4 protein]
|
CTD |
PMID:18533110 PMID:20359164 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Fabp5
|
fatty acid binding protein 5
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of FABP5 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
|
|
| G
|
Fadd
|
Fas associated via death domain
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of FADD protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FADD protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FADD protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FADD protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fam162a
|
family with sequence similarity 162, member A
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of FAM162A mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression multiple interactions affects expression
|
ISO EXP
|
Capsaicin results in increased expression of FAS mRNA; Capsaicin results in increased expression of FAS protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FAS protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FAS protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FAS protein] Capsaicin promotes the reaction [resveratrol results in increased expression of FAS protein] Capsaicin affects the expression of FAS mRNA
|
CTD |
PMID:19502594 PMID:19846903 PMID:21310942 PMID:22150557 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FASLG protein]
|
CTD |
PMID:22150557 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fbxl2
|
F-box and leucine-rich repeat protein 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of FBXL2 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 8:122,794,870...122,843,265
Ensembl chr 8:122,794,870...122,854,798
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of FDFT1 mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fdps
|
farnesyl diphosphate synthase
|
increases expression
|
EXP
|
Capsaicin results in increased expression of FDPS mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of FGF2 protein
|
CTD |
PMID:14521749 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgfbp1
|
fibroblast growth factor binding protein 1
|
multiple interactions affects expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of FGFR1 protein
|
CTD |
PMID:14521749 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgl1
|
fibrinogen-like 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429
|
|
| G
|
Fkbp4
|
FKBP prolyl isomerase 4
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of FKBP4 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
|
|
| G
|
Flcn
|
folliculin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of FLCN mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
|
|
| G
|
Fmod
|
fibromodulin
|
increases expression
|
EXP
|
Capsaicin results in increased expression of FMOD mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr13:48,045,567...48,056,184
Ensembl chr13:47,990,774...48,056,183
|
|
| G
|
Fnta
|
farnesyltransferase, CAAX box, subunit alpha
|
increases expression
|
EXP
|
Capsaicin results in increased expression of FNTA mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:72,767,864...72,786,193
Ensembl chr16:72,767,627...72,788,229
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of FOS mRNA Capsaicin results in increased expression of FOS protein Capsaicin results in increased expression of FOS; Capsaicin results in increased expression of FOS mRNA; Capsaicin results in increased expression of FOS protein 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline inhibits the reaction [Capsaicin results in increased expression of FOS]; 2-amino-4-phosphonobutyric acid inhibits the reaction [Capsaicin results in increased expression of FOS]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS]; Capsaicin inhibits the reaction [8-sulfocholecystokinin octapeptide results in increased expression of FOS protein]; Capsaicin inhibits the reaction [Cyclophosphamide results in increased expression of FOS protein]; Capsaicin inhibits the reaction [GHRL results in increased expression of FOS protein]; Capsaicin inhibits the reaction [Hydrochloric Acid results in increased expression of FOS protein]; Melatonin inhibits the reaction [Capsaicin results in increased expression of FOS protein] Capsaicin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein]; Capsaicin inhibits the reaction [EGF results in increased localization of FOS protein] Capsaicin inhibits the reaction [Cyclophosphamide results in increased expression of FOS mRNA]; Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]; GHRL protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]; GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]]; HTR1B protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]; HTR1D protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]; HTR1F protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]; LY 344864 inhibits the reaction [Capsaicin results in increased expression of FOS protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FOS protein]
|
CTD |
PMID:1922926 PMID:9372230 PMID:9580328 PMID:10401552 PMID:10749792 PMID:10880996 PMID:12110114 PMID:12360474 PMID:12588467 PMID:15385614 PMID:16162281 PMID:18093676 PMID:18202139 PMID:18687398 PMID:19172228 PMID:19502594 PMID:20727678 PMID:21462327 More...
|
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
EXP
|
N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Capsaicin results in increased expression of FOSL1 protein]
|
CTD |
PMID:20054487 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Foxa1
|
forkhead box A1
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of FOXA1 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191
|
|
| G
|
Foxe3
|
forkhead box E3
|
increases expression
|
EXP
|
Capsaicin results in increased expression of FOXE3 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 5:133,681,684...133,683,266
Ensembl chr 5:133,681,702...133,683,266
|
|
| G
|
Fstl1
|
follistatin-like 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
|
|
| G
|
Fxyd6
|
FXYD domain-containing ion transport regulator 6
|
increases expression
|
EXP
|
Capsaicin results in increased expression of FXYD6 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715
|
|
| G
|
Gabrr3
|
gamma-aminobutyric acid type A receptor subunit rho3
|
increases expression
|
EXP
|
Capsaicin results in increased expression of GABRR3 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr11:54,372,017...54,424,466
Ensembl chr11:54,372,017...54,424,466
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression
|
ISO
|
Capsaicin results in increased expression of GADD45A mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
multiple interactions increases expression decreases response to substance
|
EXP ISO
|
GAL protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein alternative form] Capsaicin results in increased expression of GAL mRNA GAL protein results in decreased susceptibility to Capsaicin
|
CTD |
PMID:8971780 PMID:17999197 PMID:18553211 PMID:19112407 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Galr2
|
galanin receptor 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of GALR2 mRNA
|
CTD |
PMID:18553211 |
|
NCBI chr10:102,012,086...102,016,057
Ensembl chr10:102,013,370...102,016,055
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of GAPDH protein Capsaicin inhibits the reaction [Dietary Fats results in increased expression of GAPDH protein]
|
CTD |
PMID:18991268 PMID:20359164 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gast
|
gastrin
|
increases secretion decreases secretion
|
EXP
|
Capsaicin results in increased secretion of GAST protein Capsaicin results in decreased secretion of GAST protein
|
CTD |
PMID:8093880 PMID:19208342 PMID:19296048 |
|
NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880
|
|
| G
|
Gata1
|
GATA binding protein 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of GATA1 mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr X:17,193,291...17,209,462
Ensembl chr X:17,201,633...17,209,459
|
|
| G
|
Gcg
|
glucagon
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Deoxyglucose results in increased secretion of GCG protein]
|
CTD |
PMID:1378463 |
|
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
affects response to substance
|
ISO
|
GCH1 gene SNP affects the susceptibility to Capsaicin
|
CTD |
PMID:19081190 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
multiple interactions increases phosphorylation increases expression
|
ISO
|
[CEBPB protein binds to GDF15 promoter] promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA]; ATF3 mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]; CEBPB mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]; CEBPB protein promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA]; GSK3B mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA] Capsaicin results in increased phosphorylation of GDF15 protein
|
CTD |
PMID:20110283 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of GFAP mRNA Capsaicin results in increased expression of GFAP protein 7-nitroindazole inhibits the reaction [Capsaicin results in increased expression of GFAP protein]; [7-nitroindazole co-treated with pimagedine] promotes the reaction [Capsaicin results in increased expression of GFAP protein]; Capsaicin inhibits the reaction [IL6 protein results in increased expression of GFAP mRNA]; capsazepine inhibits the reaction [Capsaicin results in increased expression of GFAP protein]; pimagedine inhibits the reaction [Capsaicin results in increased expression of GFAP protein]
|
CTD |
PMID:18405923 PMID:19285962 PMID:20826152 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfra1
|
GDNF family receptor alpha 1
|
affects expression multiple interactions
|
EXP
|
Capsaicin affects the expression of GFRA1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
|
|
| G
|
Gfra2
|
GDNF family receptor alpha 2
|
affects expression multiple interactions
|
EXP
|
Capsaicin affects the expression of GFRA2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
|
|
| G
|
Gh1
|
growth hormone 1
|
decreases secretion increases expression multiple interactions
|
EXP
|
Capsaicin results in decreased secretion of GH protein Capsaicin results in increased expression of GH1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GH1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of GH1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of GH1 protein]
|
CTD |
PMID:12360474 PMID:22150557 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Ghr
|
growth hormone receptor
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of GHR protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GHR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of GHR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of GHR protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
multiple interactions decreases activity
|
ISO EXP
|
GHRL protein inhibits the reaction [Capsaicin results in increased expression of FOS protein] Capsaicin results in decreased activity of GHRL protein Capsaicin inhibits the reaction [GHRL results in increased expression of FOS protein]
|
CTD |
PMID:12360474 PMID:15177919 PMID:18202139 |
|
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969
|
|
| G
|
Gjb6
|
gap junction protein, beta 6
|
increases expression
|
EXP
|
Capsaicin results in increased expression of GJB6 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr15:35,400,147...35,410,649
Ensembl chr15:35,398,770...35,410,849
|
|
| G
|
Glp1r
|
glucagon-like peptide 1 receptor
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of GLP1R mRNA
|
CTD |
PMID:22031786 |
|
NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of GLUD1 protein
|
CTD |
PMID:18991268 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [ferric sulfate results in increased activity of GOT1 protein]; Capsaicin inhibits the reaction [Iron results in increased activity of GOT1 protein]
|
CTD |
PMID:16956363 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpr132
|
G protein-coupled receptor 132
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of GPR132 mRNA
|
CTD |
PMID:19602228 |
|
NCBI chr 6:137,745,142...137,763,037
Ensembl chr 6:137,745,241...137,763,157
|
|
| G
|
Gpr176
|
G protein-coupled receptor 176
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of GPR176 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 3:125,690,750...125,791,172
Ensembl chr 3:125,690,751...125,791,172
|
|
| G
|
Gpr4
|
G protein-coupled receptor 4
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of GPR4 mRNA
|
CTD |
PMID:19602228 |
|
NCBI chr 1:87,993,398...88,004,568
Ensembl chr 1:87,993,430...88,006,254
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [ferric sulfate results in increased activity of GPT protein]; Capsaicin inhibits the reaction [Iron results in increased activity of GPT protein]
|
CTD |
PMID:16956363 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Ethanol results in decreased expression of GPX1 mRNA]
|
CTD |
PMID:18926900 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Ethanol results in decreased expression of GPX4 mRNA]
|
CTD |
PMID:18926900 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
increases phosphorylation multiple interactions
|
EXP
|
Capsaicin results in increased phosphorylation of GRIA1 protein KN 93 inhibits the reaction [Capsaicin results in increased phosphorylation of GRIA1 protein]
|
CTD |
PMID:12019337 |
|
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
multiple interactions increases phosphorylation increases expression
|
EXP
|
N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Capsaicin results in increased phosphorylation of GRIN1 protein]; phenyl-N-tert-butylnitrone inhibits the reaction [Capsaicin results in increased expression of GRIN1 protein modified form]
|
CTD |
PMID:17317010 PMID:20054487 |
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
increases phosphorylation multiple interactions
|
EXP
|
Capsaicin results in increased phosphorylation of GRIN2B protein capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of GRIN2B protein]; Excitatory Amino Acid Antagonists inhibits the reaction [Capsaicin results in increased phosphorylation of GRIN2B protein]
|
CTD |
PMID:18577691 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Grk6
|
G protein-coupled receptor kinase 6
|
multiple interactions decreases response to substance
|
ISO
|
GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]] GRK6 results in decreased susceptibility to Capsaicin
|
CTD |
PMID:18687398 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
ISO
|
Capsaicin promotes the reaction [CEBPB protein binds to ATF3 protein binds to GSK3B protein]; GSK3B mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]
|
CTD |
PMID:20110283 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]; Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSR]
|
CTD |
PMID:18023135 PMID:18338764 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]; Capsaicin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]
|
CTD |
PMID:15313406 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gtf2h2
|
general transcription factor IIH subunit 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of GTF2H2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:33,358,863...33,386,726
Ensembl chr 2:33,358,869...33,386,688
|
|
| G
|
Gypa
|
glycophorin A
|
increases expression
|
ISO
|
Capsaicin results in increased expression of GYPA mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291
|
|
| G
|
Gzma
|
granzyme A
|
multiple interactions increases expression
|
ISO
|
Capsaicin results in increased expression of and results in increased secretion of GZMA protein Capsaicin results in increased expression of GZMA mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases localization
|
ISO
|
Capsaicin results in increased localization of H2AX protein
|
CTD |
PMID:22226932 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2bc1
|
H2B clustered histone 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of H2BC1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr17:41,599,912...41,600,381
Ensembl chr17:41,599,211...41,608,681
|
|
| G
|
H6pd
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of H6PD protein]
|
CTD |
PMID:18338764 |
|
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125
|
|
| G
|
Hbb
|
hemoglobin subunit beta
|
increases expression
|
ISO
|
Capsaicin results in increased expression of HBB-B1 mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
multiple interactions
|
ISO
|
[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of HBEGF mRNA
|
CTD |
PMID:20660715 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hbg1
|
hemoglobin subunit gamma 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of HBG1 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 1:167,683,760...167,685,315
Ensembl chr 1:167,683,760...167,706,139
|
|
| G
|
Hcrt
|
hypocretin neuropeptide precursor
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of HCRT protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of HCRT protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of HCRT protein]
|
CTD |
PMID:22150557 |
|
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524
|
|
| G
|
Hdac2
|
histone deacetylase 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HDAC2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311
|
|
| G
|
Hey2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HEY2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
increases expression
|
ISO
|
Capsaicin results in increased expression of HIF1A mRNA
|
CTD |
PMID:12242509 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hip1r
|
huntingtin interacting protein 1 related
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of HIP1R mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654
|
|
| G
|
Hmgb2
|
high mobility group box 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HMGB2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of HMOX1 mRNA; Capsaicin results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of HMOX1 mRNA] Capsaicin inhibits the reaction [monophosphoryl lipid A results in increased expression of HMOX1 mRNA]; Capsaicin promotes the reaction [Hydrochloric Acid results in increased expression of HMOX1 protein]
|
CTD |
PMID:11738242 PMID:17979524 PMID:18617559 PMID:36044967 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnrnpa1
|
heterogeneous nuclear ribonucleoprotein A1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HNRNPA1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085
|
|
| G
|
Hpcal1
|
hippocalcin-like 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HPCAL1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
increases expression
|
ISO
|
Capsaicin results in increased expression of HRAS mRNA
|
CTD |
PMID:9461043 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of HSF1 mRNA
|
CTD |
PMID:24746025 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of HSP90B1 protein Capsaicin inhibits the reaction [Dietary Fats results in increased expression of HSP90B1 protein]
|
CTD |
PMID:18991268 PMID:20359164 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression increases localization
|
ISO
|
Capsaicin results in increased expression of HSPA5; Capsaicin results in increased expression of HSPA5 protein Capsaicin results in increased localization of HSPA5 protein
|
CTD |
PMID:19139269 PMID:19331147 PMID:19699254 PMID:21859781 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of HSP27 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Htr1b
|
5-hydroxytryptamine receptor 1B
|
multiple interactions
|
ISO
|
HTR1B protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]
|
CTD |
PMID:12110114 |
|
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
|
|
| G
|
Htr1d
|
5-hydroxytryptamine receptor 1D
|
multiple interactions
|
ISO
|
HTR1D protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]
|
CTD |
PMID:12110114 |
|
NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012
|
|
| G
|
Htr1f
|
5-hydroxytryptamine receptor 1F
|
multiple interactions
|
ISO
|
HTR1F protein inhibits the reaction [Capsaicin results in increased expression of FOS protein]
|
CTD |
PMID:12110114 |
|
NCBI chr11:16,089,266...16,090,665
Ensembl chr11:16,081,053...16,274,580
|
|
| G
|
Htr3a
|
5-hydroxytryptamine receptor 3A
|
decreases activity
|
ISO
|
Capsaicin results in decreased activity of HTR3A protein
|
CTD |
PMID:26456648 |
|
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884
|
|
| G
|
Htr3b
|
5-hydroxytryptamine receptor 3B
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of HTR3B mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:58,175,785...58,204,939
Ensembl chr 8:58,175,101...58,204,939
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Freund's Adjuvant results in increased expression of ICAM1]
|
CTD |
PMID:20600813 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ide
|
insulin degrading enzyme
|
multiple interactions affects expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IDE protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IDE protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IDE protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
|
|
| G
|
Ifng
|
interferon gamma
|
decreases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of IFNG Capsaicin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; Capsaicin inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA]; Capsaicin inhibits the reaction [IFNG protein results in increased expression of H2-AB1 mRNA]; Capsaicin inhibits the reaction [IFNG results in increased activity of STAT1 protein]; Capsaicin inhibits the reaction [IFNG results in increased expression of NOS2 protein] [Capsaicin results in increased susceptibility to Glyoxal] which results in increased expression of IFNG mRNA; [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]; Naproxen inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]; Sumatriptan inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]
|
CTD |
PMID:14530214 PMID:17306834 PMID:19825429 PMID:22150557 PMID:29496360 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
multiple interactions increases expression
|
ISO EXP
|
CALCA protein affects the reaction [Capsaicin results in increased expression of IGF1 mRNA]; CALCA protein affects the reaction [Capsaicin results in increased expression of IGF1 protein]; Isoflavones promotes the reaction [Capsaicin results in increased expression of IGF1 protein] Capsaicin results in increased expression of IGF1 mRNA; Capsaicin results in increased expression of IGF1 protein [Capsaicin co-treated with Isoflavones] results in increased expression of IGF1 protein; TRPV1 affects the reaction [Capsaicin results in increased expression of IGF1 mRNA] capsazepine inhibits the reaction [Capsaicin results in increased expression of IGF1 protein]
|
CTD |
PMID:17307377 PMID:17569567 PMID:17693108 PMID:19502719 PMID:21310942 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
increases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of IGF1R mRNA TRPV1 affects the reaction [Capsaicin results in increased expression of IGF1R mRNA]
|
CTD |
PMID:21310942 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of IGF2 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions increases expression
|
ISO EXP
|
Capsaicin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL10 protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL10 protein]] Capsaicin results in increased expression of IL10 mRNA; Capsaicin results in increased expression of IL10 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL10 protein]
|
CTD |
PMID:15502055 PMID:18460982 PMID:19878665 PMID:22150557 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il11ra1
|
interleukin 11 receptor subunit alpha 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of IL11RA1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:61,727,931...61,737,264
|
|
| G
|
Il12b
|
interleukin 12B
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of IL12B mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il13
|
interleukin 13
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL13 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL13 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL13 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions decreases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]; Naproxen inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]; Sumatriptan inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
decreases secretion increases response to substance multiple interactions increases expression affects expression
|
ISO EXP
|
Capsaicin results in decreased secretion of IL1B protein IL1B gene SNP results in increased susceptibility to Capsaicin [Capsaicin results in increased susceptibility to Formaldehyde] which results in increased expression of IL1B mRNA; [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL1B protein]; Capsaicin inhibits the reaction [Ibotenic Acid results in increased expression of IL1B protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IL1B protein]; Ranitidine inhibits the reaction [Capsaicin results in increased expression of IL1B protein]; spantide II inhibits the reaction [Capsaicin results in increased expression of IL1B protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IL1B protein] Capsaicin results in increased expression of IL1B mRNA; Capsaicin results in increased expression of IL1B protein Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]] Capsaicin inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Capsaicin inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
|
CTD |
PMID:12034025 PMID:15265675 PMID:18769453 PMID:19878665 PMID:22150557 PMID:22264228 PMID:22414649 PMID:28005965 PMID:30244119 PMID:36925032 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
multiple interactions
|
EXP
|
IL1RN protein inhibits the reaction [Nicotine results in increased activity of Capsaicin]
|
CTD |
PMID:27180639 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il2
|
interleukin 2
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Capsaicin results in decreased expression of IL2 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL2 protein]
|
CTD |
PMID:17306834 PMID:22150557 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il3
|
interleukin 3
|
multiple interactions affects expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL3 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IL3 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of IL3 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
|
|
| G
|
Il4
|
interleukin 4
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of IL4 Capsaicin results in increased expression of IL4 mRNA; Capsaicin results in increased expression of IL4 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL4 protein]
|
CTD |
PMID:17306834 PMID:22150557 PMID:29496360 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il5
|
interleukin 5
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Capsaicin results in decreased expression of IL5 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL5 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL5 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL5 protein] Capsaicin results in increased expression of IL5 mRNA; Capsaicin results in increased expression of IL5 protein
|
CTD |
PMID:17306834 PMID:22150557 PMID:29496360 |
|
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases secretion increases expression decreases secretion decreases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; 7-oxozeanol inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]; bisindolylmaleimide inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Capsaicin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]; Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; capsazepine inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]; capsazepine inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]; DUSP1 mutant form promotes the reaction [Capsaicin results in increased secretion of IL6 protein]; Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]; MAPK8 mutant form inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]; RTKI cpd affects the reaction [Capsaicin results in increased secretion of IL6 protein]; Ruthenium Red inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]; TRPV1 protein promotes the reaction [Capsaicin results in increased expression of IL6 mRNA]; TRPV1 protein promotes the reaction [Capsaicin results in increased expression of IL6 protein] Capsaicin results in increased expression of IL6 mRNA; Capsaicin results in increased expression of IL6 protein Capsaicin results in decreased secretion of IL6 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Capsaicin inhibits the reaction [Ibotenic Acid results in increased expression of IL6 protein]; Capsaicin inhibits the reaction [IL6 protein results in increased expression of GFAP mRNA]; Capsaicin inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; Ketotifen inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Ranitidine inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; spantide II inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of IL6 protein] Capsaicin results in decreased expression of IL6 protein capsazepine inhibits the reaction [Capsaicin results in decreased secretion of IL6 protein]; troglitazone promotes the reaction [Capsaicin results in decreased secretion of IL6 protein] Capsaicin results in decreased expression of IL6 mRNA; Capsaicin results in decreased expression of IL6 protein
|
CTD |
PMID:15265675 PMID:15502055 PMID:16173059 PMID:17306835 PMID:17505005 PMID:17560936 PMID:17719033 PMID:19285962 PMID:19798065 PMID:20619260 PMID:21474332 PMID:22150557 PMID:22171160 PMID:30244119 PMID:36925032 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of IL6ST protein
|
CTD |
PMID:19285962 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Il7
|
interleukin 7
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of IL7 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of INHBA protein Capsaicin inhibits the reaction [Ibotenic Acid results in increased expression of INHBA protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of INHBA protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of INHBA protein]
|
CTD |
PMID:22150557 PMID:36925032 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions decreases expression increases expression affects response to substance
|
EXP ISO
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of INS1 protein]; Capsaicin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of INS1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of INS1 protein] Capsaicin results in decreased expression of INS1 protein Capsaicin affects the susceptibility to INS1 protein
|
CTD |
PMID:16322403 PMID:17241282 PMID:19798065 PMID:22150557 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ins2
|
insulin 2
|
multiple interactions
|
EXP
|
[INS protein co-treated with Capsaicin] promotes the reaction [Capsaicin results in increased uptake of cobaltous chloride]
|
CTD |
PMID:14622148 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of IRS1 mRNA
|
CTD |
PMID:19798065 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Itga5
|
integrin subunit alpha 5
|
increases expression
|
EXP
|
Capsaicin results in increased expression of ITGA5 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
|
|
| G
|
Jak1
|
Janus kinase 1
|
multiple interactions
|
ISO
|
Capsaicin results in decreased phosphorylation of and results in decreased activity of JAK1 protein
|
CTD |
PMID:17505005 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of JUN mRNA Capsaicin results in increased expression of JUN mRNA [Capsaicin results in increased activity of MAPK8 protein] which results in increased phosphorylation of JUN protein; Capsaicin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein]; Capsaicin inhibits the reaction [EGF results in increased localization of JUN protein]
|
CTD |
PMID:1922926 PMID:9580328 PMID:17292493 PMID:19502594 PMID:21462327 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Capsaicin results in increased expression of JUND mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
|
|
| G
|
Kcnq4
|
potassium voltage-gated channel subfamily Q member 4
|
increases expression
|
EXP
|
Capsaicin results in increased expression of KCNQ4 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 5:139,560,366...139,612,212
Ensembl chr 5:139,560,366...139,612,102
|
|
| G
|
Kif11
|
kinesin family member 11
|
increases expression
|
EXP
|
Capsaicin results in increased expression of KIF11 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
|
|
| G
|
Klf1
|
KLF transcription factor 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of KLF1 mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr19:40,155,476...40,158,651
Ensembl chr19:40,155,480...40,158,607
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
increases expression
|
EXP
|
Capsaicin results in increased expression of KLF4 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]; Capsaicin inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]
|
CTD |
PMID:16540674 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Klk6
|
kallikrein related-peptidase 6
|
increases expression
|
EXP
|
Capsaicin results in increased expression of KLK6 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 1:103,415,411...103,422,682
Ensembl chr 1:103,416,886...103,422,690
|
|
| G
|
Kng1
|
kininogen 1
|
increases response to substance multiple interactions affects activity
|
EXP ISO
|
KNG1 protein results in increased susceptibility to Capsaicin KNG1 protein alternative form affects the reaction [P2RY2 protein affects the susceptibility to Capsaicin] Capsaicin affects the activity of KNG1 protein 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [KNG1 protein results in increased susceptibility to Capsaicin]; 2-aminoethyl diphenylborinate inhibits the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Capsaicin inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates]; Capsaicin promotes the reaction [Nicotine results in decreased activity of KNG1 protein alternative form]; HU 211 inhibits the reaction [KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Indomethacin inhibits the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; U 73343 promotes the reaction [KNG1 protein results in increased susceptibility to Capsaicin] BDKRB2 affects the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]]; KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]
|
CTD |
PMID:7807204 PMID:10490893 PMID:15363968 PMID:15750287 PMID:16696851 PMID:17324588 PMID:17347322 PMID:18343036 More...
|
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
|
|
| G
|
Lep
|
leptin
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Capsaicin results in decreased expression of LEP protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of LEP protein]; Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of LEP mRNA]; Naproxen inhibits the reaction [Capsaicin results in increased expression of LEP protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of LEP protein] Capsaicin results in increased expression of LEP mRNA; Capsaicin results in increased expression of LEP protein
|
CTD |
PMID:16278290 PMID:17295509 PMID:19798065 PMID:20359164 PMID:22150557 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lgals1
|
galectin 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of LGALS1 protein
|
CTD |
PMID:18991268 |
|
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
|
|
| G
|
LOC120095693
|
small ubiquitin-related modifier 2-like
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SUMO4 protein
|
CTD |
PMID:18991268 |
|
NCBI chr11:92,667,392...92,668,480
|
|
| G
|
Lrp1
|
LDL receptor related protein 1
|
multiple interactions decreases response to substance decreases expression
|
ISO
|
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein]; [Capsaicin results in decreased expression of LRP1 protein] which results in decreased uptake of Cholesterol; [Capsaicin results in decreased expression of LRP1 protein] which results in increased secretion of Cholesterol; APOE affects the reaction [Capsaicin results in decreased expression of LRP1 protein]; Cyclosporine inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein]; KT 5720 inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein] LRP1 results in decreased susceptibility to Capsaicin
|
CTD |
PMID:21908651 |
|
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196
|
|
| G
|
Ltb4r2
|
leukotriene B4 receptor 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of LTB4R2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr15:33,228,634...33,230,453
Ensembl chr15:33,228,634...33,230,453
|
|
| G
|
Ltf
|
lactotransferrin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of LTF protein
|
CTD |
PMID:9537786 |
|
NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
multiple interactions affects localization
|
ISO
|
acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein]; dorsomorphin inhibits the reaction [Capsaicin affects the localization of MAP1LC3A protein]
|
CTD |
PMID:36044967 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MAP2 mRNA
|
CTD |
PMID:18405923 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MAP2K1 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
multiple interactions
|
ISO
|
7-oxozeanol inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAP3K7 protein]; Capsaicin results in increased phosphorylation of and results in increased activity of MAP3K7 protein; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAP3K7 protein]
|
CTD |
PMID:22171160 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases activity increases phosphorylation multiple interactions increases expression increases localization increases activity
|
ISO EXP
|
Capsaicin results in decreased activity of MAPK1 protein Capsaicin results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; AG 1879 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK1 protein]; Capsaicin results in increased phosphorylation of and results in increased activity of MAPK1 protein; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Dizocilpine Maleate inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; Lidocaine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; SR140333B inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; staurosporine aglycone inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)- inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Xenon inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein] 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein; AG 1879 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]; Capsaicin results in increased activity of and results in increased phosphorylation of MAPK1 protein; Capsaicin results in increased expression of and results in increased phosphorylation of MAPK1 protein; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK1 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; 7-oxozeanol inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein]; bafilomycin A1 inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK1 protein]; Capsaicin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; Capsaicin results in increased phosphorylation of and results in increased activity of MAPK1 protein; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; tricyclodecane-9-yl-xanthogenate inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein] Capsaicin results in increased expression of MAPK1 protein modified form Capsaicin results in increased localization of MAPK1 protein modified form
|
CTD |
PMID:12196597 PMID:12478662 PMID:12941468 PMID:14530214 PMID:15385614 PMID:16788306 PMID:17056180 PMID:17828457 PMID:19059400 PMID:19139269 PMID:19855437 PMID:20371669 PMID:20383154 PMID:20619260 PMID:20660715 PMID:21056583 PMID:21462327 PMID:21474332 PMID:22171160 PMID:22508518 PMID:39800145 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK14 protein]
|
CTD |
PMID:21745629 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk15
|
mitogen-activated protein kinase 15
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MAPK15 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:109,575,561...109,595,346
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases activity increases phosphorylation multiple interactions increases expression increases localization increases activity
|
ISO EXP
|
Capsaicin results in decreased activity of MAPK3 protein Capsaicin results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; AG 1879 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; Capsaicin inhibits the reaction [CCK protein results in increased phosphorylation of MAPK3 protein]; Capsaicin results in increased phosphorylation of and results in increased activity of MAPK3 protein; Dizocilpine Maleate inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; Lidocaine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Ro 31-8425 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]]; Ro 31-8425 inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; Ro 31-8425 promotes the reaction [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]]; SR140333B inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; staurosporine aglycone inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)- inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Xenon inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein] 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein; AG 1879 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK3 protein]; Capsaicin results in increased activity of and results in increased phosphorylation of MAPK3 protein; Capsaicin results in increased expression of and results in increased phosphorylation of MAPK3 protein; EGFR gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased phosphorylation of MAPK3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; 7-oxozeanol inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein]; bafilomycin A1 inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein]; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK3 protein]; Capsaicin results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; Capsaicin results in increased phosphorylation of and results in increased activity of MAPK3 protein; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; tricyclodecane-9-yl-xanthogenate inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein] Capsaicin results in increased expression of MAPK3 protein modified form Capsaicin results in increased localization of MAPK3 protein modified form
|
CTD |
PMID:12196597 PMID:12478662 PMID:12941468 PMID:14530214 PMID:15385614 PMID:16788306 PMID:17056180 PMID:17828457 PMID:19059400 PMID:19139269 PMID:19855437 PMID:20371669 PMID:20383154 PMID:20619260 PMID:20660715 PMID:21056583 PMID:21462327 PMID:21474332 PMID:22171160 PMID:22508518 PMID:39800145 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk7
|
mitogen-activated protein kinase 7
|
increases phosphorylation
|
EXP
|
Capsaicin results in increased phosphorylation of MAPK7 protein
|
CTD |
PMID:17237256 |
|
NCBI chr10:46,669,721...46,675,768
Ensembl chr10:46,669,721...46,675,806
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases activity increases phosphorylation
|
ISO
|
7-oxozeanol inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; 7-oxozeanol promotes the reaction [MAPK8 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of NFKBIA protein]]; [Capsaicin results in increased activity of MAPK8 protein] which results in increased phosphorylation of JUN protein; Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK8 protein]; Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein; capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; DUSP1 mutant form promotes the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; MAPK8 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of NFKBIA protein]; MAPK8 mutant form inhibits the reaction [Capsaicin results in increased secretion of CXCL8 protein]; MAPK8 mutant form inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]; MAPK8 protein promotes the reaction [Capsaicin results in decreased degradation of TP53 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein] Capsaicin results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:9580328 PMID:12478662 PMID:17292493 PMID:20619260 PMID:21462327 PMID:21745629 PMID:22171160 More...
|
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
increases activity increases phosphorylation multiple interactions
|
ISO
|
Capsaicin results in increased activity of MAPK9 protein Capsaicin results in increased phosphorylation of MAPK9 protein Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK9 protein]; Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:9580328 PMID:20619260 PMID:21462327 PMID:21745629 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MAPT mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
increases expression
|
EXP
|
Capsaicin results in increased expression of MARCKS mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MCL1 mRNA
|
CTD |
PMID:19502594 PMID:36044967 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
|
|
| G
|
Mcpt1
|
mast cell protease 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of MCPT1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr15:33,841,606...33,844,174
Ensembl chr15:33,841,606...33,844,174
|
|
| G
|
Mcu
|
mitochondrial calcium uniporter
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MCU mRNA; Capsaicin results in increased expression of MCU protein
|
CTD |
PMID:39800145 |
|
NCBI chr20:27,960,520...28,123,103
Ensembl chr20:27,961,327...28,123,103
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of MDH1 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
increases expression decreases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of MDM2 mRNA Capsaicin results in decreased expression of MDM2 protein Capsaicin promotes the reaction [resveratrol results in decreased expression of MDM2 protein]; resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein]; TP53 affects the reaction [Capsaicin results in decreased expression of MDM2 protein]
|
CTD |
PMID:19502594 PMID:19846903 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of MIF protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MIF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MIF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MIF protein]
|
CTD |
PMID:22150557 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]
|
CTD |
PMID:29155087 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
multiple interactions increases expression
|
ISO
|
capsazepine inhibits the reaction [Capsaicin results in increased expression of MMP1 protein] Capsaicin results in increased expression of MMP1 mRNA; Capsaicin results in increased expression of MMP1 protein
|
CTD |
PMID:17508023 PMID:21310942 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp12
|
matrix metallopeptidase 12
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of MMP12 mRNA; Capsaicin results in decreased expression of MMP12 protein
|
CTD |
PMID:18441096 |
|
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
decreases expression multiple interactions increases expression
|
EXP
|
Capsaicin results in decreased expression of MMP13 mRNA [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]
|
CTD |
PMID:16278290 PMID:22150557 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [EGF results in increased expression of MMP14]
|
CTD |
PMID:21462327 |
|
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions increases expression
|
ISO EXP
|
Capsaicin inhibits the reaction [EGF results in increased activity of MMP2 protein]; Capsaicin inhibits the reaction [EGF results in increased expression of MMP2] Capsaicin results in increased expression of MMP2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]
|
CTD |
PMID:21462327 PMID:22150557 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions increases expression
|
ISO
|
4-aminobenzamide inhibits the reaction [Capsaicin results in increased activity of MMP9 protein]; Capsaicin inhibits the reaction [EGF results in increased activity of MMP9 protein]; Capsaicin inhibits the reaction [EGF results in increased expression of MMP9]; Capsaicin results in increased expression of and results in increased activity of MMP9 protein; TRPV1 inhibits the reaction [Capsaicin results in increased expression of and results in increased activity of MMP9 protein] Capsaicin results in increased expression of MMP9 mRNA
|
CTD |
PMID:21310942 PMID:21462327 PMID:22230393 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mobp
|
myelin-associated oligodendrocyte basic protein
|
increases expression
|
EXP
|
Capsaicin results in increased expression of MOBP mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 8:128,747,117...128,777,238
Ensembl chr 8:128,747,232...128,777,936
|
|
| G
|
Mog
|
myelin oligodendrocyte glycoprotein
|
increases expression
|
EXP
|
Capsaicin results in increased expression of MOG mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr20:1,514,110...1,528,716
|
|
| G
|
Mpo
|
myeloperoxidase
|
affects activity decreases expression multiple interactions
|
EXP
|
Capsaicin affects the activity of MPO protein Capsaicin results in decreased expression of MPO protein Capsaicin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Capsaicin inhibits the reaction [Diquat results in increased activity of MPO protein]; Capsaicin inhibits the reaction [Indomethacin results in increased activity of MPO protein]; Capsaicin inhibits the reaction [Iodoacetamide results in increased activity of MPO protein]; Capsaicin promotes the reaction [Ethanol results in increased activity of MPO protein]; Indomethacin inhibits the reaction [Capsaicin affects the activity of MPO protein]
|
CTD |
PMID:10671773 PMID:12024109 PMID:12893632 PMID:15046732 PMID:15573930 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mrpl3
|
mitochondrial ribosomal protein L3
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of MRPL3 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:114,548,970...114,572,330
Ensembl chr 8:114,548,970...114,573,996
|
|
| G
|
Msmo1
|
methylsterol monooxygenase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MSMO1 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
|
|
| G
|
Mt-co1
|
mitochondrially encoded cytochrome c oxidase I
|
increases expression
|
ISO
|
Capsaicin results in increased expression of COX1 protein
|
CTD |
PMID:39800145 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
|
|
| G
|
Mt-nd1
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
|
increases response to substance multiple interactions
|
ISO
|
ND1 gene mutant form results in increased susceptibility to Capsaicin [ND1 gene mutant form results in increased susceptibility to Capsaicin] which results in increased activity of CASP3 protein
|
CTD |
PMID:29991444 |
|
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions decreases phosphorylation increases phosphorylation
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein]; acadesine promotes the reaction [Capsaicin results in decreased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [Capsaicin results in decreased phosphorylation of MTOR protein]; Wortmannin inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein]
|
CTD |
PMID:19139269 PMID:22226932 PMID:36044967 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
increases secretion multiple interactions
|
ISO
|
Capsaicin results in increased secretion of MUC5AC protein Capsaicin promotes the reaction [Citric Acid results in increased secretion of MUC5AC protein]
|
CTD |
PMID:22566028 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
|
|
| G
|
Muc5b
|
mucin 5B, oligomeric mucus/gel-forming
|
increases secretion
|
ISO
|
Capsaicin results in increased secretion of MUC5B protein
|
CTD |
PMID:21981454 |
|
NCBI chr 1:206,346,400...206,378,367
Ensembl chr 1:206,346,400...206,378,367
|
|
| G
|
Musk
|
muscle associated receptor tyrosine kinase
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MUSK protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MUSK protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of MUSK protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:77,853,560...77,967,653
Ensembl chr 5:77,853,736...77,964,338
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MYC mRNA
|
CTD |
PMID:9461043 PMID:19502594 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myh1
|
myosin heavy chain 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MYH1 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047
|
|
| G
|
Myl1
|
myosin, light chain 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of MYL1 protein]
|
CTD |
PMID:20359164 |
|
Ensembl chr 9:75,887,227...75,907,971
|
|
| G
|
Myl4
|
myosin, light chain 4
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of MYL4 mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
|
|
| G
|
Myod1
|
myogenic differentiation 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MYOD1 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871
|
|
| G
|
Myog
|
myogenin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of MYOG mRNA; Capsaicin results in increased expression of MYOG protein
|
CTD |
PMID:39800145 |
|
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065
|
|
| G
|
Ncr1
|
natural cytotoxicity triggering receptor 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of NCR1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:78,659,262...78,703,273
|
|
| G
|
Ndufb4
|
NADH:ubiquinone oxidoreductase subunit B4
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of NDUFB4 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr11:76,569,178...76,575,879
Ensembl chr11:76,569,178...76,575,879
|
|
| G
|
Ndufb8
|
NADH:ubiquinone oxidoreductase subunit B8
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NDUFB8 protein
|
CTD |
PMID:39800145 |
|
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936
|
|
| G
|
Nectin1
|
nectin cell adhesion molecule 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of NECTIN1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664
|
|
| G
|
Nek2
|
NIMA-related kinase 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NEK2 mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
|
|
| G
|
Nfatc4
|
nuclear factor of activated T-cells 4
|
increases localization
|
EXP
|
Capsaicin results in increased localization of NFATC4 protein
|
CTD |
PMID:16849427 |
|
NCBI chr15:33,256,912...33,284,522
Ensembl chr15:33,274,153...33,285,582
|
|
| G
|
Nfe2
|
nuclear factor, erythroid 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NFE2 mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:136,261,236...136,268,585
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases localization
|
ISO
|
Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein]
|
CTD |
PMID:17979524 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
affects expression multiple interactions
|
ISO
|
Capsaicin affects the expression of NFKB1 mRNA [NFKB1 mutant form inhibits the reaction [Capsaicin results in increased expression of PRKCD protein]] which results in increased expression of DUSP1 protein; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased expression of PRKCD protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased secretion of CXCL8 protein]; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased secretion of IL6 protein]
|
CTD |
PMID:19502594 PMID:22171160 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions increases localization increases phosphorylation decreases degradation
|
ISO
|
7-oxozeanol promotes the reaction [MAPK8 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of NFKBIA protein]]; Capsaicin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; MAPK8 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of NFKBIA protein] Capsaicin results in increased localization of NFKBIA protein Capsaicin results in decreased degradation of NFKBIA protein
|
CTD |
PMID:12214859 PMID:16540674 PMID:22171160 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions increases response to substance increases expression decreases expression
|
ISO EXP
|
NTRK1 promotes the reaction [NGF protein results in increased susceptibility to Capsaicin]; NTRK1 protein mutant form affects the reaction [NGF protein results in increased susceptibility to Capsaicin] Capsaicin results in increased expression of NGF protein Capsaicin results in decreased expression of NGF protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [U 0126 inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; [Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein; [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGF protein]; bisindolylmaleimide I inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; epothilone B affects the reaction [[Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein]; Ketotifen inhibits the reaction [Capsaicin results in increased expression of NGF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NGF protein]; NGF protein promotes the reaction [Capsaicin results in increased expression of CALCA protein]; NGF protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Promethazine inhibits the reaction [Capsaicin results in increased expression of NGF protein]; Ranitidine inhibits the reaction [Capsaicin results in increased expression of NGF protein]; spantide II inhibits the reaction [Capsaicin results in increased expression of NGF protein]; staurosporine aglycone inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NGF protein]; U 0126 inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; U 0126 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]] NGF protein results in increased susceptibility to Capsaicin; NGF results in increased susceptibility to Capsaicin Capsaicin results in decreased expression of NGF mRNA bisindolylmaleimide I inhibits the reaction [NGF results in increased susceptibility to Capsaicin]; Capsaicin inhibits the reaction [CCK protein alternative form results in decreased expression of NGF mRNA]; Capsaicin promotes the reaction [CCK protein alternative form results in increased expression of NGF protein]; KN 62 inhibits the reaction [NGF results in increased susceptibility to Capsaicin]; PIK3R1 gene mutant form inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]; Staurosporine inhibits the reaction [NGF results in increased susceptibility to Capsaicin]; wortmannin inhibits the reaction [NGF results in increased susceptibility to Capsaicin]
|
CTD |
PMID:9259450 PMID:10683199 PMID:11166474 PMID:12815188 PMID:15265675 PMID:16777323 PMID:17324588 PMID:17687396 PMID:22150557 PMID:26883566 More...
|
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
increases expression multiple interactions decreases expression
|
EXP
|
Capsaicin results in increased expression of NGFR protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NGFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NGFR protein] Capsaicin results in decreased expression of NGFR mRNA
|
CTD |
PMID:8971780 PMID:22150557 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NME2 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497 Ensembl chr10:11,179,066...11,179,497
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
increases expression multiple interactions
|
EXP ISO
|
Capsaicin results in increased expression of NOS1 mRNA; Capsaicin results in increased expression of NOS1 protein TP53 affects the reaction [Capsaicin results in increased expression of NOS1 protein]
|
CTD |
PMID:7477891 PMID:10880996 PMID:11576744 PMID:19846903 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
ISO EXP
|
Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]; resveratrol promotes the reaction [Capsaicin results in increased expression of NOS2 protein]; TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]]; TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS2 protein]] Capsaicin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 protein] Capsaicin results in increased expression of NOS2; Capsaicin results in increased expression of NOS2 mRNA; Capsaicin results in increased expression of NOS2 protein Capsaicin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [[Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [IFNG results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
|
CTD |
PMID:10671773 PMID:11576744 PMID:14530214 PMID:15681035 PMID:19846903 PMID:20712533 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]; resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein]; TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]]; TP53 affects the reaction [Capsaicin results in increased expression of NOS3 protein]; TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein]] Capsaicin results in decreased expression of NOS3 mRNA
|
CTD |
PMID:16278290 PMID:18037908 PMID:19846903 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox3
|
NADPH oxidase 3
|
multiple interactions increases expression
|
EXP ISO
|
NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 protein] NOX3 mutant form inhibits the reaction [Capsaicin results in increased abundance of Reactive Oxygen Species] Capsaicin results in increased expression of NOX3 mRNA; Capsaicin results in increased expression of NOX3 protein
|
CTD |
PMID:20712533 |
|
NCBI chr 1:46,643,277...46,708,109
Ensembl chr 1:46,642,564...46,708,109
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
affects expression
|
ISO
|
Capsaicin affects the expression of NOX4 mRNA; Capsaicin affects the expression of NOX4 protein
|
CTD |
PMID:34939720 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Npc1
|
NPC intracellular cholesterol transporter 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NPC1 mRNA
|
CTD |
PMID:18533110 PMID:36044967 |
|
NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800
|
|
| G
|
Npy
|
neuropeptide Y
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [NPY protein affects the susceptibility to Potassium]
|
CTD |
PMID:18055875 |
|
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
| G
|
Npy1r
|
neuropeptide Y receptor Y1
|
multiple interactions increases response to substance
|
EXP
|
neuropeptide Y, Leu(31)-Pro(34)- inhibits the reaction [NPY1R protein results in increased susceptibility to Capsaicin]
|
CTD |
PMID:16714086 |
|
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased activity of NQO1 protein] Capsaicin results in increased expression of NQO1 mRNA Capsaicin results in decreased expression of NQO1 protein
|
CTD |
PMID:10880996 PMID:17979524 PMID:19449198 PMID:33512557 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nqo2
|
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of NQO2 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662
|
|
| G
|
Nrp1
|
neuropilin 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
multiple interactions decreases expression
|
ISO EXP
|
NTRK1 promotes the reaction [NGF protein results in increased susceptibility to Capsaicin]; NTRK1 protein mutant form affects the reaction [NGF protein results in increased susceptibility to Capsaicin] Capsaicin results in decreased expression of NTRK1 mRNA
|
CTD |
PMID:8971780 PMID:9259450 PMID:17324588 |
|
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
|
|
| G
|
Nupr1
|
nuclear protein 1, transcriptional regulator
|
increases expression
|
ISO
|
Capsaicin results in increased expression of NUPR1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
|
|
| G
|
Ogdh
|
oxoglutarate dehydrogenase
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in decreased expression of OGDH]
|
CTD |
PMID:18023135 |
|
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:85,364,014...85,432,271
|
|
| G
|
Olig1
|
oligodendrocyte transcription factor 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of OLIG1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr11:44,000,450...44,002,592
Ensembl chr11:44,000,281...44,002,592
|
|
| G
|
Olr1271
|
olfactory receptor 1271
|
increases expression
|
EXP
|
Capsaicin results in increased expression of OLR1271 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 8:48,024,543...48,029,052
Ensembl chr 8:48,024,562...48,029,042
|
|
| G
|
Oprl1
|
opioid related nociceptin receptor 1
|
multiple interactions
|
EXP
|
OPRL1 protein promotes the reaction [nociceptin (1-13) amide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]
|
CTD |
PMID:17640294 |
|
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:189,212,175...189,217,426
|
|
| G
|
Oprm1
|
opioid receptor, mu 1
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [carfentanil binds to OPRM1 protein]
|
CTD |
PMID:12406535 |
|
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:45,565,371...45,638,756
|
|
| G
|
Optn
|
optineurin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of OPTN mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
|
|
| G
|
Or2ak6e
|
olfactory receptor family 2 subfamily AK member 6E
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of OR2AK6E protein]
|
CTD |
PMID:20359164 |
|
NCBI chr10:43,573,289...43,574,209
Ensembl chr10:43,573,289...43,574,209
|
|
| G
|
P22k15
|
cystatin related protein 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of P22K15 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 3:157,420,930...157,427,988
Ensembl chr 3:157,420,933...157,427,988
|
|
| G
|
P2ry2
|
purinergic receptor P2Y2
|
affects response to substance multiple interactions
|
ISO
|
P2RY2 protein affects the susceptibility to Capsaicin KNG1 protein alternative form affects the reaction [P2RY2 protein affects the susceptibility to Capsaicin]
|
CTD |
PMID:18343036 |
|
NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage increases expression increases ADP-ribosylation multiple interactions
|
ISO
|
Capsaicin results in increased cleavage of PARP1 protein Capsaicin results in increased expression of PARP1 protein Capsaicin results in increased ADP-ribosylation of PARP1 protein modified form 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]; 3-aminobenzamide inhibits the reaction [Capsaicin results in increased ADP-ribosylation of PARP1 protein modified form]; 3-aminobenzamide promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]; 3-aminobenzamide promotes the reaction [Capsaicin results in increased expression of PARP1 protein]; Caffeine promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein]; Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein; pifithrin promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]
|
CTD |
PMID:17295509 PMID:17505005 PMID:19855437 PMID:22200406 PMID:22226932 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pclaf
|
PCNA clamp associated factor
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PCLAF mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106
|
|
| G
|
Pcolce
|
procollagen C-endopeptidase enhancer
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PCOLCE mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287
|
|
| G
|
Pcsk5
|
proprotein convertase subtilisin/kexin type 5
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PCSK5 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347
|
|
| G
|
Pctp
|
phosphatidylcholine transfer protein
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of PCTP mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr10:75,305,999...75,351,919
Ensembl chr10:75,305,999...75,326,432
|
|
| G
|
Pde2a
|
phosphodiesterase 2A
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PDE2A mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of PDGFA protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]
|
CTD |
PMID:22150557 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PDX1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
| G
|
Pdyn
|
prodynorphin
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of PDYN mRNA; Capsaicin results in increased expression of PDYN protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased expression of PDYN protein]
|
CTD |
PMID:15385614 |
|
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503
|
|
| G
|
Pdzd2
|
PDZ domain containing 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PDZD2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478
|
|
| G
|
Per2
|
period circadian regulator 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PER2 mRNA
|
CTD |
PMID:24746025 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993
|
|
| G
|
Pgm1
|
phosphoglucomutase 1
|
increases expression decreases expression
|
ISO EXP
|
Capsaicin results in increased expression of PGM1 mRNA; Capsaicin results in increased expression of PGM1 protein Capsaicin results in decreased expression of PGM1 mRNA
|
CTD |
PMID:19891501 PMID:20349343 |
|
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159
|
|
| G
|
Phb2
|
prohibitin 2
|
multiple interactions
|
ISO
|
Capsaicin binds to and results in increased localization of PHB2 protein
|
CTD |
PMID:19116139 |
|
NCBI chr 4:159,203,948...159,208,561
Ensembl chr 4:159,203,926...159,209,231
|
|
| G
|
Phox2a
|
paired-like homeobox 2a
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PHOX2A mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:165,590,757...165,595,122
Ensembl chr 1:165,590,757...165,595,122
|
|
| G
|
Phykpl
|
5-phosphohydroxy-L-lysine phospho-lyase
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PHYKPL mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr10:36,340,905...36,372,555
Ensembl chr10:36,340,945...36,363,721
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions
|
ISO
|
PIK3R1 gene mutant form inhibits the reaction [NGF protein results in increased susceptibility to Capsaicin]
|
CTD |
PMID:17324588 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pink1
|
PTEN induced kinase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of PINK1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
| G
|
Pla2g15
|
phospholipase A2, group XV
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PLA2G15 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr19:50,960,568...50,977,948
Ensembl chr19:50,960,598...50,977,946
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
multiple interactions increases phosphorylation
|
ISO
|
SB 203580 inhibits the reaction [Capsaicin results in increased phosphorylation of PLA2G4A protein]
|
CTD |
PMID:19959817 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
increases expression
|
ISO
|
Capsaicin results in increased expression of PLAU mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
increases expression
|
ISO
|
Capsaicin results in increased expression of PLAUR mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Plcb3
|
phospholipase C beta 3
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PLCB3 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:213,574,166...213,589,583
|
|
| G
|
Plin2
|
perilipin 2
|
affects expression multiple interactions
|
EXP
|
Capsaicin affects the expression of PLIN2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
|
|
| G
|
Plp1
|
proteolipid protein 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PLP1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314
|
|
| G
|
Pnisr
|
PNN interacting serine and arginine rich protein
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PNISR mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611
|
|
| G
|
Polb
|
DNA polymerase beta
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of POLB mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180
|
|
| G
|
Polr2f
|
RNA polymerase II, I and III subunit F
|
increases expression
|
EXP
|
Capsaicin results in increased expression of POLR2F mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666
|
|
| G
|
Pomc
|
proopiomelanocortin
|
multiple interactions increases secretion increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of POMC protein]; Capsaicin inhibits the reaction [[Clonidine co-treated with Naloxone co-treated with Morphine] results in increased secretion of POMC protein]; Capsaicin inhibits the reaction [[Morphine co-treated with Naloxone] results in increased secretion of POMC protein]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of POMC protein]; CP 96345 inhibits the reaction [Capsaicin results in increased secretion of POMC protein]; Dizocilpine Maleate inhibits the reaction [Capsaicin results in increased secretion of POMC protein]; Lidocaine inhibits the reaction [Capsaicin results in increased secretion of POMC protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of POMC protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of POMC protein]
|
CTD |
PMID:2846107 PMID:8925284 PMID:22150557 |
|
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
|
|
| G
|
Por
|
cytochrome p450 oxidoreductase
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of POR protein]
|
CTD |
PMID:19449198 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
decreases expression increases expression
|
ISO
|
Capsaicin results in decreased expression of PPARA mRNA Capsaicin results in increased expression of PPARA mRNA
|
CTD |
PMID:18769453 PMID:19798065 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of PPARD mRNA
|
CTD |
PMID:18769453 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions increases expression increases activity decreases expression
|
ISO EXP
|
bisphenol A diglycidyl ether inhibits the reaction [Capsaicin results in increased activity of PPARG protein] Capsaicin results in increased expression of PPARG mRNA; Capsaicin results in increased expression of PPARG protein Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] Capsaicin results in decreased expression of PPARG protein Capsaicin results in decreased expression of PPARG mRNA
|
CTD |
PMID:15383218 PMID:17295509 PMID:18769453 PMID:20359164 PMID:39800145 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of PPARGC1A mRNA; Capsaicin results in increased expression of PPARGC1A protein Capsaicin promotes the reaction [Dietary Fats results in increased expression of PPARGC1A mRNA]
|
CTD |
PMID:19798065 PMID:20359164 PMID:39800145 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppp1r12a
|
protein phosphatase 1, regulatory subunit 12A
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [Colforsin results in increased phosphorylation of PPP1R12A protein]
|
CTD |
PMID:21474433 |
|
NCBI chr 7:45,368,922...45,480,158
Ensembl chr 7:45,369,315...45,480,157
|
|
| G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
multiple interactions
|
EXP
|
PPP3CA protein affects the reaction [mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]]
|
CTD |
PMID:17590514 |
|
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
|
|
| G
|
Ppp5c
|
protein phosphatase 5, catalytic subunit
|
increases expression
|
EXP
|
Capsaicin results in increased expression of PPP5C mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:86,818,297...86,842,950
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of PRDX1 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
increases expression
|
ISO
|
Capsaicin results in increased expression of PRDX6 protein
|
CTD |
PMID:18991268 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
multiple interactions increases expression increases phosphorylation
|
ISO EXP
|
[Genistein co-treated with Capsaicin] results in increased activity of PRKAA1 protein; acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA1 protein]; dorsomorphin inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein] Capsaicin results in increased expression of PRKAA1 mRNA Capsaicin results in increased phosphorylation of PRKAA1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]
|
CTD |
PMID:19723084 PMID:22150557 PMID:36044967 PMID:39800145 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
increases phosphorylation multiple interactions
|
ISO
|
Capsaicin results in increased phosphorylation of PRKAA2 protein acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein]; dorsomorphin inhibits the reaction [Capsaicin results in increased expression of PRKAA2 protein]
|
CTD |
PMID:36044967 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
|
|
| G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
increases phosphorylation increases expression
|
ISO
|
Capsaicin results in increased phosphorylation of PRKACA protein Capsaicin results in increased expression of PRKACA protein
|
CTD |
PMID:21908651 PMID:39800145 |
|
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
increases expression multiple interactions
|
EXP ISO
|
Capsaicin results in increased expression of PRKCA mRNA; Capsaicin results in increased expression of PRKCA protein bisindolylmaleimide inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] chelerythrine inhibits the reaction [Capsaicin results in increased expression of PRKCA protein]; iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of PRKCA protein]
|
CTD |
PMID:18752301 PMID:21474332 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
increases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of PRKCD protein [NFKB1 mutant form inhibits the reaction [Capsaicin results in increased expression of PRKCD protein]] which results in increased expression of DUSP1 protein; NFKB1 mutant form inhibits the reaction [Capsaicin results in increased expression of PRKCD protein]
|
CTD |
PMID:22171160 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkce
|
protein kinase C, epsilon
|
multiple interactions
|
ISO
|
PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]]
|
CTD |
PMID:16793902 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
| G
|
Prkcz
|
protein kinase C, zeta
|
increases response to substance
|
ISO
|
PRKCZ protein alternative form results in increased susceptibility to Capsaicin
|
CTD |
PMID:27899695 |
|
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
|
|
| G
|
Prkd1
|
protein kinase D1
|
multiple interactions
|
ISO EXP
|
PRKD1 promotes the reaction [Capsaicin results in increased uptake of Calcium] PRKD1 mutant form inhibits the reaction [Capsaicin results in increased uptake of Calcium]
|
CTD |
PMID:15471852 |
|
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
| G
|
Prkdc
|
protein kinase, DNA-activated, catalytic subunit
|
multiple interactions increases phosphorylation
|
ISO
|
3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of PRKDC protein]; ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein]; Capsaicin results in increased phosphorylation of and results in increased activity of PRKDC protein; pifithrin inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein]
|
CTD |
PMID:22226932 |
|
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:98,544,954...98,762,108
|
|
| G
|
Prlr
|
prolactin receptor
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of PRLR protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRLR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PRLR protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of PRLR protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882
|
|
| G
|
Prok1
|
prokineticin 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 2:197,538,747...197,547,550
Ensembl chr 2:197,537,068...197,547,550
|
|
| G
|
Prok2
|
prokineticin 2
|
increases response to substance
|
ISO
|
PROK2 protein results in increased susceptibility to Capsaicin
|
CTD |
PMID:17107623 |
|
NCBI chr 4:133,903,210...133,918,126
Ensembl chr 4:133,903,210...133,917,933
|
|
| G
|
Prokr1
|
prokineticin receptor 1
|
multiple interactions increases response to substance
|
ISO
|
PROKR1 protein affects the reaction [Capsaicin results in increased abundance of Calcium] PROKR1 protein results in increased susceptibility to Capsaicin
|
CTD |
PMID:16793879 |
|
NCBI chr 4:121,579,630...121,590,695
Ensembl chr 4:121,579,630...121,590,695
|
|
| G
|
Prokr2
|
prokineticin receptor 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of PROKR2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:140,077,630...140,092,093
|
|
| G
|
Ptgir
|
prostaglandin I2 receptor
|
increases response to substance
|
ISO
|
PTGIR results in increased susceptibility to Capsaicin
|
CTD |
PMID:15985616 |
|
NCBI chr 1:86,707,690...86,710,073
Ensembl chr 1:86,707,503...86,711,874
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
Capsaicin promotes the reaction [Genistein results in decreased expression of PTGS2 protein] Capsaicin results in increased expression of PTGS2 mRNA; Capsaicin results in increased expression of PTGS2 protein [Genistein co-treated with Capsaicin] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; Botulinum Toxins, Type A inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein] [Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein; Capsaicin inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; Capsaicin inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; EGFR gene mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]]; EGFR gene mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]]; EGFR gene mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; RTKI cpd inhibits the reaction [TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]]; SRC mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]]; TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]; U 0126 inhibits the reaction [TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]] Capsaicin results in decreased expression of PTGS2 mRNA Capsaicin results in decreased expression of PTGS2 protein
|
CTD |
PMID:11125845 PMID:14530214 PMID:17141941 PMID:17719033 PMID:19723084 PMID:20660715 PMID:20712533 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [EGF results in increased phosphorylation of PTK2 protein]
|
CTD |
PMID:21462327 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22
|
increases expression
|
ISO
|
Capsaicin results in increased expression of PTPN22 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 2:194,055,165...194,103,209
Ensembl chr 2:194,045,746...194,103,209
|
|
| G
|
Ranbp3l
|
RAN binding protein 3-like
|
increases expression
|
EXP
|
Capsaicin results in increased expression of RANBP3L mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 2:59,785,070...59,840,338
Ensembl chr 2:59,785,450...59,840,334
|
|
| G
|
Rarres2
|
retinoic acid receptor responder 2
|
multiple interactions
|
ISO
|
RARRES2 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]
|
CTD |
PMID:20383154 |
|
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457
|
|
| G
|
Rbm5
|
RNA binding motif protein 5
|
increases expression
|
EXP
|
Capsaicin results in increased expression of RBM5 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 8:117,298,866...117,328,107
Ensembl chr 8:117,299,084...117,327,706
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
decreases activity decreases localization
|
ISO
|
Capsaicin results in decreased activity of RELA protein Capsaicin results in decreased localization of RELA protein
|
CTD |
PMID:12214859 PMID:16540674 PMID:17719033 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Retn
|
resistin
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of RETN protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETN protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of RETN protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of RETN protein]
|
CTD |
PMID:22150557 |
|
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116
|
|
| G
|
Retnlb
|
resistin like beta
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]
|
CTD |
PMID:22150557 |
|
NCBI chr11:65,446,433...65,448,319
Ensembl chr11:65,446,434...65,448,319
|
|
| G
|
Ripk2
|
receptor-interacting serine-threonine kinase 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of RIPK2 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:34,428,573...34,459,663
|
|
| G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
increases expression
|
ISO
|
Capsaicin results in increased expression of RPS6KA3 protein
|
CTD |
PMID:18991268 |
|
NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678
|
|
| G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
decreases phosphorylation increases phosphorylation
|
ISO
|
Capsaicin results in decreased phosphorylation of RPS6KB1 protein Capsaicin results in increased phosphorylation of RPS6KB1 mRNA
|
CTD |
PMID:22226932 PMID:36044967 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
| G
|
Rragc
|
Ras-related GTP binding C
|
increases expression
|
ISO
|
Capsaicin results in increased expression of RRAGC mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
|
|
| G
|
Rragd
|
Ras-related GTP binding D
|
increases expression
|
ISO
|
Capsaicin results in increased expression of RRAGD mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 5:52,170,234...52,205,700
Ensembl chr 5:52,169,783...52,209,000
|
|
| G
|
RT1-Bb
|
RT1 class II, locus Bb
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [IFNG protein results in increased expression of H2-AB1 mRNA]
|
CTD |
PMID:19825429 |
|
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of RXRA mRNA
|
CTD |
PMID:18769453 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
Rxrb
|
retinoid X receptor beta
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of RXRB mRNA
|
CTD |
PMID:18769453 |
|
NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,818,709...4,825,359
|
|
| G
|
Ryr1
|
ryanodine receptor 1
|
multiple interactions increases expression
|
ISO
|
[BRL 37344 co-treated with Capsaicin] results in increased expression of RYR1 protein Capsaicin results in increased expression of RYR1 mRNA; Capsaicin results in increased expression of RYR1 protein
|
CTD |
PMID:39800145 |
|
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305
|
|
| G
|
Ryr2
|
ryanodine receptor 2
|
multiple interactions increases expression
|
ISO
|
[BRL 37344 co-treated with Capsaicin] results in increased expression of RYR2 protein Capsaicin results in increased expression of RYR2 mRNA; Capsaicin results in increased expression of RYR2 protein
|
CTD |
PMID:39800145 |
|
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705
|
|
| G
|
S100a4
|
S100 calcium-binding protein A4
|
increases expression
|
ISO
|
Capsaicin results in increased expression of S100A4 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
increases expression
|
EXP
|
Capsaicin results in increased expression of S100B protein
|
CTD |
PMID:17635592 |
|
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
S100g
|
S100 calcium binding protein G
|
increases expression
|
EXP
|
Capsaicin results in increased expression of S100G mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205
|
|
| G
|
Scn10a
|
sodium voltage-gated channel alpha subunit 10
|
multiple interactions increases response to substance
|
ISO
|
SCN10A protein affects the reaction [Capsaicin results in increased secretion of TAC1 protein alternative form] SCN10A results in increased susceptibility to Capsaicin
|
CTD |
PMID:12351708 PMID:18845912 |
|
NCBI chr 8:128,228,424...128,340,749
Ensembl chr 8:128,228,424...128,340,298
|
|
| G
|
Scp2
|
sterol carrier protein 2
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of SCP2 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:128,008,125...128,110,043
|
|
| G
|
Sdhb
|
succinate dehydrogenase complex iron sulfur subunit B
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SDHB protein
|
CTD |
PMID:39800145 |
|
NCBI chr 5:158,547,775...158,568,589
Ensembl chr 5:158,547,689...158,569,667
|
|
| G
|
Sele
|
selectin E
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of SELE protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELE protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SELE protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of SELE protein]
|
CTD |
PMID:22150557 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Sell
|
selectin L
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of SELL protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELL protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SELL protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of SELL protein]
|
CTD |
PMID:22150557 |
|
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
|
|
| G
|
Senp5
|
SUMO specific peptidase 5
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of SENP5 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr11:82,289,680...82,324,545
Ensembl chr11:82,289,648...82,324,542
|
|
| G
|
Serpine1
|
serpin family E member 1
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of SERPINE1 mRNA
|
CTD |
PMID:21310942 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Sesn1
|
sestrin 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SESN1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
|
|
| G
|
Sesn3
|
sestrin 3
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SESN3 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 8:19,415,307...19,470,943
Ensembl chr 8:19,415,347...19,466,904
|
|
| G
|
Sfpq
|
splicing factor proline and glutamine rich
|
increases expression
|
EXP
|
Capsaicin results in increased expression of SFPQ mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926
|
|
| G
|
Sh3bp5
|
SH3-domain binding protein 5
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of SH3BP5 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
|
|
| G
|
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of SH3KBP1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr X:38,686,530...39,031,658
Ensembl chr X:38,686,530...39,031,393
|
|
| G
|
Sirt1
|
sirtuin 1
|
affects expression increases expression
|
ISO
|
Capsaicin affects the expression of SIRT1 mRNA; Capsaicin affects the expression of SIRT1 protein Capsaicin results in increased expression of SIRT1 mRNA; Capsaicin results in increased expression of SIRT1 protein
|
CTD |
PMID:34939720 PMID:39800145 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc12a1
|
solute carrier family 12 member 1
|
multiple interactions increases expression
|
EXP
|
[Capsaicin co-treated with Sodium Chloride, Dietary] results in increased expression of SLC12A1 mRNA Capsaicin results in increased expression of SLC12A1 mRNA
|
CTD |
PMID:17414671 |
|
NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340
|
|
| G
|
Slc12a2
|
solute carrier family 12 member 2
|
affects response to substance
|
ISO
|
SLC12A2 affects the susceptibility to Capsaicin
|
CTD |
PMID:15135928 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
| G
|
Slc16a10
|
solute carrier family 16 member 10
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of SLC16A10 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr20:45,014,229...45,122,392
Ensembl chr20:45,014,235...45,122,358
|
|
| G
|
Slc22a2
|
solute carrier family 22 member 2
|
multiple interactions
|
ISO
|
Capsaicin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
|
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SLC2A4 mRNA
|
CTD |
PMID:19798065 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slc37a1
|
solute carrier family 37 member 1
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of SLC37A1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr20:9,361,733...9,435,227
Ensembl chr20:9,379,664...9,435,229
|
|
| G
|
Slit1
|
slit guidance ligand 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of SLIT1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:250,358,917...250,507,476
Ensembl chr 1:250,358,919...250,507,476
|
|
| G
|
Sln
|
sarcolipin
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SLN mRNA; Capsaicin results in increased expression of SLN protein
|
CTD |
PMID:39800145 |
|
NCBI chr 8:63,117,577...63,144,290
Ensembl chr 8:63,139,722...63,143,971
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
increases expression decreases response to substance multiple interactions
|
ISO
|
Capsaicin results in increased expression of SOD2 protein modified form SOD2 results in decreased susceptibility to Capsaicin phenyl-N-tert-butylnitrone inhibits the reaction [Capsaicin results in decreased activity of SOD2 protein]; phenyl-N-tert-butylnitrone inhibits the reaction [Capsaicin results in increased expression of SOD2 protein modified form]; tempol inhibits the reaction [Capsaicin results in decreased activity of SOD2 protein]; tempol inhibits the reaction [Capsaicin results in increased expression of SOD2 protein modified form]
|
CTD |
PMID:19129394 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sostdc1
|
sclerostin domain containing 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of SOSTDC1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 6:58,778,623...58,782,797
Ensembl chr 6:58,778,623...58,782,866
|
|
| G
|
Sp1
|
Sp1 transcription factor
|
multiple interactions increases localization
|
ISO
|
Capsaicin promotes the reaction [SP1 protein binds to TNFSF10 promoter] Capsaicin results in increased localization of SP1 protein
|
CTD |
PMID:22200406 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
| G
|
Spi1
|
Spi-1 proto-oncogene
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SPI1 mRNA
|
CTD |
PMID:17603282 |
|
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:97,527,572...97,549,540
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SPP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SPP1 protein]; Sumatriptan promotes the reaction [Capsaicin results in increased expression of SPP1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions increases activity
|
ISO EXP
|
Capsaicin results in decreased phosphorylation of and results in decreased activity of SRC protein AG 1879 inhibits the reaction [Capsaicin results in increased activity of SRC protein] SRC mutant form inhibits the reaction [Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]]
|
CTD |
PMID:17505005 PMID:20660715 PMID:21340460 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of SREBF1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Sst
|
somatostatin
|
multiple interactions increases secretion decreases expression increases expression
|
EXP ISO
|
AMN protein inhibits the reaction [Capsaicin results in increased expression of SST protein] Capsaicin results in increased secretion of SST protein Capsaicin results in decreased expression of SST mRNA
|
CTD |
PMID:8093704 PMID:8093880 PMID:9932722 PMID:16938409 PMID:19296048 PMID:19878665 More...
|
|
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
|
|
| G
|
Stat1
|
signal transducer and activator of transcription 1
|
increases expression multiple interactions increases response to substance
|
EXP ISO
|
Capsaicin results in increased expression of STAT1 mRNA; Capsaicin results in increased expression of STAT1 protein Capsaicin inhibits the reaction [IFNG results in increased activity of STAT1 protein]; Capsaicin results in increased phosphorylation of and results in increased activity of STAT1 protein STAT1 results in increased susceptibility to Capsaicin Capsaicin results in increased phosphorylation of and results in increased activity of STAT1 protein; CYBB mutant form inhibits the reaction [Capsaicin results in increased expression of STAT1 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TRPV1 protein]
|
CTD |
PMID:14530214 PMID:20712533 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions increases phosphorylation affects localization
|
ISO EXP
|
Bortezomib promotes the reaction [Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Capsaicin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]; Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein; pervanadate inhibits the reaction [Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Thalidomide promotes the reaction [Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein] Capsaicin results in increased phosphorylation of STAT3 protein Capsaicin inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; SR140333B inhibits the reaction [Capsaicin results in increased phosphorylation of STAT3 protein] Capsaicin affects the localization of STAT3 protein
|
CTD |
PMID:16788306 PMID:17505005 PMID:19285962 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Steap3
|
STEAP3 metalloreductase
|
multiple interactions
|
EXP
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of STEAP3 protein]
|
CTD |
PMID:20359164 |
|
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
|
|
| G
|
Suv39h1
|
SUV39H1 histone lysine methyltransferase
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of SUV39H1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
|
|
| G
|
Syn2
|
synapsin II
|
increases response to substance
|
ISO
|
SYN2 results in increased susceptibility to Capsaicin
|
CTD |
PMID:18701217 |
|
NCBI chr 4:149,858,919...150,016,845
Ensembl chr 4:149,851,520...150,019,650
|
|
| G
|
Syngap1
|
synaptic Ras GTPase activating protein 1
|
affects response to substance
|
ISO
|
SYNGAP1 affects the susceptibility to Capsaicin
|
CTD |
PMID:21525372 |
|
NCBI chr20:5,028,226...5,058,519
Ensembl chr20:5,026,707...5,057,751
|
|
| G
|
Syt7
|
synaptotagmin 7
|
increases expression
|
EXP
|
Capsaicin results in increased expression of SYT7 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 1:216,456,148...216,518,718
Ensembl chr 1:216,456,259...216,518,718
|
|
| G
|
Tac1
|
tachykinin, precursor 1
|
affects expression decreases activity decreases expression decreases secretion increases secretion increases expression multiple interactions
|
ISO EXP
|
Capsaicin affects the expression of TAC1 protein TAC1 protein results in decreased activity of Capsaicin Capsaicin results in decreased expression of TAC1 mRNA; Capsaicin results in decreased expression of TAC1 protein Capsaicin results in decreased secretion of TAC1 protein Capsaicin results in increased secretion of TAC1 protein; Capsaicin results in increased secretion of TAC1 protein alternative form Capsaicin results in increased expression of TAC1 mRNA; Capsaicin results in increased expression of TAC1 protein [Capsaicin co-treated with CCK protein alternative form] results in increased expression of TAC1 protein; Capsaicin inhibits the reaction [sodium arsenite results in increased secretion of TAC1 protein]; SCN10A protein affects the reaction [Capsaicin results in increased secretion of TAC1 protein alternative form]; TAC1 protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin] 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; 2-aminoethyl diphenylborinate inhibits the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; AMN protein inhibits the reaction [Capsaicin results in increased expression of TAC1 protein]; bisindolylmaleimide I inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Capsaicin inhibits the reaction [Freund's Adjuvant results in increased expression of TAC1 mRNA]; Capsaicin inhibits the reaction [Potassium results in increased secretion of TAC1 protein modified form]; Capsaicin results in increased expression of and results in increased secretion of TAC1 protein; capsazepine inhibits the reaction [Capsaicin results in increased secretion of TAC1 protein]; capsazepine inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; cochinchinenin inhibits the reaction [Capsaicin results in increased secretion of TAC1 protein]; Colforsin promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; CP 96345 inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; dragon's blood inhibits the reaction [Capsaicin results in increased secretion of TAC1 protein]; Freund's Adjuvant promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Gabapentin inhibits the reaction [Freund's Adjuvant promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; GAL protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein alternative form]; Go 6976 inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; HU 211 inhibits the reaction [Colforsin promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; HU 211 inhibits the reaction [KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Iloprost promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Indomethacin inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Indomethacin inhibits the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; KNG1 protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Morphine promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [KNG1 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; NGF protein promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Phorbol 12,13-Dibutyrate promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]; Pregabalin inhibits the reaction [Freund's Adjuvant promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; Pregabalin inhibits the reaction [Phorbol 12,13-Dibutyrate promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; pyrazolanthrone promotes the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; SB 203580 inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]; U 0126 inhibits the reaction [GR 73632 promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]] Capsaicin results in increased secretion of TAC1 protein; Capsaicin results in increased secretion of TAC1 protein alternative form; Capsaicin results in increased secretion of TAC1 protein modified form
|
CTD |
PMID:2325850 PMID:2480171 PMID:3412491 PMID:6205719 PMID:7473211 PMID:7530819 PMID:8971780 PMID:9259450 PMID:9460767 PMID:9932722 PMID:9973426 PMID:10683199 PMID:13680092 PMID:14499429 PMID:14521749 PMID:14985054 PMID:14987252 PMID:15750287 PMID:15964684 PMID:16039053 PMID:16696851 PMID:16938409 PMID:16959413 PMID:17056641 PMID:17574719 PMID:17687396 PMID:18203709 PMID:18311519 PMID:18344596 PMID:18441096 PMID:18809416 PMID:18845912 PMID:19112407 PMID:19333140 PMID:21294877 PMID:22062353 PMID:22198006 More...
|
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
|
|
| G
|
Tac3
|
tachykinin precursor 3
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of TAC2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:65,447,817...65,454,427
Ensembl chr 7:65,447,817...65,454,427
|
|
| G
|
Tacr1
|
tachykinin receptor 1
|
decreases expression increases expression multiple interactions affects expression increases response to substance
|
ISO EXP
|
Capsaicin results in decreased expression of TACR1 mRNA; Capsaicin results in decreased expression of TACR1 protein Capsaicin results in increased expression of TACR1 protein Capsaicin affects the reaction [Vehicle Emissions affects the expression of TACR1 mRNA]; Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR1 mRNA]; Capsaicin promotes the reaction [Vehicle Emissions results in increased expression of TACR1 protein] Capsaicin affects the expression of TACR1 mRNA TACR1 results in increased susceptibility to Capsaicin
|
CTD |
PMID:10360863 PMID:11166975 PMID:13680092 PMID:18441096 PMID:19399481 PMID:21294877 More...
|
|
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492
|
|
| G
|
Tacr2
|
tachykinin receptor 2
|
increases response to substance multiple interactions decreases expression
|
ISO EXP
|
TACR2 gene polymorphism results in increased susceptibility to Capsaicin Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR2 mRNA] Capsaicin results in decreased expression of TACR2 mRNA
|
CTD |
PMID:16278290 PMID:16893949 PMID:19399481 |
|
NCBI chr20:30,751,645...30,766,181
Ensembl chr20:30,751,557...30,766,180
|
|
| G
|
Tal1
|
TAL bHLH transcription factor 1, erythroid differentiation factor
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of TAL1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:133,823,093...133,837,737
Ensembl chr 5:133,826,003...133,837,738
|
|
| G
|
Tek
|
TEK receptor tyrosine kinase
|
increases expression multiple interactions
|
EXP ISO
|
Capsaicin results in increased expression of TEK protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TEK protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TEK protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TEK protein] Capsaicin results in increased expression of TEK mRNA
|
CTD |
PMID:21310942 PMID:22150557 |
|
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
|
|
| G
|
Tgfa
|
transforming growth factor alpha
|
increases expression
|
EXP
|
Capsaicin results in increased expression of TGFA mRNA; Capsaicin results in increased expression of TGFA protein
|
CTD |
PMID:11989832 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in decreased expression of TGFB1 mRNA Capsaicin results in increased expression of TGFB1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]
|
CTD |
PMID:18533110 PMID:22150557 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of TGFB2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tgfb3
|
transforming growth factor, beta 3
|
multiple interactions increases expression
|
EXP
|
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
|
|
| G
|
Thop1
|
thimet oligopeptidase 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of THOP1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 7:9,283,617...9,295,957
Ensembl chr 7:9,283,617...9,295,957
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of TIMP1 mRNA Capsaicin results in increased expression of TIMP1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]
|
CTD |
PMID:21310942 PMID:22150557 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of TIMP2 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Timp3
|
TIMP metallopeptidase inhibitor 3
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of TIMP3 mRNA Capsaicin results in increased expression of TIMP3 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]
|
CTD |
PMID:21310942 PMID:22150557 |
|
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of TLR4 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tm7sf2
|
transmembrane 7 superfamily member 2
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of TM7SF2 mRNA
|
CTD |
PMID:18533110 |
|
NCBI chr 1:212,785,217...212,789,572
Ensembl chr 1:212,785,217...212,789,557
|
|
| G
|
Tmem37
|
transmembrane protein 37
|
increases expression
|
EXP
|
Capsaicin results in increased expression of TMEM37 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747
|
|
| G
|
Tnc
|
tenascin C
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of TNC mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
decreases secretion increases expression decreases expression multiple interactions increases secretion increases response to substance affects response to substance
|
ISO EXP
|
Capsaicin results in decreased secretion of TNF protein Capsaicin results in increased expression of TNF mRNA; Capsaicin results in increased expression of TNF protein Capsaicin results in decreased expression of TNF mRNA; Capsaicin results in decreased expression of TNF protein [Capsaicin results in increased susceptibility to Formaldehyde] which results in increased expression of TNF mRNA; [Capsaicin results in increased susceptibility to Glyoxal] which results in increased expression of TNF mRNA; [Lipopolysaccharides co-treated with Capsaicin] results in increased expression of TNF protein; [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of TNF mRNA]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Capsaicin inhibits the reaction [monophosphoryl lipid A results in decreased expression of TNF protein]; Capsaicin inhibits the reaction [Nitroglycerin results in decreased expression of TNF protein]; capsazepine inhibits the reaction [Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Ketotifen inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TNF protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Ranitidine inhibits the reaction [Capsaicin results in increased expression of TNF protein]; spantide II inhibits the reaction [Capsaicin results in increased expression of TNF protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNF protein] Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]] Capsaicin results in increased secretion of TNF protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased secretion of TNF protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased secretion of TNF protein]; bisindolylmaleimide inhibits the reaction [Capsaicin results in increased secretion of TNF protein]; CALCA protein alternative form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; Capsaicin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Capsaicin inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]; Capsaicin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]; Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; capsazepine inhibits the reaction [Capsaicin results in increased secretion of TNF protein] TNF protein results in increased susceptibility to Capsaicin TNF protein affects the susceptibility to Capsaicin
|
CTD |
PMID:11408036 PMID:11744139 PMID:12024109 PMID:12034025 PMID:15265675 PMID:15313406 PMID:15502055 PMID:15579495 PMID:16540674 PMID:17719033 PMID:18460982 PMID:18463260 PMID:18508045 PMID:18582539 PMID:19798065 PMID:19878665 PMID:20359164 PMID:20712533 PMID:21474332 PMID:22150557 PMID:28005965 PMID:29496360 PMID:30244119 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf10b
|
TNF receptor superfamily member 10b
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TNFRSF10A mRNA; Capsaicin results in increased expression of TNFRSF10A protein
|
CTD |
PMID:19502594 PMID:19846903 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
|
|
| G
|
Tnfrsf19
|
TNF receptor superfamily member 19
|
affects expression multiple interactions
|
EXP
|
Capsaicin affects the expression of TNFRSF19 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]; Sumatriptan inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
increases expression multiple interactions
|
ISO
|
Capsaicin results in increased expression of TNFRSF1A mRNA capsazepine inhibits the reaction [Capsaicin results in increased expression of TNFRSF1A protein]; phenyl-N-tert-butylnitrone inhibits the reaction [Capsaicin results in increased expression of TNFRSF1A protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in increased expression of TNFRSF1A protein]
|
CTD |
PMID:19531269 PMID:21310942 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf25
|
TNF receptor superfamily member 25
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TNFRSF25 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions increases expression increases response to substance increases activity
|
ISO EXP
|
[Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP2 protein; [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP6 protein; [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP7 protein; [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein; [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein; BIRC5 results in decreased activity of [Capsaicin co-treated with TNFSF10 protein]; Capsaicin promotes the reaction [SP1 protein binds to TNFSF10 promoter]; Capsaicin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP3 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP8 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP9 protein]; Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of BID protein]; Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein]; Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of TNFSF10 mRNA]; staurosporine aglycone inhibits the reaction [Capsaicin results in increased expression of TNFSF10 mRNA]; TNFRSF10B mutant form inhibits the reaction [Capsaicin results in increased susceptibility to TNFSF10 protein] [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein] Capsaicin results in increased expression of TNFSF10 mRNA; Capsaicin results in increased expression of TNFSF10 protein Capsaicin results in increased activity of TNFSF10 protein
|
CTD |
PMID:19939880 PMID:22150557 PMID:22200406 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Tom1
|
target of myb1 membrane trafficking protein
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of TOM1 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr19:13,411,227...13,446,129
Ensembl chr19:13,411,157...13,446,110
|
|
| G
|
Tp53
|
tumor protein p53
|
decreases degradation affects response to substance increases phosphorylation multiple interactions increases expression increases degradation
|
ISO
|
Capsaicin results in decreased degradation of TP53 protein TP53 affects the susceptibility to Capsaicin Capsaicin results in increased phosphorylation of TP53 protein 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased expression of TP53 protein]; 3-aminobenzamide inhibits the reaction [Capsaicin results in increased expression of TP53 protein]; 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in increased degradation of TP53 protein]; Caffeine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; Capsaicin promotes the reaction [resveratrol results in increased expression of TP53 protein]; Capsaicin results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein; Capsaicin results in increased phosphorylation of and results in increased expression of TP53 protein; CAT protein inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein]; MAPK8 protein promotes the reaction [Capsaicin results in decreased degradation of TP53 protein]; pifithrin inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; pyrazolanthrone inhibits the reaction [Capsaicin results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein]; resveratrol promotes the reaction [Capsaicin results in increased expression of TP53 protein]; TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]]; TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]]; TP53 affects the reaction [Capsaicin results in decreased expression of MDM2 protein]; TP53 affects the reaction [Capsaicin results in increased expression of NOS1 protein]; TP53 affects the reaction [Capsaicin results in increased expression of NOS3 protein]; TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS2 protein]]; TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein]]; TP53 protein promotes the reaction [Capsaicin results in increased expression of BAX protein]; Tunicamycin promotes the reaction [Capsaicin results in increased degradation of TP53 protein] Capsaicin results in increased expression of TP53 mRNA; Capsaicin results in increased expression of TP53 protein Capsaicin results in increased expression of TRP53
|
CTD |
PMID:9461043 PMID:14871840 PMID:16540674 PMID:17292493 PMID:18991268 PMID:19139269 PMID:19331147 PMID:19502594 PMID:19699254 PMID:19846903 PMID:20069556 PMID:20646592 PMID:22226932 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53inp2
|
tumor protein p53 inducible nuclear protein 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TP53INP2 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 3:164,341,618...164,350,270
Ensembl chr 3:164,343,205...164,350,225
|
|
| G
|
Tpi1
|
triosephosphate isomerase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TPI1 mRNA; Capsaicin results in increased expression of TPI1 protein
|
CTD |
PMID:19891501 |
|
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
|
|
| G
|
Traf3
|
Tnf receptor-associated factor 3
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TRAF3 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr 6:136,025,097...136,128,363
Ensembl chr 6:136,027,157...136,128,363
|
|
| G
|
Traf4
|
Tnf receptor associated factor 4
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TRAF4 mRNA
|
CTD |
PMID:19502594 |
|
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,552,253...63,558,356
|
|
| G
|
Trafd1
|
TRAF type zinc finger domain containing 1
|
increases expression
|
EXP
|
Capsaicin results in increased expression of TRAFD1 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr12:40,826,251...40,840,169
Ensembl chr12:40,825,851...40,841,320
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TRIB3 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Triml1
|
tripartite motif family-like 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of TRIML1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr16:55,727,383...55,737,770
Ensembl chr16:55,729,691...55,737,769
|
|
| G
|
Trpa1
|
transient receptor potential cation channel, subfamily A, member 1
|
multiple interactions increases activity decreases expression
|
EXP ISO
|
Calcium affects the reaction [Capsaicin inhibits the reaction [TRPA1 protein affects the susceptibility to mustard oil]] Capsaicin results in increased activity of TRPA1 protein Capsaicin results in decreased expression of TRPA1 mRNA
|
CTD |
PMID:17590514 PMID:18079164 PMID:29054683 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:9,163,060...9,217,325
|
|
| G
|
Trpc5
|
transient receptor potential cation channel, subfamily C, member 5
|
increases expression
|
EXP
|
Capsaicin results in increased expression of TRPC5 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr X:112,742,828...113,027,638
Ensembl chr X:112,742,828...113,027,638
|
|
| G
|
Trpm8
|
transient receptor potential cation channel, subfamily M, member 8
|
decreases expression increases activity
|
EXP ISO
|
Capsaicin results in decreased expression of TRPM8 mRNA Capsaicin results in increased activity of TRPM8 protein
|
CTD |
PMID:18079164 PMID:29054683 |
|
NCBI chr 9:96,315,567...96,437,959
Ensembl chr 9:96,351,681...96,436,617
|
|
| G
|
Trpv1
|
transient receptor potential cation channel, subfamily V, member 1
|
affects response to substance decreases expression increases response to substance increases activity increases expression affects binding affects localization multiple interactions decreases response to substance
|
ISO EXP
|
TRPV1 protein affects the susceptibility to Capsaicin; TRPV1 protein polymorphism affects the susceptibility to Capsaicin analog Capsaicin results in decreased expression of TRPV1 mRNA; Capsaicin results in decreased expression of TRPV1 protein TRPV1 protein results in increased susceptibility to Capsaicin; TRPV1 protein results in increased susceptibility to Capsaicin analog Capsaicin results in increased activity of TRPV1 protein Capsaicin results in increased expression of TRPV1 mRNA; Capsaicin results in increased expression of TRPV1 protein Capsaicin results in increased activity of TRPV1; Capsaicin results in increased activity of TRPV1 protein Capsaicin binds to TRPV1 protein Capsaicin affects the localization of TRPV1 protein Capsaicin analog results in increased activity of TRPV1 protein; Capsaicin results in increased activity of TRPV1; Capsaicin results in increased activity of TRPV1 protein 1-Methyl-3-isobutylxanthine promotes the reaction [Capsaicin results in increased activity of TRPV1]; 3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP promotes the reaction [Capsaicin results in increased activity of TRPV1]; [Capsaicin binds to and results in increased activity of TRPV1 protein] which results in increased abundance of Calcium; [Capsaicin binds to TRPV1 protein] which results in increased uptake of Calcium; [Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium; [Capsaicin results in increased activity of TRPV1 protein] which results in increased import of Calcium; [Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium; [Capsaicin results in increased activity of TRPV1] which results in increased uptake of Calcium; BDKRB2 affects the reaction [Capsaicin results in increased activity of TRPV1 protein]; BDKRB2 affects the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]]; Cannabidiol inhibits the reaction [[Capsaicin binds to TRPV1 protein] which results in increased uptake of Calcium]; Cannabidiol inhibits the reaction [Capsaicin binds to TRPV1 protein]; Capsaicin binds to and results in increased activity of TRPV1 protein; Capsaicin promotes the reaction [TRPV1 protein results in increased abundance of Calcium]; Capsaicin promotes the reaction [TRPV1 protein results in increased activity of CASP3 protein]; Capsaicin promotes the reaction [TRPV1 protein results in increased uptake of Calcium]; capsazepine inhibits the reaction [Capsaicin binds to and results in increased activity of TRPV1 protein]; capsazepine inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased abundance of Calcium]]; capsazepine inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased uptake of Calcium]]; capsazepine inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; capsazepine inhibits the reaction [Phosphatidylinositol 4,5-Diphosphate affects the reaction [Capsaicin results in increased activity of TRPV1 protein]]; capsazepine promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Colforsin promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Colforsin promotes the reaction [Capsaicin results in increased activity of TRPV1]; Edetic Acid inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased uptake of Calcium]]; EDN1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Egtazic Acid inhibits the reaction [Capsaicin binds to and results in increased activity of TRPV1 protein]; F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]; iodoresiniferatoxin inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased abundance of Calcium]]; KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Phosphatidylinositol 4,5-Diphosphate affects the reaction [Capsaicin results in increased activity of TRPV1 protein]; PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]]; Rimonabant inhibits the reaction [Capsaicin binds to and results in increased activity of TRPV1 protein]; Ruthenium Red inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased abundance of Calcium]]; Tetradecanoylphorbol Acetate inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; TRPV1 affects the reaction [Capsaicin results in increased expression of IGF1 mRNA]; TRPV1 affects the reaction [Capsaicin results in increased expression of IGF1R mRNA]; TRPV1 inhibits the reaction [Capsaicin results in increased expression of and results in increased activity of MMP9 protein]; TRPV1 promotes the reaction [Capsaicin results in increased uptake of Calcium]; TRPV1 protein promotes the reaction [Capsaicin results in increased expression of IL6 mRNA]; TRPV1 protein promotes the reaction [Capsaicin results in increased expression of IL6 protein]; Xenon inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein] 1-Methyl-3-isobutylxanthine promotes the reaction [Capsaicin results in increased activity of TRPV1]; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; 2,4-bis(4'-fluorophenethylamino)-6-(3'-(N,N-dimethylamino)propylamino)-1,3,5-triazine inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; 3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; 3-amino-5-((2-((2-methoxyethyl)amino)-6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)quinoxalin-2(1H)-one inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP promotes the reaction [Capsaicin results in increased activity of TRPV1]; [Capsaicin binds to and affects the activity of TRPV1 protein] which results in increased secretion of Adenosine Triphosphate; [Capsaicin results in increased activity of TRPV1 protein] which results in increased transport of Calcium; [Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium; [Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Cobalt; [Capsaicin results in increased activity of TRPV1] which results in increased uptake of Calcium; Acrylamide analog inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Amitriptyline inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; benzimidazole analog inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Bupivacaine affects the reaction [Capsaicin results in increased activity of TRPV1 protein]; Butyrates promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Butyrates promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Cadmium inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Calcium affects the reaction [Capsaicin inhibits the reaction [TRPV1 protein affects the susceptibility to Capsaicin]]; Calcium affects the reaction [mustard oil inhibits the reaction [TRPV1 protein affects the susceptibility to Capsaicin]]; Capsaicin binds to and results in increased activity of TRPV1 protein; Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TRPV1 mRNA]; Capsaicin promotes the reaction [adenosine 5'-O-(3-thiotriphosphate) results in increased activity of TRPV1 protein]; Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of TRPV1 protein]; Capsaicin promotes the reaction [TRPV1 protein binds to TRPV1 protein]; capsazepine inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Cobalt]; capsazepine inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; chelerythrine inhibits the reaction [Capsaicin results in increased expression of TRPV1 protein]; Cobalt inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Colforsin promotes the reaction [Capsaicin results in increased activity of TRPV1]; Copper inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Docosahexaenoic Acids promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Eicosapentaenoic Acid inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Estradiol inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Fulvestrant inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; gamma-Linolenic Acid inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; geldanamycin affects the reaction [Capsaicin results in increased activity of TRPV1]; iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of TRPV1 protein]; JYL 1421 inhibits the reaction [Capsaicin binds to TRPV1 protein]; JYL 1421 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; KJM 429 inhibits the reaction [Capsaicin binds to TRPV1 protein]; Lidocaine promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; MCS-18 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; N-((4-(((3-(6-((2-amino-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)) -6-(trifluoromethyl)pyridin-2-yl)amino)methyl)-2-fluorophenyl)methanesulfonamide inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Nickel inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Octoxynol inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; oxophenylarsine inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; oxophenylarsine inhibits the reaction [Lidocaine promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]]; Ruthenium Red inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Ruthenium Red inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Cobalt]; Serotonin promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased transport of Calcium]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of TRPV1 protein]; Tamoxifen inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]]; Tamoxifen inhibits the reaction [Estradiol inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]]; tert-butyl-2-(6-((2-(acetylamino)-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)-5-(trifluoromethyl)phenylcarbamate inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Tetracaine promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]; TRPV1 protein affects the reaction [Capsaicin results in increased secretion of CALCA protein] 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; [BRL 37344 co-treated with Capsaicin] results in increased expression of TRPV1 protein; [N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide co-treated with Capsaicin] results in increased expression of TRPV1 protein; CALCA protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin]; Capsaicin binds to and results in increased activity of TRPV1 protein; capsazepine inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; CYBB protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin]; Linolenic Acids inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; RARRES2 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; RTKI cpd inhibits the reaction [TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]]; TAC1 protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin]; TRPV1 gene mutant form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]]; TRPV1 gene mutant form inhibits the reaction [Capsaicin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; TRPV1 gene mutant form inhibits the reaction [Capsaicin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL10 protein]]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in increased abundance of Reactive Oxygen Species]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein]; TRPV1 gene mutant form inhibits the reaction [Capsaicin results in increased expression of TNFRSF1A protein]; TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]; TRPV1 mutant form inhibits the reaction [Capsaicin results in increased abundance of Reactive Oxygen Species]; TRPV1 protein affects the reaction [Capsaicin results in increased abundance of Calcium]; TRPV1 protein affects the reaction [Capsaicin results in increased transport of Calcium]; TRPV1 results in decreased susceptibility to [Capsaicin co-treated with Tetradecanoylphorbol Acetate]; U 0126 inhibits the reaction [TRPV1 gene mutant form promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Capsaicin] results in increased expression of PTGS2 protein]] TRPV1 protein results in increased susceptibility to Capsaicin; TRPV1 results in increased susceptibility to Capsaicin TRPV1 protein mutant form results in decreased susceptibility to Capsaicin; TRPV1 results in decreased susceptibility to Capsaicin
|
CTD |
PMID:11140687 PMID:11278420 PMID:11358970 PMID:11606325 PMID:11930156 PMID:12196566 PMID:12237342 PMID:12569099 PMID:12886029 PMID:14975683 PMID:14987252 PMID:15331673 PMID:15363968 PMID:15471852 PMID:15601931 PMID:15615864 PMID:15781048 PMID:15854744 PMID:16135784 PMID:16278290 PMID:16319926 PMID:16597917 PMID:16788306 PMID:16793902 PMID:16901936 PMID:16926503 PMID:17018028 PMID:17038422 PMID:17110039 PMID:17306835 PMID:17347480 PMID:17353553 PMID:17392452 PMID:17442041 PMID:17590514 PMID:17627983 PMID:17825279 PMID:17881535 PMID:17913835 PMID:17984664 PMID:18079164 PMID:18172555 PMID:18178321 PMID:18203709 PMID:18230619 PMID:18249134 PMID:18331834 PMID:18508045 PMID:18550765 PMID:18579526 PMID:18617618 PMID:18752301 PMID:18769453 PMID:18804451 PMID:19056576 PMID:19399481 PMID:19429182 PMID:19531269 PMID:19537933 PMID:19566590 PMID:19602228 PMID:19798065 PMID:19860742 PMID:19878665 PMID:19959817 PMID:20383154 PMID:20660715 PMID:20712533 PMID:21056583 PMID:21246380 PMID:21310942 PMID:21343315 PMID:21908651 PMID:21950613 PMID:21984481 PMID:22566028 PMID:23264033 PMID:24746025 PMID:27545873 PMID:28790335 PMID:29054683 PMID:29658714 PMID:30424709 PMID:30636360 PMID:31096838 PMID:39800145 More...
|
|
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021
|
|
| G
|
Trpv4
|
transient receptor potential cation channel, subfamily V, member 4
|
increases expression affects expression decreases expression
|
EXP ISO
|
Capsaicin results in increased expression of TRPV4 mRNA Capsaicin affects the expression of TRPV4 mRNA Capsaicin results in decreased expression of TRPV4 mRNA
|
CTD |
PMID:16278290 PMID:39800145 |
|
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143
|
|
| G
|
Trpv6
|
transient receptor potential cation channel, subfamily V, member 6
|
multiple interactions increases response to substance
|
ISO
|
TRPV6 protein promotes the reaction [Capsaicin results in increased abundance of Calcium]; TRPV6 protein promotes the reaction [Capsaicin results in increased expression of BAX protein] TRPV6 protein results in increased susceptibility to Capsaicin
|
CTD |
PMID:17292493 |
|
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671
|
|
| G
|
Txnip
|
thioredoxin interacting protein
|
decreases expression
|
ISO
|
Capsaicin results in decreased expression of TXNIP mRNA
|
CTD |
PMID:33512557 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
| G
|
Ucp1
|
uncoupling protein 1
|
decreases expression multiple interactions
|
EXP
|
Capsaicin results in decreased expression of UCP1 mRNA; Capsaicin results in decreased expression of UCP1 protein Capsaicin promotes the reaction [Dietary Fats results in increased expression of UCP1 mRNA]
|
CTD |
PMID:18079164 PMID:20359164 |
|
NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
affects response to substance increases expression multiple interactions
|
ISO EXP
|
UCP2 protein polymorphism affects the susceptibility to Capsaicin analog Capsaicin results in increased expression of UCP2 mRNA; Capsaicin results in increased expression of UCP2 protein [BRL 37344 co-treated with Capsaicin] results in increased expression of UCP2 protein Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of UCP2 mRNA]
|
CTD |
PMID:19056576 PMID:20359164 PMID:39800145 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Ucp3
|
uncoupling protein 3
|
multiple interactions increases expression
|
EXP ISO
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of UCP3 protein] [BRL 37344 co-treated with Capsaicin] results in increased expression of UCP3 protein Capsaicin results in increased expression of UCP3 mRNA; Capsaicin results in increased expression of UCP3 protein
|
CTD |
PMID:20517883 PMID:39800145 |
|
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210
|
|
| G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
increases glucuronidation
|
ISO
|
UGT1A1 protein results in increased glucuronidation of Capsaicin
|
CTD |
PMID:14557274 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
increases glucuronidation
|
ISO
|
UGT1A9 protein results in increased glucuronidation of Capsaicin
|
CTD |
PMID:14557274 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ulk1
|
unc-51 like autophagy activating kinase 1
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ULK1 mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
|
|
| G
|
Unc13a
|
unc-13 homolog A
|
increases expression
|
EXP
|
Capsaicin results in increased expression of UNC13A mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr16:18,367,891...18,415,808
Ensembl chr16:18,367,919...18,415,899
|
|
| G
|
Uqcrc2
|
ubiquinol cytochrome c reductase core protein 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of UQCRC2 protein
|
CTD |
PMID:39800145 |
|
NCBI chr 1:184,599,240...184,629,804
Ensembl chr 1:184,599,212...184,630,946
|
|
| G
|
Usp5
|
ubiquitin specific peptidase 5
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of USP5 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr 4:159,305,927...159,321,345
Ensembl chr 4:159,305,938...159,320,956
|
|
| G
|
Vamp2
|
vesicle-associated membrane protein 2
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of VAMP2 mRNA
|
CTD |
PMID:20349343 |
|
NCBI chr10:54,292,423...54,296,657
Ensembl chr10:54,292,806...54,296,654
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
increases expression multiple interactions
|
ISO EXP
|
Capsaicin results in increased expression of VCAM1 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]
|
CTD |
PMID:9973426 PMID:22150557 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vdac2
|
voltage-dependent anion channel 2
|
increases expression
|
ISO
|
Capsaicin results in increased expression of VDAC2 mRNA
|
CTD |
PMID:39800145 |
|
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,512,216...2,532,229
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
decreases expression increases expression multiple interactions decreases activity increases secretion
|
ISO EXP
|
Capsaicin results in decreased expression of VEGFA protein Capsaicin results in increased expression of VEGFA mRNA Capsaicin results in increased expression of VEGFA protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VEGFA protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of VEGFA protein]; Sumatriptan affects the reaction [Capsaicin results in increased expression of VEGFA protein] Capsaicin results in decreased activity of VEGFA Capsaicin results in increased secretion of VEGFA protein
|
CTD |
PMID:12242509 PMID:14744780 PMID:17505005 PMID:21310942 PMID:22150557 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vim
|
vimentin
|
multiple interactions decreases expression
|
EXP ISO
|
Capsaicin inhibits the reaction [Dietary Fats results in increased expression of VIM protein] Capsaicin results in decreased expression of VIM protein
|
CTD |
PMID:20359164 PMID:36044967 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vip
|
vasoactive intestinal peptide
|
decreases expression increases expression
|
EXP
|
Capsaicin results in decreased expression of VIP mRNA Capsaicin results in increased expression of VIP mRNA
|
CTD |
PMID:8971780 PMID:20349343 |
|
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:44,470,462...44,478,558
|
|
| G
|
Vom1r90
|
vomeronasal 1 receptor 90
|
increases expression
|
EXP
|
Capsaicin results in increased expression of VOM1R90 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 4:123,696,273...123,705,276
Ensembl chr 4:123,696,273...123,705,287
|
|
| G
|
Wnt7a
|
Wnt family member 7A
|
decreases expression
|
EXP
|
Capsaicin results in decreased expression of WNT7A mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr 4:125,420,276...125,466,149
Ensembl chr 4:125,420,276...125,466,149
|
|
| G
|
Zc3h12a
|
zinc finger CCCH type containing 12A
|
increases expression
|
ISO
|
Capsaicin results in increased expression of ZC3H12A mRNA
|
CTD |
PMID:36044967 |
|
NCBI chr 5:142,661,193...142,670,051
Ensembl chr 5:142,661,199...142,669,985
|
|
| G
|
Zfp2
|
zinc finger protein 2
|
increases expression
|
EXP
|
Capsaicin results in increased expression of ZFP2 mRNA
|
CTD |
PMID:16278290 |
|
NCBI chr10:35,701,303...35,729,861
Ensembl chr10:35,702,151...35,730,108
|
|
| G
|
Zfp866
|
zinc finger protein 866
|
increases expression multiple interactions
|
EXP
|
Capsaicin results in increased expression of CXCL5 protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]
|
CTD |
PMID:22150557 |
|
NCBI chr16:19,687,869...19,710,407
Ensembl chr16:19,702,297...19,709,330
|
|
|
|
| G
|
Aacs
|
acetoacetyl-CoA synthetase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AACS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543
|
|
| G
|
Aak1
|
AP2 associated kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AAK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:120,845,012...121,009,170
Ensembl chr 4:120,858,557...121,004,236
|
|
| G
|
Aars1
|
alanyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
affects expression multiple interactions
|
ISO EXP
|
Carbamazepine affects the expression of ABCA1 mRNA [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ABCA1 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ABCA1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of ABCA1 mRNA
|
CTD |
PMID:25979313 PMID:35786680 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abca6
|
ATP binding cassette subfamily A member 6
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of ABCA6 mRNA Carbamazepine affects the expression of ABCA6 mRNA
|
CTD |
PMID:17112801 PMID:25979313 |
|
NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899
|
|
| G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of ABCB11 protein
|
CTD |
PMID:39023798 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
affects response to substance multiple interactions increases expression decreases activity affects transport
|
ISO EXP
|
ABCB1 gene polymorphism affects the susceptibility to Carbamazepine; ABCB1 protein affects the susceptibility to Carbamazepine Amino Acids, Peptides, and Proteins inhibits the reaction [Carbamazepine results in increased expression of ABCB1 protein]; Carbamazepine results in increased expression of and results in increased activity of ABCB1A protein Carbamazepine results in increased expression of ABCB1 mRNA; Carbamazepine results in increased expression of ABCB1 protein Carbamazepine results in decreased activity of ABCB1 protein ABCB1 protein affects the transport of Carbamazepine
|
CTD |
PMID:14749549 PMID:15371980 PMID:15569486 PMID:16753003 PMID:16842400 PMID:17376120 PMID:18408562 PMID:18440557 PMID:18473823 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
affects abundance
|
ISO
|
ABCB1B protein affects the abundance of Carbamazepine
|
CTD |
PMID:12122045 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Abcb7
|
ATP binding cassette subfamily B member 7
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of ABCB7 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:73,361,310...73,502,547
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
increases expression multiple interactions
|
EXP
|
Carbamazepine results in increased expression of ABCC1 protein KN 62 inhibits the reaction [Carbamazepine results in increased expression of ABCC1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Carbamazepine results in increased expression of ABCC1 protein]
|
CTD |
PMID:18473823 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Abcc10
|
ATP binding cassette subfamily C member 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABCC10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:22,154,811...22,174,743
Ensembl chr 9:22,154,804...22,174,743
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
affects response to substance increases expression increases transport multiple interactions
|
ISO EXP
|
ABCC2 gene SNP affects the susceptibility to Carbamazepine Carbamazepine results in increased expression of ABCC2 mRNA; Carbamazepine results in increased expression of ABCC2 protein ABCC2 protein results in increased transport of Carbamazepine KN 62 inhibits the reaction [Carbamazepine results in increased expression of ABCC2 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Carbamazepine results in increased expression of ABCC2 protein]
|
CTD |
PMID:15371980 PMID:17112801 PMID:18473823 PMID:20216337 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of ABCC3 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABCC4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcf1
|
ATP binding cassette subfamily F member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABCF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of ABCG2 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Abl2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABL2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr13:71,223,902...71,319,770
Ensembl chr13:71,224,019...71,389,775
|
|
| G
|
Abracl
|
ABRA C-terminal like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABRACL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:14,474,802...14,484,992
Ensembl chr 1:14,474,803...14,485,055
|
|
| G
|
Abtb3
|
ankyrin repeat and BTB domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ABTB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:19,922,883...20,199,740
Ensembl chr 7:19,923,814...20,198,110
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACIN1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Ackr3
|
atypical chemokine receptor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACKR3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214
|
|
| G
|
Acot13
|
acyl-CoA thioesterase 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACOT13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876
|
|
| G
|
Acot9
|
acyl-CoA thioesterase 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACOT9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:43,922,943...43,973,311
Ensembl chr X:43,914,923...43,973,205
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ACOX1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of ACOX1 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Acp2
|
acid phosphatase 2, lysosomal
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565
|
|
| G
|
Acsbg1
|
acyl-CoA synthetase bubblegum family member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACSBG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178
|
|
| G
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACSL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACSL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Acsm3
|
acyl-CoA synthetase medium-chain family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACSM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACTA1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Actc1
|
actin, alpha, cardiac muscle 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACTC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACTG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Actmap
|
actin maturation protease
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACTMAP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:91,618,012...91,627,490
Ensembl chr 1:91,617,859...91,627,489
|
|
| G
|
Actn1
|
actinin, alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACTN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Acvr1
|
activin A receptor type 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACVR1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:63,387,378...63,506,980
Ensembl chr 3:63,387,381...63,477,884
|
|
| G
|
Acvr1b
|
activin A receptor type 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACVR1B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:134,164,987...134,208,389
Ensembl chr 7:134,164,991...134,208,388
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACVR2B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Acyp1
|
acylphosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ACYP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:110,650,213...110,663,612
|
|
| G
|
Adam19
|
ADAM metallopeptidase domain 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADAM19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455
|
|
| G
|
Adam28
|
ADAM metallopeptidase domain 28
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADAM28 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:50,184,286...50,250,605
Ensembl chr15:50,127,516...50,250,526
|
|
| G
|
Adam9
|
ADAM metallopeptidase domain 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADAM9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646
|
|
| G
|
Adamts5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADAMTS5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516
|
|
| G
|
Adcy6
|
adenylate cyclase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADCY6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
|
|
| G
|
Adcy9
|
adenylate cyclase 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADCY9 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
|
|
| G
|
Adgrf4
|
adhesion G protein-coupled receptor F4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADGRF4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438
|
|
| G
|
Adgrg6
|
adhesion G protein-coupled receptor G6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADGRG6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023
|
|
| G
|
Adgrl4
|
adhesion G protein-coupled receptor L4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADGRL4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222
|
|
| G
|
Adgrv1
|
adhesion G protein-coupled receptor V1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADGRV1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372
|
|
| G
|
Adi1
|
acireductone dioxygenase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855
|
|
| G
|
Adm
|
adrenomedullin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adpgk
|
ADP-dependent glucokinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADPGK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:68,595,248...68,623,178
|
|
| G
|
Adra2a
|
adrenoceptor alpha 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADRA2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of ADRB1 protein
|
CTD |
PMID:16478526 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adss1
|
adenylosuccinate synthase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ADSS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:137,500,549...137,523,087
Ensembl chr 6:137,501,001...137,523,086
|
|
| G
|
Aen
|
apoptosis enhancing nuclease
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AEN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898
|
|
| G
|
Aga
|
aspartylglucosaminidase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of AGER mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Aggf1
|
angiogenic factor with G patch and FHA domains 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGGF1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:28,354,073...28,380,794
Ensembl chr 2:28,354,073...28,380,759
|
|
| G
|
Ago1
|
argonaute RISC component 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGO1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGO2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Ago3
|
argonaute RISC catalytic component 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGO3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:143,913,957...143,998,746
Ensembl chr 5:143,926,501...143,998,737
|
|
| G
|
Ago4
|
argonaute RISC component 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AGO4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402
|
|
| G
|
Ahnak2
|
AHNAK nucleoprotein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AHNAK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AHR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AHRR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AIFM1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AIMP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
|
|
| G
|
Ajuba
|
ajuba LIM protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AJUBA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKAP12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akr1a1
|
aldo-keto reductase family 1 member A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKR1A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035
|
|
| G
|
Akr1b10
|
aldo-keto reductase family 1 member B10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKR1B10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
|
|
| G
|
Akr1c3
|
aldo-keto reductase family 1, member C3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKR1C3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
|
|
| G
|
Akr1d1
|
aldo-keto reductase family 1, member D1
|
affects activity
|
ISO
|
Carbamazepine affects the activity of AKR1D1 protein
|
CTD |
PMID:39988211 |
|
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
|
|
| G
|
Akr7a3
|
aldo-keto reductase family 7 member A3
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of AKR7A3 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AKT2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Alas2
|
5'-aminolevulinate synthase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ALAS2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:22,890,650...22,914,046
Ensembl chr X:22,890,689...22,914,043
|
|
| G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of ALDH1A1 mRNA
|
CTD |
PMID:17381134 PMID:28138970 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ALDH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ALDOA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Amh
|
anti-Mullerian hormone
|
increases expression multiple interactions decreases expression
|
ISO
|
Carbamazepine results in increased expression of AMH protein [Carbamazepine co-treated with Lamotrigine] results in increased secretion of AMH protein Carbamazepine results in decreased expression of AMH mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867
|
|
| G
|
Amotl1
|
angiomotin-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AMOTL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:19,634,510...19,748,869
|
|
| G
|
Amotl2
|
angiomotin like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AMOTL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030
|
|
| G
|
Ank1
|
ankyrin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ankfy1
|
ankyrin repeat and FYVE domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKFY1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:57,810,781...57,882,495
Ensembl chr10:57,810,781...57,882,495
|
|
| G
|
Ankh
|
ANKH inorganic pyrophosphate transport regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699
|
|
| G
|
Ankrd10
|
ankyrin repeat domain 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846
|
|
| G
|
Ankrd16
|
ankyrin repeat domain 16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:71,645,171...71,658,377
Ensembl chr17:71,647,107...71,658,377
|
|
| G
|
Ankrd26
|
ankyrin repeat domain containing 26
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD26 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256
|
|
| G
|
Ankrd27
|
ankyrin repeat domain 27
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD27 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:97,387,997...97,440,501
Ensembl chr 1:97,388,099...97,440,501
|
|
| G
|
Ankrd28
|
ankyrin repeat domain 28
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD28 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593
|
|
| G
|
Ankrd33b
|
ankyrin repeat domain 33B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD33B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936
|
|
| G
|
Ankrd35
|
ankyrin repeat domain 35
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANKRD35 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:186,895,896...186,915,903
Ensembl chr 2:186,895,945...186,915,902
|
|
| G
|
Ano6
|
anoctamin 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANO6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:128,812,842...128,992,805
Ensembl chr 7:128,813,068...128,992,799
|
|
| G
|
Antxr2
|
ANTXR cell adhesion molecule 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANTXR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168
|
|
| G
|
Anxa1
|
annexin A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANXA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa11
|
annexin A11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANXA11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839
|
|
| G
|
Anxa3
|
annexin A3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANXA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Anxa4
|
annexin A4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANXA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513
|
|
| G
|
Anxa5
|
annexin A5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ANXA5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Ap1m2
|
adaptor related protein complex 1 subunit mu 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AP1M2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:28,114,748...28,132,642
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of APAF1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apbb2
|
amyloid beta precursor protein binding family B member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of APBB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280
|
|
| G
|
Apcdd1
|
APC down-regulated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of APCDD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of APEH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Aplp2
|
amyloid beta precursor like protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of APLP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
| G
|
Apob
|
apolipoprotein B
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of APOB mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Aqp11
|
aquaporin 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AQP11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:161,457,754...161,467,945
|
|
| G
|
Aqp3
|
aquaporin 3 (Gill blood group)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AQP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
|
|
| G
|
Aqr
|
aquarius intron-binding spliceosomal factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AQR mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:121,329,287...121,399,375
Ensembl chr 3:121,329,289...121,399,321
|
|
| G
|
Ar
|
androgen receptor
|
increases expression multiple interactions increases activity
|
ISO
|
Carbamazepine results in increased expression of AR mRNA Carbamazepine inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] Carbamazepine results in increased activity of AR protein
|
CTD |
PMID:19490052 PMID:28728110 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Araf
|
A-Raf proto-oncogene, serine/threonine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARAF mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611
|
|
| G
|
Arhgap15
|
Rho GTPase activating protein 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGAP15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:48,382,945...49,002,213
Ensembl chr 3:48,382,904...49,011,378
|
|
| G
|
Arhgap18
|
Rho GTPase activating protein 18
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGAP18 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670
|
|
| G
|
Arhgap19
|
Rho GTPase activating protein 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGAP19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:250,519,703...250,566,705
Ensembl chr 1:250,530,214...250,580,190
|
|
| G
|
Arhgap26
|
Rho GTPase activating protein 26
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGAP26 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr18:30,702,602...31,489,047
Ensembl chr18:31,089,787...31,489,047
|
|
| G
|
Arhgef10l
|
Rho guanine nucleotide exchange factor 10 like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF10L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:158,075,370...158,218,358
Ensembl chr 5:158,075,370...158,180,685
|
|
| G
|
Arhgef12
|
Rho guanine nucleotide exchange factor 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:52,247,047...52,372,376
|
|
| G
|
Arhgef19
|
Rho guanine nucleotide exchange factor 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:158,818,840...158,837,196
Ensembl chr 5:158,818,932...158,837,196
|
|
| G
|
Arhgef2
|
Rho/Rac guanine nucleotide exchange factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
|
|
| G
|
Arhgef3
|
Rho guanine nucleotide exchange factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819
|
|
| G
|
Arhgef7
|
Rho guanine nucleotide exchange factor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARHGEF7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:84,373,123...84,484,759
Ensembl chr16:84,373,123...84,484,597
|
|
| G
|
Arih2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARIH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284
|
|
| G
|
Arl4c
|
ARF like GTPase 4C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARL4C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772
|
|
| G
|
Arl8b
|
ARF like GTPase 8B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARL8B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:143,304,597...143,348,580
Ensembl chr 4:143,304,621...143,349,068
|
|
| G
|
Arln
|
allregulin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARLN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:213,740,519...213,742,279
Ensembl chr 2:213,740,525...213,742,952
|
|
| G
|
Arnt
|
aryl hydrocarbon receptor nuclear translocator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARNT mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
|
|
| G
|
Arrdc3
|
arrestin domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARRDC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
|
|
| G
|
Arrdc4
|
arrestin domain containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ARRDC4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
|
|
| G
|
Art5
|
ADP-ribosyltransferase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ART5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306
|
|
| G
|
Asah1
|
N-acylsphingosine amidohydrolase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASAH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
|
|
| G
|
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASAP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:97,675,354...97,982,523
Ensembl chr 7:97,675,354...97,982,024
|
|
| G
|
Asb13
|
ankyrin repeat and SOCS box-containing 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASB13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:71,474,531...71,493,238
Ensembl chr17:71,474,531...71,505,633
|
|
| G
|
Ascc3
|
activating signal cointegrator 1 complex subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASCC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374
|
|
| G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASF1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
|
|
| G
|
Ash2l
|
ASH2 like histone lysine methyltransferase complex subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASH2L mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:72,943,527...72,966,791
Ensembl chr16:72,944,949...72,967,839
|
|
| G
|
Asl
|
argininosuccinate lyase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASL mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASNS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Asxl3
|
ASXL transcriptional regulator 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ASXL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:13,868,223...14,040,867
Ensembl chr18:13,868,674...14,037,373
|
|
| G
|
Atcay
|
ATCAY kinesin light chain interacting caytaxin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATCAY mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:9,138,485...9,162,249
Ensembl chr 7:9,138,587...9,163,370
|
|
| G
|
Atf2
|
activating transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATF2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745
|
|
| G
|
Atf3
|
activating transcription factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATF3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
affects expression increases expression
|
ISO
|
Carbamazepine affects the expression of ATF4 mRNA Carbamazepine results in increased expression of ATF4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atg12
|
autophagy related 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATG12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261
|
|
| G
|
Atg5
|
autophagy related 5
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atl2
|
atlastin GTPase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
|
|
| G
|
Atp13a4
|
ATPase 13A4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP13A4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:84,727,014...84,864,747
Ensembl chr11:84,731,041...84,864,747
|
|
| G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP1A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP1B1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP2B2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239
|
|
| G
|
Atp2c1
|
ATPase secretory pathway Ca2+ transporting 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP2C1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826
|
|
| G
|
Atp6v0d1
|
ATPase H+ transporting V0 subunit D1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP6V0D1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
|
|
| G
|
Atp6v0e1
|
ATPase H+ transporting V0 subunit e1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATP6V0E1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
|
|
| G
|
Atpsckmt
|
ATP synthase c subunit lysine N-methyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATPSCKMT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:84,313,991...84,329,195
Ensembl chr 2:84,313,921...84,329,194
|
|
| G
|
Atxn1
|
ataxin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ATXN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:19,208,200...19,356,790
|
|
| G
|
Aurkc
|
aurora kinase C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AURKC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:75,876,773...75,882,893
Ensembl chr 1:75,876,773...75,897,426
|
|
| G
|
Axin2
|
axin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AXIN2 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
|
|
| G
|
Axl
|
Axl receptor tyrosine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AXL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
|
|
| G
|
Azin1
|
antizyme inhibitor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of AZIN1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515
|
|
| G
|
B3galt2
|
Beta-1,3-galactosyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of B3GALT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:57,939,724...57,948,735
Ensembl chr13:57,930,539...57,956,539
|
|
| G
|
B3galt6
|
Beta-1,3-galactosyltransferase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of B3GALT6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:171,866,428...171,868,564
Ensembl chr 5:171,864,094...171,874,789
|
|
| G
|
B4galt4
|
beta-1,4-galactosyltransferase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of B4GALT4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:75,501,358...75,527,291
Ensembl chr11:75,501,366...75,527,177
|
|
| G
|
B4galt7
|
beta-1,4-galactosyltransferase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of B4GALT7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:9,023,667...9,032,742
Ensembl chr17:9,023,618...9,032,745
|
|
| G
|
Baalc
|
BAALC binder of MAP3K1 and KLF4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BAALC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:71,803,640...71,877,608
Ensembl chr 7:71,774,898...71,879,261
|
|
| G
|
Bach1
|
BTB domain and CNC homolog 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BACH1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277
|
|
| G
|
Bag2
|
BAG cochaperone 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BAG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BAG3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bard1
|
BRCA1 associated RING domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BARD1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873
|
|
| G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BASP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BAX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz1a
|
bromodomain adjacent to zinc finger domain, 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BAZ1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BCAT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bcat2
|
branched chain amino acid transaminase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BCAT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463
|
|
| G
|
Bckdha
|
branched chain keto acid dehydrogenase E1 subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BCKDHA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:90,261,629...90,295,749
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of BCL2 mRNA; Carbamazepine results in increased expression of BCL2 protein
|
CTD |
PMID:18719996 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BCL2L1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BCL2L11 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
increases expression affects expression
|
EXP
|
Carbamazepine results in increased expression of BDNF mRNA; Carbamazepine results in increased expression of BDNF protein Carbamazepine affects the expression of BDNF mRNA
|
CTD |
PMID:18719996 PMID:31324950 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of BECN1 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bend3
|
BEN domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BEND3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:48,562,383...48,599,194
Ensembl chr20:48,576,311...48,596,808
|
|
| G
|
Bend4
|
BEN domain containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BEND4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:41,106,206...41,142,572
Ensembl chr14:41,106,763...41,136,979
|
|
| G
|
Bex2
|
brain expressed X-linked 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BEX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:103,811,458...103,812,986
Ensembl chr X:103,808,935...103,812,092
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BHLHE40 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bicral
|
BICRA like chromatin remodeling complex associated protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BICRAL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:21,597,886...21,682,985
Ensembl chr 9:21,597,855...21,682,983
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BID mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bik
|
BCL2-interacting killer
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BIK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
|
|
| G
|
Bivm
|
basic, immunoglobulin-like variable motif containing
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BIVM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:53,760,885...53,797,125
Ensembl chr 9:53,761,331...53,797,118
|
|
| G
|
Bloc1s2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BLOC1S2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873
|
|
| G
|
Bmp2k
|
BMP-2 inducible kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BMP2K mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BMP4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BMP6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BNIP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bok
|
BCL2 family apoptosis regulator BOK
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BOK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833
|
|
| G
|
Bpnt2
|
3'(2'), 5'-bisphosphate nucleotidase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BPNT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
|
|
| G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BRAF mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
|
|
| G
|
Brd3
|
bromodomain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BRD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629
|
|
| G
|
Brd8
|
bromodomain containing 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BRD8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006
|
|
| G
|
Brip1
|
BRCA1 interacting DNA helicase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BRIP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Btbd6
|
BTB domain containing 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BTBD6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:137,879,202...137,881,662
Ensembl chr 6:137,879,162...137,881,652
|
|
| G
|
Btn2a2
|
butyrophilin, subfamily 2, member A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BTN2A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:42,048,842...42,060,650
Ensembl chr17:42,048,842...42,060,650
|
|
| G
|
Btrc
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BTRC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:254,159,124...254,328,357
|
|
| G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of BUB1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
|
|
| G
|
C12h12orf76
|
similar to human chromosome 12 open reading frame 76
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C12ORF76 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:47,452,148...47,456,832
Ensembl chr12:47,452,016...47,456,829
|
|
| G
|
C1h11orf58
|
similar to human chromosome 11 open reading frame 58
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C11ORF58 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:179,769,283...179,780,437
Ensembl chr 1:179,769,293...179,782,729
|
|
| G
|
C1h19orf33
|
similar to human chromosome 19 open reading frame 33
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C19ORF33 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,677,305...93,678,141
Ensembl chr 1:93,677,305...93,678,141
|
|
| G
|
C1rl
|
complement C1r subcomponent like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C1RL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:159,080,495...159,097,066
Ensembl chr 4:159,080,495...159,097,066
|
|
| G
|
C3h11orf96
|
similar to human chromosome 11 open reading frame 96
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C11ORF96 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:100,375,474...100,376,717
Ensembl chr 3:100,351,199...100,378,346
|
|
| G
|
C6h14orf132
|
similar to human chromosome 14 open reading frame 132
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C14ORF132 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:130,130,176...130,163,153
Ensembl chr 6:130,130,794...130,158,762
|
|
| G
|
C7h12orf75
|
similar to human chromosome 12 open reading frame 75
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C12ORF75 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:21,902,745...21,945,704
Ensembl chr 7:21,902,745...21,945,748
|
|
| G
|
C8h15orf61
|
similar to human chromosome 15 open reading frame 61
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C15ORF61 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:72,763,513...72,768,248
Ensembl chr 8:72,757,256...72,768,748
|
|
| G
|
C9h6orf132
|
similar to human chromosome 6 open reading frame 132
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C6ORF132 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:21,022,482...21,058,942
Ensembl chr 9:21,023,092...21,059,125
|
|
| G
|
Ca11
|
carbonic anhydrase 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CA11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:105,306,347...105,311,651
Ensembl chr 1:105,302,289...105,311,832
|
|
| G
|
Cachd1
|
cache domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CACHD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:120,527,224...120,752,685
Ensembl chr 5:120,526,770...120,772,877
|
|
| G
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CACNA1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599
|
|
| G
|
Cacna2d2
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CACNA2D2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:116,950,907...117,081,759
|
|
| G
|
Cadm1
|
cell adhesion molecule 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CADM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192
|
|
| G
|
Cald1
|
caldesmon 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CALD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
| G
|
Calm1
|
calmodulin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CALM1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Caln1
|
calneuron 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CALN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:31,447,964...31,939,847
|
|
| G
|
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAMK2D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
|
|
| G
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAMK2N1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058
|
|
| G
|
Camkv
|
CaM kinase-like vesicle-associated
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAMKV mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:117,505,439...117,519,785
Ensembl chr 8:117,505,408...117,519,797
|
|
| G
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAND2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:150,507,659...150,535,755
Ensembl chr 4:150,507,657...150,541,293
|
|
| G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563
|
|
| G
|
Capn10
|
calpain 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAPN10 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912
|
|
| G
|
Capn12
|
calpain 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAPN12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,298,571...93,311,220
Ensembl chr 1:93,298,571...93,310,630
|
|
| G
|
Capn2
|
calpain 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAPN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625
|
|
| G
|
Capn6
|
calpain 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAPN6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:112,177,467...112,202,178
Ensembl chr X:112,177,467...112,202,178
|
|
| G
|
Carhsp1
|
calcium regulated heat stable protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CARHSP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770
|
|
| G
|
Cars1
|
cysteinyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407
|
|
| G
|
Casp2
|
caspase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CASP2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
| G
|
Casp3
|
caspase 3
|
increases expression affects expression
|
EXP ISO
|
Carbamazepine results in increased expression of CASP3 mRNA Carbamazepine affects the expression of CASP3 mRNA
|
CTD |
PMID:19815060 PMID:25979313 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp6
|
caspase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CASP6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp8
|
caspase 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CASP8 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Cav1
|
caveolin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAV1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Cav2
|
caveolin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAV2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425
|
|
| G
|
Cavin1
|
caveolae associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAVIN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383
|
|
| G
|
Cavin3
|
caveolae associated protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CAVIN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981
|
|
| G
|
Cbl
|
Cbl proto-oncogene
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CBL mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067
|
|
| G
|
Cbln1
|
cerebellin 1 precursor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CBLN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:35,782,151...35,785,960
Ensembl chr19:35,781,952...35,785,960
|
|
| G
|
Cbr1
|
carbonyl reductase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CBR1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104 Ensembl chr11:46,378,411...46,381,104
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CBS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Cbx2
|
chromobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CBX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:104,777,054...104,785,922
Ensembl chr10:104,777,056...104,785,926
|
|
| G
|
Ccdc28b
|
coiled coil domain containing 28B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCDC28B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629
|
|
| G
|
Ccdc3
|
coiled-coil domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCDC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:77,941,148...78,044,820
Ensembl chr17:77,944,977...78,044,470
|
|
| G
|
Ccdc77
|
coiled-coil domain containing 77
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCDC77 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:155,206,402...155,238,235
Ensembl chr 4:155,193,275...155,239,207
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCL26 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:26,745,972...26,750,924
|
|
| G
|
Ccm2l
|
CCM2 like scaffold protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCM2L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:161,993,717...162,009,372
Ensembl chr 3:161,859,312...162,009,371
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCN1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccnb2
|
cyclin B2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions decreases expression
|
ISO
|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Carbamazepine results in decreased expression of CCND1 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Carbamazepine results in decreased expression of CCND1 protein] Carbamazepine results in decreased expression of CCND1 mRNA; Carbamazepine results in decreased expression of CCND1 protein
|
CTD |
PMID:16965676 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd3
|
cyclin D3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCND3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033
|
|
| G
|
Ccne1
|
cyclin E1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNE1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccne2
|
cyclin E2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNE2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
|
|
| G
|
Ccnf
|
cyclin F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNF mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
|
|
| G
|
Ccng2
|
cyclin G2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
| G
|
Ccnh
|
cyclin H
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNH mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860
|
|
| G
|
Ccny
|
cyclin Y
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CCNY mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:62,079,925...62,207,780
Ensembl chr17:62,079,925...62,207,979
|
|
| G
|
Cd151
|
CD151 molecule (Raph blood group)
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of CD151 mRNA
|
CTD |
PMID:11682256 |
|
NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784
|
|
| G
|
Cd1d1
|
CD1d1 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD1D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029
|
|
| G
|
Cd200
|
Cd200 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD200 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569
|
|
| G
|
Cd24
|
CD24 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD24 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
|
|
| G
|
Cd2ap
|
CD2-associated protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD2AP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968
|
|
| G
|
Cd36
|
CD36 molecule
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of CD36 mRNA
|
CTD |
PMID:28138970 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd44
|
CD44 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD44 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd48
|
Cd48 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD48 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942
|
|
| G
|
Cd55
|
CD55 molecule (Cromer blood group)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD55 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107
|
|
| G
|
Cd83
|
CD83 molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD83 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
|
|
| G
|
Cd99l2
|
CD99 molecule-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CD99L2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:6,861,242...6,906,838
Ensembl chr15:6,864,268...6,906,952
|
|
| G
|
Cdc16
|
cell division cycle 16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:82,475,234...82,498,797
Ensembl chr16:82,474,523...82,498,765
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC25C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdc42bpa
|
CDC42 binding protein kinase alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC42BPA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681
|
|
| G
|
Cdc42ep3
|
CDC42 effector protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC42EP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540
|
|
| G
|
Cdc45
|
cell division cycle 45
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC45 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981
|
|
| G
|
Cdc6
|
cell division cycle 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdc7
|
cell division cycle 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDC7 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDCA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdca8
|
cell division cycle associated 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDCA8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283
|
|
| G
|
Cdh1
|
cadherin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDH1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh17
|
cadherin 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDH17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226
|
|
| G
|
Cdk12
|
cyclin-dependent kinase 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:83,697,174...83,793,676
Ensembl chr10:83,767,206...83,777,183 Ensembl chr10:83,767,206...83,777,183
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk5rap2
|
CDK5 regulatory subunit associated protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK5RAP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:88,807,402...88,976,005
Ensembl chr 5:88,807,402...88,976,069
|
|
| G
|
Cdk6
|
cyclin-dependent kinase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
|
|
| G
|
Cdk7
|
cyclin-dependent kinase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDK7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDKN1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDKN1B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDKN2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cdon
|
cell adhesion associated, oncogene regulated
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDON mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:42,033,042...42,119,345
|
|
| G
|
Cds2
|
CDP-diacylglycerol synthase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201
|
|
| G
|
Cdt1
|
chromatin licensing and DNA replication factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CDT1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CEBPB mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CELSR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581
|
|
| G
|
Cemip2
|
cell migration inducing hyaluronidase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CEMIP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906
|
|
| G
|
Cenatac
|
centrosomal AT-AC splicing factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENATAC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:53,632,777...53,639,661
Ensembl chr 8:53,632,044...53,639,650
|
|
| G
|
Cenpe
|
centromere protein E
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENPE mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
| G
|
Cenpf
|
centromere protein F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENPF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenph
|
centromere protein H
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENPH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:33,630,738...33,644,258
Ensembl chr 2:33,630,738...33,644,242
|
|
| G
|
Cenpu
|
centromere protein U
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENPU mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662
|
|
| G
|
Cenpv
|
centromere protein V
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CENPV mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:47,713,778...47,746,800
Ensembl chr10:47,713,778...47,727,679
|
|
| G
|
Cep126
|
centrosomal protein 126
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CEP126 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:13,485,211...13,552,711
Ensembl chr 8:13,490,685...13,552,221
|
|
| G
|
Cep57
|
centrosomal protein 57
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CEP57 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890
|
|
| G
|
Cept1
|
choline/ethanolamine phosphotransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CEPT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:196,682,455...196,724,430
Ensembl chr 2:196,681,681...196,723,812
|
|
| G
|
Cercam
|
cerebral endothelial cell adhesion molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CERCAM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:33,515,513...33,553,817
Ensembl chr 3:33,486,664...33,553,813
|
|
| G
|
Cers2
|
ceramide synthase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CERS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839
|
|
| G
|
Cfap184
|
cilia and flagella associated protein 184
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CFAP184 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:78,501,256...78,503,715
Ensembl chr14:78,486,414...78,507,808
|
|
| G
|
Cfap96
|
cilia and flagella associated protein 96
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CFAP96 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:53,023,623...53,048,176
Ensembl chr16:53,023,878...53,048,965
|
|
| G
|
Cfl2
|
cofilin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CFL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CFLAR mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Chac1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHAC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
|
|
| G
|
Chdh
|
choline dehydrogenase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHDH mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997
|
|
| G
|
Chek1
|
checkpoint kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHEK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359
|
|
| G
|
Chic2
|
cysteine-rich hydrophobic domain 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHIC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:33,511,839...33,546,181
Ensembl chr14:33,511,535...33,548,558
|
|
| G
|
Chka
|
choline kinase alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHKA mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
|
|
| G
|
Chkb
|
choline kinase beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHKB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949
|
|
| G
|
Chmp2a
|
charged multivesicular body protein 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHMP2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:82,732,231...82,738,613
|
|
| G
|
Chmp2b
|
charged multivesicular body protein 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHMP2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:16,783,971...16,810,500
Ensembl chr11:16,783,971...16,828,868
|
|
| G
|
Chmp3
|
charged multivesicular body protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHMP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:105,134,860...105,180,862
Ensembl chr 4:105,134,755...105,182,262
|
|
| G
|
Chordc1
|
cysteine and histidine rich domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHORDC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
|
|
| G
|
Chrdl1
|
chordin-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHRDL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:111,685,864...111,789,684
Ensembl chr X:111,685,866...111,789,661
|
|
| G
|
Chrna2
|
cholinergic receptor nicotinic alpha 2 subunit
|
affects response to substance
|
ISO
|
CHRNA2 gene mutant form affects the susceptibility to Carbamazepine
|
CTD |
PMID:19383498 |
|
NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHRNA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
affects binding
|
ISO
|
Carbamazepine binds to [CHRNA4 protein binds to CHRNB2 protein]
|
CTD |
PMID:12110613 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna9
|
cholinergic receptor nicotinic alpha 9 subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHRNA9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:42,588,948...42,595,669
Ensembl chr14:42,588,948...42,595,669
|
|
| G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
affects binding
|
ISO
|
Carbamazepine binds to [CHRNA4 protein binds to CHRNB2 protein]
|
CTD |
PMID:12110613 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
| G
|
Chst15
|
carbohydrate sulfotransferase 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHST15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444
|
|
| G
|
Chst2
|
carbohydrate sulfotransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHST2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301
|
|
| G
|
Chst8
|
carbohydrate sulfotransferase 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHST8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:96,431,144...96,572,880
Ensembl chr 1:96,431,145...96,572,880
|
|
| G
|
Chtop
|
chromatin target of PRMT1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CHTOP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:178,278,848...178,291,142
Ensembl chr 2:178,278,848...178,290,348
|
|
| G
|
Ciart
|
circadian associated repressor of transcription
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CIART mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246
|
|
| G
|
Cib2
|
calcium and integrin binding family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CIB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:63,826,410...63,843,301
Ensembl chr 8:63,826,411...63,843,277
|
|
| G
|
Cinp
|
cyclin-dependent kinase 2-interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CINP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:135,698,477...135,720,798
Ensembl chr 6:135,706,793...135,720,689
|
|
| G
|
Cipc
|
CLOCK-interacting pacemaker
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CIPC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:112,325,980...112,344,692
Ensembl chr 6:112,325,671...112,344,692
|
|
| G
|
Cited2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CITED2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782
|
|
| G
|
Ckb
|
creatine kinase B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CKB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Cldn3
|
claudin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLDN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841
|
|
| G
|
Cldn6
|
claudin 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLDN6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:13,213,837...13,218,578
Ensembl chr10:13,213,956...13,218,581
|
|
| G
|
Cldn7
|
claudin 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLDN7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
|
|
| G
|
Clec3a
|
C-type lectin domain family 3, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLEC3A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:59,313,746...59,321,126
Ensembl chr19:59,313,570...59,321,126
|
|
| G
|
Clip3
|
CAP-GLY domain containing linker protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLIP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642
|
|
| G
|
Clip4
|
CAP-GLY domain containing linker protein family, member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLIP4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:29,359,628...29,449,365 NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271
|
|
| G
|
Cln5
|
CLN5, intracellular trafficking protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLN5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:86,308,286...86,321,679
Ensembl chr 2:67,620,667...67,622,952 Ensembl chr15:67,620,667...67,622,952
|
|
| G
|
Cltc
|
clathrin heavy chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLTC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
|
|
| G
|
Cluap1
|
clusterin associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CLUAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:12,094,346...12,159,440
Ensembl chr10:12,094,346...12,131,693
|
|
| G
|
Cmpk2
|
cytidine/uridine monophosphate kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CMPK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652
|
|
| G
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CMTM5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:32,382,171...32,385,288
Ensembl chr15:32,382,608...32,385,271
|
|
| G
|
Cmtr1
|
cap methyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CMTR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263
|
|
| G
|
Cnbp
|
CCHC-type zinc finger, nucleic acid binding protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNBP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:121,860,105...121,869,010
|
|
| G
|
Cnksr3
|
Cnksr family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNKSR3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921
|
|
| G
|
Cnmd
|
chondromodulin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNMD mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:61,450,617...61,475,382
Ensembl chr15:61,450,450...61,475,350
|
|
| G
|
Cnn1
|
calponin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482
|
|
| G
|
Cnn3
|
calponin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815
|
|
| G
|
Cnpy1
|
canopy FGF signaling regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNPY1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:7,870,403...7,925,266
Ensembl chr 4:7,869,829...7,925,266
|
|
| G
|
Cnpy4
|
canopy FGF signaling regulator 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CNPY4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:22,178,254...22,184,432
Ensembl chr12:22,178,160...22,184,425
|
|
| G
|
Cobl
|
cordon-bleu WH2 repeat protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COBL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257
|
|
| G
|
Coch
|
cochlin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COCH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502
|
|
| G
|
Col12a1
|
collagen type XII alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL12A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711
|
|
| G
|
Col16a1
|
collagen type XVI alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL16A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011
|
|
| G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL18A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL1A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col26a1
|
collagen type XXVI alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL26A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:25,429,362...25,575,205
Ensembl chr12:25,429,387...25,575,206
|
|
| G
|
Col2a1
|
collagen type II alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL2A1 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
| G
|
Col4a1
|
collagen type IV alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL4A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482
|
|
| G
|
Col4a2
|
collagen type IV alpha 2 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL4A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
|
|
| G
|
Col9a1
|
collagen type IX alpha 1 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL9A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:34,081,364...34,164,552
Ensembl chr 9:34,003,905...34,164,543
|
|
| G
|
Col9a3
|
collagen type IX alpha 3 chain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COL9A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:188,089,337...188,112,034
Ensembl chr 3:188,089,403...188,112,270
|
|
| G
|
Colgalt2
|
collagen beta(1-O)galactosyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COLGALT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:67,073,551...67,178,194
Ensembl chr13:67,073,551...67,178,194
|
|
| G
|
Commd3
|
COMM domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COMMD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610
|
|
| G
|
Commd9
|
COMM domain containing 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COMMD9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091
|
|
| G
|
Cort
|
cortistatin
|
affects expression
|
EXP
|
Carbamazepine affects the expression of CORT mRNA
|
CTD |
PMID:31324950 |
|
NCBI chr 5:164,843,682...164,845,796
|
|
| G
|
Cotl1
|
coactosin-like F-actin binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COTL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840
|
|
| G
|
Cox10
|
cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COX10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:49,130,209...49,242,009
Ensembl chr10:49,130,209...49,242,009
|
|
| G
|
Cox7c
|
cytochrome c oxidase subunit 7C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of COX7C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170
|
|
| G
|
Cp
|
ceruloplasmin
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of CP mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Cpeb4
|
cytoplasmic polyadenylation element binding protein 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CPEB4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:16,222,271...16,284,248
Ensembl chr10:16,225,672...16,283,787
|
|
| G
|
Cpped1
|
calcineurin-like phosphoesterase domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CPPED1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:4,135,601...4,328,039
Ensembl chr10:4,208,463...4,231,065
|
|
| G
|
Cpsf6
|
cleavage and polyadenylation specific factor 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CPSF6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:54,798,452...54,887,711
Ensembl chr 7:54,842,490...54,873,998
|
|
| G
|
Cpsf7
|
cleavage and polyadenylation specific factor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CPSF7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:216,592,745...216,616,860
Ensembl chr 1:216,592,463...216,616,855
|
|
| G
|
Cpt2
|
carnitine palmitoyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CPT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
|
|
| G
|
Crb2
|
crumbs cell polarity complex component 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CRB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:41,946,694...41,974,629
Ensembl chr 3:41,947,325...41,974,629
|
|
| G
|
Creb3
|
cAMP responsive element binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CREB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500
|
|
| G
|
Creb3l4
|
cAMP responsive element binding protein 3-like 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CREB3L4 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485
|
|
| G
|
Creb5
|
cAMP responsive element binding protein 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CREB5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793
|
|
| G
|
Crebl2
|
cAMP responsive element binding protein-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CREBL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611
|
|
| G
|
Crim1
|
cysteine rich transmembrane BMP regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CRIM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416
|
|
| G
|
Crygc
|
crystallin, gamma C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CRYGC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:73,945,332...73,947,367
Ensembl chr 9:73,945,334...73,947,367
|
|
| G
|
Crym
|
crystallin, mu
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CRYM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962
|
|
| G
|
Csgalnact1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CSGALNACT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CSNK2A1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Csnk2a2
|
casein kinase 2 alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CSNK2A2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136
|
|
| G
|
Cst6
|
cystatin E/M
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CST6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384
|
|
| G
|
Cstf2
|
cleavage stimulation factor subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CSTF2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:101,546,809...101,572,760
Ensembl chr X:101,546,819...101,572,764
|
|
| G
|
Cstf3
|
cleavage stimulation factor subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CSTF3 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:111,421,291...111,492,539
Ensembl chr 3:111,421,234...111,497,046
|
|
| G
|
Ctbp2
|
C-terminal binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTBP2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261
|
|
| G
|
Ctcfl1
|
CCCTC-binding factor like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTCFL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:182,286,637...182,309,272
Ensembl chr 3:182,286,637...182,309,272
|
|
| G
|
Cth
|
cystathionine gamma-lyase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTH mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTNNB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctns
|
cystinosin, lysosomal cystine transporter
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTNS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:58,300,069...58,315,725
Ensembl chr10:58,299,967...58,321,661
|
|
| G
|
Ctps1
|
CTP synthase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTPS1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465
|
|
| G
|
Ctps2
|
CTP synthase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTPS2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:35,277,658...35,418,505
Ensembl chr X:35,277,658...35,418,505
|
|
| G
|
Ctsb
|
cathepsin B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTSB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsh
|
cathepsin H
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTSH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181
|
|
| G
|
Ctsk
|
cathepsin K
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CTSK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Cul3
|
cullin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CUL3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
|
|
| G
|
Cxcl13
|
C-X-C motif chemokine ligand 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CXCL13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions increases expression
|
ISO
|
Alprostadil inhibits the reaction [Carbamazepine results in increased expression of CXCL2 mRNA]
|
CTD |
PMID:22790970 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxhxorf58
|
similar to human chromosome X open reading frame 58
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CXORF58 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:63,095,606...63,151,659
Ensembl chr X:63,095,625...63,151,659
|
|
| G
|
Cyb5a
|
cytochrome b5 type A
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYB5A mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094 Ensembl chr18:14,453,966...14,455,094
|
|
| G
|
Cyb5b
|
cytochrome b5 type B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYB5B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980
|
|
| G
|
Cyb5d2
|
cytochrome b5 domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYB5D2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:57,892,799...57,911,831
Ensembl chr10:57,895,296...57,912,030
|
|
| G
|
Cyb5r4
|
cytochrome b5 reductase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYB5R4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:96,860,415...96,925,789
Ensembl chr 8:96,861,090...96,926,094
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of CYBA mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in increased expression of CYBA protein; [Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in decreased expression of CYBA mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYCS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyfip2
|
cytoplasmic FMR1 interacting protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYFIP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440
|
|
| G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of CYP11A1 mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
| G
|
Cyp11b3
|
cytochrome P450, family 11, subfamily b, polypeptide 3
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYP11B2 mRNA
|
CTD |
PMID:19566492 |
|
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921
|
|
| G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
decreases activity decreases expression
|
ISO
|
Carbamazepine results in decreased activity of CYP17A1 protein Carbamazepine results in decreased expression of CYP17A1 mRNA
|
CTD |
PMID:15730543 PMID:19566492 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression affects expression decreases activity
|
EXP ISO
|
Carbamazepine results in increased expression of CYP1A1 mRNA Carbamazepine affects the expression of CYP1A1 mRNA Carbamazepine results in decreased activity of CYP1A1 protein
|
CTD |
PMID:17112801 PMID:17381134 PMID:24352538 PMID:25979313 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Carbamazepine results in increased expression of CYP1A2 mRNA [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine Carbamazepine results in decreased expression of CYP1A2 mRNA
|
CTD |
PMID:17112801 PMID:17381134 PMID:23397584 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYP26A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
|
|
| G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of CYP2B1 mRNA
|
CTD |
PMID:16125621 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
| G
|
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of CYP2B2 mRNA
|
CTD |
PMID:16125621 |
|
NCBI chr 1:90,722,243...90,736,272
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
multiple interactions increases response to substance increases expression
|
ISO
|
[Carbamazepine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Carbamazepine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CYP2B6 protein results in increased susceptibility to Carbamazepine Carbamazepine results in increased expression of CYP2B6 mRNA; Carbamazepine results in increased expression of CYP2B6 protein
|
CTD |
PMID:14977870 PMID:17041008 PMID:17112801 PMID:36995427 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
multiple interactions increases expression
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine Carbamazepine results in increased expression of CYP2C19 mRNA
|
CTD |
PMID:17112801 PMID:23397584 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2c79
|
cytochrome P450, family 2, subfamily c, polypeptide 79
|
increases expression affects metabolic processing increases metabolic processing multiple interactions
|
ISO
|
Carbamazepine results in increased expression of CYP2C8 mRNA CYP2C8 protein affects the metabolism of Carbamazepine CYP2C8 protein results in increased metabolism of Carbamazepine Probenecid promotes the reaction [CYP2C8 protein affects the metabolism of Carbamazepine]
|
CTD |
PMID:12464242 PMID:15286053 PMID:15915352 PMID:17112801 |
|
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
multiple interactions
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine
|
CTD |
PMID:23397584 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of CYP2E1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp39a1
|
cytochrome P450, family 39, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYP39A1 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:24,727,817...24,804,060
|
|
| G
|
Cyp3a18
|
cytochrome P450, family 3, subfamily a, polypeptide 18
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYP3A43 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions decreases activity increases activity increases metabolic processing increases expression affects metabolic processing
|
EXP ISO
|
[SOD2 co-treated with CYP3A4] affects the susceptibility to Carbamazepine Carbamazepine results in decreased activity of CYP3A4 protein [Carbamazepine results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl Estradiol; [Carbamazepine results in increased expression of CYP3A4 protein] which results in decreased abundance of Midazolam; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine; [CYP3A4 protein results in increased metabolism of Carbamazepine] which results in increased chemical synthesis of carbamazepine epoxide; Carbamazepine promotes the reaction [CYP3A4 protein results in increased metabolism of and results in decreased abundance of Quetiapine Fumarate]; Felbamate affects the reaction [[CYP3A4 protein results in increased metabolism of Carbamazepine] which results in increased chemical synthesis of carbamazepine epoxide]; NR3C1 protein promotes the reaction [Carbamazepine results in increased expression of CYP3A4 mRNA]; Probenecid promotes the reaction [CYP3A4 protein affects the metabolism of Carbamazepine] Carbamazepine results in increased activity of CYP3A4 protein Carbamazepine results in increased expression of CYP3A4 mRNA; Carbamazepine results in increased expression of CYP3A4 protein
|
CTD |
PMID:9512926 PMID:10219967 PMID:12065438 PMID:12505310 PMID:12606595 PMID:12673034 PMID:15286053 PMID:15915352 PMID:16390352 PMID:16837568 PMID:17112801 PMID:17954527 PMID:19255940 PMID:19501153 PMID:22524704 PMID:23397584 PMID:39023798 More...
|
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of CYP3A23-3A1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYP3A5 mRNA
|
CTD |
PMID:12673034 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp4a1
|
cytochrome P450, family 4, subfamily a, polypeptide 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of CYP4A1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
|
|
| G
|
Cyp4f18
|
cytochrome P450, family 4, subfamily f, polypeptide 18
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of CYP4F3 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958
|
|
| G
|
Cyp4x1
|
cytochrome P450, family 4, subfamily x, polypeptide 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYP4X1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:133,888,439...133,923,254
Ensembl chr 5:133,888,439...133,919,642
|
|
| G
|
Cytl1
|
cytokine like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of CYTL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:77,278,635...77,283,645
Ensembl chr14:77,278,636...77,283,645
|
|
| G
|
Dact1
|
dishevelled-binding antagonist of beta-catenin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DACT1 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053
|
|
| G
|
Dag1
|
dystroglycan 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DAG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199
|
|
| G
|
Daglb
|
diacylglycerol lipase, beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DAGLB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:16,173,345...16,215,777
Ensembl chr12:16,173,345...16,215,758
|
|
| G
|
Dars1
|
aspartyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Dazl
|
deleted in azoospermia-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DAZL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:18,193,363...18,210,100
Ensembl chr 9:18,193,363...18,210,100
|
|
| G
|
Dbt
|
dihydrolipoamide branched chain transacylase E2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DBT mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525
|
|
| G
|
Dcaf10
|
DDB1 and CUL4 associated factor 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DCAF10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:64,402,307...64,442,839
Ensembl chr 5:64,403,451...64,440,614
|
|
| G
|
Dcdc2
|
doublecortin domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DCDC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:40,274,009...40,459,757
Ensembl chr17:40,274,009...40,458,790
|
|
| G
|
Dctpp1
|
dCTP pyrophosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DCTPP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405
|
|
| G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDAH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626
|
|
| G
|
Ddb1
|
damage-specific DNA binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDB1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of DDIT3 mRNA; Carbamazepine results in increased expression of DDIT3 protein Carbamazepine affects the expression of DDIT3 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDIT4L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225
|
|
| G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDR1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276
|
|
| G
|
Ddt
|
D-dopachrome tautomerase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:12,883,025...12,886,121
|
|
| G
|
Ddx25
|
DEAD-box helicase 25
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDX25 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:42,152,046...42,168,635
Ensembl chr 8:42,152,047...42,168,080
|
|
| G
|
Ddx39a
|
DExD-box helicase 39A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDX39A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
|
|
| G
|
Ddx5
|
DEAD-box helicase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDX5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300
|
|
| G
|
Ddx55
|
DEAD-box helicase 55
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DDX55 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:37,695,444...37,711,198
Ensembl chr12:37,695,444...37,711,198
|
|
| G
|
Denr
|
density regulated reinitiation and release factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DENR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:38,323,433...38,346,207
Ensembl chr12:38,323,445...38,344,797
|
|
| G
|
Dffa
|
DNA fragmentation factor subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DFFA mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728
|
|
| G
|
Dgat2
|
diacylglycerol O-acyltransferase 2
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of DGAT2 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of DGAT2 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of DGAT2 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566
|
|
| G
|
Dglucy
|
D-glutamate cyclase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DGLUCY mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:125,785,075...125,860,496
Ensembl chr 6:125,785,087...125,860,496
|
|
| G
|
Dhfr
|
dihydrofolate reductase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DHFR mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:25,320,895...25,346,004
|
|
| G
|
Dhps
|
deoxyhypusine synthase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DHPS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432
|
|
| G
|
Dhrs1
|
dehydrogenase/reductase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DHRS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734
|
|
| G
|
Dhtkd1
|
dehydrogenase E1 and transketolase domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DHTKD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071
|
|
| G
|
Diaph2
|
diaphanous-related formin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DIAPH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:96,700,535...97,528,080
Ensembl chr X:96,700,726...97,528,080
|
|
| G
|
Disp1
|
dispatched RND transporter family member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DISP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:97,252,574...97,398,329
Ensembl chr13:97,252,574...97,398,460
|
|
| G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DKK1 mRNA
|
CTD |
PMID:22634333 PMID:24752500 PMID:25979313 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
| G
|
Dlk1
|
delta like non-canonical Notch ligand 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DLK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529
|
|
| G
|
Dlk2
|
delta like non-canonical Notch ligand 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DLK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149
|
|
| G
|
Dlx4
|
distal-less homeobox 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DLX4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:80,581,878...80,587,272
Ensembl chr10:80,582,303...80,587,294
|
|
| G
|
Dlx5
|
distal-less homeobox 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DLX5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845
|
|
| G
|
Dlx6
|
distal-less homeobox 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DLX6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:35,951,005...35,956,354
Ensembl chr 4:35,951,005...35,956,354
|
|
| G
|
Dmac1
|
distal membrane arm assembly component 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DMAC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:94,288,900...94,290,053
Ensembl chr 5:94,280,654...94,290,119
|
|
| G
|
Dmkn
|
dermokine
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DMKN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439
|
|
| G
|
Dnaaf1
|
dynein, axonemal, assembly factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAAF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:64,532,859...64,560,942
Ensembl chr19:64,532,860...64,561,435
|
|
| G
|
Dnaaf10
|
dynein axonemal assembly factor 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAAF10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:95,820,272...95,841,449
Ensembl chr14:95,820,234...95,841,442
|
|
| G
|
Dnaaf4
|
dynein axonemal assembly factor 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAAF4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:82,577,044...82,601,653
Ensembl chr 8:82,578,755...82,592,205
|
|
| G
|
Dnaja1
|
DnaJ heat shock protein family (Hsp40) member A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJA1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
|
|
| G
|
Dnaja2
|
DnaJ heat shock protein family (Hsp40) member A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJA2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120
|
|
| G
|
Dnaja3
|
DnaJ heat shock protein family (Hsp40) member A3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJA3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:11,361,168...11,386,599
Ensembl chr10:11,361,168...11,386,599
|
|
| G
|
Dnajb1
|
DnaJ heat shock protein family (Hsp40) member B1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
|
|
| G
|
Dnajb14
|
DnaJ heat shock protein family (Hsp40) member B14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJB14 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:229,032,415...229,075,905
Ensembl chr 2:229,032,286...229,075,922
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJB4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnajb6
|
DnaJ heat shock protein family (Hsp40) member B6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJB6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005
|
|
| G
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJB9 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
|
|
| G
|
Dnajc10
|
DnaJ heat shock protein family (Hsp40) member C10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC10 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368
|
|
| G
|
Dnajc11
|
DnaJ heat shock protein family (Hsp40) member C11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC11 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:167,724,776...167,770,032
Ensembl chr 5:167,724,717...167,770,694
|
|
| G
|
Dnajc12
|
DnaJ heat shock protein family (Hsp40) member C12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251
|
|
| G
|
Dnajc15
|
DnaJ heat shock protein family (Hsp40) member C15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC15 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:59,594,314...59,658,862
Ensembl chr15:59,594,314...59,658,987
|
|
| G
|
Dnajc18
|
DnaJ heat shock protein family (Hsp40) member C18
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC18 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr18:27,543,438...27,577,535
Ensembl chr18:27,543,438...27,577,535
|
|
| G
|
Dnajc21
|
DnaJ heat shock protein family (Hsp40) member C21
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC21 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:61,146,669...61,173,908
Ensembl chr 2:61,145,142...61,174,126
|
|
| G
|
Dnajc5
|
DnaJ heat shock protein family (Hsp40) member C5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:188,999,508...189,033,455
Ensembl chr 3:188,999,470...189,034,089
|
|
| G
|
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:121,232,532...121,398,775
Ensembl chr 5:121,235,425...121,398,775
|
|
| G
|
Dnajc7
|
DnaJ heat shock protein family (Hsp40) member C7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489
|
|
| G
|
Dnajc8
|
DnaJ heat shock protein family (Hsp40) member C8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC8 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117
|
|
| G
|
Dnajc9
|
DnaJ heat shock protein family (Hsp40) member C9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNAJC9 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
|
|
| G
|
Dnmbp
|
dynamin binding protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DNMBP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688
|
|
| G
|
Dppa4
|
developmental pluripotency associated 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DPPA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:66,033,256...66,041,754
Ensembl chr11:66,033,256...66,041,754
|
|
| G
|
Dpy30
|
dpy-30 histone methyltransferase complex regulatory subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DPY30 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:26,872,812...26,893,580
Ensembl chr 6:26,872,732...26,894,930
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DPYSL2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Dram1
|
DNA-damage regulated autophagy modulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DRAM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354
|
|
| G
|
Drd2
|
dopamine receptor D2
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of DRD2 protein
|
CTD |
PMID:16478526 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Dse
|
dermatan sulfate epimerase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DSE mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:26,661,326...26,740,011
Ensembl chr20:26,661,326...26,740,114
|
|
| G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DTL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174
|
|
| G
|
Dtymk
|
deoxythymidylate kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DTYMK mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DUSP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp14
|
dual specificity phosphatase 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DUSP14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:69,433,949...69,463,863
Ensembl chr10:69,426,730...69,462,837
|
|
| G
|
Dut
|
deoxyuridine triphosphatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DUT mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
|
|
| G
|
Dynlt3
|
dynein light chain Tctex-type 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DYNLT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:16,000,425...16,009,632
Ensembl chr X:16,000,395...16,009,627
|
|
| G
|
Dyrk3
|
dual specificity tyrosine phosphorylation regulated kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DYRK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of E2F1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f2
|
E2F transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of E2F2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
|
|
| G
|
E2f5
|
E2F transcription factor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of E2F5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:88,718,567...88,734,143
Ensembl chr 2:88,718,567...88,734,143
|
|
| G
|
E2f8
|
E2F transcription factor 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of E2F8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
|
|
| G
|
Ebp
|
EBP, cholestenol delta-isomerase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EBP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
|
|
| G
|
Echdc1
|
ethylmalonyl-CoA decarboxylase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ECHDC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:30,304,968...30,355,957
Ensembl chr 1:30,304,971...30,337,208
|
|
| G
|
Edem1
|
ER degradation enhancing alpha-mannosidase like protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EDEM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060
|
|
| G
|
Edn3
|
endothelin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EDN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329
|
|
| G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EEF1A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
| G
|
Eef2k
|
eukaryotic elongation factor-2 kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EEF2K mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048
|
|
| G
|
Eeig2
|
EEIG family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EEIG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449
|
|
| G
|
Efr3a
|
EFR3 homolog A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EFR3A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:99,441,764...99,522,454
Ensembl chr 7:99,441,767...99,522,454
|
|
| G
|
Efs
|
embryonal Fyn-associated substrate
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EFS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743
|
|
| G
|
Ehmt2
|
euchromatic histone lysine methyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EHMT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,924,263...3,941,384
|
|
| G
|
Eid1
|
EP300 interacting inhibitor of differentiation 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EID1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:133,370,474...133,378,434
|
|
| G
|
Eif1
|
eukaryotic translation initiation factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654 Ensembl chr10:25,895,968...25,896,654
|
|
| G
|
Eif1ax
|
eukaryotic translation initiation factor 1A, X-linked
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF1AX mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:39,307,320...39,322,023
Ensembl chr X:39,307,137...39,322,021
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2ak1
|
eukaryotic translation initiation factor 2 alpha kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2AK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:15,824,431...15,858,266
Ensembl chr12:15,825,124...15,858,281
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases activity affects expression
|
ISO
|
Carbamazepine results in increased activity of EIF2AK3 protein Carbamazepine affects the expression of EIF2AK3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2ak4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2AK4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574
|
|
| G
|
Eif2b1
|
eukaryotic translation initiation factor 2B subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2B1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:37,686,149...37,694,830
Ensembl chr12:37,686,559...37,708,078
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2S1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif2s2
|
eukaryotic translation initiation factor 2 subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF2S2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF3A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3b
|
eukaryotic translation initiation factor 3, subunit B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF3B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
|
|
| G
|
Eif3c
|
eukaryotic translation initiation factor 3, subunit C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF3C mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
|
|
| G
|
Eif4a1
|
eukaryotic translation initiation factor 4A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4A1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602
|
|
| G
|
Eif4a2
|
eukaryotic translation initiation factor 4A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4A2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323
|
|
| G
|
Eif4e3
|
eukaryotic translation initiation factor 4E family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4E3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:133,709,802...133,858,398
Ensembl chr 4:133,625,768...133,885,647
|
|
| G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4EBP1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
|
|
| G
|
Eif4g1
|
eukaryotic translation initiation factor 4 gamma 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4G1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
|
|
| G
|
Eif4g3
|
eukaryotic translation initiation factor 4 gamma, 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF4G3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:155,481,378...155,702,194
Ensembl chr 5:155,481,378...155,702,194
|
|
| G
|
Eif5
|
eukaryotic translation initiation factor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EIF5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821
|
|
| G
|
Elac1
|
elaC ribonuclease Z 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELAC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:69,596,475...69,617,206
Ensembl chr18:69,598,827...69,616,175
|
|
| G
|
Elf2
|
E74 like ETS transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELF2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:137,445,787...137,536,512
Ensembl chr 2:137,445,788...137,470,355
|
|
| G
|
Elf3
|
E74 like ETS transcription factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELF3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380
|
|
| G
|
Elf4
|
E74 like ETS transcription factor 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELF4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:132,465,290...132,508,175
Ensembl chr X:132,468,539...132,478,689
|
|
| G
|
Ell3
|
elongation factor for RNA polymerase II 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:128,866,755...128,870,896
Ensembl chr 3:128,864,777...128,870,852
|
|
| G
|
Elovl2
|
ELOVL fatty acid elongase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELOVL2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601
|
|
| G
|
Elp2
|
elongator acetyltransferase complex subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:16,160,686...16,196,307
Ensembl chr18:16,160,671...16,196,414
|
|
| G
|
Elp4
|
elongator acetyltransferase complex subunit 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ELP4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963
|
|
| G
|
Emg1
|
EMG1 N1-specific pseudouridine methyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EMG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:159,195,545...159,203,826
Ensembl chr 4:159,195,564...159,203,826
|
|
| G
|
Emp1
|
epithelial membrane protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EMP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365
|
|
| G
|
Endog
|
endonuclease G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENDOG mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Eno3
|
enolase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENO3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540
|
|
| G
|
Enox1
|
ecto-NOX disulfide-thiol exchanger 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENOX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:58,924,519...59,488,919
Ensembl chr15:59,215,018...59,488,918
|
|
| G
|
Enox2
|
ecto-NOX disulfide-thiol exchanger 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENOX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:133,148,813...133,470,914
Ensembl chr X:133,148,813...133,470,891
|
|
| G
|
Enpep
|
glutamyl aminopeptidase
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of ENPEP mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218
|
|
| G
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENPP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044
|
|
| G
|
Entpd4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENTPD4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:51,040,665...51,068,450
Ensembl chr15:51,040,673...51,068,441
|
|
| G
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENTPD5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495
|
|
| G
|
Entpd7
|
ectonucleoside triphosphate diphosphohydrolase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENTPD7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:252,508,594...252,550,269
Ensembl chr 1:252,508,594...252,550,269
|
|
| G
|
Entrep2
|
endosomal transmembrane epsin interactor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENTREP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:127,699,636...128,111,850
Ensembl chr 1:127,699,636...128,111,850
|
|
| G
|
Eny2
|
ENY2, transcription and export complex 2 subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ENY2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:77,465,885...77,489,637
Ensembl chr 7:77,466,119...77,491,057
|
|
| G
|
Eomes
|
eomesodermin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EOMES mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070
|
|
| G
|
Epha1
|
Eph receptor A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPHA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
| G
|
Epha2
|
Eph receptor A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPHA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
|
|
| G
|
Epha4
|
Eph receptor A4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPHA4 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755
|
|
| G
|
Epha6
|
Eph receptor A6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPHA6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:53,226,784...54,178,120
Ensembl chr11:53,226,954...54,166,987
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
increases expression affects response to substance
|
ISO EXP
|
Carbamazepine results in increased expression of EPHX1 mRNA EPHX1 gene SNP affects the susceptibility to Carbamazepine; EPHX1 protein affects the susceptibility to Carbamazepine
|
CTD |
PMID:17112801 PMID:17381134 PMID:19620853 PMID:26555147 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of EPHX2 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Ephx3
|
epoxide hydrolase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPHX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:11,857,367...11,862,674
Ensembl chr 7:11,857,367...11,862,674
|
|
| G
|
Epn2
|
epsin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPN2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,697,238...46,759,092
|
|
| G
|
Epn3
|
epsin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPN3 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235
|
|
| G
|
Epo
|
erythropoietin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPO mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Epop
|
elongin BC and polycomb repressive complex 2 associated protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPOP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:83,120,767...83,122,287
Ensembl chr10:83,119,970...83,122,423
|
|
| G
|
Eps15
|
epidermal growth factor receptor pathway substrate 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPS15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856
|
|
| G
|
Epsti1
|
epithelial stromal interaction 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EPSTI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
decreases expression affects expression multiple interactions
|
ISO
|
Carbamazepine results in decreased expression of ERBB2 mRNA; Carbamazepine results in decreased expression of ERBB2 protein Carbamazepine affects the expression of ERBB2 mRNA Carbamazepine results in increased degradation of and results in decreased expression of ERBB2 protein
|
CTD |
PMID:16965676 PMID:17147113 PMID:22634333 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERBB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
|
|
| G
|
Ercc6l
|
ERCC excision repair 6 like, spindle assembly checkpoint helicase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERCC6L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:71,285,380...71,301,186
Ensembl chr X:71,285,380...71,301,186
|
|
| G
|
Erich1
|
glutamate-rich 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERICH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:82,203,536...82,271,361
Ensembl chr16:82,203,610...82,272,989
|
|
| G
|
Erich3
|
glutamate-rich 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERICH3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:246,275,438...246,377,673
Ensembl chr 2:246,275,757...246,375,695
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERN1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Erp27
|
endoplasmic reticulum protein 27
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERP27 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ERRFI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions increases expression decreases expression
|
ISO
|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Carbamazepine results in decreased expression of ESR1 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Carbamazepine results in decreased expression of ESR1 protein] Carbamazepine results in increased expression of ESR1 mRNA Carbamazepine results in decreased expression of ESR1 mRNA; Carbamazepine results in decreased expression of ESR1 protein
|
CTD |
PMID:16965676 PMID:19490052 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esrp1
|
epithelial splicing regulatory protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ESRP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278
|
|
| G
|
Esrrg
|
estrogen-related receptor gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ESRRG mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:101,699,043...102,316,877
Ensembl chr13:101,889,706...102,316,877
|
|
| G
|
Esyt1
|
extended synaptotagmin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ESYT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:1,513,381...1,530,836
Ensembl chr 7:1,513,381...1,530,732
|
|
| G
|
Etfb
|
electron transfer flavoprotein subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ETFB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659
|
|
| G
|
Etfdh
|
electron transfer flavoprotein dehydrogenase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ETFDH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770
|
|
| G
|
Etv1
|
ETS variant transcription factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ETV1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959
|
|
| G
|
Etv5
|
ETS variant transcription factor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ETV5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767
|
|
| G
|
Ewsr1
|
EWS RNA-binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EWSR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
|
|
| G
|
Exosc9
|
exosome component 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EXOSC9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:121,344,154...121,355,110
Ensembl chr 2:121,344,175...121,374,232
|
|
| G
|
Ext2
|
exostosin glycosyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EXT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596
|
|
| G
|
Eya1
|
EYA transcriptional coactivator and phosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EYA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:9,646,599...9,884,609
Ensembl chr 5:9,646,591...9,884,614
|
|
| G
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EYA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034
|
|
| G
|
Eya4
|
EYA transcriptional coactivator and phosphatase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of EYA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:23,991,431...24,235,131
|
|
| G
|
F10
|
coagulation factor X
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of F10 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280
|
|
| G
|
F2rl1
|
F2R like trypsin receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of F2RL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
|
|
| G
|
Fabp7
|
fatty acid binding protein 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FABP7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907
|
|
| G
|
Fads1
|
fatty acid desaturase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FADS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
|
|
| G
|
Fads2
|
fatty acid desaturase 2
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of FADS2 mRNA
|
CTD |
PMID:21123845 |
|
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
|
|
| G
|
Faim
|
Fas apoptotic inhibitory molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAIM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151
|
|
| G
|
Fam107a
|
family with sequence similarity 107, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM107A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219
|
|
| G
|
Fam107b
|
family with sequence similarity 107, member B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM107B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:79,387,795...79,594,165
Ensembl chr17:79,387,795...79,594,288
|
|
| G
|
Fam110a
|
family with sequence similarity 110, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM110A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897
|
|
| G
|
Fam110c
|
family with sequence similarity 110, member C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM110C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117
|
|
| G
|
Fam13b
|
family with sequence similarity 13, member B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM13B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,314,440...26,380,732
|
|
| G
|
Fam149a
|
family with sequence similarity 149, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM149A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072
|
|
| G
|
Fam149b1
|
family with sequence similarity 149, member B1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM149B1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:3,978,377...4,016,323
Ensembl chr15:3,978,377...4,016,317
|
|
| G
|
Fam162a
|
family with sequence similarity 162, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM162A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560
|
|
| G
|
Fam204a
|
family with sequence similarity 204, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM204A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:269,323,473...269,352,772
Ensembl chr 1:269,323,473...269,352,772
|
|
| G
|
Fam210b
|
family with sequence similarity 210, member B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM210B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834
|
|
| G
|
Fam221a
|
family with sequence similarity 221, member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM221A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:79,668,130...79,689,768
Ensembl chr 4:79,667,284...79,689,761
|
|
| G
|
Fam83d
|
family with sequence similarity 83, member D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAM83D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
|
|
| G
|
Fancb
|
FA complementation group B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:33,035,387...33,051,993
Ensembl chr X:33,035,387...33,051,808
|
|
| G
|
Fancc
|
FA complementation group C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCC mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096
|
|
| G
|
Fancd2
|
FA complementation group D2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035
|
|
| G
|
Fancf
|
FA complementation group F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCF mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:110,585,054...110,587,870
Ensembl chr 1:110,576,389...110,587,863
|
|
| G
|
Fancg
|
FA complementation group G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCG mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787
|
|
| G
|
Fanci
|
FA complementation group I
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCI mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999
|
|
| G
|
Fancl
|
FA complementation group L
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCL mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297
|
|
| G
|
Fancm
|
FA complementation group M
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FANCM mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:88,862,898...88,916,701
Ensembl chr 6:88,863,306...88,921,652
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAS mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of FASL mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Faxdc2
|
fatty acid hydroxylase domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FAXDC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:42,747,323...42,772,156
Ensembl chr10:42,747,524...42,781,458
|
|
| G
|
Fbln2
|
fibulin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBLN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029
|
|
| G
|
Fbxl17
|
F-box and leucine-rich repeat protein 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXL17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:110,227,609...110,666,184
Ensembl chr 9:110,227,609...110,653,980
|
|
| G
|
Fbxo17
|
F-box protein 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXO17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981
|
|
| G
|
Fbxo21
|
F-box protein 21
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXO21 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:44,231,918...44,266,035
Ensembl chr12:44,231,923...44,266,035
|
|
| G
|
Fbxo22
|
F-box protein 22
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXO22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062
|
|
| G
|
Fbxo5
|
F-box protein 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXO5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
|
|
| G
|
Fbxw4
|
F-box and WD repeat domain containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FBXW4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:254,375,921...254,465,173
Ensembl chr 1:254,375,923...254,463,277
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FDFT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fdxr
|
ferredoxin reductase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FDXR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542
|
|
| G
|
Fen1
|
flap structure-specific endonuclease 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FEN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016
|
|
| G
|
Fer
|
FER tyrosine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FER mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315
|
|
| G
|
Fez2
|
fasciculation and elongation protein zeta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FEZ2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:22,406,632...22,447,041
|
|
| G
|
Fgf18
|
fibroblast growth factor 18
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FGF18 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:18,210,240...18,241,929
Ensembl chr10:18,210,512...18,240,933
|
|
| G
|
Fgf4
|
fibroblast growth factor 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FGF4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:209,453,229...209,457,085
Ensembl chr 1:209,453,229...209,457,085
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FGFR1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fhdc1
|
FH2 domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FHDC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:172,088,987...172,127,838
Ensembl chr 2:172,089,010...172,125,956
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FHL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Fig4
|
FIG4 phosphoinositide 5-phosphatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FIG4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:46,183,225...46,306,686
Ensembl chr20:46,183,225...46,306,477
|
|
| G
|
Filip1
|
filamin A interacting protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FILIP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:89,641,509...89,836,772
Ensembl chr 8:89,644,579...89,802,771
|
|
| G
|
Firrm
|
FIGNL1 interacting regulator of recombination and mitosis
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FIRRM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:78,835,081...78,879,022
Ensembl chr13:78,834,216...78,879,213
|
|
| G
|
Flcn
|
folliculin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FLCN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
|
|
| G
|
Flnb
|
filamin B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FLNB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209
|
|
| G
|
Flnc
|
filamin C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FLNC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240
|
|
| G
|
Flrt2
|
fibronectin leucine rich transmembrane protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FLRT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:120,507,998...120,603,133
Ensembl chr 6:120,507,689...120,609,004
|
|
| G
|
Fn1
|
fibronectin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fnbp1
|
formin binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FNBP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117
|
|
| G
|
Fnbp1l
|
formin binding protein 1-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FNBP1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051
|
|
| G
|
Fndc3b
|
fibronectin type III domain containing 3B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FNDC3B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:112,243,202...112,546,306
|
|
| G
|
Fndc5
|
fibronectin type III domain containing 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FNDC5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540
|
|
| G
|
Fnip2
|
folliculin interacting protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FNIP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:166,894,726...167,006,490
Ensembl chr 2:166,897,075...167,006,055
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions affects expression decreases expression
|
EXP ISO
|
Carbamazepine inhibits the reaction [Methamphetamine results in increased expression of FOS protein] Carbamazepine affects the expression of FOS mRNA Carbamazepine results in decreased expression of FOS protein
|
CTD |
PMID:7789465 PMID:10731628 PMID:24752500 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxa1
|
forkhead box A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXA1 mRNA
|
CTD |
PMID:22634333 PMID:24752500 PMID:25979313 |
|
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191
|
|
| G
|
Foxa2
|
forkhead box A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXA2 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757
|
|
| G
|
Foxc1
|
forkhead box C1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,805,858...32,844,347
|
|
| G
|
Foxd1
|
forkhead box D1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:31,436,802...31,439,222
Ensembl chr 2:31,436,813...31,439,399
|
|
| G
|
Foxh1
|
forkhead box H1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:110,268,608...110,272,105
Ensembl chr 7:110,268,612...110,270,692
|
|
| G
|
Foxk2
|
forkhead box K2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:107,040,933...107,090,860
Ensembl chr10:107,040,933...107,195,823
|
|
| G
|
Foxo1
|
forkhead box O1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXO1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo3
|
forkhead box O3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXO3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Foxp2
|
forkhead box P2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:44,099,848...44,677,700
Ensembl chr 4:44,099,959...44,677,696
|
|
| G
|
Foxq1
|
forkhead box Q1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXQ1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720
|
|
| G
|
Foxred1
|
FAD-dependent oxidoreductase domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FOXRED1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:41,789,557...41,818,064
Ensembl chr 8:41,808,843...41,817,980
|
|
| G
|
Fpgt
|
fucose-1-phosphate guanylyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FPGT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:246,757,982...246,778,896
Ensembl chr 2:246,757,986...246,778,848
|
|
| G
|
Frat1
|
FRAT regulator of WNT signaling pathway 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FRAT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:250,587,641...250,590,189
Ensembl chr 1:250,587,506...250,603,039
|
|
| G
|
Frat2
|
FRAT regulator of WNT signaling pathway 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FRAT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:250,603,450...250,605,779
Ensembl chr 1:250,603,088...250,606,921
|
|
| G
|
Frem1
|
Fras1 related extracellular matrix 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FREM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:102,367,201...102,515,464
Ensembl chr 5:102,367,201...102,515,404
|
|
| G
|
Frmd6
|
FERM domain containing 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FRMD6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:95,081,958...95,155,561
Ensembl chr 6:95,081,985...95,155,560
|
|
| G
|
Frs2
|
fibroblast growth factor receptor substrate 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FRS2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:54,597,182...54,678,656
Ensembl chr 7:54,597,182...54,678,774
|
|
| G
|
Ftcd
|
formimidoyltransferase cyclodeaminase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FTCD mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FTH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
Fubp1
|
far upstream element binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FUBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428
|
|
| G
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FXYD5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364
|
|
| G
|
Fxyd6
|
FXYD domain-containing ion transport regulator 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FXYD6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715
|
|
| G
|
Fzd2
|
frizzled class receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396
|
|
| G
|
Fzd3
|
frizzled class receptor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:43,596,962...43,664,047
Ensembl chr15:43,596,965...43,663,960
|
|
| G
|
Fzd4
|
frizzled class receptor 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD4 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:152,692,507...152,701,372
|
|
| G
|
Fzd5
|
frizzled class receptor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD5 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612
|
|
| G
|
Fzd6
|
frizzled class receptor 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680
|
|
| G
|
Fzd7
|
frizzled class receptor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD7 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585
|
|
| G
|
Fzd8
|
frizzled class receptor 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of FZD8 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
|
|
| G
|
G2e3
|
G2/M-phase specific E3 ubiquitin protein ligase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of G2E3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:74,498,801...74,530,703
Ensembl chr 6:74,503,109...74,528,198
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of G6PC1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Gab1
|
GRB2-associated binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617
|
|
| G
|
Gab2
|
GRB2-associated binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAB2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:160,841,066...161,036,940
Ensembl chr 1:160,841,066...161,036,940
|
|
| G
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GABBR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
|
|
| G
|
Gabra1
|
gamma-aminobutyric acid type A receptor subunit alpha 1
|
multiple interactions increases activity
|
EXP
|
Carbamazepine inhibits the reaction [Pilocarpine results in decreased expression of GABRA1 mRNA] Carbamazepine results in increased activity of GABRA1 protein
|
CTD |
PMID:18717705 PMID:20821261 |
|
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
|
|
| G
|
Gabra2
|
gamma-aminobutyric acid type A receptor subunit alpha 2
|
increases activity
|
EXP
|
Carbamazepine results in increased activity of GABRA2 protein
|
CTD |
PMID:18717705 |
|
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457
|
|
| G
|
Gabra5
|
gamma-aminobutyric acid type A receptor subunit alpha 5
|
multiple interactions affects expression
|
EXP ISO
|
Carbamazepine inhibits the reaction [Pilocarpine results in decreased expression of GABRA5 mRNA] Carbamazepine affects the expression of GABRA5 mRNA
|
CTD |
PMID:20821261 PMID:25979313 |
|
NCBI chr 1:117,404,446...117,517,424
Ensembl chr 1:117,404,494...117,516,635
|
|
| G
|
Gabra6
|
gamma-aminobutyric acid type A receptor subunit alpha6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GABRA6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:27,311,965...27,327,337
Ensembl chr10:27,311,979...27,327,234
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GABRB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrd
|
gamma-aminobutyric acid type A receptor subunit delta
|
multiple interactions
|
EXP
|
Carbamazepine inhibits the reaction [Pilocarpine results in decreased expression of GABRD mRNA]
|
CTD |
PMID:20821261 |
|
NCBI chr 5:171,240,813...171,252,709
Ensembl chr 5:171,240,789...171,253,094
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GADD45A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GADD45B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GADD45G mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
| G
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
|
|
| G
|
Galnt13
|
polypeptide N-acetylgalactosaminyltransferase 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:59,312,628...59,969,633
Ensembl chr 3:59,383,516...59,965,379
|
|
| G
|
Galnt14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:27,507,878...27,724,033
Ensembl chr 6:27,507,627...27,724,031
|
|
| G
|
Galnt2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:69,110,657...69,222,237
Ensembl chr19:69,110,657...69,222,237
|
|
| G
|
Galnt3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323
|
|
| G
|
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GALNT7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:37,589,368...37,713,911
Ensembl chr16:37,589,425...37,713,909
|
|
| G
|
Gap43
|
growth associated protein 43
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAP43 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gapt
|
Grb2-binding adaptor protein, transmembrane
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAPT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:43,660,900...43,665,485
Ensembl chr 2:43,660,900...43,665,448
|
|
| G
|
Garin1b
|
golgi associated RAB2 interactor 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GARIN1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:58,880,537...58,903,966
Ensembl chr 4:58,880,594...58,903,961
|
|
| G
|
Garin5a
|
golgi associated RAB2 interactor 5A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GARIN5A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:104,125,477...104,130,543
Ensembl chr 1:104,125,160...104,135,840
|
|
| G
|
Gars1
|
glycyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GARS1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
|
|
| G
|
Gart
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GART mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:44,351,841...44,377,086
Ensembl chr11:44,351,851...44,377,086
|
|
| G
|
Gas2
|
growth arrest-specific 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GAS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:110,717,312...110,718,541
|
|
| G
|
Gask1b
|
golgi associated kinase 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GASK1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603
|
|
| G
|
Gata3
|
GATA binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GATA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
| G
|
Gata4
|
GATA binding protein 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GATA4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609
|
|
| G
|
Gatad2b
|
GATA zinc finger domain containing 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GATAD2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:178,046,192...178,127,633
Ensembl chr 2:178,046,085...178,147,315
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GATM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gbgt1
|
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GBGT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:32,219,370...32,227,737
|
|
| G
|
Gca
|
grancalcin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GCA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:67,705,874...67,738,475
Ensembl chr 3:67,705,890...67,737,387
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GCLC mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GCLM mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GCNT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GDF15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdpd2
|
glycerophosphodiester phosphodiesterase domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GDPD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:69,866,395...69,875,419
Ensembl chr X:69,866,799...69,875,414
|
|
| G
|
Gfpt2
|
glutamine-fructose-6-phosphate transaminase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GFPT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
|
|
| G
|
Gfra1
|
GDNF family receptor alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GFRA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
|
|
| G
|
Gfra2
|
GDNF family receptor alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GFRA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
|
|
| G
|
Gfra3
|
GDNF family receptor alpha 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GFRA3 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225
|
|
| G
|
Gga2
|
golgi associated, gamma adaptin ear containing, ARF binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GGA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:185,983,302...186,016,582
Ensembl chr 1:185,983,223...186,057,074
|
|
| G
|
Ggcx
|
gamma-glutamyl carboxylase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GGCX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:106,027,912...106,043,923
|
|
| G
|
Gh1
|
growth hormone 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of GH1
|
CTD |
PMID:28267586 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Gins2
|
GINS complex subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GINS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052
|
|
| G
|
Gins3
|
GINS complex subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GINS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679
|
|
| G
|
Git2
|
GIT ArfGAP 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GIT2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:47,490,350...47,531,232
Ensembl chr12:47,490,369...47,533,250
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GJB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Gla
|
galactosidase, alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915
|
|
| G
|
Gldc
|
glycine decarboxylase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLDC mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604
|
|
| G
|
Gldn
|
gliomedin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLDN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:63,575,270...63,619,346
Ensembl chr 8:63,575,270...63,619,346
|
|
| G
|
Gli2
|
GLI family zinc finger 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLI2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418
|
|
| G
|
Glrx2
|
glutaredoxin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLRX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150
|
|
| G
|
Gls2
|
glutaminase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of GLUL protein
|
CTD |
PMID:10323596 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Glyctk
|
glycerate kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GLYCTK mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:115,676,071...115,681,403
Ensembl chr 8:115,676,072...115,681,091
|
|
| G
|
Gmeb2
|
glucocorticoid modulatory element binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GMEB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:188,740,210...188,778,377
Ensembl chr 3:188,740,210...188,778,336
|
|
| G
|
Gmpr2
|
guanosine monophosphate reductase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GMPR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,135,455...33,144,923
Ensembl chr15:33,135,682...33,144,899
|
|
| G
|
Gna12
|
G protein subunit alpha 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNA12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
|
|
| G
|
Gna13
|
G protein subunit alpha 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNA13 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:94,837,271...94,870,290
Ensembl chr10:94,836,444...94,874,968
|
|
| G
|
Gna14
|
G protein subunit alpha 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNA14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210
|
|
| G
|
Gnaq
|
G protein subunit alpha q
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNAQ mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742
|
|
| G
|
Gnas
|
GNAS complex locus
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNAS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
|
|
| G
|
Gnb5
|
G protein subunit beta 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNB5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:84,956,629...84,985,576
Ensembl chr 8:84,953,815...84,986,888
|
|
| G
|
Gng11
|
G protein subunit gamma 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNG11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438
|
|
| G
|
Gng12
|
G protein subunit gamma 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNG12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
|
|
| G
|
Gng3
|
G protein subunit gamma 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNG3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:215,160,952...215,162,718
Ensembl chr 1:215,160,952...215,162,718
|
|
| G
|
Gng4
|
G protein subunit gamma 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNG4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr17:93,432,791...93,481,709
Ensembl chr17:93,433,195...93,481,709
|
|
| G
|
Gns
|
glucosamine (N-acetyl)-6-sulfatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GNS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:58,774,625...58,808,650
|
|
| G
|
Gosr2
|
golgi SNAP receptor complex member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GOSR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:89,085,323...89,105,665
Ensembl chr10:89,086,331...89,105,637
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GOT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpat3
|
glycerol-3-phosphate acyltransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPAT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:9,018,762...9,072,552
|
|
| G
|
Gpbp1l1
|
GC-rich promoter binding protein 1-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPBP1L1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:135,245,188...135,287,299
Ensembl chr 5:135,247,342...135,287,298
|
|
| G
|
Gpc3
|
glypican 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639
|
|
| G
|
Gpc6
|
glypican 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPC6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027
|
|
| G
|
Gpcpd1
|
glycerophosphocholine phosphodiesterase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPCPD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:140,240,575...140,285,372
|
|
| G
|
Gphn
|
gephyrin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPHN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:102,687,423...103,216,674
|
|
| G
|
Gpld1
|
glycosylphosphatidylinositol specific phospholipase D1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPLD1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975
|
|
| G
|
Gpr160
|
G protein-coupled receptor 160
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPR160 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:114,414,084...114,491,590
Ensembl chr 2:114,410,261...114,474,790
|
|
| G
|
Gpr87
|
G protein-coupled receptor 87
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPR87 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442
|
|
| G
|
Gprc5c
|
G protein-coupled receptor, class C, group 5, member C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPRC5C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:100,385,682...100,407,953
Ensembl chr10:100,383,631...100,426,962
|
|
| G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of GPX1 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of GPX1 mRNA; [Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in decreased expression of GPX1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of GPX1 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
affects expression multiple interactions
|
ISO EXP
|
Carbamazepine affects the expression of GPX2 mRNA [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in increased expression of GPX2 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in increased expression of GPX2 mRNA; [Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in increased expression of GPX2 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of GPX2 mRNA
|
CTD |
PMID:24752500 PMID:35786680 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx8
|
glutathione peroxidase 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GPX8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:46,409,139...46,413,406
|
|
| G
|
Grb10
|
growth factor receptor bound protein 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GRB10 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
|
|
| G
|
Grb14
|
growth factor receptor bound protein 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GRB14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921
|
|
| G
|
Grem2
|
gremlin 2, DAN family BMP antagonist
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GREM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312
|
|
| G
|
Grhl2
|
grainyhead-like transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GRHL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:70,280,360...70,415,277
Ensembl chr 7:70,285,310...70,415,274
|
|
| G
|
Grik2
|
glutamate ionotropic receptor kainate type subunit 2
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of GRIK2 mRNA; Carbamazepine results in decreased expression of GRIK2 protein
|
CTD |
PMID:19596362 |
|
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
|
|
| G
|
Grm2
|
glutamate metabotropic receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GRM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GSK3B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of GSTA1 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of GSTA2 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
increases response to substance increases expression
|
ISO EXP
|
GSTM1 gene mutant form results in increased susceptibility to Carbamazepine Carbamazepine results in increased expression of GSTM1 mRNA
|
CTD |
PMID:17381134 PMID:17465707 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm2
|
glutathione S-transferase mu 2
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of GSTM2 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
| G
|
Gsto2
|
glutathione S-transferase omega 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GSTO2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:256,673,376...256,695,154
Ensembl chr 1:256,673,274...256,695,146
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GSTT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gstz1
|
glutathione S-transferase zeta 1
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of GSTZ1 mRNA Carbamazepine affects the expression of GSTZ1 mRNA
|
CTD |
PMID:17112801 PMID:25979313 |
|
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233
|
|
| G
|
Gtf2h4
|
general transcription factor 2H subunit 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GTF2H4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760
|
|
| G
|
Gtf2h5
|
general transcription factor IIH subunit 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GTF2H5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:49,061,904...49,068,612
Ensembl chr 1:49,061,959...49,070,039
|
|
| G
|
Gtpbp2
|
GTP binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GTPBP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:22,311,532...22,321,405
Ensembl chr 9:22,311,158...22,321,441
|
|
| G
|
Guca1a
|
guanylate cyclase activator 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GUCA1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:21,080,782...21,096,221
Ensembl chr 9:21,086,642...21,096,221
|
|
| G
|
Gulp1
|
GULP PTB domain containing engulfment adaptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GULP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452
|
|
| G
|
Gusb
|
glucuronidase, beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of GUSB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024
|
|
| G
|
Gzmb
|
granzyme B
|
increases secretion
|
ISO
|
Carbamazepine results in increased secretion of GZMB protein
|
CTD |
PMID:29644860 |
|
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469
|
|
| G
|
H1f0
|
H1.0 linker histone
|
affects expression
|
ISO
|
Carbamazepine affects the expression of H1-0 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
|
|
| G
|
H1f10
|
H1.10 linker histone
|
affects expression
|
ISO
|
Carbamazepine affects the expression of H1-10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:121,997,831...121,998,966
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of H2AX protein
|
CTD |
PMID:36995427 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2az2
|
H2A.Z variant histone 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of H2AZ2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:85,507,228...85,526,166
Ensembl chr14:85,507,228...85,526,207 Ensembl chr16:85,507,228...85,526,207
|
|
| G
|
H3f3b
|
H3.3 histone B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of H3-3B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636
|
|
| G
|
Hacd1
|
3-hydroxyacyl-CoA dehydratase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HACD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592
|
|
| G
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HACL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410
|
|
| G
|
Hat1
|
histone acetyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HAT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696
|
|
| G
|
Hax1
|
HCLS1 associated protein X-1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HAX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:177,731,918...177,735,670
Ensembl chr 2:177,731,921...177,735,390
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HBEGF mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hdac1
|
histone deacetylase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HDAC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387
|
|
| G
|
Hdac3
|
histone deacetylase 3
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of HDAC3 protein
|
CTD |
PMID:15850602 |
|
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025
|
|
| G
|
Hdac7
|
histone deacetylase 7
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of HDAC7 protein
|
CTD |
PMID:15850602 |
|
NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017
|
|
| G
|
Hddc3
|
HD domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HDDC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:143,708,703...143,711,010
Ensembl chr 1:143,705,320...143,711,010
|
|
| G
|
Heg1
|
heart development protein with EGF-like domains 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HEG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:80,512,096...80,600,150
Ensembl chr11:80,512,096...80,600,092
|
|
| G
|
Herc4
|
HECT and RLD domain containing E3 ubiquitin protein ligase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HERC4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:25,329,005...25,403,443
Ensembl chr20:25,328,822...25,403,372
|
|
| G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HERPUD1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
| G
|
Hes5
|
hes family bHLH transcription factor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HES5 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021
|
|
| G
|
Hesx1
|
HESX homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HESX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:2,198,589...2,200,694
Ensembl chr16:2,198,589...2,200,694
|
|
| G
|
Hexb
|
hexosaminidase subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HEXB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
|
|
| G
|
Hgsnat
|
heparan-alpha-glucosaminide N-acetyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HGSNAT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:72,807,967...72,840,180
Ensembl chr16:72,807,849...72,840,176
|
|
| G
|
Hhex
|
hematopoietically expressed homeobox
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HHEX mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604
|
|
| G
|
Hhip
|
Hedgehog-interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HHIP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
|
|
| G
|
Hilpda
|
hypoxia inducible lipid droplet-associated
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HILPDA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423
|
|
| G
|
Hjurp
|
Holliday junction recognition protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HJURP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657
|
|
| G
|
Hk1
|
hexokinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
|
|
| G
|
Hmbs
|
hydroxymethylbilane synthase
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of HMBS protein
|
CTD |
PMID:6132132 |
|
NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of HMGB1 protein Carbamazepine affects the expression of HMGB1 mRNA
|
CTD |
PMID:22790970 PMID:24752500 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of HMGCR mRNA
|
CTD |
PMID:19566492 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HMGCS1 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression affects expression
|
EXP ISO
|
Carbamazepine results in increased expression of HMOX1 mRNA Carbamazepine affects the expression of HMOX1 mRNA
|
CTD |
PMID:17381134 PMID:25091725 PMID:25979313 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hmx2
|
H6 family homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HMX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:195,749,284...195,758,347
Ensembl chr 1:195,749,284...195,756,945
|
|
| G
|
Hnf1a
|
HNF1 homeobox A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HNF1A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
| G
|
Hnrnpd
|
heterogeneous nuclear ribonucleoprotein D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HNRNPD mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066
|
|
| G
|
Hnrnpl
|
heterogeneous nuclear ribonucleoprotein L
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HNRNPL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:93,235,729...93,239,061
|
|
| G
|
Hnrnpu
|
heterogeneous nuclear ribonucleoprotein U
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HNRNPU mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:92,609,791...92,618,580
Ensembl chr13:92,605,216...92,618,612
|
|
| G
|
Hoxa1
|
homeobox A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HOXA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209
|
|
| G
|
Hoxb1
|
homeo box B1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HOXB1 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr10:81,827,915...81,830,404
Ensembl chr10:81,827,915...81,830,404
|
|
| G
|
Hoxb4
|
homeo box B4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HOXB4 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr10:81,781,090...81,783,672
Ensembl chr10:81,781,090...81,783,666
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HRAS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hs2st1
|
heparan sulfate 2-O-sulfotransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HS2ST1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:236,168,391...236,302,186
Ensembl chr 2:236,168,392...236,302,133
|
|
| G
|
Hs3st1
|
heparan sulfate-glucosamine 3-sulfotransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HS3ST1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848
|
|
| G
|
Hsd17b4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HSD17B4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467
|
|
| G
|
Hsd3b2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of HSD3B2 protein
|
CTD |
PMID:15730543 |
|
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases activity
|
ISO
|
Carbamazepine results in increased activity of HSF1 protein
|
CTD |
PMID:34170685 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
decreases expression increases expression
|
EXP
|
Carbamazepine results in decreased expression of HSP90AA1 mRNA Carbamazepine results in increased expression of HSP90AA1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
affects response to substance affects expression
|
ISO
|
HSPA1A gene SNP affects the susceptibility to Carbamazepine Carbamazepine affects the expression of HSPA1A mRNA
|
CTD |
PMID:16538175 PMID:25979313 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1l
|
heat shock protein family A (Hsp70) member 1 like
|
affects response to substance
|
ISO
|
HSPA1L gene SNP affects the susceptibility to Carbamazepine
|
CTD |
PMID:16538175 |
|
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HSPA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Hspa4l
|
heat shock protein family A (Hsp70) member 4 like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HSPA4L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986
|
|
| G
|
Hspb8
|
heat shock protein family B (small) member 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HSPB8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
|
|
| G
|
Hsph1
|
heat shock protein family H (Hsp110) member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HSPH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
|
|
| G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
multiple interactions
|
EXP
|
Carbamazepine inhibits the reaction [Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]]; Carbamazepine inhibits the reaction [Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]; Carbamazepine inhibits the reaction [Pilocarpine results in decreased expression of HTR2C mRNA]; Carbamazepine inhibits the reaction [Pilocarpine results in decreased expression of HTR2C protein]; Carbamazepine inhibits the reaction [Pilocarpine results in increased expression of HTR2C mRNA]
|
CTD |
PMID:19439326 PMID:19700373 |
|
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ICAM1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ID1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Idh3a
|
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IDH3A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223
|
|
| G
|
Idi1
|
isopentenyl-diphosphate delta isomerase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IDI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524
|
|
| G
|
Ids
|
iduronate 2-sulfatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IDS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:154,070,781...154,093,681
Ensembl chr X:154,070,781...154,091,444
|
|
| G
|
Ier2
|
immediate early response 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IER2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708
|
|
| G
|
Iffo2
|
intermediate filament family orphan 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IFFO2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:157,114,089...157,160,135
Ensembl chr 5:157,114,089...157,160,135
|
|
| G
|
Ifng
|
interferon gamma
|
decreases expression increases secretion
|
ISO EXP
|
Carbamazepine results in decreased expression of IFNG mRNA Carbamazepine results in increased secretion of IFNG protein
|
CTD |
PMID:22790970 PMID:28267586 PMID:29644860 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifrd1
|
interferon-related developmental regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IFRD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
|
|
| G
|
Ift22
|
intraflagellar transport 22
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IFT22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:25,397,092...25,405,522
Ensembl chr12:25,387,347...25,405,510
|
|
| G
|
Ift57
|
intraflagellar transport 57
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IFT57 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:64,528,349...64,593,545
Ensembl chr11:64,528,349...64,593,545
|
|
| G
|
Igbp1
|
immunoglobulin binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:69,622,925...69,645,167
Ensembl chr X:69,622,917...69,646,149
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of IGF1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGF1R mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGF2BP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:79,391,367...79,525,923
Ensembl chr 4:79,393,067...79,525,730
|
|
| G
|
Igf2r
|
insulin-like growth factor 2 receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGF2R mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265
|
|
| G
|
Igfbp1
|
insulin-like growth factor binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGFBP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGFBP3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGFBP5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGFBP6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Igfbp7
|
insulin-like growth factor binding protein 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGFBP7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
|
|
| G
|
Igsf9b
|
immunoglobulin superfamily, member 9B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IGSF9B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:33,971,779...34,027,390
Ensembl chr 8:33,971,779...34,018,128
|
|
| G
|
Ik
|
IK cytokine
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IKBKG mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Il11
|
interleukin 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
| G
|
Il12a
|
interleukin 12A
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of IL12A mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
| G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL13RA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
| G
|
Il17a
|
interleukin 17A
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of IL17A
|
CTD |
PMID:28267586 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of IL1B
|
CTD |
PMID:28267586 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL1R1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il2
|
interleukin 2
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of IL2
|
CTD |
PMID:28267586 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il23a
|
interleukin 23 subunit alpha
|
increases expression multiple interactions
|
ISO
|
Carbamazepine results in increased expression of IL23A mRNA Alprostadil inhibits the reaction [Carbamazepine results in increased expression of IL23A mRNA]
|
CTD |
PMID:22790970 |
|
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
|
|
| G
|
Il27ra
|
interleukin 27 receptor subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL27RA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760
|
|
| G
|
Il4
|
interleukin 4
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of IL4
|
CTD |
PMID:28267586 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL4R mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
decreases expression increases expression multiple interactions
|
ISO
|
Carbamazepine results in decreased expression of IL6 protein Carbamazepine results in increased expression of IL6 mRNA Alprostadil inhibits the reaction [Carbamazepine results in increased expression of IL6 mRNA]
|
CTD |
PMID:10467277 PMID:22790970 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il7r
|
interleukin 7 receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IL7R mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
|
|
| G
|
Immp2l
|
inner mitochondrial membrane peptidase subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IMMP2L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:63,797,189...64,696,906
Ensembl chr 6:63,797,237...64,697,749
|
|
| G
|
Impdh1
|
inosine monophosphate dehydrogenase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IMPDH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:58,767,230...58,782,825
Ensembl chr 4:58,767,230...58,783,124
|
|
| G
|
Impdh2
|
inosine monophosphate dehydrogenase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IMPDH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873
|
|
| G
|
Inhbb
|
inhibin subunit beta B
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of INHBB mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609
|
|
| G
|
Inhbe
|
inhibin subunit beta E
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INHBE mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
|
|
| G
|
Inpp1
|
inositol polyphosphate-1-phosphatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INPP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:56,161,816...56,209,774
Ensembl chr 9:56,161,852...56,234,569
|
|
| G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INPP5D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
| G
|
Insig1
|
insulin induced gene 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INSIG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
| G
|
Insr
|
insulin receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INSR mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803
|
|
| G
|
Ints2
|
integrator complex subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of INTS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Ipo5
|
importin 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IPO5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985
|
|
| G
|
Ipo9
|
importin 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IPO9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477
|
|
| G
|
Iqcg
|
IQ motif containing G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of DRC9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:81,235,204...81,276,249
Ensembl chr11:81,235,090...81,276,249
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRAK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irf2bp2
|
interferon regulatory factor 2 binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRF2BP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRS1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Irx2
|
iroquois homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:32,489,512...32,494,930
Ensembl chr 1:32,489,512...32,494,930
|
|
| G
|
Irx3
|
iroquois homeobox 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:31,384,803...31,388,241
Ensembl chr19:31,384,833...31,388,238
|
|
| G
|
Irx5
|
iroquois homeobox 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IRX5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029
|
|
| G
|
Iscu
|
iron-sulfur cluster assembly enzyme
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ISCU mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:48,512,852...48,518,696
Ensembl chr12:48,512,852...48,518,696
|
|
| G
|
Isg20
|
interferon stimulated exonuclease gene 20
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ISG20 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401
|
|
| G
|
Isl1
|
ISL LIM homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ISL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITGA2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITGAV mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Itgb1
|
integrin subunit beta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITGB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
| G
|
Itgb5
|
integrin subunit beta 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITGB5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:80,333,588...80,449,373
Ensembl chr11:80,333,590...80,449,373
|
|
| G
|
Itm2b
|
integral membrane protein 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITM2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455
|
|
| G
|
Itpr2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITPR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763
|
|
| G
|
Itpripl2
|
ITPRIP like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ITPRIPL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:182,235,361...182,237,256
Ensembl chr 1:182,231,093...182,245,858
|
|
| G
|
Ivns1abp
|
influenza virus NS1A binding protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of IVNS1ABP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547
|
|
| G
|
Jakmip1
|
janus kinase and microtubule interacting protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of JAKMIP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:77,871,034...77,991,566
Ensembl chr14:77,871,034...77,991,525
|
|
| G
|
Jdp2
|
Jun dimerization protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of JDP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392
|
|
| G
|
Jpt2
|
Jupiter microtubule associated homolog 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of JPT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of JUN mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of JUNB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Kank4
|
KN motif and ankyrin repeat domains 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KANK4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002
|
|
| G
|
Kansl3
|
KAT8 regulatory NSL complex subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KANSL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:46,058,070...46,101,643
Ensembl chr 9:46,058,071...46,101,521
|
|
| G
|
Kat6b
|
lysine acetyltransferase 6B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KAT6B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343
|
|
| G
|
Kbtbd3
|
kelch repeat and BTB domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KBTBD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:9,749,229...9,780,036
Ensembl chr 8:9,749,175...9,774,555
|
|
| G
|
Kbtbd7
|
kelch repeat and BTB domain containing 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KBTBD7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:61,215,957...61,220,536
Ensembl chr15:61,215,396...61,223,671
|
|
| G
|
Kcmf1
|
potassium channel modulatory factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCMF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:106,447,974...106,508,359
Ensembl chr 4:106,447,981...106,508,359
|
|
| G
|
Kcna5
|
potassium voltage-gated channel subfamily A member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNA5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:160,996,950...161,044,408
|
|
| G
|
Kcne5
|
potassium voltage-gated channel subfamily E regulatory subunit 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNE5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:110,727,234...110,727,849
Ensembl chr X:110,726,282...110,728,047
|
|
| G
|
Kcng3
|
potassium voltage-gated channel modifier subfamily G member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNG3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:16,803,842...16,851,791
Ensembl chr 6:16,803,665...16,851,791
|
|
| G
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNJ12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:46,196,110...46,245,008
Ensembl chr10:46,195,428...46,260,169
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNJ8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kcnk1
|
potassium two pore domain channel subfamily K member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:70,856,985...70,895,053
Ensembl chr19:70,856,985...70,895,051
|
|
| G
|
Kcnk12
|
potassium two pore domain channel subfamily K member 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNK12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:12,492,609...12,544,250
Ensembl chr 6:12,494,850...12,544,221
|
|
| G
|
Kcnn1
|
potassium calcium-activated channel subfamily N member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCNN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:18,608,782...18,632,571
Ensembl chr16:18,610,769...18,632,571
|
|
| G
|
Kcnn2
|
potassium calcium-activated channel subfamily N member 2
|
decreases activity
|
EXP
|
Carbamazepine results in decreased activity of KCNN2 protein
|
CTD |
PMID:10915830 |
|
NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045
|
|
| G
|
Kctd2
|
potassium channel tetramerization domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KCTD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:101,162,091...101,173,721
Ensembl chr10:101,162,091...101,173,721
|
|
| G
|
Kdelr2
|
KDEL endoplasmic reticulum protein retention receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDELR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:16,252,424...16,270,737
Ensembl chr12:16,252,424...16,270,719
|
|
| G
|
Kdm1a
|
lysine demethylase 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDM1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775
|
|
| G
|
Kdm3a
|
lysine demethylase 3A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDM3A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:105,189,208...105,233,370
|
|
| G
|
Kdm5b
|
lysine demethylase 5B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDM5B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:48,554,420...48,626,423
|
|
| G
|
Kdm7a
|
lysine demethylase 7A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDM7A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506
|
|
| G
|
Kdsr
|
3-ketodihydrosphingosine reductase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KDSR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897
|
|
| G
|
Khdrbs1
|
KH RNA binding domain containing, signal transduction associated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KHDRBS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
|
|
| G
|
Khdrbs3
|
KH RNA binding domain containing, signal transduction associated 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KHDRBS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:102,726,628...102,884,545
Ensembl chr 7:102,726,843...102,884,541
|
|
| G
|
Khnyn
|
KH and NYN domain containing
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KHNYN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,335,290...33,349,553
Ensembl chr15:33,335,274...33,349,552
|
|
| G
|
Kif13b
|
kinesin family member 13B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIF13B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:43,084,059...43,241,719
Ensembl chr15:43,080,910...43,241,719
|
|
| G
|
Kif15
|
kinesin family member 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIF15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202
|
|
| G
|
Kif20a
|
kinesin family member 20A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIF20A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
|
|
| G
|
Kif3b
|
kinesin family member 3B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIF3B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:162,218,621...162,258,191
Ensembl chr 3:162,218,682...162,258,581
|
|
| G
|
Kifc1
|
kinesin family member C1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIFC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
|
|
| G
|
Kirrel3
|
kirre like nephrin family adhesion molecule 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KIRREL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:41,123,692...41,663,528
Ensembl chr 8:41,123,878...41,664,147
|
|
| G
|
Kitlg
|
KIT ligand
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KITLG mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
| G
|
Klf10
|
KLF transcription factor 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLF10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948
|
|
| G
|
Klf15
|
KLF transcription factor 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLF15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
|
|
| G
|
Klf2
|
KLF transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLF2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768
|
|
| G
|
Klf6
|
KLF transcription factor 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLF6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601
|
|
| G
|
Klhl22
|
kelch-like family member 22
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLHL22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:96,695,168...96,736,079
Ensembl chr11:96,695,171...96,738,065
|
|
| G
|
Klhl4
|
kelch-like family member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLHL4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:83,626,047...83,916,328
Ensembl chr X:83,819,076...83,916,328
|
|
| G
|
Klhl5
|
kelch-like family member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLHL5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894
|
|
| G
|
Klk7
|
kallikrein-related peptidase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KLK7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:103,403,206...103,407,907
Ensembl chr 1:103,403,212...103,407,907
|
|
| G
|
Kntc1
|
kinetochore associated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KNTC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:38,429,925...38,500,564
Ensembl chr12:38,429,925...38,500,457
|
|
| G
|
Kpna1
|
karyopherin subunit alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KPNA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
|
|
| G
|
Kras
|
KRAS proto-oncogene, GTPase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KRAS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
|
|
| G
|
Krtcap3
|
keratinocyte associated protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KRTCAP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:30,840,906...30,842,500
Ensembl chr 6:30,840,906...30,842,475
|
|
| G
|
L1cam
|
L1 cell adhesion molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of L1CAM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077
|
|
| G
|
Lamb1
|
laminin subunit beta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LAMB1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:53,563,073...53,630,760
|
|
| G
|
Lamc1
|
laminin subunit gamma 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LAMC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986
|
|
| G
|
Lamp1
|
lysosomal-associated membrane protein 1
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of LAMP1 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of LAMP1 mRNA; [Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in decreased expression of LAMP1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of LAMP1 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159
|
|
| G
|
Lamp2
|
lysosomal-associated membrane protein 2
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of LAMP2 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of LAMP2 mRNA; [Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in decreased expression of LAMP2 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of LAMP2 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
|
|
| G
|
Larp1b
|
La ribonucleoprotein 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LARP1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:125,860,935...125,897,189
Ensembl chr 2:125,863,997...125,897,189
|
|
| G
|
Larp7
|
La ribonucleoprotein 7, transcriptional regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LARP7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:218,672,145...218,687,332
Ensembl chr 2:218,672,208...218,687,308
|
|
| G
|
Lars1
|
leucyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:34,452,567...34,507,030
Ensembl chr18:34,452,561...34,506,938
|
|
| G
|
Las1l
|
LAS1-like, ribosome biogenesis factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LAS1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:64,861,472...64,883,221
Ensembl chr X:64,861,258...64,883,308
|
|
| G
|
Lats2
|
large tumor suppressor kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LATS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842
|
|
| G
|
Lcmt1
|
leucine carboxyl methyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LCMT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:187,327,706...187,391,516
|
|
| G
|
Lcp1
|
lymphocyte cytosolic protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LCP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092
|
|
| G
|
Ldb3
|
LIM domain binding 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LDB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:9,862,161...9,926,338
Ensembl chr16:9,862,161...9,926,985
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
decreases expression affects expression
|
ISO
|
Carbamazepine results in decreased expression of LDLR mRNA Carbamazepine affects the expression of LDLR mRNA
|
CTD |
PMID:21123845 PMID:22634333 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lemd1
|
LEM domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LEMD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:46,183,860...46,250,105
Ensembl chr13:46,218,085...46,250,562
|
|
| G
|
Lgals1
|
galectin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LGALS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
|
|
| G
|
Lgi1
|
leucine-rich, glioma inactivated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LGI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:245,455,691...245,497,036
Ensembl chr 1:245,455,599...245,499,095
|
|
| G
|
Lhfpl6
|
LHFPL tetraspan subfamily member 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LHFPL6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:139,276,810...139,474,740
Ensembl chr 2:139,276,789...139,474,737
|
|
| G
|
Lhx2
|
LIM homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LHX2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:42,535,744...42,553,645
|
|
| G
|
Lhx5
|
LIM homeobox 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LHX5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:41,786,746...41,795,183
Ensembl chr12:41,786,746...41,795,183
|
|
| G
|
Lifr
|
LIF receptor subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LIFR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364
|
|
| G
|
Lig1
|
DNA ligase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LIG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
|
|
| G
|
Lilra5
|
leukocyte immunoglobulin like receptor A5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LILRA5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:79,011,865...79,073,860
Ensembl chr 1:79,045,546...79,050,111
|
|
| G
|
Lin28a
|
lin-28 homolog A
|
affects expression decreases expression
|
ISO
|
Carbamazepine affects the expression of LIN28A mRNA Carbamazepine results in decreased expression of LIN28A mRNA
|
CTD |
PMID:25979313 PMID:37505509 |
|
NCBI chr 5:151,510,891...151,527,884
Ensembl chr 5:151,510,891...151,527,884
|
|
| G
|
Lingo1
|
leucine rich repeat and Ig domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LINGO1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:65,907,275...66,089,485
Ensembl chr 8:65,897,844...66,091,740
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LITAF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LMCD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Lmna
|
lamin A/C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LMNA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
|
|
| G
|
Lmo1
|
LIM domain only 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LMO1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:172,567,156...172,603,282
Ensembl chr 1:172,567,156...172,603,157
|
|
| G
|
Lmo4
|
LIM domain only 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LMO4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:235,924,574...235,941,609
Ensembl chr 2:235,924,403...235,941,275
|
|
| G
|
Lonp2
|
lon peptidase 2, peroxisomal
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LONP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:36,580,736...36,672,242
Ensembl chr19:36,580,736...36,672,242
|
|
| G
|
Loxl1
|
lysyl oxidase-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LOXL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
|
|
| G
|
Loxl3
|
lysyl oxidase-like 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LOXL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:117,098,358...117,114,673
Ensembl chr 4:117,099,635...117,115,046
|
|
| G
|
Lpar6
|
lysophosphatidic acid receptor 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LPAR6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:54,826,110...54,827,919
Ensembl chr15:54,823,717...54,978,783
|
|
| G
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LPCAT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946
|
|
| G
|
Lpcat4
|
lysophosphatidylcholine acyltransferase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LPCAT4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:119,499,128...119,507,275
Ensembl chr 3:119,499,128...119,507,362
|
|
| G
|
Lpin2
|
lipin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LPIN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:118,529,988...118,604,796
Ensembl chr 9:118,529,943...118,604,796
|
|
| G
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LPP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:89,292,060...89,933,973
Ensembl chr11:89,305,187...89,805,264
|
|
| G
|
Lratd2
|
LRAT domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRATD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:94,270,753...94,276,445
Ensembl chr 7:94,073,513...94,277,046
|
|
| G
|
Lrch1
|
leucine rich repeats and calponin homology domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRCH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:56,469,403...56,659,201
Ensembl chr15:56,481,395...56,659,100
|
|
| G
|
Lrp11
|
LDL receptor related protein 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRP11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:3,868,665...3,928,513
Ensembl chr 1:3,899,985...3,928,507
|
|
| G
|
Lrp1b
|
LDL receptor related protein 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRP1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:45,004,001...47,125,147
Ensembl chr 3:45,004,689...45,957,692
|
|
| G
|
Lrp2
|
LDL receptor related protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:74,597,148...74,754,535
|
|
| G
|
Lrp4
|
LDL receptor related protein 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRP4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:97,885,373...97,939,366
Ensembl chr 3:97,885,400...97,939,370
|
|
| G
|
Lrpap1
|
LDL receptor related protein associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRPAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:79,876,002...79,888,011
Ensembl chr14:79,875,708...79,890,034
|
|
| G
|
Lrrc34
|
leucine rich repeat containing 34
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRC34 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:114,680,787...114,702,961
Ensembl chr 2:114,680,094...114,702,961
|
|
| G
|
Lrrc4
|
leucine rich repeat containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRC4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:58,398,942...58,402,538
Ensembl chr 4:58,397,302...58,402,808
|
|
| G
|
Lrrc4c
|
leucine rich repeat containing 4C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRC4C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:102,760,152...104,139,222
Ensembl chr 3:103,970,485...104,146,212
|
|
| G
|
Lrrc8a
|
leucine rich repeat containing 8 VRAC subunit A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRC8A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:33,902,299...33,934,989
Ensembl chr 3:33,908,268...33,933,625
|
|
| G
|
Lrrc8b
|
leucine rich repeat containing 8 VRAC subunit B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRC8B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:4,655,273...4,721,648
Ensembl chr14:4,655,273...4,721,076
|
|
| G
|
Lrrtm1
|
leucine rich repeat transmembrane neuronal 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LRRTM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:111,246,213...111,295,638
Ensembl chr 4:111,235,054...111,276,818
|
|
| G
|
Lsm14a
|
LSM14A mRNA processing body assembly factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LSM14A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:96,101,990...96,146,578
Ensembl chr 1:96,101,992...96,146,448
|
|
| G
|
Lta4h
|
leukotriene A4 hydrolase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LTA4H mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LTBP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Luzp1
|
leucine zipper protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LUZP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:153,989,570...154,065,071
Ensembl chr 5:153,987,683...154,070,438
|
|
| G
|
Lyrm1
|
LYR motif containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of LYRM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:183,715,941...183,736,406
Ensembl chr 1:183,715,468...183,736,406
|
|
| G
|
Macc1
|
MET transcriptional regulator MACC1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MACC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:146,495,544...146,574,254
Ensembl chr 6:146,495,861...146,574,260
|
|
| G
|
Macrod1
|
mono-ADP ribosylhydrolase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MACROD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348
|
|
| G
|
Mad2l2
|
mitotic arrest deficient 2 like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAD2L2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:163,846,687...163,859,851
|
|
| G
|
Mafb
|
MAF bZIP transcription factor B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAFB mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAFF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Magi1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAGI1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:127,762,590...128,367,833
|
|
| G
|
Mal2
|
mal, T-cell differentiation protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:87,790,239...87,850,403
|
|
| G
|
Mamdc2
|
MAM domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAMDC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:230,290,482...230,443,014
Ensembl chr 1:230,290,499...230,442,711
|
|
| G
|
Man1c1
|
mannosidase, alpha, class 1C, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAN1C1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138
|
|
| G
|
Maoa
|
monoamine oxidase A
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of MAOA mRNA Carbamazepine affects the expression of MAOA mRNA
|
CTD |
PMID:17112801 PMID:24752500 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Maob
|
monoamine oxidase B
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of MAOB mRNA Carbamazepine affects the expression of MAOB mRNA
|
CTD |
PMID:17112801 PMID:24752500 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
multiple interactions
|
EXP
|
[Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of MAP1LC3A protein
|
CTD |
PMID:35786680 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of MAP1LC3B mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k3
|
mitogen activated protein kinase kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP2K3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004
|
|
| G
|
Map2k5
|
mitogen activated protein kinase kinase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP2K5 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:72,520,617...72,747,373
|
|
| G
|
Map2k6
|
mitogen-activated protein kinase kinase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP2K6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
|
|
| G
|
Map3k21
|
mitogen-activated protein kinase kinase kinase 21
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP3K21 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:70,776,233...70,810,889
Ensembl chr19:70,777,472...70,810,882
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP3K7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Map4k1
|
mitogen activated protein kinase kinase kinase kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP4K1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,398,460...93,419,996
Ensembl chr 1:93,398,454...93,419,993
|
|
| G
|
Map4k4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP4K4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353
|
|
| G
|
Map7
|
microtubule-associated protein 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:16,730,000...16,857,173
Ensembl chr 1:16,730,075...16,857,170
|
|
| G
|
Map9
|
microtubule-associated protein 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAP9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:170,005,792...170,042,003
Ensembl chr 2:170,006,834...170,042,001
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk13
|
mitogen activated protein kinase 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPK13 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPK14 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPK8 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapkap1
|
MAPK associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPKAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:38,113,268...38,315,913
Ensembl chr 3:38,113,323...38,315,913
|
|
| G
|
Mapkapk2
|
MAPK activated protein kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MAPKAPK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326
|
|
| G
|
Marchf1
|
membrane associated ring-CH-type finger 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MARCHF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:28,022,159...28,880,872
Ensembl chr16:28,022,159...28,881,054
|
|
| G
|
Marchf5
|
membrane associated ring-CH-type finger 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MARCHF5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:244,343,674...244,365,160
Ensembl chr 1:244,343,630...244,366,462
|
|
| G
|
Marchf7
|
membrane associated ring-CH-type finger 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MARCHF7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:65,090,640...65,128,768
Ensembl chr 3:65,090,310...65,128,864
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
increases phosphorylation
|
EXP
|
Carbamazepine results in increased phosphorylation of MARCKS protein
|
CTD |
PMID:14642444 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Mars1
|
methionyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:65,006,456...65,023,880
Ensembl chr 7:64,998,544...65,023,753
|
|
| G
|
Marveld3
|
MARVEL domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MARVELD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:54,818,180...54,832,871
Ensembl chr19:54,818,180...54,832,871
|
|
| G
|
Mbnl1
|
muscleblind-like splicing regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MBNL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:146,789,596...146,964,134
|
|
| G
|
Mcam
|
melanoma cell adhesion molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCAM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
|
|
| G
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCF2L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956
|
|
| G
|
Mchr1
|
melanin-concentrating hormone receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCHR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:114,641,721...114,644,913
Ensembl chr 7:114,641,580...114,644,919
|
|
| G
|
Mcm3
|
minichromosome maintenance complex component 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
|
|
| G
|
Mcm6
|
minichromosome maintenance complex component 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCM6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Mcm7
|
minichromosome maintenance complex component 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCM7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771
|
|
| G
|
Mctp1
|
multiple C2 and transmembrane domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCTP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:7,798,968...8,493,596
Ensembl chr 2:7,803,382...8,493,596
|
|
| G
|
Mcub
|
mitochondrial calcium uniporter dominant negative subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCUB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:221,153,525...221,223,814
Ensembl chr 2:221,153,525...221,223,814
|
|
| G
|
Mcur1
|
mitochondrial calcium uniporter regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MCUR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:21,348,490...21,365,614
Ensembl chr17:21,348,012...21,368,764
|
|
| G
|
Mdfic
|
MyoD family inhibitor domain containing
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MDFIC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:44,938,301...45,018,157
Ensembl chr 4:44,938,480...45,018,156
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MDM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Me1
|
malic enzyme 1
|
increases expression affects expression
|
EXP ISO
|
Carbamazepine results in increased expression of ME1 mRNA Carbamazepine affects the expression of ME1 mRNA
|
CTD |
PMID:17381134 PMID:25979313 |
|
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
|
|
| G
|
Med10
|
mediator complex subunit 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED10 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:35,298,494...35,310,163
Ensembl chr 1:35,298,495...35,304,154
|
|
| G
|
Med13
|
mediator complex subunit 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED13 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,584,354...71,673,901
|
|
| G
|
Med13l
|
mediator complex subunit 13L
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED13L mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr12:43,468,556...43,665,819
Ensembl chr12:43,468,556...43,665,819
|
|
| G
|
Med14
|
mediator complex subunit 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED14 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:12,709,406...12,800,642
Ensembl chr X:12,709,472...12,800,640
|
|
| G
|
Med17
|
mediator complex subunit 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED17 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:20,382,995...20,401,993
Ensembl chr 8:20,382,995...20,401,993
|
|
| G
|
Med30
|
mediator complex subunit 30
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED30 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:85,894,638...85,916,373
Ensembl chr 7:85,894,605...85,917,973
|
|
| G
|
Med31
|
mediator complex subunit 31
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED31 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:57,335,507...57,338,889
Ensembl chr10:57,335,507...57,338,889
|
|
| G
|
Med6
|
mediator complex subunit 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MED6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:107,001,664...107,015,130
Ensembl chr 6:106,990,116...107,015,130
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MEF2A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Megf10
|
multiple EGF-like domains 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MEGF10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:52,803,292...52,953,431
Ensembl chr18:52,847,781...52,950,675
|
|
| G
|
Meioc
|
meiosis specific with coiled-coil domain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MEIOC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:88,128,939...88,147,833
Ensembl chr10:88,128,990...88,147,829
|
|
| G
|
Meox1
|
mesenchyme homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MEOX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:87,318,668...87,338,169
Ensembl chr10:87,318,695...87,337,976
|
|
| G
|
Mep1a
|
meprin A subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MEP1A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:24,971,901...25,001,414
Ensembl chr 9:24,971,886...25,001,414
|
|
| G
|
Mesp1
|
mesoderm posterior bHLH transcription factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MESP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:143,147,671...143,149,189
Ensembl chr 1:143,147,671...143,149,189
|
|
| G
|
Mettl22
|
methyltransferase 22, Kin17 lysine
|
affects expression
|
ISO
|
Carbamazepine affects the expression of METTL22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:7,620,279...7,637,334
Ensembl chr10:7,620,279...7,638,222
|
|
| G
|
Mfap1a
|
microfibrillar-associated protein 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MFAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:128,893,880...128,910,460
Ensembl chr 3:128,893,880...128,911,481
|
|
| G
|
Mfge8
|
milk fat globule EGF and factor V/VIII domain containing
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MFGE8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431
|
|
| G
|
Mfsd1
|
major facilitator superfamily domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MFSD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:154,156,167...154,176,209
Ensembl chr 2:154,156,166...154,177,086
|
|
| G
|
Mfsd5
|
major facilitator superfamily domain containing 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC61A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:135,287,683...135,289,964
Ensembl chr 7:135,269,076...135,290,342
|
|
| G
|
Mgat4a
|
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MGAT4A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:47,169,229...47,282,577
Ensembl chr 9:47,169,232...47,282,574
|
|
| G
|
Mgll
|
monoglyceride lipase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MGLL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MGST1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mical2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MICAL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:175,780,441...175,965,157
Ensembl chr 1:175,825,596...175,905,155
|
|
| G
|
Micb
|
MHC class I polypeptide-related sequence B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MICB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:87,623,826...87,641,075
Ensembl chr 1:87,623,826...87,640,872
|
|
| G
|
Mid1
|
midline 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MID1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:27,678,248...28,053,049
Ensembl chr X:27,681,867...27,906,105
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MIF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mir155
|
microRNA 155
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of MIR155 mRNA
|
CTD |
PMID:29644860 |
|
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir18a
|
microRNA 18a
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of MIR18A mRNA
|
CTD |
PMID:29644860 |
|
NCBI chr15:98,587,984...98,588,079
Ensembl chr15:98,587,984...98,588,079
|
|
| G
|
Mir21
|
microRNA 21
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of MIR21 mRNA
|
CTD |
PMID:29644860 |
|
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mitf
|
melanocyte inducing transcription factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MITF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790
|
|
| G
|
Mixl1
|
Mix paired-like homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MIXL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:94,953,907...94,957,938
Ensembl chr13:94,953,907...94,957,938
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MKI67 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mknk2
|
MAPK interacting serine/threonine kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MKNK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529
|
|
| G
|
Mllt3
|
MLLT3, super elongation complex subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MLLT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:107,305,008...107,561,352
Ensembl chr 5:107,284,766...107,561,352
|
|
| G
|
Mln
|
motilin
|
affects response to substance
|
ISO
|
MLN gene SNP affects the susceptibility to Carbamazepine
|
CTD |
PMID:16538176 |
|
NCBI chr20:5,306,126...5,310,825
Ensembl chr20:5,306,126...5,310,825
|
|
| G
|
Mlph
|
melanophilin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MLPH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556
|
|
| G
|
Mmab
|
metabolism of cobalamin associated B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MMAB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:47,819,757...47,833,127
Ensembl chr12:47,819,724...47,833,118
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MMP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp10
|
matrix metallopeptidase 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MMP10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MMP9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mnx1
|
motor neuron and pancreas homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MNX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:6,541,645...6,546,604
Ensembl chr 4:6,541,645...6,546,604
|
|
| G
|
Mocos
|
molybdenum cofactor sulfurase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MOCOS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:16,206,402...16,251,928
Ensembl chr18:16,206,402...16,251,928
|
|
| G
|
Moxd1
|
monooxygenase, DBH-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MOXD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:22,894,543...22,984,599
Ensembl chr 1:22,894,543...22,984,223
|
|
| G
|
Mpc1
|
mitochondrial pyruvate carrier 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MPC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:54,985,301...54,997,064
|
|
| G
|
Mpp2
|
MAGUK p55 scaffold protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MPP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029
|
|
| G
|
Mpz
|
myelin protein zero
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MPZ mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:86,103,290...86,109,156
Ensembl chr13:86,103,290...86,109,155
|
|
| G
|
Mr1
|
major histocompatibility complex, class I-related
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MR1 mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502
|
|
| G
|
Mrap2
|
melanocortin 2 receptor accessory protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRAP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:96,968,239...97,024,581
Ensembl chr 8:96,988,079...97,024,579
|
|
| G
|
Mras
|
muscle RAS oncogene homolog
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRAS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911
|
|
| G
|
Mreg
|
melanoregulin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MREG mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:81,236,019...81,291,601
Ensembl chr 9:81,236,019...81,291,310
|
|
| G
|
Mrgprf
|
MAS related GPR family member F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRGPRF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:209,893,384...209,902,852
Ensembl chr 1:209,892,450...209,903,614
|
|
| G
|
Mrm3
|
mitochondrial rRNA methyltransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:61,594,155...61,623,659
Ensembl chr10:61,593,999...61,600,865
|
|
| G
|
Mrpl16
|
mitochondrial ribosomal protein L16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRPL16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:218,058,439...218,063,251
Ensembl chr 1:218,058,433...218,064,898
|
|
| G
|
Mrpl9
|
mitochondrial ribosomal protein L9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRPL9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:184,768,837...184,775,787
Ensembl chr 2:184,763,529...184,775,777
|
|
| G
|
Mrps14
|
mitochondrial ribosomal protein S14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRPS14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:74,962,597...74,968,344
Ensembl chr13:74,962,515...74,970,975
|
|
| G
|
Mrps22
|
mitochondrial ribosomal protein S22
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MRPS22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:108,063,468...108,076,638
Ensembl chr 8:108,063,471...108,076,638
|
|
| G
|
Msra
|
methionine sulfoxide reductase A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MSRA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:42,527,045...42,853,279
|
|
| G
|
Msrb3
|
methionine sulfoxide reductase B3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MSRB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:57,968,124...58,311,116
|
|
| G
|
Msx1
|
msh homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MSX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:77,185,802...77,189,735
Ensembl chr14:77,185,802...77,189,735
|
|
| G
|
Msx2
|
msh homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MSX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
|
|
| G
|
Mta3
|
metastasis associated 1 family, member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MTA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:16,619,575...16,739,732
Ensembl chr 6:16,621,998...16,739,485
|
|
| G
|
Mtdh
|
metadherin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MTDH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:67,192,592...67,250,819
Ensembl chr 7:67,192,393...67,249,584
|
|
| G
|
Mtg1
|
mitochondrial ribosome-associated GTPase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MTG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:204,361,176...204,373,917
Ensembl chr 1:204,361,147...204,373,924
|
|
| G
|
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MTHFD1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309
|
|
| G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MTHFD2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
| G
|
Mxd1
|
max dimerization protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MXD1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
|
|
| G
|
Myadm
|
myeloid-associated differentiation marker
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYADM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:74,779,616...74,796,752
Ensembl chr 1:74,775,698...74,789,710
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYC mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYD88 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Myl4
|
myosin, light chain 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYL4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
|
|
| G
|
Myl7
|
myosin light chain 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYL7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:84,994,644...84,997,173
Ensembl chr14:84,993,736...84,997,372
|
|
| G
|
Myl9
|
myosin light chain 9
|
multiple interactions affects expression
|
ISO
|
Carbamazepine results in decreased phosphorylation of and results in decreased activity of MYL9 protein Carbamazepine affects the expression of MYL9 mRNA
|
CTD |
PMID:24352538 PMID:25979313 |
|
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410
|
|
| G
|
Mylk
|
myosin light chain kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYLK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Myo1c
|
myosin 1C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYO1C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:60,996,642...61,019,022
Ensembl chr10:60,996,638...61,019,022
|
|
| G
|
Myo5a
|
myosin VA
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYO5A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265
|
|
| G
|
Myo6
|
myosin VI
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYO6 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:89,967,377...90,122,215
|
|
| G
|
Myof
|
myoferlin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYOF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768
|
|
| G
|
Myt1l
|
myelin transcription factor 1-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of MYT1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:51,892,858...52,291,830
Ensembl chr 6:52,155,754...52,291,828
|
|
| G
|
Nabp1
|
nucleic acid binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NABP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NAMPT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nap1l4
|
nucleosome assembly protein 1-like 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NAP1L4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:208,139,105...208,175,597
Ensembl chr 1:208,139,113...208,174,569
|
|
| G
|
Napepld
|
N-acyl phosphatidylethanolamine phospholipase D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NAPEPLD mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:14,251,591...14,291,010
Ensembl chr 4:14,252,692...14,291,014
|
|
| G
|
Narf
|
nuclear prelamin A recognition factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NARF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:107,017,344...107,035,777
Ensembl chr10:107,016,510...107,037,283
|
|
| G
|
Nars1
|
asparaginyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
|
|
| G
|
Nars2
|
asparaginyl-tRNA synthetase 2, mitochondrial
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NARS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:160,711,680...160,823,311
Ensembl chr 1:160,711,696...160,827,606
|
|
| G
|
Nasp
|
nuclear autoantigenic sperm protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NASP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591
|
|
| G
|
Nat1
|
N-acetyltransferase 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of NAT1 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of NAT2 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Nbeal2
|
neurobeachin-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NBEAL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:119,481,608...119,511,997
Ensembl chr 8:119,481,608...119,514,384
|
|
| G
|
Nbl1
|
NBL1, DAN family BMP antagonist
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NBL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186
|
|
| G
|
Ncapd3
|
non-SMC condensin II complex, subunit D3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCAPD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:33,696,214...33,765,520
Ensembl chr 8:33,696,270...33,765,518
|
|
| G
|
Ncapg2
|
non-SMC condensin II complex, subunit G2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCAPG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:143,485,944...143,560,249
|
|
| G
|
Ncf2
|
neutrophil cytosolic factor 2
|
multiple interactions
|
EXP
|
[Carbamazepine affects the susceptibility to [Dietary Fats co-treated with Streptozocin]] which results in decreased expression of NCF2 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149
|
|
| G
|
Ncl
|
nucleolin
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of NCL mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Ncoa3
|
nuclear receptor coactivator 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCOA3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631
|
|
| G
|
Ncoa4
|
nuclear receptor coactivator 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCOA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:7,395,502...7,415,846
Ensembl chr16:7,401,802...7,415,840
|
|
| G
|
Ncoa6
|
nuclear receptor coactivator 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCOA6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:164,351,062...164,422,079
Ensembl chr 3:164,351,062...164,421,991
|
|
| G
|
Ncor1
|
nuclear receptor co-repressor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NCOR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
|
|
| G
|
Ndfip1
|
Nedd4 family interacting protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NDFIP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471
|
|
| G
|
Ndst3
|
N-deacetylase and N-sulfotransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NDST3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:214,386,804...214,552,739
Ensembl chr 2:214,389,447...214,539,164
|
|
| G
|
Ndst4
|
N-deacetylase and N-sulfotransferase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NDST4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:216,461,542...216,794,035
Ensembl chr 2:216,461,543...216,794,035
|
|
| G
|
Ndufaf7
|
NADH:ubiquinone oxidoreductase complex assembly factor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NDUFAF7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:21,860,788...21,871,965
Ensembl chr 6:21,856,865...21,872,146
|
|
| G
|
Ndufaf8
|
NADH:ubiquinone oxidoreductase complex assembly factor 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NDUFAF8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:105,879,908...105,882,059
Ensembl chr10:105,879,908...105,882,904
|
|
| G
|
Nebl
|
nebulette
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NEBL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:85,022,953...85,374,848
Ensembl chr17:85,022,963...85,374,172
|
|
| G
|
Nedd1
|
NEDD1 gamma-tubulin ring complex targeting factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NEDD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:29,120,200...29,161,634
Ensembl chr 7:29,120,200...29,161,634
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
affects expression
|
EXP
|
Carbamazepine affects the expression of NEFH mRNA
|
CTD |
PMID:22954530 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nek6
|
NIMA-related kinase 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NEK6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773
|
|
| G
|
Nelfcd
|
negative elongation factor complex member C/D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NELFCD mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:183,631,968...183,643,088
Ensembl chr 3:183,631,968...183,643,088
|
|
| G
|
Neto2
|
neuropilin and tolloid like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NETO2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:37,517,518...37,588,961
Ensembl chr19:37,517,587...37,591,413
|
|
| G
|
Neurod1
|
neuronal differentiation 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NEUROD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
|
|
| G
|
Neurog1
|
neurogenin 1
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of NEUROG1
|
CTD |
PMID:25524013 |
|
NCBI chr17:8,368,096...8,369,615
Ensembl chr17:8,368,096...8,369,615
|
|
| G
|
Nexn
|
nexilin (F actin binding protein)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NEXN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114
|
|
| G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NFE2L1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases activity affects expression
|
ISO
|
Carbamazepine results in increased activity of NFE2L2 protein Carbamazepine affects the expression of NFE2L2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfia
|
nuclear factor I/A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NFIA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395
|
|
| G
|
Nfil3
|
nuclear factor, interleukin 3 regulated
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NFIL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
Carbamazepine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased localization of and results in increased activity of NFKB1 protein]
|
CTD |
PMID:10700573 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfxl1
|
nuclear transcription factor, X-box binding-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NFXL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:35,980,058...36,021,478
Ensembl chr14:35,980,057...36,023,281
|
|
| G
|
Ngly1
|
N-glycanase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NGLY1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:11,584,475...11,640,977
Ensembl chr15:11,584,475...11,635,328
|
|
| G
|
Nhlh1
|
nescient helix loop helix 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NHLH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:87,049,733...87,054,934
Ensembl chr13:87,049,629...87,055,033
|
|
| G
|
Nhsl1
|
NHS-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NHSL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:14,775,874...15,008,327
Ensembl chr 1:14,705,839...15,008,327
|
|
| G
|
Niban1
|
niban apoptosis regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NIBAN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
|
|
| G
|
Nid1
|
nidogen 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NID1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
|
|
| G
|
Nim1k
|
NIM1 serine/threonine protein kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NIM1K mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:53,403,467...53,451,248
Ensembl chr 2:53,403,473...53,419,656
|
|
| G
|
Nme3
|
NME/NM23 nucleoside diphosphate kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NME3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:14,421,922...14,422,878
Ensembl chr10:14,421,702...14,422,907
|
|
| G
|
Nme5
|
NME/NM23 family member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NME5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,437,705...26,454,828
Ensembl chr18:26,437,781...26,454,828
|
|
| G
|
Nmnat2
|
nicotinamide nucleotide adenylyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NMNAT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:67,655,794...67,831,609
Ensembl chr13:67,655,807...67,831,608
|
|
| G
|
Nmral1
|
NmrA like redox sensor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NMRAL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:11,348,080...11,356,621
Ensembl chr10:11,348,213...11,356,620
|
|
| G
|
Nnat
|
neuronatin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NNAT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086
|
|
| G
|
Noa1
|
nitric oxide associated 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:31,189,570...31,205,600
Ensembl chr14:31,188,978...31,205,599
|
|
| G
|
Nol12
|
nucleolar protein 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOL12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:112,373,749...112,379,362
Ensembl chr 7:112,373,845...112,380,357
|
|
| G
|
Nol4
|
nucleolar protein 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOL4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:14,207,303...14,569,697
Ensembl chr18:14,207,303...14,569,677
|
|
| G
|
Nol4l
|
nucleolar protein 4-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOL4L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:162,345,059...162,467,849
Ensembl chr 3:162,348,211...162,468,048
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of NOS2 mRNA; Carbamazepine results in increased expression of NOS2 protein
|
CTD |
PMID:12429386 PMID:14511393 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Notch2
|
notch receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOTCH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NOX4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Npffr2
|
neuropeptide FF receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NPFFR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:18,794,868...18,842,186
Ensembl chr14:18,797,234...18,842,186
|
|
| G
|
Npr2
|
natriuretic peptide receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NPR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:62,678,197...62,697,360
Ensembl chr 5:62,678,367...62,697,343
|
|
| G
|
Npr3
|
natriuretic peptide receptor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NPR3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066
|
|
| G
|
Nprl3
|
NPR3-like, GATOR1 complex subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NPRL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:15,859,739...15,900,261
Ensembl chr10:15,859,789...15,902,332
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression multiple interactions affects expression
|
EXP ISO
|
Carbamazepine results in increased expression of NQO1 mRNA Carbamazepine inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]; NQO1 protein results in increased reduction of and results in decreased glutathionylation of Carbamazepine metabolite Carbamazepine affects the expression of NQO1 mRNA
|
CTD |
PMID:17381134 PMID:24752500 PMID:25979313 PMID:29281794 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nqo2
|
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
|
multiple interactions
|
ISO
|
NQO2 protein results in increased reduction of and results in decreased glutathionylation of Carbamazepine metabolite
|
CTD |
PMID:29281794 |
|
NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662
|
|
| G
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR0B2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
|
|
| G
|
Nr1d2
|
nuclear receptor subfamily 1, group D, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR1D2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions increases activity increases expression
|
ISO EXP
|
Carbamazepine binds to and results in increased activity of NR1I2 protein Carbamazepine results in increased activity of NR1I2 protein Carbamazepine results in increased expression of NR1I2 mRNA Carbamazepine results in increased expression of NR1I2 protein
|
CTD |
PMID:12065438 PMID:14977870 PMID:17112801 PMID:18473823 PMID:25680588 PMID:28728110 More...
|
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
multiple interactions affects response to substance increases expression
|
ISO EXP
|
[Carbamazepine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Carbamazepine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA NR1I3 protein affects the susceptibility to Carbamazepine Carbamazepine results in increased expression of NR1I3 protein Carbamazepine results in increased expression of NR1I3 mRNA
|
CTD |
PMID:17041008 PMID:17112801 PMID:18473823 PMID:22503787 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR2F1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924
|
|
| G
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR2F2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:133,420,227...133,431,975
|
|
| G
|
Nr2f6
|
nuclear receptor subfamily 2, group F, member 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR2F6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,080,003...18,087,449
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
increases expression affects expression multiple interactions
|
ISO
|
Carbamazepine results in increased expression of NR3C1 mRNA Carbamazepine affects the expression of NR3C1 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] NR3C1 protein promotes the reaction [Carbamazepine results in increased expression of CYP3A4 mRNA]
|
CTD |
PMID:10219967 PMID:15249158 PMID:17112801 PMID:24752500 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of NR3C2 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
| G
|
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NR6A1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:42,904,832...43,094,622
Ensembl chr 3:42,904,832...43,092,951
|
|
| G
|
Nras
|
NRAS proto-oncogene, GTPase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRAS mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:193,271,399...193,282,023
Ensembl chr 2:193,271,430...193,278,543
|
|
| G
|
Nrgn
|
neurogranin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRGN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:45,444,223...45,452,417
Ensembl chr 8:45,444,223...45,452,417
|
|
| G
|
Nrm
|
nurim
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:2,893,126...2,897,725
Ensembl chr20:2,882,369...2,896,605
|
|
| G
|
Nrp1
|
neuropilin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRP1 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Nrtn
|
neurturin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRTN mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 9:1,669,099...1,674,957
Ensembl chr 9:1,641,618...1,675,133
|
|
| G
|
Nrxn3
|
neurexin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NRXN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:113,443,524...115,002,540
|
|
| G
|
Nsmce4a
|
NSE4 homolog A, SMC5-SMC6 complex component
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NSMCE4A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:194,532,364...194,539,456
Ensembl chr 1:194,525,648...194,539,456
|
|
| G
|
Ntn5
|
netrin 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NTN5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:105,293,408...105,302,163
Ensembl chr 1:105,293,434...105,302,163
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NTRK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
|
|
| G
|
Nuak1
|
NUAK family kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUAK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:21,217,729...21,289,608
Ensembl chr 7:21,217,681...21,289,354
|
|
| G
|
Nuak2
|
NUAK family kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUAK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:46,305,744...46,322,755
Ensembl chr13:46,305,975...46,322,748
|
|
| G
|
Nudcd1
|
NudC domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUDCD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:77,436,035...77,480,651
Ensembl chr 7:77,436,036...77,480,575
|
|
| G
|
Nudt19
|
nudix hydrolase 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUDT19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:97,351,373...97,362,969
Ensembl chr 1:97,351,378...97,362,969
|
|
| G
|
Nudt4
|
nudix hydrolase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUDT4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491
|
|
| G
|
Nup214
|
nucleoporin 214
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUP214 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:35,652,841...35,738,323
Ensembl chr 3:35,652,858...35,739,192
|
|
| G
|
Nup62cl
|
nucleoporin 62 C-terminal like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NUP62CL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:108,457,043...108,513,525
Ensembl chr X:108,457,043...108,512,664
|
|
| G
|
Nxph1
|
neurexophilin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NXPH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:37,964,325...38,277,364
Ensembl chr 4:38,223,093...38,277,172
|
|
| G
|
Nxph3
|
neurexophilin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of NXPH3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:80,953,080...80,956,746
Ensembl chr10:80,952,227...80,956,668
|
|
| G
|
Oaz2
|
ornithine decarboxylase antizyme 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OAZ2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:75,094,817...75,108,634
Ensembl chr 8:75,094,798...75,108,630
|
|
| G
|
Ociad2
|
OCIA domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OCIAD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ODC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
Odf2
|
outer dense fiber of sperm tails 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ODF2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:33,557,738...33,605,076
Ensembl chr 3:33,558,832...33,605,076
|
|
| G
|
Olfm3
|
olfactomedin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OLFM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:205,417,962...205,640,479
Ensembl chr 2:205,598,959...205,640,479
|
|
| G
|
Olfml2a
|
olfactomedin-like 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OLFML2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:43,098,299...43,127,621
|
|
| G
|
Olfml3
|
olfactomedin-like 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OLFML3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494
|
|
| G
|
Olig2
|
oligodendrocyte transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OLIG2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634
|
|
| G
|
Oma1
|
OMA1 zinc metallopeptidase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OMA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:123,312,038...123,455,540
Ensembl chr 5:123,312,766...123,366,005
|
|
| G
|
Orai1
|
ORAI calcium release-activated calcium modulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ORAI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:39,195,139...39,209,030
Ensembl chr12:39,195,163...39,209,408
|
|
| G
|
Oscp1
|
organic solute carrier partner 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OSCP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:143,618,186...143,649,765
Ensembl chr 5:143,615,360...143,663,986
|
|
| G
|
Osr2
|
odd-skipped related transcription factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OSR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:68,372,500...68,380,195
Ensembl chr 7:68,373,049...68,380,805
|
|
| G
|
Otx2
|
orthodenticle homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OTX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:24,422,876...24,432,709
Ensembl chr15:24,422,876...24,432,472
|
|
| G
|
Ovol2
|
ovo-like zinc finger 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OVOL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:152,130,767...152,160,487
Ensembl chr 3:152,130,767...152,160,487
|
|
| G
|
Oxsm
|
3-oxoacyl-ACP synthase, mitochondrial
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OXSM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:11,641,177...11,645,370
Ensembl chr15:11,634,473...11,683,429
|
|
| G
|
Oxtr
|
oxytocin receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of OXTR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:147,154,374...147,170,750
|
|
| G
|
Padi3
|
peptidyl arginine deiminase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PADI3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:158,372,764...158,400,193
Ensembl chr 5:158,372,764...158,400,193
|
|
| G
|
Pafah1b3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAFAH1B3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:90,009,085...90,011,611
Ensembl chr 1:90,009,085...90,011,611
|
|
| G
|
Pag1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:93,842,747...93,984,314
Ensembl chr 2:93,964,594...93,977,227
|
|
| G
|
Pagr1
|
Paxip1-associated glutamate-rich protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAGR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:191,053,228...191,055,554
|
|
| G
|
Pak2
|
p21 (RAC1) activated kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:82,212,896...82,273,803
Ensembl chr11:82,212,951...82,273,803
|
|
| G
|
Pak3
|
p21 (RAC1) activated kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:111,912,967...112,171,037
Ensembl chr X:111,913,059...112,165,035
|
|
| G
|
Pan2
|
poly(A) specific ribonuclease subunit PAN2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:1,313,654...1,332,252
Ensembl chr 7:1,313,655...1,332,252
|
|
| G
|
Pank2
|
pantothenate kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PANK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:138,936,448...138,974,196
Ensembl chr 3:138,936,452...138,974,194
|
|
| G
|
Panx1
|
Pannexin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PANX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:20,128,783...20,171,200
Ensembl chr 8:20,132,165...20,171,200
|
|
| G
|
Paqr9
|
progestin and adipoQ receptor family member 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAQR9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:104,993,884...104,996,180
Ensembl chr 8:104,993,827...104,998,285
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PARP1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pask
|
PAS domain containing serine/threonine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PASK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504
|
|
| G
|
Patj
|
PATJ, crumbs cell polarity complex component
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PATJ mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301
|
|
| G
|
Patl1
|
PAT1 homolog 1, processing body mRNA decay factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PATL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:218,255,801...218,287,662
Ensembl chr 1:218,255,848...218,287,657
|
|
| G
|
Pax6
|
paired box 6
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of PAX6 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pax7
|
paired box 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PAX7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:157,279,623...157,381,188
Ensembl chr 5:157,279,623...157,381,121
|
|
| G
|
Pbx3
|
PBX homeobox 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PBX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:37,886,241...38,079,956
Ensembl chr 3:37,886,687...38,079,895
|
|
| G
|
Pc
|
pyruvate carboxylase
|
multiple interactions
|
EXP
|
Carbamazepine results in decreased expression of and results in decreased activity of PC protein
|
CTD |
PMID:12840165 |
|
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940
|
|
| G
|
Pcdhb19
|
protocadherin beta 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCDHB12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:29,478,848...29,481,656
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pck2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864
|
|
| G
|
Pclaf
|
PCNA clamp associated factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCLAF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106
|
|
| G
|
Pclo
|
piccolo (presynaptic cytomatrix protein)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCLO mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:20,646,604...21,005,171
Ensembl chr 4:20,646,604...21,005,111
|
|
| G
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of PCSK9 mRNA
|
CTD |
PMID:21123845 |
|
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
|
|
| G
|
Pcyox1l
|
prenylcysteine oxidase 1 like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PCYOX1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:57,420,971...57,431,632
Ensembl chr18:57,420,977...57,431,632
|
|
| G
|
Pdcd4
|
programmed cell death 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDCD4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
|
|
| G
|
Pde2a
|
phosphodiesterase 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDE2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDE5A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pde6d
|
phosphodiesterase 6D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDE6D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:94,640,932...94,685,918
Ensembl chr 9:94,640,932...94,685,918
|
|
| G
|
Pde9a
|
phosphodiesterase 9A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDE9A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:9,471,136...9,564,286
Ensembl chr20:9,471,167...9,564,286
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDGFA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdgfc
|
platelet derived growth factor C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDGFC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:168,613,409...168,791,575
Ensembl chr 2:168,614,353...168,791,573
|
|
| G
|
Pdk1
|
pyruvate dehydrogenase kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145
|
|
| G
|
Pdk3
|
pyruvate dehydrogenase kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:62,480,535...62,547,371
Ensembl chr X:62,480,535...62,547,371
|
|
| G
|
Pdp1
|
pyruvate dehydrogenase phosphatase catalytic subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960
|
|
| G
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PDPK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
|
|
| G
|
Pea15
|
proliferation and apoptosis adaptor protein 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PEA15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
|
|
| G
|
Penk
|
proenkephalin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PENK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705
|
|
| G
|
Pet117
|
PET117 cytochrome c oxidase chaperone
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PET117 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:152,187,473...152,195,173
Ensembl chr 3:152,189,892...152,194,868
|
|
| G
|
Pex11g
|
peroxisomal biogenesis factor 11 gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PEX11G mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:6,301,461...6,329,741
Ensembl chr12:6,277,664...6,318,919
|
|
| G
|
Pex3
|
peroxisomal biogenesis factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PEX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:9,732,641...9,774,479
Ensembl chr 1:9,732,492...9,774,576
|
|
| G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PFKFB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052
|
|
| G
|
Pfkfb4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PFKFB4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:118,522,371...118,565,478
Ensembl chr 8:118,522,365...118,565,468
|
|
| G
|
Pgk1
|
phosphoglycerate kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PGK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959
|
|
| G
|
Pgrmc1
|
progesterone receptor membrane component 1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of PGRMC1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:120,698,610...120,706,805
|
|
| G
|
Phactr2
|
phosphatase and actin regulator 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHACTR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:9,411,412...9,680,648
Ensembl chr 1:9,418,085...9,680,583
|
|
| G
|
Phka2
|
phosphorylase kinase regulatory subunit alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHKA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:37,979,629...38,102,656
Ensembl chr X:37,979,629...38,102,144
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHLDA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Phlda2
|
pleckstrin homology-like domain, family A, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHLDA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920
|
|
| G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHLDA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621
|
|
| G
|
Phldb2
|
pleckstrin homology-like domain, family B, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PHLDB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:68,321,738...68,540,724
Ensembl chr11:68,355,959...68,540,734
|
|
| G
|
Pias3
|
protein inhibitor of activated STAT, 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIAS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:186,921,384...186,930,292
Ensembl chr 2:186,921,428...186,936,714
|
|
| G
|
Pierce1
|
piercer of microtubule wall 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIERCE1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:32,195,024...32,201,111
Ensembl chr 3:32,195,024...32,199,561
|
|
| G
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIEZO1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:67,453,120...67,515,347
Ensembl chr19:67,453,122...67,515,037
|
|
| G
|
Piezo2
|
piezo-type mechanosensitive ion channel component 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIEZO2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:58,738,734...59,115,252
Ensembl chr18:58,738,740...59,115,215
|
|
| G
|
Piga
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
affects expression increases mutagenesis
|
ISO
|
Carbamazepine affects the expression of PIGA mRNA Carbamazepine results in increased mutagenesis of PIGA gene
|
CTD |
PMID:25979313 PMID:36995427 |
|
NCBI chr X:33,672,832...33,687,747
Ensembl chr X:33,674,923...33,687,636
|
|
| G
|
Pigg
|
phosphatidylinositol glycan anchor biosynthesis, class G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIGG mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:1,549,891...1,578,174
Ensembl chr14:1,549,891...1,578,167
|
|
| G
|
Pigh
|
phosphatidylinositol glycan anchor biosynthesis, class H
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIGH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:103,601,369...103,630,214
Ensembl chr 6:103,601,520...103,630,159
|
|
| G
|
Pih1d1
|
PIH1 domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIH1D1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:104,774,562...104,781,757
Ensembl chr 1:104,776,082...104,781,756
|
|
| G
|
Pik3c2a
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3C2A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:180,012,248...180,117,786
Ensembl chr 1:180,012,248...180,117,773
|
|
| G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3CA mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
|
|
| G
|
Pik3cd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3CD mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3R1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pik3r2
|
phosphoinositide-3-kinase regulatory subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3R2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
|
|
| G
|
Pik3r3
|
phosphoinositide-3-kinase regulatory subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIK3R3 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
|
|
| G
|
Pipox
|
pipecolic acid and sarcosine oxidase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIPOX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:63,267,946...63,281,556
Ensembl chr10:63,267,972...63,282,273
|
|
| G
|
Pir
|
pirin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PIR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:33,740,429...33,851,049
|
|
| G
|
Pitx2
|
paired-like homeodomain 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PITX2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 2:220,391,417...220,411,588
Ensembl chr 2:220,391,888...220,411,591
|
|
| G
|
Pkia
|
cAMP-dependent protein kinase inhibitor alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PKIA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:96,306,181...96,380,959
Ensembl chr 2:96,306,184...96,321,262
|
|
| G
|
Pla2g12a
|
phospholipase A2, group XIIA
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLA2G12A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
|
|
| G
|
Pla2g3
|
phospholipase A2, group III
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLA2G3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:82,589,908...82,597,542
Ensembl chr14:82,591,862...82,597,542
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
decreases expression increases expression
|
ISO
|
Carbamazepine results in decreased expression of PLA2G4A mRNA; Carbamazepine results in decreased expression of PLA2G4A protein Carbamazepine results in increased expression of PLA2G4A mRNA; Carbamazepine results in increased expression of PLA2G4A protein
|
CTD |
PMID:15312812 PMID:17594078 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLA2G7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plagl1
|
PLAG1 like zinc finger 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLAGL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:9,297,066...9,337,394
Ensembl chr 1:9,330,204...9,337,394
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLAT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLAU mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plcg1
|
phospholipase C, gamma 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLCG1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
|
|
| G
|
Plcl2
|
phospholipase C-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLCL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:3,529,117...3,713,712
Ensembl chr 9:3,529,841...3,713,712
|
|
| G
|
Plcxd3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLCXD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:55,294,597...55,473,968
Ensembl chr 2:55,294,613...55,474,220
|
|
| G
|
Plekha6
|
pleckstrin homology domain containing A6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLEKHA6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:47,166,899...47,307,003
Ensembl chr13:47,167,160...47,307,003
|
|
| G
|
Plekha7
|
pleckstrin homology domain containing A7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLEKHA7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:179,798,856...179,982,155
Ensembl chr 1:179,799,040...179,982,281
|
|
| G
|
Plk2
|
polo-like kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
|
|
| G
|
Plpp2
|
phospholipid phosphatase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLPP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:10,826,534...10,834,628
Ensembl chr 7:10,826,549...10,834,627
|
|
| G
|
Plpp5
|
phospholipid phosphatase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLPP5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:73,052,204...73,056,609
Ensembl chr16:73,052,204...73,056,643
|
|
| G
|
Plppr5
|
phospholipid phosphatase related 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLPPR5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:208,143,058...208,422,836
Ensembl chr 2:208,142,871...208,439,051
|
|
| G
|
Pls1
|
plastin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:105,196,312...105,306,252
Ensembl chr 8:105,197,455...105,292,447
|
|
| G
|
Pls3
|
plastin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:116,401,247...116,495,898
Ensembl chr X:116,401,293...116,495,893
|
|
| G
|
Plxna2
|
plexin A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLXNA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453
|
|
| G
|
Plxna4
|
plexin A4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLXNA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:61,687,483...62,129,467
Ensembl chr 4:61,687,510...62,129,445
|
|
| G
|
Plxnb2
|
plexin B2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLXNB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746
|
|
| G
|
Plxnd1
|
plexin D1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PLXND1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:150,675,377...150,715,706
Ensembl chr 4:150,675,377...150,715,566
|
|
| G
|
Pm20d2
|
peptidase M20 domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PM20D2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:52,362,384...52,382,647
Ensembl chr 5:52,362,392...52,382,532
|
|
| G
|
Pnrc1
|
proline-rich nuclear receptor coactivator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PNRC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491
|
|
| G
|
Podxl
|
podocalyxin-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PODXL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789
|
|
| G
|
Pola1
|
DNA polymerase alpha 1, catalytic subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLA1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:62,028,475...62,342,455
Ensembl chr X:62,028,476...62,342,355
|
|
| G
|
Pold3
|
DNA polymerase delta 3, accessory subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202
|
|
| G
|
Pole3
|
DNA polymerase epsilon 3, accessory subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLE3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:80,989,508...80,992,742
Ensembl chr 5:80,989,511...80,992,742 Ensembl chr 7:80,989,511...80,992,742
|
|
| G
|
Pole4
|
DNA polymerase epsilon 4, accessory subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLE4 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:116,723,040...116,728,873
Ensembl chr 4:116,716,719...116,728,851
|
|
| G
|
Polg
|
DNA polymerase gamma, catalytic subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLG mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:142,792,119...142,808,838
|
|
| G
|
Polh
|
DNA polymerase eta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLH mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577
|
|
| G
|
Polq
|
DNA polymerase theta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLQ mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr11:77,179,190...77,281,270
Ensembl chr11:77,179,209...77,281,268
|
|
| G
|
Polr1d
|
RNA polymerase I and III subunit D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLR1D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:13,084,505...13,118,069
Ensembl chr12:13,084,512...13,095,627
|
|
| G
|
Polr2f
|
RNA polymerase II, I and III subunit F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLR2F mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666
|
|
| G
|
Polr3a
|
RNA polymerase III subunit A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLR3A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:56,066...95,060
Ensembl chr16:56,066...95,060
|
|
| G
|
Polr3d
|
RNA polymerase III subunit D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLR3D mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:51,921,283...51,925,952
Ensembl chr15:51,921,283...51,925,691
|
|
| G
|
Polr3h
|
RNA polymerase III subunit H
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POLR3H mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:115,309,571...115,319,881
Ensembl chr 7:115,309,589...115,319,915
|
|
| G
|
Pomc
|
proopiomelanocortin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POMC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
|
|
| G
|
Pon1
|
paraoxonase 1
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of PON1 protein
|
CTD |
PMID:28032682 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Popdc3
|
popeye domain cAMP effector 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POPDC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:50,354,775...50,383,050
Ensembl chr20:50,354,767...50,385,674
|
|
| G
|
Por
|
cytochrome p450 oxidoreductase
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of POR mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
| G
|
Pou2f1
|
POU class 2 homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POU2F1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr13:80,653,602...80,796,279
Ensembl chr13:80,663,714...80,796,356
|
|
| G
|
Pou3f1
|
POU class 3 homeobox 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of POU3F1 protein
|
CTD |
PMID:12781989 |
|
NCBI chr 5:142,195,090...142,198,070
Ensembl chr 5:142,194,066...142,202,704
|
|
| G
|
Pou4f1
|
POU class 4 homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of POU4F1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:87,668,328...87,674,643
Ensembl chr15:87,668,328...87,674,643
|
|
| G
|
Pou5f1
|
POU class 5 homeobox 1
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of POU5F1 mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions
|
EXP
|
[[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of PPARA mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPARG mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPARGC1A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPAT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405
|
|
| G
|
Ppef1
|
protein phosphatase with EF-hand domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPEF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:37,803,204...37,960,378
Ensembl chr X:37,830,055...37,960,375
|
|
| G
|
Ppfia4
|
PTPRF interacting protein alpha 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPFIA4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279
|
|
| G
|
Ppia
|
peptidylprolyl isomerase A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPIA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:85,491,223...85,496,884
Ensembl chr14:85,492,484...85,497,115
|
|
| G
|
Ppl
|
periplakin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658
|
|
| G
|
Ppm1b
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPM1B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:15,399,562...15,460,756
|
|
| G
|
Ppm1g
|
protein phosphatase, Mg2+/Mn2+ dependent, 1G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPM1G mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:30,873,531...30,893,735
Ensembl chr 6:30,873,481...30,893,732
|
|
| G
|
Ppm1j
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPM1J mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:194,966,854...194,972,228
Ensembl chr 2:194,966,950...194,972,227
|
|
| G
|
Ppm1n
|
protein phosphatase, Mg2+/Mn2+ dependent 1N
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPM1N mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:88,057,365...88,062,912
Ensembl chr 1:88,058,624...88,060,700
|
|
| G
|
Ppp1cb
|
protein phosphatase 1 catalytic subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1CB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924
|
|
| G
|
Ppp1r12a
|
protein phosphatase 1, regulatory subunit 12A
|
decreases activity
|
ISO
|
Carbamazepine results in decreased activity of PPP1R12A protein
|
CTD |
PMID:24352538 |
|
NCBI chr 7:45,368,922...45,480,158
Ensembl chr 7:45,369,315...45,480,157
|
|
| G
|
Ppp1r14a
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R14A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147
|
|
| G
|
Ppp1r14b
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R14B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431 Ensembl chr 1:21,088,517...21,101,431
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R15A mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp1r17
|
protein phosphatase 1, regulatory subunit 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:86,544,024...86,560,839
Ensembl chr 4:86,544,121...86,560,835
|
|
| G
|
Ppp1r35
|
protein phosphatase 1, regulatory subunit 35
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R35 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:24,552,709...24,556,040
|
|
| G
|
Ppp1r7
|
protein phosphatase 1, regulatory subunit 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP1R7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:101,333,472...101,358,589
Ensembl chr 9:101,333,497...101,360,959
|
|
| G
|
Ppp2r1b
|
protein phosphatase 2 scaffold subunit A beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP2R1B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 8:60,092,540...60,125,512
Ensembl chr 8:60,081,553...60,125,795
|
|
| G
|
Ppp2r2a
|
protein phosphatase 2, regulatory subunit B, alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP2R2A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:45,380,142...45,439,428
Ensembl chr15:45,379,683...45,439,405
|
|
| G
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP2R2C mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr14:78,071,274...78,156,212
Ensembl chr14:78,071,274...78,156,212
|
|
| G
|
Ppp2r5a
|
protein phosphatase 2, regulatory subunit B', alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP2R5A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr13:105,462,371...105,506,767
Ensembl chr13:105,462,371...105,506,767
|
|
| G
|
Ppp2r5c
|
protein phosphatase 2, regulatory subunit B', gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP2R5C mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:135,282,947...135,419,591
Ensembl chr 6:135,324,067...135,419,597
|
|
| G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of PPP3CA mRNA; Carbamazepine results in decreased expression of PPP3CA protein
|
CTD |
PMID:14642444 |
|
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
|
|
| G
|
Ppp3r2
|
protein phosphatase 3, regulatory subunit B, beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP3R2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:68,822,387...68,823,382
Ensembl chr 5:68,822,387...68,823,818
|
|
| G
|
Ppp6r3
|
protein phosphatase 6, regulatory subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PPP6R3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:210,122,394...210,236,839
Ensembl chr 1:210,122,394...210,236,809
|
|
| G
|
Prdm4
|
PR/SET domain 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRDM4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:19,841,560...19,868,224
Ensembl chr 7:19,841,743...19,869,313
|
|
| G
|
Prdx5
|
peroxiredoxin 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRDX5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020
|
|
| G
|
Prepl
|
prolyl endopeptidase-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PREPL mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:15,333,107...15,362,825
Ensembl chr 6:15,333,077...15,363,231
|
|
| G
|
Prkab2
|
protein kinase AMP-activated non-catalytic subunit beta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKAB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:187,946,008...187,961,615
Ensembl chr 2:187,945,982...187,961,608
|
|
| G
|
Prkacb
|
protein kinase cAMP-activated catalytic subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKACB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:238,300,127...238,386,315
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKCA mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Prkci
|
protein kinase C, iota
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKCI mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
|
|
| G
|
Prkd2
|
protein kinase D2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
|
|
| G
|
Prkd3
|
protein kinase D3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRKD3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600
|
|
| G
|
Prmt5
|
protein arginine methyltransferase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRMT5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:31,938,927...31,948,318
Ensembl chr15:31,938,719...31,948,426
|
|
| G
|
Prnp
|
prion protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRNP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
|
|
| G
|
Prpsap1
|
phosphoribosyl pyrophosphate synthetase-associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRPSAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:102,199,949...102,221,642
Ensembl chr10:102,199,950...102,221,642
|
|
| G
|
Prr36
|
proline rich 36
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRR36 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:7,358,385...7,365,616
Ensembl chr12:7,358,277...7,365,614
|
|
| G
|
Prss23
|
serine protease 23
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRSS23 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871
|
|
| G
|
Prtg
|
protogenin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRTG mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:82,429,106...82,538,612
Ensembl chr 8:82,429,132...82,538,602
|
|
| G
|
Prune2
|
prune homolog 2 with BCH domain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PRUNE2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:223,779,617...224,130,058
Ensembl chr 1:223,969,102...224,051,592
|
|
| G
|
Psat1
|
phosphoserine aminotransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PSAT1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
|
|
| G
|
Psmf1
|
proteasome inhibitor subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PSMF1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:160,695,744...160,720,915
Ensembl chr 3:160,695,745...160,720,915
|
|
| G
|
Psph
|
phosphoserine phosphatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PSPH mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:32,527,091...32,541,182
Ensembl chr12:32,519,269...32,541,180
|
|
| G
|
Ptchd4
|
patched domain containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTCHD4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:25,951,395...26,163,296
Ensembl chr 9:25,959,954...26,163,284
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTEN mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptgfrn
|
prostaglandin F2 receptor inhibitor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTGFRN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:191,158,166...191,233,432
Ensembl chr 2:191,158,166...191,234,115
|
|
| G
|
Ptgr1
|
prostaglandin reductase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTGR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811
|
|
| G
|
Ptgr3
|
prostaglandin reductase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTGR3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:79,729,282...79,738,632
Ensembl chr18:79,729,282...79,738,632
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
decreases activity affects expression
|
ISO
|
Carbamazepine results in decreased activity of PTK2 protein Carbamazepine affects the expression of PTK2 mRNA
|
CTD |
PMID:24352538 PMID:24752500 PMID:25979313 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Ptp4a1
|
protein tyrosine phosphatase 4A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTP4A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176
|
|
| G
|
Ptpn14
|
protein tyrosine phosphatase, non-receptor type 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTPN14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:103,799,473...103,951,708
Ensembl chr13:103,799,494...103,951,708
|
|
| G
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTPRF mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
|
|
| G
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PTPRZ1 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903
|
|
| G
|
Pura
|
purine rich element binding protein A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PURA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:28,159,103...28,179,539
Ensembl chr18:28,125,126...28,211,111
|
|
| G
|
Pxn
|
paxillin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PXN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:46,721,546...46,768,706
Ensembl chr12:46,721,546...46,768,697
|
|
| G
|
Pxylp1
|
2-phosphoxylose phosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of PXYLP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:106,299,303...106,364,603
Ensembl chr 8:106,299,304...106,364,603
|
|
| G
|
Qsox2
|
quiescin sulfhydryl oxidase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of QSOX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:29,433,091...29,462,739
Ensembl chr 3:29,433,091...29,463,036
|
|
| G
|
Qtrt1
|
queuine tRNA-ribosyltransferase catalytic subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of QTRT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:28,239,993...28,249,983
Ensembl chr 8:28,242,472...28,250,398
|
|
| G
|
Rab17
|
RAB17, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:99,001,045...99,014,032
|
|
| G
|
Rab20
|
RAB20, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB20 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:84,721,427...84,745,610
Ensembl chr16:84,721,427...84,745,610
|
|
| G
|
Rab22a
|
RAB22A, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB22A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:182,877,746...182,924,400
Ensembl chr 3:182,877,998...182,924,400
|
|
| G
|
Rab23
|
RAB23, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB23 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:43,440,047...43,463,327
Ensembl chr 9:43,440,273...43,463,325
|
|
| G
|
Rab25
|
RAB25, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB25 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:176,298,124...176,304,221
Ensembl chr 2:176,298,124...176,304,221
|
|
| G
|
Rab26
|
RAB26, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB26 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:14,057,942...14,062,602
Ensembl chr10:14,057,942...14,062,577
|
|
| G
|
Rab31
|
RAB31, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB31 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:112,693,597...112,828,092
|
|
| G
|
Rab34
|
RAB34, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB34 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:63,581,542...63,585,608
Ensembl chr10:63,580,997...63,586,083
|
|
| G
|
Rab3ip
|
RAB3A interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB3IP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:54,417,418...54,461,253
Ensembl chr 7:54,418,358...54,447,000
|
|
| G
|
Rab6b
|
RAB6B, member RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAB6B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:112,574,223...112,642,911
Ensembl chr 8:112,574,167...112,642,907
|
|
| G
|
Rabep1
|
rabaptin, RAB GTPase binding effector protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RABEP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:56,064,742...56,168,778
Ensembl chr10:56,064,753...56,166,177
|
|
| G
|
Rabgap1l
|
RAB GTPase activating protein 1-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RABGAP1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:74,997,542...75,593,240
Ensembl chr13:74,997,542...75,533,816
|
|
| G
|
Rabl6
|
RAB, member RAS oncogene family-like 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RABL6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:28,800,802...28,826,722
Ensembl chr 3:28,800,802...28,826,722
|
|
| G
|
Rack1
|
receptor for activated C kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RACK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
|
|
| G
|
Rad50
|
RAD50 double strand break repair protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAD50 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
|
|
| G
|
Rad51
|
RAD51 recombinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAD51 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469
|
|
| G
|
Rad51c
|
RAD51 paralog C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAD51C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,702,299...72,729,143
|
|
| G
|
Ralgdsl1
|
ral guanine nucleotide dissociation stimulator like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RGL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:67,184,402...67,454,019
Ensembl chr13:67,184,402...67,454,019
|
|
| G
|
Rap1gds1
|
Rap1 GTPase-GDP dissociation stimulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAP1GDS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:230,173,713...230,318,555
Ensembl chr 2:230,173,713...230,318,538
|
|
| G
|
Rap2a
|
RAP2A, member of RAS oncogene family
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAP2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:104,003,744...104,004,234
|
|
| G
|
Rapgef5
|
Rap guanine nucleotide exchange factor 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RAPGEF5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:144,588,162...144,822,908
Ensembl chr 6:144,580,976...144,822,908
|
|
| G
|
Rarres2
|
retinoic acid receptor responder 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RARRES2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457
|
|
| G
|
Rasa1
|
RAS p21 protein activator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RASA1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:17,593,136...17,676,707
Ensembl chr 2:17,593,136...17,676,161
|
|
| G
|
Rasd1
|
ras related dexamethasone induced 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RASD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710
|
|
| G
|
Rasgrp2
|
RAS guanyl releasing protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RASGRP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:213,135,034...213,152,246
Ensembl chr 1:213,136,015...213,151,884
|
|
| G
|
Rasl12
|
RAS-like, family 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RASL12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:74,813,000...74,827,041
Ensembl chr 8:74,813,000...74,827,897
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Rbbp4
|
RB binding protein 4, chromatin remodeling factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBBP4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501
|
|
| G
|
Rbbp6
|
RB binding protein 6, ubiquitin ligase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBBP6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:186,934,938...186,966,852
|
|
| G
|
Rbbp7
|
RB binding protein 7, chromatin remodeling factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBBP7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:35,544,873...35,563,030
Ensembl chr X:35,544,873...35,563,030
|
|
| G
|
Rbm12
|
RNA binding motif protein 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBM12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:165,069,744...165,089,994
Ensembl chr 3:165,042,878...165,090,021
|
|
| G
|
Rbm14
|
RNA binding motif protein 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBM14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:211,523,972...211,535,065
|
|
| G
|
Rbm15
|
RNA binding motif protein 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBM15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:197,634,174...197,642,697
Ensembl chr 2:197,583,002...197,643,037
|
|
| G
|
Rbm3
|
RNA binding motif protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:17,020,863...17,024,341
Ensembl chr X:17,020,864...17,024,841
|
|
| G
|
Rbms2
|
RNA binding motif, single stranded interacting protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBMS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:1,145,240...1,201,690
Ensembl chr 7:1,149,032...1,185,004
|
|
| G
|
Rbmx
|
RNA binding motif protein, X-linked
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBMX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:140,342,544...140,352,121
Ensembl chr X:140,345,571...140,352,035
|
|
| G
|
Rbp1
|
retinol binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847
|
|
| G
|
Rd3
|
RD3 regulator of GUCY2D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:106,060,657...106,097,063
Ensembl chr13:106,084,171...106,093,540
|
|
| G
|
Rdh14
|
retinol dehydrogenase 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RDH14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:38,875,693...38,880,836
Ensembl chr 6:38,875,693...38,880,836
|
|
| G
|
Rec8
|
REC8 meiotic recombination protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of REC8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,079,818...33,087,283
Ensembl chr15:33,079,801...33,087,282
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions affects expression
|
ISO
|
Carbamazepine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased localization of and results in increased activity of RELA protein] Carbamazepine affects the expression of RELA mRNA
|
CTD |
PMID:10700573 PMID:24752500 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Reln
|
reelin
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of RELN
|
CTD |
PMID:25524013 |
|
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
|
|
| G
|
Reps1
|
RALBP1 associated Eps domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of REPS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:14,517,589...14,595,404
Ensembl chr 1:14,517,589...14,595,404
|
|
| G
|
Rer1
|
retention in endoplasmic reticulum sorting receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RER1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:170,916,643...170,929,073
Ensembl chr 5:170,916,905...170,928,980
|
|
| G
|
Rest
|
RE1-silencing transcription factor
|
multiple interactions
|
ISO
|
Carbamazepine inhibits the reaction [REST protein results in increased expression of TAC3 mRNA]
|
CTD |
PMID:19539370 |
|
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:31,213,415...31,248,662
|
|
| G
|
Retreg1
|
reticulophagy regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RETREG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356
|
|
| G
|
Rev3l
|
REV3 like, DNA directed polymerase zeta catalytic subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of REV3L mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr20:44,686,482...44,844,668
Ensembl chr20:44,686,940...44,844,668
|
|
| G
|
Rexo2
|
RNA exonuclease 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of REXO2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:57,708,420...57,720,142
Ensembl chr 8:57,707,558...57,720,142
|
|
| G
|
Rfc1
|
replication factor C subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RFC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:43,319,768...43,395,028
Ensembl chr14:43,319,935...43,395,026
|
|
| G
|
Rfk
|
riboflavin kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RFK mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:224,226,632...224,234,185
Ensembl chr 1:224,226,628...224,235,698 Ensembl chr X:224,226,628...224,235,698
|
|
| G
|
Rftn1
|
raftlin lipid raft linker 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RFTN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:18,285,934...18,499,819
|
|
| G
|
Rfx5
|
regulatory factor X5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RFX5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:185,210,206...185,217,735
Ensembl chr 2:185,210,217...185,217,743
|
|
| G
|
Rfx6
|
regulatory factor X, 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RFX6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:31,562,490...31,615,967
Ensembl chr20:31,562,490...31,615,967
|
|
| G
|
Rgma
|
repulsive guidance molecule BMP co-receptor a
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RGMA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:136,538,782...136,582,763
Ensembl chr 1:136,538,759...136,582,763
|
|
| G
|
Rgs10
|
regulator of G-protein signaling 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RGS10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:192,376,774...192,418,904
|
|
| G
|
Rgs13
|
regulator of G-protein signaling 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RGS13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:58,472,604...58,505,922
Ensembl chr13:58,472,604...58,505,922
|
|
| G
|
Rhbdl3
|
rhomboid like 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHBDL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:65,797,145...65,851,949
Ensembl chr10:65,797,209...65,851,937
|
|
| G
|
Rhob
|
ras homolog family member B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHOB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
|
|
| G
|
Rhobtb3
|
Rho-related BTB domain containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHOBTB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906
|
|
| G
|
Rhod
|
ras homolog family member D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHOD mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:211,138,126...211,153,953
Ensembl chr 1:211,138,126...211,152,061
|
|
| G
|
Rhoq
|
ras homolog family member Q
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHOQ mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:115,757,909...115,759,467
|
|
| G
|
Rhot2
|
ras homolog family member T2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RHOT2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:15,363,467...15,369,263
Ensembl chr10:15,361,726...15,369,006
|
|
| G
|
Riok3
|
RIO kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RIOK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:3,602,535...3,628,108
Ensembl chr18:3,602,535...3,628,108
|
|
| G
|
Ripor2
|
RHO family interacting cell polarization regulator 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RIPOR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337
|
|
| G
|
Rnase1
|
ribonuclease A family member 1, pancreatic
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNASE1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:26,835,436...26,837,145
Ensembl chr15:26,835,463...26,837,248
|
|
| G
|
Rnaseh2c
|
ribonuclease H2, subunit C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNASEH2C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:212,323,916...212,325,011
Ensembl chr 1:212,323,939...212,329,571
|
|
| G
|
Rnaset2
|
ribonuclease T2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNASET2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:55,133,532...55,150,701
Ensembl chr 1:55,117,492...55,150,701
|
|
| G
|
Rnd2
|
Rho family GTPase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RND2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:86,899,395...86,902,992
Ensembl chr10:86,899,395...86,902,992
|
|
| G
|
Rnd3
|
Rho family GTPase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RND3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
|
|
| G
|
Rnf150
|
ring finger protein 150
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNF150 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:41,912,276...42,133,217
Ensembl chr19:41,912,276...42,133,217
|
|
| G
|
Rnf170
|
ring finger protein 170
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNF170 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:72,631,638...72,656,893
Ensembl chr16:72,631,638...72,656,469
|
|
| G
|
Rnf44
|
ring finger protein 44
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNF44 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:9,925,100...9,939,496
Ensembl chr17:9,930,375...9,939,478
|
|
| G
|
Rnft1
|
ring finger protein, transmembrane 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNFT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:71,807,403...71,821,132
Ensembl chr10:71,807,456...71,821,141
|
|
| G
|
Rnps1
|
RNA binding protein with serine rich domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RNPS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:13,950,151...13,960,396
Ensembl chr10:13,950,184...13,960,393
|
|
| G
|
Rock1
|
Rho-associated coiled-coil containing protein kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ROCK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147
|
|
| G
|
Rock2
|
Rho-associated coiled-coil containing protein kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ROCK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:45,407,965...45,502,771
|
|
| G
|
Rorc
|
RAR-related orphan receptor C
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of RORC mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
|
|
| G
|
Rpa1
|
replication protein A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPA1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
|
|
| G
|
Rpa2
|
replication protein A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPA2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546
|
|
| G
|
Rpl15
|
ribosomal protein L15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPL15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308
|
|
| G
|
Rpl28
|
ribosomal protein L28
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPL28 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:78,080,945...78,083,771
|
|
| G
|
Rpl3
|
ribosomal protein L3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:113,491,943...113,508,115
Ensembl chr 7:113,501,960...113,507,990
|
|
| G
|
Rpl39l1
|
ribosomal protein L39 like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPL39L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:5,962,506...5,966,621
Ensembl chr10:5,962,515...5,966,621
|
|
| G
|
Rpp30
|
ribonuclease P/MRP subunit p30
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPP30 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:243,198,647...243,221,559
Ensembl chr 1:243,198,713...243,221,553
|
|
| G
|
Rps27l
|
ribosomal protein S27-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPS27L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130 Ensembl chr 8:33,713,661...33,714,130
|
|
| G
|
Rps6ka1
|
ribosomal protein S6 kinase A1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPS6KA1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:151,362,819...151,476,044
|
|
| G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPS6KA3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678
|
|
| G
|
Rpusd2
|
RNA pseudouridine synthase domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RPUSD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:126,471,620...126,476,869
Ensembl chr 3:126,471,579...126,477,180
|
|
| G
|
Rragc
|
Ras-related GTP binding C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RRAGC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
|
|
| G
|
Rras2
|
RAS related 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RRAS2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:177,668,143...177,737,551
Ensembl chr 1:177,668,144...177,737,551
|
|
| G
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RRM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
|
|
| G
|
Rrm2b
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RRM2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670
|
|
| G
|
Rspo3
|
R-spondin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RSPO3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:30,112,529...30,197,267
Ensembl chr 1:30,112,114...30,197,938
|
|
| G
|
Rsrc2
|
arginine and serine rich coiled-coil 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RSRC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:38,500,709...38,520,715
Ensembl chr12:38,500,770...38,520,707
|
|
| G
|
RT1-A2
|
RT1 class Ia, locus A2
|
affects response to substance
|
ISO
|
HLA-E gene SNP affects the susceptibility to Carbamazepine
|
CTD |
PMID:16538176 |
|
NCBI chr20:4,872,720...4,876,425
|
|
| G
|
RT1-Bb
|
RT1 class II, locus Bb
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HLA-DQB1 mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
|
|
| G
|
RT1-CE16
|
RT1 class I, locus CE16
|
affects response to substance
|
ISO
|
HLA-A gene polymorphism affects the susceptibility to Carbamazepine; HLA-A gene SNP affects the susceptibility to Carbamazepine
|
CTD |
PMID:16538176 PMID:21428769 |
|
NCBI chr20:3,261,656...3,265,548
|
|
| G
|
RT1-DOa
|
RT1 class II, locus DOa
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HLA-DOA mRNA
|
CTD |
PMID:25811541 PMID:25979313 |
|
NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,755,499...4,758,478
|
|
| G
|
RT1-Hb-ps1
|
RT1 class II, locus Hb, pseudogene 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HLA-DPB1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:4,777,494...4,781,486
Ensembl chr20:4,776,547...4,781,574
|
|
| G
|
RT1-M3-1
|
RT1 class Ib, locus M3, gene 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of HLA-G mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366
|
|
| G
|
Rtl5
|
retrotransposon Gag like 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RTL5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:71,223,914...71,228,713
Ensembl chr X:71,221,371...71,232,653
|
|
| G
|
Rtn4
|
reticulon 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RTN4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:107,651,001...107,698,610
Ensembl chr14:107,650,732...107,698,611
|
|
| G
|
Rubcn
|
rubicon autophagy regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of RUBCN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:81,420,261...81,469,415
Ensembl chr11:81,412,617...81,469,424
|
|
| G
|
S100a1
|
S100 calcium binding protein A1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of S100A1
|
CTD |
PMID:28138970 |
|
NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:178,291,503...178,296,346
|
|
| G
|
S100a10
|
S100 calcium binding protein A10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of S100A10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103
|
|
| G
|
S100a11
|
S100 calcium binding protein A11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of S100A11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
| G
|
S100a16
|
S100 calcium binding protein A16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of S100A16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:178,313,986...178,319,696
Ensembl chr 2:178,313,910...178,319,821
|
|
| G
|
S100a8
|
S100 calcium binding protein A8
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of S100A8 mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
| G
|
S100a9
|
S100 calcium binding protein A9
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of S100A9 mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
|
|
| G
|
Sall1
|
spalt-like transcription factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SALL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:34,179,316...34,196,278
Ensembl chr19:34,181,078...34,196,278
|
|
| G
|
Sall3
|
spalt-like transcription factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SALL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:76,680,997...76,700,905
Ensembl chr18:76,681,005...76,700,905
|
|
| G
|
Samd13
|
sterile alpha motif domain containing 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAMD13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:238,194,962...238,200,790
Ensembl chr 2:238,194,965...238,233,496
|
|
| G
|
Samd4a
|
sterile alpha motif domain containing 4A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAMD4A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:22,616,200...22,831,872
Ensembl chr15:22,614,287...22,831,872
|
|
| G
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAMSN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:27,971,565...28,021,944
Ensembl chr11:27,970,564...28,021,944
|
|
| G
|
Sap130
|
Sin3A associated protein 130
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAP130 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:23,518,773...23,619,840
Ensembl chr18:23,518,680...23,619,840
|
|
| G
|
Sap30l
|
SAP30-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAP30L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:42,480,201...42,488,139
Ensembl chr10:42,480,201...42,488,139
|
|
| G
|
Sars1
|
seryl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SARS1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365
|
|
| G
|
Sat1
|
spermidine/spermine N1-acetyl transferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAT1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374
|
|
| G
|
Sat2
|
spermidine/spermine N1-acetyltransferase family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SAT2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:54,839,531...54,841,651
Ensembl chr10:54,839,189...54,841,958
|
|
| G
|
Satb2
|
SATB homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SATB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:65,842,351...66,028,569
Ensembl chr 9:65,844,570...66,021,238
|
|
| G
|
Sc5d
|
sterol-C5-desaturase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SC5D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:51,526,669...51,538,277
Ensembl chr 8:51,529,346...51,538,277
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression multiple interactions
|
ISO EXP
|
Carbamazepine results in decreased expression of SCD mRNA [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of SCD1 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of SCD1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of SCD1 mRNA
|
CTD |
PMID:21123845 PMID:35786680 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Scfd2
|
sec1 family domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SCFD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:34,037,392...34,369,423
Ensembl chr14:34,037,430...34,363,436
|
|
| G
|
Scg5
|
secretogranin V
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SCG5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:120,998,420...121,042,881
Ensembl chr 3:120,998,420...121,042,795
|
|
| G
|
Scgb3a2
|
secretoglobin, family 3A, member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SCGB3A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:36,183,745...36,186,667
Ensembl chr18:36,183,698...36,186,742
|
|
| G
|
Scn1a
|
sodium voltage-gated channel alpha subunit 1
|
decreases response to substance affects response to substance
|
ISO
|
SCN1A gene polymorphism results in decreased susceptibility to Carbamazepine SCN1A protein affects the susceptibility to Carbamazepine
|
CTD |
PMID:15805193 PMID:18489610 |
|
NCBI chr 3:71,360,840...71,479,870
Ensembl chr 3:71,360,841...71,479,791
|
|
| G
|
Scn9a
|
sodium voltage-gated channel alpha subunit 9
|
affects activity affects response to substance
|
ISO
|
Carbamazepine affects the activity of SCN9A protein mutant form SCN9A gene mutant form affects the susceptibility to Carbamazepine
|
CTD |
PMID:17145499 PMID:19557861 |
|
NCBI chr 3:71,553,185...71,701,377
Ensembl chr 3:71,553,189...71,701,377
|
|
| G
|
Scrg1
|
stimulator of chondrogenesis 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SCRG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:37,770,739...37,799,010
Ensembl chr16:37,770,739...37,799,010
|
|
| G
|
Scube2
|
signal peptide, CUB domain and EGF like domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SCUBE2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:173,264,862...173,341,323
Ensembl chr 1:173,264,865...173,334,372
|
|
| G
|
Sdc2
|
syndecan 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SDC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:66,108,853...66,126,294
|
|
| G
|
Sdccag8
|
SHH signaling and ciliogenesis regulator SDCCAG8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SDCCAG8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:91,286,787...91,518,255
Ensembl chr13:91,286,645...91,511,490
|
|
| G
|
Sdr39u1
|
short chain dehydrogenase/reductase family 39U, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SDR39U1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,348,057...33,350,892
Ensembl chr15:33,348,059...33,354,600
|
|
| G
|
Sec24a
|
SEC24 homolog A, COPII coat complex component
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEC24A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:36,450,043...36,525,303
Ensembl chr10:36,450,043...36,525,303
|
|
| G
|
Sec31a
|
SEC31 homolog A, COPII coat complex component
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEC31A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:9,518,655...9,573,579
Ensembl chr14:9,518,648...9,573,585
|
|
| G
|
Sec61a1
|
SEC61 translocon subunit alpha 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEC61A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:122,530,785...122,545,141
Ensembl chr 4:122,530,789...122,545,141
|
|
| G
|
Sec61a2
|
SEC61 translocon subunit alpha 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEC61A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:77,316,901...77,354,978
Ensembl chr17:77,316,910...77,350,743
|
|
| G
|
Sel1l
|
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEL1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:116,466,163...116,510,578
|
|
| G
|
Sema3g
|
semaphorin 3G
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMA3G mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:6,420,025...6,431,655
Ensembl chr16:6,420,012...6,432,553
|
|
| G
|
Sema4d
|
semaphorin 4D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMA4D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:13,582,085...13,688,889
Ensembl chr17:13,582,098...13,688,891
|
|
| G
|
Sema5a
|
semaphorin 5A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMA5A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:85,020,724...85,451,938
Ensembl chr 2:85,020,724...85,451,938
|
|
| G
|
Sema5b
|
semaphorin 5B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMA5B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:78,607,805...78,730,724
Ensembl chr11:78,607,805...78,730,589
|
|
| G
|
Sema6d
|
semaphorin 6D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMA6D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:131,801,680...132,394,578
Ensembl chr 3:132,337,343...132,394,584
|
|
| G
|
Semg1
|
semenogelin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SEMG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:173,329,413...173,332,261
Ensembl chr 3:173,329,414...173,332,261
|
|
| G
|
Senp2
|
SUMO specific peptidase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SENP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:92,487,259...92,522,795
Ensembl chr11:92,485,931...92,522,735
|
|
| G
|
Serpine1
|
serpin family E member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SERPINE1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Sertm1
|
serine-rich and transmembrane domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SERTM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:141,237,054...141,256,669
Ensembl chr 2:141,235,409...141,265,984
|
|
| G
|
Sesn1
|
sestrin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SESN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
|
|
| G
|
Sesn2
|
sestrin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SESN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
|
|
| G
|
Sf3a3
|
splicing factor 3a, subunit 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SF3A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:142,246,556...142,272,053
Ensembl chr 5:142,246,568...142,272,052
|
|
| G
|
Sfn
|
stratifin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SFN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995
|
|
| G
|
Sfrp1
|
secreted frizzled-related protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SFRP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736
|
|
| G
|
Sft2d1
|
SFT2 domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SFT2D1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:54,957,247...54,973,143
Ensembl chr 1:54,960,692...54,973,143
|
|
| G
|
Sfxn3
|
sideroflexin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SFXN3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:253,856,935...253,866,219
Ensembl chr 1:253,856,882...253,887,542
|
|
| G
|
Sfxn4
|
sideroflexin 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SFXN4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:269,962,527...269,984,849
Ensembl chr 1:269,962,535...269,984,836
|
|
| G
|
Sgk1
|
serum/glucocorticoid regulated kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SGK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
|
|
| G
|
Sgms1
|
sphingomyelin synthase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SGMS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:239,409,991...239,681,195
Ensembl chr 1:239,409,991...239,505,774
|
|
| G
|
Sgsm3
|
small G protein signaling modulator 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SGSM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:114,394,813...114,424,489
|
|
| G
|
Sgtb
|
small glutamine rich tetratricopeptide repeat co-chaperone beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SGTB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:36,966,840...37,003,318
Ensembl chr 2:36,966,838...37,003,311
|
|
| G
|
Sh2d2a
|
SH2 domain containing 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH2D2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:175,610,127...175,616,685
Ensembl chr 2:175,609,874...175,616,685
|
|
| G
|
Sh2d3a
|
SH2 domain containing 3A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH2D3A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:2,235,359...2,239,578
|
|
| G
|
Sh3bgr
|
SH3 domain binding glutamate-rich protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3BGR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:48,973,033...48,997,328
Ensembl chr11:48,973,097...48,997,326
|
|
| G
|
Sh3bp5
|
SH3-domain binding protein 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3BP5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
|
|
| G
|
Sh3d19
|
SH3 domain containing 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3D19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:173,654,234...173,814,030
Ensembl chr 2:173,654,420...173,814,025
|
|
| G
|
Sh3glb1
|
SH3 domain -containing GRB2-like endophilin B1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3GLB1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:236,410,436...236,445,140
|
|
| G
|
Sh3rf1
|
SH3 domain containing ring finger 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3RF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:33,746,396...33,912,127
Ensembl chr16:33,746,396...33,912,153
|
|
| G
|
Sh3rf3
|
SH3 domain containing ring finger 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SH3RF3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:27,306,937...27,642,315
Ensembl chr20:27,308,188...27,640,544
|
|
| G
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHANK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:208,598,772...209,018,736
|
|
| G
|
Shbg
|
sex hormone binding globulin
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SHBG protein
|
CTD |
PMID:11148232 |
|
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760
|
|
| G
|
Shc1
|
SHC adaptor protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914
|
|
| G
|
Shc3
|
SHC adaptor protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:13,803,980...13,924,433
Ensembl chr17:13,803,781...13,924,433
|
|
| G
|
Shisa2
|
shisa family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHISA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:37,982,913...37,987,211
Ensembl chr15:37,982,169...37,988,535
|
|
| G
|
Shisa6
|
shisa family member 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHISA6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:51,396,806...51,691,156
Ensembl chr10:51,396,806...51,691,156
|
|
| G
|
Shisal1
|
shisa like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHISAL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:117,388,210...117,491,539
|
|
| G
|
Shmt1
|
serine hydroxymethyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHMT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,960,434...45,997,326
|
|
| G
|
Shmt2
|
serine hydroxymethyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHMT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567
|
|
| G
|
Shroom3
|
shroom family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SHROOM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:15,383,769...15,681,158
Ensembl chr14:15,383,769...15,680,462
|
|
| G
|
Sigirr
|
single Ig and TIR domain containing
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIGIRR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:205,625,742...205,637,883
Ensembl chr 1:205,627,708...205,637,802
|
|
| G
|
Sik1
|
salt-inducible kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,105...9,958,698
|
|
| G
|
Sik3
|
SIK family kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:55,208,969...55,419,138
Ensembl chr 8:55,208,815...55,419,138
|
|
| G
|
Sin3a
|
SIN3 transcription regulator family member A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIN3A mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 8:66,377,471...66,432,150
Ensembl chr 8:66,381,657...66,434,542
|
|
| G
|
Sipa1l2
|
signal-induced proliferation-associated 1 like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIPA1L2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773
|
|
| G
|
Six1
|
SIX homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIX1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:97,482,617...97,487,853
|
|
| G
|
Six3
|
SIX homeobox 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:14,791,937...14,796,365
Ensembl chr 6:14,789,354...14,804,175
|
|
| G
|
Six4
|
SIX homeobox 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SIX4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:97,538,202...97,551,872
Ensembl chr 6:97,538,202...97,551,872
|
|
| G
|
Six6os1
|
Six6 opposite strand transcript 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of C14ORF39 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:97,314,829...97,351,069
Ensembl chr 6:97,314,712...97,351,171
|
|
| G
|
Ska2
|
spindle and kinetochore associated complex subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SKA2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:72,418,707...72,436,721
Ensembl chr10:72,418,617...72,436,718
|
|
| G
|
Skap2
|
src kinase associated phosphoprotein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SKAP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:82,281,221...82,431,664
Ensembl chr 4:82,263,709...82,432,886
|
|
| G
|
Skp1
|
S-phase kinase-associated protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SKP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:36,898,670...36,917,828
Ensembl chr10:36,903,078...36,918,308
|
|
| G
|
Slc10a1
|
solute carrier family 10 member 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLC10A1 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
|
|
| G
|
Slc12a2
|
solute carrier family 12 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC12A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
| G
|
Slc13a3
|
solute carrier family 13 member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC13A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:174,561,174...174,623,893
Ensembl chr 3:174,561,168...174,623,895
|
|
| G
|
Slc16a2
|
solute carrier family 16 member 2
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of SLC16A2 mRNA Carbamazepine affects the expression of SLC16A2 mRNA
|
CTD |
PMID:17112801 PMID:25979313 |
|
NCBI chr X:72,791,096...72,914,299
Ensembl chr X:72,781,876...72,914,498
|
|
| G
|
Slc16a9
|
solute carrier family 16, member 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC16A9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,334,946...18,376,195
|
|
| G
|
Slc17a5
|
solute carrier family 17 member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC17A5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:88,274,497...88,309,734
Ensembl chr 8:88,274,721...88,309,664
|
|
| G
|
Slc18a2
|
solute carrier family 18 member A2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC18A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231
|
|
| G
|
Slc19a1
|
solute carrier family 19 member 1
|
decreases activity affects expression multiple interactions decreases expression
|
EXP ISO
|
Carbamazepine results in decreased activity of SLC19A1 protein Carbamazepine affects the expression of SLC19A1 mRNA [Carbamazepine results in decreased expression of SLC19A1 protein] which results in decreased transport of Methotrexate; Carbamazepine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]
|
CTD |
PMID:17482559 PMID:21737571 PMID:24752500 |
|
NCBI chr20:11,583,928...11,601,959
Ensembl chr20:11,583,929...11,601,488
|
|
| G
|
Slc19a2
|
solute carrier family 19 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC19A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315
|
|
| G
|
Slc1a1
|
solute carrier family 1 member 1
|
multiple interactions affects expression increases activity
|
EXP ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbamazepine results in increased activity of SLC1A1 protein]; Wortmannin inhibits the reaction [Carbamazepine results in increased activity of SLC1A1 protein] Carbamazepine affects the expression of SLC1A1 mRNA
|
CTD |
PMID:16150575 PMID:25979313 |
|
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:235,963,437...236,045,469
|
|
| G
|
Slc1a4
|
solute carrier family 1 member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC1A4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:98,730,450...98,761,790
|
|
| G
|
Slc22a5
|
solute carrier family 22 member 5
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of SLC22A5 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077
|
|
| G
|
Slc22a7
|
solute carrier family 22 member 7
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of SLC22A7 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
|
|
| G
|
Slc23a2
|
solute carrier family 23 member 2
|
increases expression affects expression
|
ISO
|
Carbamazepine results in increased expression of SLC23A2 mRNA Carbamazepine affects the expression of SLC23A2 mRNA
|
CTD |
PMID:17112801 PMID:25979313 |
|
NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:139,755,584...139,847,343
|
|
| G
|
Slc25a12
|
solute carrier family 25 member 12
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC25A12 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:76,504,868...76,599,536
|
|
| G
|
Slc25a15
|
solute carrier family 25 member 15
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLC25A15 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr16:76,334,037...76,357,325
Ensembl chr16:76,324,288...76,357,321
|
|
| G
|
Slc25a46
|
solute carrier family 25, member 46
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC25A46 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:23,490,422...23,519,599
Ensembl chr18:23,490,425...23,518,730
|
|
| G
|
Slc25a51
|
solute carrier family 25, member 51
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC25A51 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:64,445,610...64,459,172
Ensembl chr 5:64,443,616...64,459,462
|
|
| G
|
Slc28a2
|
solute carrier family 28 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC28A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:129,807,537...129,841,291
|
|
| G
|
Slc2a3
|
solute carrier family 2 member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC2A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
|
|
| G
|
Slc31a2
|
solute carrier family 31 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC31A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:80,753,589...80,764,126
Ensembl chr 5:80,753,618...80,764,123
|
|
| G
|
Slc35b1
|
solute carrier family 35, member B1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC35B1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:80,824,972...80,832,048
Ensembl chr10:80,824,696...80,832,045
|
|
| G
|
Slc35d1
|
solute carrier family 35 member D1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC35D1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:123,157,739...123,210,350
Ensembl chr 5:123,155,407...123,210,073
|
|
| G
|
Slc35d2
|
solute carrier family 35 member D2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC35D2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:992,153...1,025,476
Ensembl chr17:993,646...1,025,475
|
|
| G
|
Slc35f6
|
solute carrier family 35, member F6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC35F6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:31,445,738...31,457,580
Ensembl chr 6:31,445,742...31,457,608
|
|
| G
|
Slc35g2
|
solute carrier family 35, member G2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC35G2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:109,964,589...109,992,347
Ensembl chr 8:109,964,378...109,992,412
|
|
| G
|
Slc37a4
|
solute carrier family 37 member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC37A4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:53,620,141...53,626,110
|
|
| G
|
Slc38a3
|
solute carrier family 38, member 3
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLC38A3 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630
|
|
| G
|
Slc39a10
|
solute carrier family 39 member 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC39A10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:62,331,281...62,454,754
Ensembl chr 9:62,370,598...62,454,747
|
|
| G
|
Slc39a2
|
solute carrier family 39 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC39A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:27,063,699...27,066,349
Ensembl chr15:27,064,237...27,066,349
|
|
| G
|
Slc3a2
|
solute carrier family 3 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC3A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
|
|
| G
|
Slc48a1
|
solute carrier family 48 member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC48A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:130,794,233...130,802,119
Ensembl chr 7:130,794,245...130,803,022
|
|
| G
|
Slc49a4
|
solute carrier family 49 member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC49A4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:78,500,918...78,574,205
Ensembl chr11:78,500,960...78,574,202
|
|
| G
|
Slc4a7
|
solute carrier family 4 member 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC4A7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:13,015,854...13,095,485
Ensembl chr15:13,015,854...13,095,292
|
|
| G
|
Slc5a3
|
solute carrier family 5 member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC5A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
|
|
| G
|
Slc5a5
|
solute carrier family 5 member 5
|
multiple interactions
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbamazepine promotes the reaction [Tretinoin results in increased expression of SLC5A5 protein]]; Carbamazepine promotes the reaction [Tretinoin results in increased expression of SLC5A5 mRNA]; Carbamazepine promotes the reaction [Tretinoin results in increased expression of SLC5A5 protein]; wortmannin inhibits the reaction [Carbamazepine promotes the reaction [Tretinoin results in increased expression of SLC5A5 protein]]
|
CTD |
PMID:20300827 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
| G
|
Slc66a2
|
solute carrier family 66 member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC66A2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:75,976,000...76,014,651
Ensembl chr18:75,977,458...76,014,651
|
|
| G
|
Slc6a16
|
solute carrier family 6, member 16
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLC6A16 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 1:104,858,108...104,886,741
Ensembl chr 1:104,873,144...104,886,740
|
|
| G
|
Slc6a3
|
solute carrier family 6 member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC6A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
| G
|
Slc6a8
|
solute carrier family 6 member 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC6A8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:156,536,017...156,545,321
Ensembl chr X:156,536,017...156,545,321
|
|
| G
|
Slc7a1
|
solute carrier family 7 member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:11,664,399...11,740,030
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Slc7a3
|
solute carrier family 7 member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:70,250,089...70,256,610
Ensembl chr X:70,250,099...70,256,059
|
|
| G
|
Slc7a5
|
solute carrier family 7 member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
|
|
| G
|
Slc7a6
|
solute carrier family 7 member 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:50,982,459...51,010,140
Ensembl chr19:50,984,132...51,010,134
|
|
| G
|
Slc7a7
|
solute carrier family 7 member 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC7A7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683
|
|
| G
|
Slc9a6
|
solute carrier family 9 member A6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC9A6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:139,468,045...139,524,111
Ensembl chr X:139,458,127...139,524,109
|
|
| G
|
Slc9a9
|
solute carrier family 9 member A9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLC9A9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891
|
|
| G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLCO1A2 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
|
|
| G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLCO1B3 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
| G
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SLCO2B1 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279
|
|
| G
|
Slit2
|
slit guidance ligand 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLIT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146
|
|
| G
|
Slitrk1
|
SLIT and NTRK-like family, member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLITRK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:92,137,703...92,141,741
Ensembl chr15:92,135,994...92,142,105
|
|
| G
|
Slitrk5
|
SLIT and NTRK-like family, member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLITRK5 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr15:95,261,397...95,270,465
Ensembl chr15:95,261,005...95,276,090
|
|
| G
|
Slx4
|
SLX4 structure-specific endonuclease subunit
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SLX4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:12,032,131...12,055,685
Ensembl chr10:12,033,048...12,055,650
|
|
| G
|
Smad3
|
SMAD family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMAD3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad4
|
SMAD family member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMAD4 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
|
|
| G
|
Smad7
|
SMAD family member 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMAD7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
| G
|
Smagp
|
small cell adhesion glycoprotein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMAGP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:133,599,043...133,617,492
Ensembl chr 7:133,599,043...133,616,642
|
|
| G
|
Smap1
|
small ArfGAP 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:33,746,489...33,838,488
Ensembl chr 9:33,746,489...33,838,734
|
|
| G
|
Smc4
|
structural maintenance of chromosomes 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMC4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:155,550,262...155,581,937
|
|
| G
|
Smim14
|
small integral membrane protein 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMIM14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:43,136,754...43,180,622
Ensembl chr14:43,136,867...43,183,416
|
|
| G
|
Smim15
|
small integral membrane protein 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMIM15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:41,261,710...41,266,870
Ensembl chr 2:41,261,702...41,267,507
|
|
| G
|
Smim24
|
small integral membrane protein 24
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMIM24 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:8,964,107...8,967,234
Ensembl chr 7:8,964,107...8,967,234
|
|
| G
|
Smim27
|
small integral membrane protein 27
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMIM27 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:60,195,679...60,196,346
Ensembl chr 5:60,195,679...60,196,346
|
|
| G
|
Smyd2
|
SET and MYND domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SMYD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:103,956,470...103,997,774
Ensembl chr13:103,956,473...103,997,774
|
|
| G
|
Snai2
|
snail family transcriptional repressor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNAI2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
|
|
| G
|
Snrnp48
|
small nuclear ribonucleoprotein U11/U12 subunit 48
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNRNP48 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:26,801,818...26,821,605
Ensembl chr17:26,780,344...26,821,592
|
|
| G
|
Snrnp70
|
small nuclear ribonucleoprotein U1 subunit 70
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNRNP70 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:104,992,442...105,012,851
|
|
| G
|
Snrpa
|
small nuclear ribonucleoprotein polypeptide A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNRPA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:91,609,419...91,618,119
Ensembl chr 1:91,609,420...91,618,042
|
|
| G
|
Sntb1
|
syntrophin, beta 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNTB1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:88,950,642...89,219,017
|
|
| G
|
Sntb2
|
syntrophin, beta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNTB2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:51,739,492...51,832,083
Ensembl chr19:51,741,183...51,823,872
|
|
| G
|
Snx19
|
sorting nexin 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SNX19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:37,088,142...37,125,317
Ensembl chr 8:37,088,191...37,125,264
|
|
| G
|
Socs2
|
suppressor of cytokine signaling 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOCS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
|
|
| G
|
Socs3
|
suppressor of cytokine signaling 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOCS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
| G
|
Socs6
|
suppressor of cytokine signaling 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOCS6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr18:84,386,587...84,413,927
Ensembl chr18:84,384,573...84,414,053
|
|
| G
|
Socs7
|
suppressor of cytokine signaling 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOCS7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:82,848,525...82,885,201
Ensembl chr10:82,848,612...82,885,201
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions affects expression
|
EXP ISO
|
[SOD2 co-treated with CYP3A4] affects the susceptibility to Carbamazepine Carbamazepine affects the expression of SOD2 mRNA
|
CTD |
PMID:19501153 PMID:24752500 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sorbs1
|
sorbin and SH3 domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SORBS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:249,057,324...249,279,608
|
|
| G
|
Sorcs1
|
sortilin-related VPS10 domain containing receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SORCS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:259,022,007...259,535,731
Ensembl chr 1:259,021,631...259,535,685
|
|
| G
|
Sorl1
|
sortilin related receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SORL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:51,238,722...51,401,446
|
|
| G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOS1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
|
|
| G
|
Sos2
|
SOS Ras/Rho guanine nucleotide exchange factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOS2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:93,778,971...93,892,161
Ensembl chr 6:93,778,971...93,892,811
|
|
| G
|
Sost
|
sclerostin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOST mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:87,412,722...87,415,766
Ensembl chr10:87,411,721...87,415,766
|
|
| G
|
Sowahc
|
sosondowah ankyrin repeat domain family member C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOWAHC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:27,738,247...27,742,713
Ensembl chr20:27,736,326...27,752,912
|
|
| G
|
Sox13
|
SRY-box transcription factor 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOX13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:47,383,145...47,427,572
Ensembl chr13:47,383,145...47,435,663
|
|
| G
|
Sox15
|
SRY-box transcription factor 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOX15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:54,871,793...54,873,497
Ensembl chr10:54,871,788...54,873,497
|
|
| G
|
Sox17
|
SRY-box transcription factor 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SOX17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:19,814,360...19,819,854
|
|
| G
|
Sox9
|
SRY-box transcription factor 9
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of SOX9 mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
| G
|
Sp3
|
Sp3 transcription factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:78,219,421...78,272,318
Ensembl chr 3:78,219,426...78,264,517
|
|
| G
|
Sp5
|
Sp5 transcription factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SP5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:75,682,677...75,685,479
Ensembl chr 3:75,682,677...75,685,479
|
|
| G
|
Spag4
|
sperm associated antigen 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPAG4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:165,040,682...165,047,963
Ensembl chr 3:165,041,134...165,045,519
|
|
| G
|
Spag5
|
sperm associated antigen 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPAG5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811
|
|
| G
|
Sparc
|
secreted protein acidic and cysteine rich
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPARC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
| G
|
Spats1
|
spermatogenesis associated, serine-rich 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPATS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:23,024,129...23,059,734
Ensembl chr 9:23,024,609...23,059,730
|
|
| G
|
Spats2l
|
spermatogenesis associated, serine-rich 2-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPATS2L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:66,814,217...66,988,084
Ensembl chr 9:66,814,228...66,988,578
|
|
| G
|
Spink2
|
serine peptidase inhibitor, Kazal type 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPINK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:31,321,976...31,328,622
Ensembl chr14:31,322,010...31,328,622
|
|
| G
|
Spint2
|
serine peptidase inhibitor, Kunitz type, 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPINT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:93,685,637...93,708,091
Ensembl chr 1:93,685,641...93,708,091
|
|
| G
|
Spire1
|
spire-type actin nucleation factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPIRE1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:63,311,800...63,441,545
Ensembl chr18:63,311,800...63,441,534
|
|
| G
|
Spns1
|
SPNS lysolipid transporter 1, lysophospholipid
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPNS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:190,372,663...190,380,192
Ensembl chr 1:190,372,666...190,379,943
|
|
| G
|
Spock2
|
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPOCK2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:28,580,262...28,607,198
Ensembl chr20:28,580,226...28,608,409
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Sppl2a
|
signal peptide peptidase-like 2A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPPL2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:134,602,684...134,646,752
Ensembl chr 3:134,605,750...134,646,752
|
|
| G
|
Sppl2c
|
signal peptide peptidase like 2C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPPL2C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:89,595,265...89,597,470
Ensembl chr10:89,592,397...89,610,842
|
|
| G
|
Sppl3
|
signal peptide peptidase like 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPPL3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:47,176,317...47,260,756
Ensembl chr12:47,176,804...47,260,482
|
|
| G
|
Spred1
|
sprouty-related, EVH1 domain containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPRED1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:124,437,230...124,504,358
Ensembl chr 3:124,437,230...124,504,358
|
|
| G
|
Spred2
|
sprouty-related, EVH1 domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPRED2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:98,350,577...98,452,143
Ensembl chr14:98,350,290...98,452,143
|
|
| G
|
Spring1
|
SREBF pathway regulator in golgi 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPRING1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:43,967,146...43,990,083
Ensembl chr12:43,967,146...43,990,213
|
|
| G
|
Spry2
|
sprouty RTK signaling antagonist 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPRY2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr15:89,106,809...89,111,926
Ensembl chr15:89,103,731...89,115,074
|
|
| G
|
Spsb1
|
splA/ryanodine receptor domain and SOCS box containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPSB1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:165,642,851...165,654,225
|
|
| G
|
Sptssa
|
serine palmitoyltransferase, small subunit A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SPTSSA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:77,879,941...77,891,403
|
|
| G
|
Sqstm1
|
sequestosome 1
|
affects expression multiple interactions
|
ISO EXP
|
Carbamazepine affects the expression of SQSTM1 mRNA [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of SQSTM1 protein
|
CTD |
PMID:25979313 PMID:35786680 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRC mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Srd5a3
|
steroid 5 alpha-reductase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRD5A3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:32,400,603...32,414,987
Ensembl chr14:32,400,603...32,415,117
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
EXP
|
[[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of SREBF1 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of SREBF1 mRNA
|
CTD |
PMID:35786680 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
decreases expression multiple interactions
|
ISO EXP
|
Carbamazepine results in decreased expression of SREBF2 mRNA [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of SREBF2 mRNA; [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of SREBF2 mRNA; [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in decreased expression of SREBF2 mRNA
|
CTD |
PMID:21123845 PMID:35786680 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
| G
|
Srprb
|
SRP receptor subunit beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRPRB mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:112,647,577...112,661,524
|
|
| G
|
Srpx
|
sushi-repeat-containing protein, X-linked
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRPX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:15,349,498...15,420,389
Ensembl chr X:15,349,440...15,420,392
|
|
| G
|
Srrt
|
serrate, RNA effector molecule
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRRT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:25,027,883...25,042,847
Ensembl chr12:25,029,334...25,042,845
|
|
| G
|
Srsf1
|
serine and arginine rich splicing factor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRSF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548
|
|
| G
|
Srsf2
|
serine and arginine rich splicing factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRSF2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,553,072...102,554,141
|
|
| G
|
Srxn1
|
sulfiredoxin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SRXN1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
|
|
| G
|
Ss18l2
|
SS18 like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SS18L2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:130,252,774...130,255,388
Ensembl chr 8:130,252,782...130,257,367
|
|
| G
|
Ssbp2
|
single-stranded DNA binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSBP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:24,385,494...24,673,768
Ensembl chr 2:24,385,687...24,673,768
|
|
| G
|
Ssh1
|
slingshot protein phosphatase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSH1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:48,281,756...48,343,812
Ensembl chr12:48,281,756...48,343,812
|
|
| G
|
Sspn
|
sarcospan
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSPN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:180,620,762...180,666,893
Ensembl chr 4:180,627,848...180,662,284
|
|
| G
|
Ssr1
|
signal sequence receptor subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:27,039,203...27,067,352
Ensembl chr17:27,039,269...27,067,348
|
|
| G
|
Ssrp1
|
structure specific recognition protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSRP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:90,531,024...90,541,132
Ensembl chr 3:90,530,829...90,541,129
|
|
| G
|
Sst
|
somatostatin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SST mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
|
|
| G
|
Ssx2ip
|
SSX family member 2 interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SSX2IP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017
|
|
| G
|
St13
|
ST13, Hsp70 interacting protein
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of ST13 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 7:114,769,758...114,805,877
Ensembl chr 7:114,769,759...114,805,941
|
|
| G
|
St6gal1
|
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ST6GAL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:91,032,450...91,040,415
|
|
| G
|
St6galnac3
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ST6GALNAC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:244,789,627...245,304,975
Ensembl chr 2:244,789,627...245,304,977
|
|
| G
|
St6galnac5
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ST6GALNAC5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:244,398,604...244,571,100
Ensembl chr 2:244,402,589...244,571,097
|
|
| G
|
Stac
|
SH3 and cysteine rich domain
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:120,409,165...120,531,394
Ensembl chr 8:120,409,165...120,531,320
|
|
| G
|
Stap2
|
signal transducing adaptor family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:915,546...924,604
Ensembl chr 9:915,550...924,380
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of STAR mRNA
|
CTD |
PMID:37505509 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stard13
|
StAR-related lipid transfer domain containing 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STARD13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:5,401,878...5,797,937
Ensembl chr12:5,401,995...5,794,967
|
|
| G
|
Stat1
|
signal transducer and activator of transcription 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAT1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAT3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Stat5b
|
signal transducer and activator of transcription 5B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAT5B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990
|
|
| G
|
Stat6
|
signal transducer and activator of transcription 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STAT6 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
| G
|
Stbd1
|
starch binding domain 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STBD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659
|
|
| G
|
Stc1
|
stanniocalcin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082
|
|
| G
|
Stc2
|
stanniocalcin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
|
|
| G
|
Steap1
|
STEAP family member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STEAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:29,231,809...29,242,317
Ensembl chr 4:29,231,753...29,242,317
|
|
| G
|
Stk26
|
serine/threonine kinase 26
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STK26 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:135,195,176...135,259,994
Ensembl chr X:135,195,204...135,259,993
|
|
| G
|
Stk40
|
serine/threonine kinase 40
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STK40 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:143,660,438...143,702,336
Ensembl chr 5:143,665,090...143,702,335
|
|
| G
|
Stmn1
|
stathmin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STMN1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
|
|
| G
|
Stmn3
|
stathmin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STMN3 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 3:188,794,358...188,802,494
Ensembl chr 3:188,794,358...188,802,873
|
|
| G
|
Stom
|
stomatin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STOM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:39,042,503...39,064,818
Ensembl chr 3:39,042,503...39,064,818
|
|
| G
|
Stx3
|
syntaxin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of STX3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:217,909,169...218,110,466
|
|
| G
|
Sucnr1
|
succinate receptor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SUCNR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:146,368,858...146,380,360
Ensembl chr 2:146,368,858...146,380,360
|
|
| G
|
Suco
|
SUN domain containing ossification factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SUCO mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:76,726,095...76,791,174
Ensembl chr13:76,726,859...76,791,174
|
|
| G
|
Sulf2
|
sulfatase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SULF2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651
|
|
| G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
decreases expression
|
EXP
|
Carbamazepine results in decreased expression of SULT1A1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
|
|
| G
|
Sult2a6
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of SULT2A6 mRNA
|
CTD |
PMID:28138970 |
|
NCBI chr 1:84,046,685...84,097,808
Ensembl chr 1:84,046,685...84,097,808
|
|
| G
|
Susd2
|
sushi domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SUSD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:13,016,960...13,024,264
Ensembl chr20:13,016,907...13,024,264
|
|
| G
|
Suv39h1
|
SUV39H1 histone lysine methyltransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SUV39H1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
|
|
| G
|
Suv39h1-ps1
|
SUV39H1 histone lysine methyltransferase, pseudogene 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SUV39H1 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr X:146,828,818...146,831,485
|
|
| G
|
Sv2a
|
synaptic vesicle glycoprotein 2a
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SV2A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:186,430,363...186,446,161
Ensembl chr 2:186,430,345...186,448,065
|
|
| G
|
Syn1
|
synapsin I
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of SYN1 mRNA
|
CTD |
PMID:27413119 |
|
NCBI chr X:3,725,745...3,780,940
Ensembl chr X:3,725,714...3,780,938
|
|
| G
|
Syne4
|
spectrin repeat containing nuclear envelope family member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYNE4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:94,696,866...94,701,230
Ensembl chr 1:94,696,609...94,701,230
|
|
| G
|
Syngr1
|
synaptogyrin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYNGR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:113,516,246...113,542,918
Ensembl chr 7:113,516,265...113,542,917
|
|
| G
|
Syngr3
|
synaptogyrin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYNGR3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:14,215,088...14,219,844
Ensembl chr10:14,215,088...14,220,179
|
|
| G
|
Synj1
|
synaptojanin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYNJ1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:43,678,709...43,755,526
Ensembl chr11:43,678,709...43,755,526
|
|
| G
|
Synm
|
synemin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYNM mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:130,743,891...130,774,254
Ensembl chr 1:130,743,897...130,773,824
|
|
| G
|
Syp
|
synaptophysin
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of SYP mRNA
|
CTD |
PMID:27413119 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:17,521,348...17,536,984
|
|
| G
|
Sys1
|
Sys1 golgi trafficking protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:173,610,332...173,637,624
Ensembl chr 3:173,610,710...173,614,814
|
|
| G
|
Sytl2
|
synaptotagmin-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYTL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:153,685,403...153,791,758
Ensembl chr 1:153,665,327...153,791,756
|
|
| G
|
Sytl5
|
synaptotagmin-like 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of SYTL5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:15,461,215...15,702,660
Ensembl chr X:15,460,472...15,550,471
|
|
| G
|
Tab3
|
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:53,923,473...53,995,777
Ensembl chr X:53,923,492...53,995,610
|
|
| G
|
Tac1
|
tachykinin, precursor 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
|
|
| G
|
Tac3
|
tachykinin precursor 3
|
multiple interactions affects expression
|
ISO
|
Carbamazepine inhibits the reaction [REST protein results in increased expression of TAC3 mRNA] Carbamazepine affects the expression of TAC3 mRNA
|
CTD |
PMID:19539370 PMID:25979313 |
|
NCBI chr 7:65,447,817...65,454,427
Ensembl chr 7:65,447,817...65,454,427
|
|
| G
|
Tacc2
|
transforming, acidic coiled-coil containing protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TACC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:194,546,428...194,758,152
Ensembl chr 1:194,569,650...194,758,152
|
|
| G
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TACC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:81,275,755...81,289,894
Ensembl chr14:81,275,755...81,289,698
|
|
| G
|
Tacstd2
|
tumor-associated calcium signal transducer 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TACSTD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:98,037,620...98,039,320
Ensembl chr 4:98,033,251...98,039,323
|
|
| G
|
Taf1d
|
TATA-box binding protein associated factor, RNA polymerase I subunit D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAF1D mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:20,427,894...20,438,046
Ensembl chr 8:20,427,954...20,434,556
|
|
| G
|
Taf3
|
TATA-box binding protein associated factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAF3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr17:73,365,162...73,518,053
|
|
| G
|
Taf4b
|
TATA-box binding protein associated factor 4b
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAF4B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:6,227,299...6,360,970
Ensembl chr18:6,227,345...6,356,275
|
|
| G
|
Taf7
|
TATA-box binding protein associated factor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAF7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:29,704,182...29,713,382
Ensembl chr18:29,705,920...29,712,712
|
|
| G
|
Taf9b
|
TATA-box binding protein associated factor 9b
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAF9B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:75,354,823...75,366,166
Ensembl chr X:75,354,825...75,366,414
|
|
| G
|
Tagln
|
transgelin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAGLN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563
|
|
| G
|
Tagln2
|
transgelin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAGLN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330
|
|
| G
|
Tanc1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TANC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:64,508,037...64,741,826
Ensembl chr 3:64,508,085...64,741,825
|
|
| G
|
Tank
|
TRAF family member-associated NFKB activator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TANK mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:66,522,834...66,598,864
Ensembl chr 3:66,537,175...66,598,864
|
|
| G
|
Taok3
|
TAO kinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAOK3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:44,973,180...45,134,439
Ensembl chr12:44,973,180...45,134,439
|
|
| G
|
Tars2
|
threonyl-tRNA synthetase 2, mitochondrial
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TARS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:185,982,042...185,999,155
Ensembl chr 2:185,982,086...185,999,113
|
|
| G
|
Tasor
|
transcription activation suppressor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TASOR mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:2,612,942...2,669,870
Ensembl chr16:2,613,505...2,669,867
|
|
| G
|
Tax1bp3
|
Tax1 binding protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TAX1BP3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:58,294,357...58,298,875
Ensembl chr10:58,294,073...58,298,875
|
|
| G
|
Tbc1d30
|
TBC1 domain family, member 30
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TBC1D30 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:58,665,054...58,754,614
|
|
| G
|
Tbc1d5
|
TBC1 domain family, member 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TBC1D5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:3,740,032...4,256,971
Ensembl chr 9:3,750,325...4,253,581
|
|
| G
|
Tbrg1
|
transforming growth factor beta regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TBRG1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:45,544,018...45,551,676
Ensembl chr 8:45,544,018...45,551,676
|
|
| G
|
Tbx21
|
T-box transcription factor 21
|
decreases expression
|
ISO
|
Carbamazepine results in decreased expression of TBX21 mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253
|
|
| G
|
Tbxt
|
T-box transcription factor T
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TBXT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:54,845,674...54,859,340
Ensembl chr 1:54,845,674...54,853,583
|
|
| G
|
Tcf3
|
transcription factor 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TCF3 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,928,685...9,953,044
|
|
| G
|
Tcf7
|
transcription factor 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TCF7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279
|
|
| G
|
Tcf7l1
|
transcription factor 7 like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TCF7L1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:106,238,892...106,404,012
Ensembl chr 4:106,238,896...106,403,421
|
|
| G
|
Tcf7l2
|
transcription factor 7 like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TCF7L2 mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225
|
|
| G
|
Tdrd7
|
tudor domain containing 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TDRD7 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 5:65,034,317...65,108,165
Ensembl chr 5:65,034,341...65,108,161
|
|
| G
|
Tead4
|
TEA domain transcription factor 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TEAD4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:163,180,192...163,258,342
Ensembl chr 4:163,180,192...163,258,479
|
|
| G
|
Tent5a
|
terminal nucleotidyltransferase 5A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TENT5A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:95,102,349...95,109,100
Ensembl chr 8:95,105,412...95,109,100
|
|
| G
|
Tent5c
|
terminal nucleotidyltransferase 5C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TENT5C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:190,541,668...190,563,902
Ensembl chr 2:190,540,650...190,565,995
|
|
| G
|
Tes
|
testin LIM domain protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TES mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:46,331,257...46,369,780
|
|
| G
|
Tesmin
|
testis expressed metallothionein like protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TESMIN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:210,059,414...210,077,704
Ensembl chr 1:210,059,393...210,077,703
|
|
| G
|
Tet1
|
tet methylcytosine dioxygenase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TET1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:25,766,806...25,839,598
Ensembl chr20:25,760,057...25,832,730
|
|
| G
|
Tfap2c
|
transcription factor AP-2 gamma
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TFAP2C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:181,733,524...181,742,412
Ensembl chr 3:181,733,419...181,741,404
|
|
| G
|
Tfb1m
|
transcription factor B1, mitochondrial
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TFB1M mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:46,520,510...46,567,004
Ensembl chr 1:46,524,435...46,566,948
|
|
| G
|
Tfdp1
|
transcription factor Dp-1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TFDP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:82,864,226...82,902,996
|
|
| G
|
Tfpi2
|
tissue factor pathway inhibitor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TFPI2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of TGFB1
|
CTD |
PMID:28267586 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TGFB2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tgfbi
|
transforming growth factor, beta induced
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TGFBI mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
|
|
| G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TGFBR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
| G
|
Tgif1
|
TGFB-induced factor homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TGIF1 mRNA
|
CTD |
PMID:22634333 PMID:25979313 |
|
NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:118,194,444...118,204,442
|
|
| G
|
Thbs1
|
thrombospondin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THBS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Thbs2
|
thrombospondin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THBS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918
|
|
| G
|
Thbs3
|
thrombospondin 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THBS3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:176,919,549...176,931,357
Ensembl chr 2:176,919,230...176,931,357
|
|
| G
|
Thbs4
|
thrombospondin 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THBS4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369
|
|
| G
|
Them4
|
thioesterase superfamily member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THEM4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:184,642,603...184,663,752
Ensembl chr 2:184,642,595...184,665,344
|
|
| G
|
Thnsl2
|
threonine synthase-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THNSL2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:104,671,305...104,691,084
Ensembl chr 4:104,670,925...104,691,959
|
|
| G
|
Thsd7b
|
thrombospondin type 1 domain containing 7B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of THSD7B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:43,320,895...44,219,546
Ensembl chr13:43,320,891...44,218,785
|
|
| G
|
Tiam2
|
TIAM Rac1 associated GEF 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TIAM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:46,323,450...46,524,769
Ensembl chr 1:46,323,456...46,524,769
|
|
| G
|
Tigar
|
TP53 induced glycolysis regulatory phosphatase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TIGAR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:161,613,306...161,632,248
Ensembl chr 4:161,613,306...161,632,229
|
|
| G
|
Timm17a
|
translocase of inner mitochondrial membrane 17A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TIMM17A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:49,282,918...49,296,363
Ensembl chr13:49,282,918...49,307,904
|
|
| G
|
Timm22
|
translocase of inner mitochondrial membrane 22
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TIMM22 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:61,751,686...61,759,444
Ensembl chr10:61,751,666...61,760,850
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TIMP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tjp1
|
tight junction protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TJP1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
| G
|
Tk1
|
thymidine kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TK1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228
|
|
| G
|
Tk2
|
thymidine kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr19:713,043...737,345
Ensembl chr19:715,318...738,355
|
|
| G
|
Tkt
|
transketolase
|
increases expression decreases expression
|
EXP
|
Carbamazepine results in increased expression of TKT mRNA Carbamazepine results in decreased expression of TKT mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
|
|
| G
|
Tktl1
|
transketolase-like 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TKTL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:157,105,455...157,138,510
Ensembl chr X:157,105,495...157,138,503
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of TLR4 mRNA
|
CTD |
PMID:22790970 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tlx2
|
T-cell leukemia homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TLX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:117,131,516...117,133,359
Ensembl chr 4:117,131,516...117,133,359
|
|
| G
|
Tm4sf1
|
transmembrane 4 L six family member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TM4SF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:143,603,271...143,616,176
|
|
| G
|
Tm9sf1
|
transmembrane 9 superfamily member 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TM9SF1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:33,097,541...33,108,106
Ensembl chr15:33,097,552...33,105,290
|
|
| G
|
Tmbim1
|
transmembrane BAX inhibitor motif containing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMBIM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:83,320,972...83,338,469
Ensembl chr 9:83,320,979...83,338,657
|
|
| G
|
Tmc7
|
transmembrane channel-like 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMC7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:182,287,742...182,340,000
Ensembl chr 1:182,287,742...182,339,947
|
|
| G
|
Tmco1
|
transmembrane and coiled-coil domains 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMCO1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:81,993,172...82,016,496
Ensembl chr13:81,993,097...82,017,201
|
|
| G
|
Tmco6
|
transmembrane and coiled-coil domains 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMCO6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:28,623,269...28,629,864
Ensembl chr18:28,623,269...28,629,864
|
|
| G
|
Tmem126a
|
transmembrane protein 126A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM126A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:153,837,015...153,843,192
Ensembl chr 1:153,835,236...153,843,160
|
|
| G
|
Tmem127
|
transmembrane protein 127
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM127 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:134,919,416...134,932,210
Ensembl chr 3:134,919,414...134,932,550
|
|
| G
|
Tmem135
|
transmembrane protein 135
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM135 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:152,418,929...152,692,405
Ensembl chr 1:152,418,930...152,633,717
|
|
| G
|
Tmem144
|
transmembrane protein 144
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM144 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:167,258,788...167,291,701
Ensembl chr 2:167,258,789...167,290,902
|
|
| G
|
Tmem17
|
transmembrane protein 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM17 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:100,684,655...100,725,471
Ensembl chr14:100,685,093...100,725,470
|
|
| G
|
Tmem18
|
transmembrane protein 18
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM18 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:52,934,419...52,941,868
Ensembl chr 6:52,934,419...52,941,866
|
|
| G
|
Tmem19
|
transmembrane protein 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:52,844,985...52,871,708
Ensembl chr 7:52,844,985...52,872,012
|
|
| G
|
Tmem268
|
transmembrane protein 268
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM268 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:81,990,314...82,016,970
Ensembl chr 5:81,991,367...82,016,968
|
|
| G
|
Tmem30b
|
transmembrane protein 30B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM30B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:97,987,130...97,991,170
|
|
| G
|
Tmem41b
|
transmembrane protein 41B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM41B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:173,447,362...173,461,760
Ensembl chr 1:173,447,367...173,461,597
|
|
| G
|
Tmem47
|
transmembrane protein 47
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM47 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:49,338,532...49,365,026
Ensembl chr X:49,338,326...49,521,541
|
|
| G
|
Tmem65
|
transmembrane protein 65
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMEM65 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:92,163,632...92,268,430
Ensembl chr 7:92,163,635...92,268,214
|
|
| G
|
Tmprss11e
|
transmembrane serine protease 11E
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMPRSS11E mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:21,638,418...21,683,029
Ensembl chr14:21,638,418...21,683,029
|
|
| G
|
Tmprss13
|
transmembrane serine protease 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMPRSS13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:54,522,069...54,550,673
Ensembl chr 8:54,522,443...54,550,670
|
|
| G
|
Tmsb10
|
thymosin, beta 10
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMSB10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:106,568,080...106,569,210
|
|
| G
|
Tmsb15b2
|
thymosin beta 15B2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMSB15A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:105,090,980...105,093,094
|
|
| G
|
Tmtc3
|
transmembrane O-mannosyltransferase targeting cadherins 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TMTC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:37,151,456...37,196,550
Ensembl chr 7:37,151,456...37,196,540
|
|
| G
|
Tnc
|
tenascin C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNC mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
affects response to substance increases expression
|
ISO EXP
|
TNF gene SNP affects the susceptibility to Carbamazepine Carbamazepine results in increased expression of TNF
|
CTD |
PMID:11294926 PMID:28267586 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf10b
|
TNF receptor superfamily member 10b
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF10A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF11B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF12A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnfrsf19
|
TNF receptor superfamily member 19
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF19 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF1A mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf21
|
TNF receptor superfamily member 21
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFRSF21 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:25,376,400...25,451,323
|
|
| G
|
Tnfsf4
|
TNF superfamily member 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNFSF4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:76,256,654...76,280,133
|
|
| G
|
Tnmd
|
tenomodulin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNMD mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:101,350,432...101,365,929
Ensembl chr X:101,350,269...101,365,929
|
|
| G
|
Tnnc2
|
troponin C2, fast skeletal type
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNNC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:173,932,611...173,935,339
Ensembl chr 3:173,932,611...173,935,339
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNNI3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tnnt1
|
troponin T1, slow skeletal type
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TNNT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:78,349,035...78,359,394
|
|
| G
|
Tollip
|
toll interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOLLIP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:206,391,120...206,413,809
Ensembl chr 1:206,380,308...206,411,988
|
|
| G
|
Tomm20
|
translocase of outer mitochondrial membrane 20
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOMM20 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:71,822,411...71,832,510
|
|
| G
|
Tomm40l
|
translocase of outer mitochondrial membrane 40 like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOMM40L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:86,169,160...86,174,121
Ensembl chr13:86,168,021...86,173,824
|
|
| G
|
Top1mt
|
DNA topoisomerase I mitochondrial
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOP1MT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:109,223,269...109,248,855
Ensembl chr 7:109,139,527...109,246,799
|
|
| G
|
Top2b
|
DNA topoisomerase II beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOP2B mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr15:11,482,089...11,542,464
Ensembl chr15:11,482,089...11,542,464
|
|
| G
|
Topbp1
|
DNA topoisomerase II binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOPBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:112,766,508...112,810,540
|
|
| G
|
Tox2
|
TOX high mobility group box family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TOX2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:172,272,718...172,400,235
Ensembl chr 3:172,272,736...172,400,233
|
|
| G
|
Tp53
|
tumor protein p53
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TP53 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53i11
|
tumor protein p53 inducible protein 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TP53I11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432
|
|
| G
|
Tp53i3
|
tumor protein p53 inducible protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TP53I3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:33,537,779...33,545,204
|
|
| G
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TP53INP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484
|
|
| G
|
Tpgs2
|
tubulin polyglutamylase complex subunit 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TPGS2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:16,707,336...16,764,278
Ensembl chr18:16,696,950...16,764,278
|
|
| G
|
Tpi1
|
triosephosphate isomerase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TPI1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
|
|
| G
|
Tpm1
|
tropomyosin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TPM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
|
|
| G
|
Tpp1
|
tripeptidyl peptidase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TPP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:169,509,816...169,515,939
Ensembl chr 1:169,509,815...169,516,024
|
|
| G
|
Tram2
|
translocation associated membrane protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRAM2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:30,915,624...30,995,162
Ensembl chr 9:30,915,624...30,995,162
|
|
| G
|
Trappc6a
|
trafficking protein particle complex subunit 6A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRAPPC6A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:88,286,533...88,293,493
Ensembl chr 1:88,286,362...88,293,493
|
|
| G
|
Trhde
|
thyrotropin-releasing hormone degrading enzyme
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRHDE mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:51,829,473...52,236,843
Ensembl chr 7:51,832,111...52,236,843
|
|
| G
|
Triap1
|
TP53 regulated inhibitor of apoptosis 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRIAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:46,928,273...46,930,766
Ensembl chr12:46,928,273...46,930,766
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRIB3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Trim24
|
tripartite motif-containing 24
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRIM24 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:67,534,335...67,684,226
|
|
| G
|
Trim9
|
tripartite motif-containing 9
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRIM9 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:94,492,789...94,592,597
Ensembl chr 6:94,493,268...94,592,551
|
|
| G
|
Trmo
|
tRNA methyltransferase O
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRMO mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:65,461,489...65,472,019
Ensembl chr 5:65,447,167...65,472,019
|
|
| G
|
Trmt112
|
tRNA methyltransferase activator subunit 11-2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRMT112 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:213,532,507...213,533,360
Ensembl chr 1:213,532,175...213,533,356
|
|
| G
|
Trmt9b
|
tRNA methyltransferase 9B (putative)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRMT9B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:62,439,625...62,495,526
Ensembl chr16:62,446,393...62,495,518
|
|
| G
|
Trnp1
|
TMF1-regulated nuclear protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRNP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:150,990,312...150,997,148
Ensembl chr 5:150,989,973...150,997,277
|
|
| G
|
Trpm3
|
transient receptor potential cation channel, subfamily M, member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TRPM3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:229,099,741...229,984,172
Ensembl chr 1:229,099,542...229,984,172
|
|
| G
|
Tsc1
|
TSC complex subunit 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSC1 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:32,367,434...32,416,565
Ensembl chr 3:32,367,670...32,416,568
|
|
| G
|
Tsen15
|
tRNA splicing endonuclease subunit 15
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSEN15 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:67,040,134...67,055,509
Ensembl chr13:67,040,134...67,055,509
|
|
| G
|
Tshz1
|
teashirt zinc finger homeobox 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSHZ1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:79,651,256...79,727,662
Ensembl chr18:79,651,256...79,727,662
|
|
| G
|
Tshz3
|
teashirt zinc finger homeobox 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSHZ3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:98,525,584...98,597,428
Ensembl chr 1:98,518,681...98,598,007
|
|
| G
|
Tspan11
|
tetraspanin 11
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSPAN11 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:162,424,327...162,491,653
Ensembl chr 4:162,424,549...162,492,932
|
|
| G
|
Tspan13
|
tetraspanin 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSPAN13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:58,466,051...58,492,804
Ensembl chr 6:58,465,684...58,492,819
|
|
| G
|
Tspan2
|
tetraspanin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSPAN2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:192,866,212...192,923,489
Ensembl chr 2:192,866,237...192,923,487
|
|
| G
|
Tspan33
|
tetraspanin 33
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TSPAN33 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:59,270,713...59,294,249
Ensembl chr 4:59,270,703...59,294,249
|
|
| G
|
Ttc29
|
tetratricopeptide repeat domain 29
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TTC29 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:46,436,526...46,654,891
Ensembl chr19:46,424,935...46,654,870
|
|
| G
|
Ttc32
|
tetratricopeptide repeat domain 32
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TTC32 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:37,553,628...37,560,227
Ensembl chr 6:37,553,628...37,561,821
|
|
| G
|
Ttll6
|
tubulin tyrosine ligase like 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TTLL6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:81,579,110...81,623,917
Ensembl chr10:81,579,178...81,623,919
|
|
| G
|
Ttr
|
transthyretin
|
affects binding
|
ISO
|
Carbamazepine binds to TTR protein
|
CTD |
PMID:29427707 |
|
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969
|
|
| G
|
Tuba1a
|
tubulin, alpha 1A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUBA1A mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Tuba1c
|
tubulin, alpha 1C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUBA1C mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
affects expression decreases expression
|
ISO
|
Carbamazepine affects the expression of TUBB3 mRNA Carbamazepine results in decreased expression of TUBB3
|
CTD |
PMID:24752500 PMID:25524013 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
| G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUBB4B mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
|
|
| G
|
Tubb6
|
tubulin, beta 6 class V
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUBB6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
|
|
| G
|
Tuft1
|
tuftelin 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUFT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:184,949,437...184,995,321
Ensembl chr 2:184,949,437...184,995,383
|
|
| G
|
Tulp3
|
TUB like protein 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TULP3 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 4:163,276,583...163,318,297
Ensembl chr 4:163,276,583...163,318,390
|
|
| G
|
Tunar
|
transmembrane neural differentiation associated intracellular calcium regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TUNAR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:130,011,067...130,058,157
|
|
| G
|
Txndc16
|
thioredoxin domain containing 16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TXNDC16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:20,831,541...20,905,661
Ensembl chr15:20,831,391...20,905,452
|
|
| G
|
Txnip
|
thioredoxin interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TXNIP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
increases expression affects expression
|
EXP ISO
|
Carbamazepine results in increased expression of TXNRD1 mRNA Carbamazepine affects the expression of TXNRD1 mRNA
|
CTD |
PMID:17381134 PMID:24752500 PMID:25979313 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Txnrd2
|
thioredoxin reductase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TXNRD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
|
|
| G
|
Tyro3
|
TYRO3 protein tyrosine kinase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of TYRO3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:127,231,468...127,254,806
Ensembl chr 3:127,231,903...127,250,943
|
|
| G
|
Ubash3b
|
ubiquitin associated and SH3 domain containing, B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBASH3B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:50,282,510...50,430,034
Ensembl chr 8:50,285,431...50,326,351
|
|
| G
|
Ube2b
|
ubiquitin-conjugating enzyme E2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:36,749,365...36,764,335
Ensembl chr10:36,749,369...36,765,587
|
|
| G
|
Ube2d2b
|
ubiquitin-conjugating enzyme E2D 2B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2D4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:2,060,926...2,062,400
Ensembl chr14:2,048,235...2,063,764
|
|
| G
|
Ube2e1
|
ubiquitin-conjugating enzyme E2E 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2E1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:9,870,528...9,924,194
Ensembl chr15:9,862,219...9,924,194
|
|
| G
|
Ube2f
|
ubiquitin-conjugating enzyme E2F (putative)
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2F mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:99,293,506...99,328,690
Ensembl chr 9:99,293,515...99,330,479
|
|
| G
|
Ube2j1
|
ubiquitin-conjugating enzyme E2, J1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2J1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:52,218,807...52,237,805
Ensembl chr 5:52,218,807...52,237,805
|
|
| G
|
Ube2l6
|
ubiquitin-conjugating enzyme E2L 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2L6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:90,279,705...90,294,721
Ensembl chr 3:90,279,668...90,294,717
|
|
| G
|
Ube2t
|
ubiquitin-conjugating enzyme E2T
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE2T mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:48,955,166...48,965,668
Ensembl chr13:48,955,183...48,966,646
|
|
| G
|
Ube4b
|
ubiquitination factor E4B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBE4B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:165,049,897...165,153,572
Ensembl chr 5:165,049,897...165,153,572
|
|
| G
|
Ubr5
|
ubiquitin protein ligase E3 component n-recognin 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UBR5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:71,000,197...71,109,813
|
|
| G
|
Uck2
|
uridine-cytidine kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UCK2 mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:81,916,818...81,971,091
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UCP2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Ufm1
|
ubiquitin-fold modifier 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UFM1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:140,119,722...140,127,866
Ensembl chr 2:140,119,725...140,127,866
|
|
| G
|
Ugdh
|
UDP-glucose 6-dehydrogenase
|
decreases expression increases expression
|
EXP
|
Carbamazepine results in decreased expression of UGDH mRNA Carbamazepine results in increased expression of UGDH mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629
|
|
| G
|
Uggt2
|
UDP-glucose glycoprotein glucosyltransferase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UGGT2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:102,480,239...102,646,291
Ensembl chr15:102,480,781...102,646,410
|
|
| G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
increases expression increases activity
|
EXP ISO
|
Carbamazepine results in increased expression of UGT1A1 mRNA Carbamazepine results in increased activity of UGT1A1 protein
|
CTD |
PMID:17381134 PMID:27413119 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a6a
|
UDP glucuronosyltransferase family 1 member A6a
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of UGT1A6 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1
|
increases expression
|
EXP
|
Carbamazepine results in increased expression of UGT2B1 mRNA
|
CTD |
PMID:17381134 |
|
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331
|
|
| G
|
Ugt2b34l1
|
UDP glucuronosyltransferase 2 family, polypeptide B34 like 1
|
increases expression
|
ISO
|
Carbamazepine results in increased expression of UGT2B28 mRNA
|
CTD |
PMID:17112801 |
|
NCBI chr14:21,500,948...21,524,095
Ensembl chr14:21,501,091...21,522,265
|
|
| G
|
Ulk2
|
unc-51 like autophagy activating kinase 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ULK2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr10:46,951,038...47,029,844
Ensembl chr10:46,951,038...47,029,844
|
|
| G
|
Unc5b
|
unc-5 netrin receptor B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UNC5B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270
|
|
| G
|
Unc5c
|
unc-5 netrin receptor C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UNC5C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:232,854,352...233,208,482
Ensembl chr 2:232,846,262...233,208,482
|
|
| G
|
Ung
|
uracil-DNA glycosylase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UNG mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
|
|
| G
|
Upf3b
|
UPF3B, regulator of nonsense mediated mRNA decay
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UPF3B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:121,200,993...121,219,059
Ensembl chr X:121,200,993...121,218,921
|
|
| G
|
Upp1
|
uridine phosphorylase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UPP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
|
|
| G
|
Uqcr10
|
ubiquinol-cytochrome c reductase, complex III subunit X
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UQCR10 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:83,789,657...83,791,914
Ensembl chr14:83,789,658...83,791,914
|
|
| G
|
Uros
|
uroporphyrinogen III synthase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UROS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:197,920,827...197,943,183
Ensembl chr 1:197,921,701...197,936,150
|
|
| G
|
Ushbp1
|
USH1 protein network component harmonin binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USHBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:18,091,311...18,101,927
Ensembl chr16:18,091,316...18,101,867
|
|
| G
|
Usp1
|
ubiquitin specific peptidase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:118,703,056...118,714,426
Ensembl chr 5:118,702,868...118,714,434
|
|
| G
|
Usp13
|
ubiquitin specific peptidase 13
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP13 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:117,502,811...117,617,049
Ensembl chr 2:117,505,122...117,630,161
|
|
| G
|
Usp30
|
ubiquitin specific peptidase 30
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP30 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:48,161,905...48,215,878
Ensembl chr12:48,161,908...48,215,968
|
|
| G
|
Usp40
|
ubiquitin specific peptidase 40
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP40 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 9:96,055,741...96,126,766
Ensembl chr 9:96,055,741...96,126,721
|
|
| G
|
Usp44
|
ubiquitin specific peptidase 44
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP44 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:30,251,142...30,301,185
Ensembl chr 7:30,251,205...30,297,906
|
|
| G
|
Usp46
|
ubiquitin specific peptidase 46
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP46 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:34,504,074...34,573,318
Ensembl chr14:34,504,118...34,573,307
|
|
| G
|
Usp53
|
ubiquitin specific peptidase 53
|
affects expression
|
ISO
|
Carbamazepine affects the expression of USP53 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:213,744,106...213,805,619
Ensembl chr 2:213,744,106...213,790,544
|
|
| G
|
Ust
|
uronyl-2-sulfotransferase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of UST mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:4,487,316...4,782,579
Ensembl chr 1:4,489,925...4,782,356
|
|
| G
|
Vars1
|
valyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:3,810,427...3,825,193
Ensembl chr20:3,810,429...3,824,951
|
|
| G
|
Vash2
|
vasohibin 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VASH2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:105,060,857...105,092,325
Ensembl chr13:105,060,857...105,092,275
|
|
| G
|
Vasp
|
vasodilator-stimulated phosphoprotein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VASP mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 1:88,038,026...88,053,783
Ensembl chr 1:88,038,037...88,058,650
|
|
| G
|
Vat1l
|
vesicle amine transport 1-like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VAT1L mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:59,103,636...59,272,950
Ensembl chr19:59,103,636...59,272,950
|
|
| G
|
Vcan
|
versican
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VCAN mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
| G
|
Vcl
|
vinculin
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VCL mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VEGFA mRNA
|
CTD |
PMID:24752500 PMID:25979313 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vegfd
|
vascular endothelial growth factor D
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VEGFD mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:33,706,055...33,740,167
|
|
| G
|
Vldlr
|
very low density lipoprotein receptor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VLDLR mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154
|
|
| G
|
Vps26a
|
VPS26 retromer complex component A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VPS26A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:30,947,018...30,976,964
Ensembl chr20:30,947,023...30,976,827
|
|
| G
|
Vps33b
|
VPS33B, late endosome and lysosome associated
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VPS33B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:143,633,167...143,656,228
Ensembl chr 1:143,633,197...143,659,552
|
|
| G
|
Vps35
|
VPS35 retromer complex component
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VPS35 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:37,938,989...37,974,887
Ensembl chr19:37,938,720...37,974,886
|
|
| G
|
Vrk1
|
VRK serine/threonine kinase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VRK1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:130,679,400...130,746,089
Ensembl chr 6:130,679,515...130,746,752
|
|
| G
|
Vwde
|
von Willebrand factor D and EGF domains
|
affects expression
|
ISO
|
Carbamazepine affects the expression of VWDE mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:42,419,676...42,468,992
Ensembl chr 4:42,419,669...42,511,840
|
|
| G
|
Wars1
|
tryptophanyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
|
|
| G
|
Wdhd1
|
WD repeat and HMG-box DNA binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDHD1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:22,957,492...23,002,820
Ensembl chr15:22,958,069...23,002,820
|
|
| G
|
Wdr54
|
WD repeat domain 54
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR54 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 4:117,212,677...117,236,456
Ensembl chr 4:117,212,677...117,219,270
|
|
| G
|
Wdr59
|
WD repeat domain 59
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR59 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:56,321,529...56,393,195
Ensembl chr19:56,325,438...56,393,132
|
|
| G
|
Wdr5b
|
WD repeat domain 5B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR5B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr11:78,216,266...78,218,125
Ensembl chr11:78,190,355...78,218,501
|
|
| G
|
Wdr6
|
WD repeat domain 6
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR6 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
|
|
| G
|
Wdr73
|
WD repeat domain 73
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR73 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:144,269,561...144,277,707
Ensembl chr 1:144,269,562...144,277,840
|
|
| G
|
Wdr76
|
WD repeat domain 76
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WDR76 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:128,910,500...128,945,241
Ensembl chr 3:128,910,503...128,945,239
|
|
| G
|
Wfdc17
|
WAP four-disulfide core domain 17
|
affects expression
|
ISO
|
Carbamazepine affects the expression of KAL1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:69,059,451...69,060,298
|
|
| G
|
Wfdc2
|
WAP four-disulfide core domain 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WFDC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
|
|
| G
|
Wls
|
Wnt ligand secretion mediator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WLS mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:251,590,653...251,705,991
Ensembl chr 2:251,590,614...251,706,380
|
|
| G
|
Wnt10b
|
Wnt family member 10B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WNT10B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:131,801,046...131,806,850
Ensembl chr 7:131,801,046...131,806,850
|
|
| G
|
Wnt8a
|
Wnt family member 8A
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WNT8A mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:26,411,833...26,417,426
Ensembl chr18:26,411,833...26,417,426
|
|
| G
|
Wscd2
|
WSC domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WSCD2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:48,707,056...48,801,443
Ensembl chr12:48,707,056...48,801,319
|
|
| G
|
Wt1
|
WT1 transcription factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WT1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444
|
|
| G
|
Wtip
|
WT1 interacting protein
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WTIP mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:95,868,399...95,902,117
Ensembl chr 1:95,868,399...95,902,427
|
|
| G
|
Wwc2
|
WW and C2 domain containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WWC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr16:50,991,096...51,154,529
Ensembl chr16:50,991,096...51,154,526
|
|
| G
|
Wwc3
|
WWC family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WWC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:27,146,018...27,263,446
Ensembl chr X:27,145,812...27,263,446
|
|
| G
|
Wwox
|
WW domain-containing oxidoreductase
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WWOX mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:59,341,233...60,269,441
|
|
| G
|
Wwtr1
|
WW domain containing transcription regulator 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of WWTR1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:143,801,181...143,916,941
Ensembl chr 2:143,801,181...143,991,950
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of XBP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Xiap
|
X-linked inhibitor of apoptosis
|
affects expression
|
ISO
|
Carbamazepine affects the expression of XIAP mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:125,737,971...125,803,978
|
|
| G
|
Xpa
|
XPA, DNA damage recognition and repair factor
|
affects expression
|
ISO
|
Carbamazepine affects the expression of XPA mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425
|
|
| G
|
Xpot
|
exportin for tRNA
|
affects expression
|
ISO
|
Carbamazepine affects the expression of XPOT mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:58,997,025...59,037,506
Ensembl chr 7:58,997,025...59,037,502
|
|
| G
|
Xrcc1
|
X-ray repair cross complementing 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of XRCC1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
|
|
| G
|
Yaf2
|
YY1 associated factor 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YAF2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:126,323,604...126,379,061
Ensembl chr 7:126,323,604...126,379,260
|
|
| G
|
Yap1
|
Yes1 associated transcriptional regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YAP1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:13,380,551...13,451,640
Ensembl chr 8:13,380,551...13,451,437
|
|
| G
|
Yars1
|
tyrosyl-tRNA synthetase 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YARS1 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
|
|
| G
|
Ybey
|
ybeY metalloendoribonuclease
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YBEY mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr20:12,164,678...12,175,150
Ensembl chr20:12,164,723...12,174,199
|
|
| G
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YWHAB mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854
|
|
| G
|
Ywhaq
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
affects expression
|
ISO
|
Carbamazepine affects the expression of YWHAQ mRNA
|
CTD |
PMID:24752500 |
|
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:46,664,358...46,694,875
|
|
| G
|
Zbed5
|
zinc finger BED-type containing 5
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZBED5 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:32,443,687...32,449,817
Ensembl chr12:32,443,763...32,449,817
|
|
| G
|
Zbtb16
|
zinc finger and BTB domain containing 16
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZBTB16 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507
|
|
| G
|
Zc3h4
|
zinc finger CCCH-type containing 4
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZC3H4 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:86,234,457...86,271,963
Ensembl chr 1:86,234,457...86,271,963
|
|
| G
|
Zcchc14
|
zinc finger CCHC-type containing 14
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZCCHC14 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:66,582,800...66,627,136
Ensembl chr19:66,582,800...66,627,136
|
|
| G
|
Zcchc2
|
zinc finger CCHC-type containing 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZCCHC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr13:22,621,275...22,708,232
Ensembl chr13:22,634,171...22,708,464
|
|
| G
|
Zcchc7
|
zinc finger CCHC-type containing 7
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZCCHC7 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:63,787,292...63,968,960
Ensembl chr 5:63,788,217...63,968,549
|
|
| G
|
Zcchc8
|
zinc finger CCHC-type containing 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZCCHC8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr12:38,530,037...38,553,595
Ensembl chr12:38,530,164...38,553,595
|
|
| G
|
Zdhhc24
|
zinc finger, DHHC-type containing 24
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZDHHC24 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:211,605,163...211,612,267
Ensembl chr 1:211,605,185...211,612,277
|
|
| G
|
Zdhhc3
|
zinc finger DHHC-type palmitoyltransferase 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZDHHC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:131,602,663...131,650,998
Ensembl chr 8:131,602,663...131,650,998
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZEB2 mRNA
|
CTD |
PMID:22634333 |
|
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
| G
|
Zfp106
|
zinc finger protein 106
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF106 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:127,912,981...127,964,254
Ensembl chr 3:127,912,981...127,964,254
|
|
| G
|
Zfp217
|
zinc finger protein 217
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF217 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:179,309,178...179,349,853
Ensembl chr 3:179,310,973...179,321,892
|
|
| G
|
Zfp236
|
zinc finger protein 236
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF236 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr18:78,251,248...78,351,037
Ensembl chr18:78,251,248...78,347,236
|
|
| G
|
Zfp330
|
zinc finger protein 330
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF330 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr19:42,218,213...42,229,516
Ensembl chr19:42,205,549...42,229,516
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZFP36 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
| G
|
Zfp36l2
|
zinc finger protein 36, C3H type-like 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZFP36L2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:16,242,610...16,246,653
|
|
| G
|
Zfp385b
|
zinc finger protein 385B
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF385B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:82,762,387...83,140,856
Ensembl chr 3:82,762,387...83,084,615
|
|
| G
|
Zfp385c
|
zinc finger protein 385C
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF385C mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:86,062,329...86,118,454
Ensembl chr10:86,062,512...86,106,063
|
|
| G
|
Zfp395
|
zinc finger protein 395
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF395 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:43,757,350...43,797,513
Ensembl chr15:43,757,473...43,797,512
|
|
| G
|
Zfp410
|
zinc finger protein 410
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF410 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 6:109,695,223...109,721,369
Ensembl chr 6:109,695,185...109,722,569
|
|
| G
|
Zfp46
|
zinc finger protein 46
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF436 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:153,802,887...153,813,388
Ensembl chr 5:153,802,834...153,812,941
|
|
| G
|
Zfp62
|
zinc finger protein 62
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZFP62 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:34,019,367...34,040,564
Ensembl chr10:33,971,943...34,054,637
|
|
| G
|
Zfp653
|
zinc finger protein 653
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF653 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 8:28,862,618...28,881,439
Ensembl chr 8:28,862,618...28,881,070
|
|
| G
|
Zfr2
|
zinc finger RNA binding protein 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZFR2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:9,117,490...9,136,315
Ensembl chr 7:9,117,490...9,136,162
|
|
| G
|
Zic2
|
Zic family member 2
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZIC2 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr15:105,982,711...105,988,167
Ensembl chr15:105,983,342...105,988,167
|
|
| G
|
Zic3
|
Zic family member 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZIC3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr X:141,159,623...141,165,587
Ensembl chr X:141,149,594...141,170,464
|
|
| G
|
Zmat3
|
zinc finger, matrin type 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZMAT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294
|
|
| G
|
Zmynd8
|
zinc finger, MYND-type containing 8
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZMYND8 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 3:174,948,162...175,061,382
Ensembl chr 3:174,948,537...175,061,571
|
|
| G
|
Znf16l-ps1
|
Zinc finger protein 16 like, pseudogene 1
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF16 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:110,531,504...110,550,857
|
|
| G
|
Znf624l
|
zinc finger protein 624 like
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNF624 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 7:8,504,136...8,550,137
Ensembl chr 7:8,503,571...8,541,778
|
|
| G
|
Znhit3
|
zinc finger, HIT-type containing 3
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZNHIT3 mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr10:70,246,749...70,287,927
|
|
| G
|
Zyg11b
|
zyg-11 family member B, cell cycle regulator
|
affects expression
|
ISO
|
Carbamazepine affects the expression of ZYG11B mRNA
|
CTD |
PMID:25979313 |
|
NCBI chr 5:128,214,293...128,271,446
Ensembl chr 5:128,214,293...128,271,446
|
|
|
|
| G
|
A2ml1
|
alpha-2-macroglobulin-like 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of A2ML1 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 4:163,501,210...163,543,419
Ensembl chr 4:163,501,585...163,543,506
|
|
| G
|
Aacs
|
acetoacetyl-CoA synthetase
|
affects expression
|
EXP
|
Cocaine affects the expression of AACS mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543
|
|
| G
|
Aadac
|
arylacetamide deacetylase
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of AADAC mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:146,293,449...146,351,061
Ensembl chr 2:146,313,279...146,324,525
|
|
| G
|
Aanat
|
aralkylamine N-acetyltransferase
|
affects response to substance
|
ISO
|
AANAT protein affects the susceptibility to Cocaine
|
CTD |
PMID:12138020 |
|
NCBI chr10:102,323,647...102,330,639
Ensembl chr10:102,326,135...102,330,635
|
|
| G
|
Abat
|
4-aminobutyrate aminotransferase
|
increases response to substance
|
ISO
|
ABAT mRNA results in increased susceptibility to Cocaine
|
CTD |
PMID:10850552 |
|
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
|
|
| G
|
Abca4
|
ATP binding cassette subfamily A member 4
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ABCA4 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:212,849,470...212,986,730
Ensembl chr 2:212,755,803...212,986,729
|
|
| G
|
Abca5
|
ATP binding cassette subfamily A member 5
|
multiple interactions
|
ISO
|
HDAC5 affects the reaction [Cocaine affects the expression of ABCA5 mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr10:95,739,610...95,808,633
Ensembl chr10:95,739,610...95,808,424
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
affects expression
|
EXP
|
Cocaine affects the expression of ABCC3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc5
|
ATP binding cassette subfamily C member 5
|
affects expression
|
EXP
|
Cocaine affects the expression of ABCC5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655
|
|
| G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
affects expression
|
EXP
|
Cocaine affects the expression of ABCC9 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
|
|
| G
|
Abcd4
|
ATP binding cassette subfamily D member 4
|
affects expression
|
EXP
|
Cocaine affects the expression of ABCD4 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:109,977,541...109,992,050
Ensembl chr 6:109,977,550...109,991,983
|
|
| G
|
Abhd1
|
abhydrolase domain containing 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ABHD1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464
|
|
| G
|
Abhd14a
|
abhydrolase domain containing 14A
|
affects expression
|
EXP
|
Cocaine affects the expression of ABHD14A mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697
|
|
| G
|
Abhd17a
|
abhydrolase domain containing 17A, depalmitoylase
|
affects expression
|
EXP
|
Cocaine affects the expression of ABHD17A mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:9,775,016...9,781,447
|
|
| G
|
Abl1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
affects expression
|
ISO
|
Cocaine affects the expression of ABL1 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846
|
|
| G
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B
|
increases expression
|
ISO
|
Cocaine results in increased expression of ACAA1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 8:127,750,771...127,759,589
Ensembl chr 8:127,750,743...127,759,569
|
|
| G
|
Acan
|
aggrecan
|
affects expression
|
EXP
|
Cocaine affects the expression of ACAN mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
multiple interactions
|
ISO
|
ACE inhibits the reaction [Cocaine affects the abundance of Dinoprostone]; ACE inhibits the reaction [Cocaine affects the abundance of Epoprostenol]
|
CTD |
PMID:14738173 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
affects expression
|
ISO
|
Cocaine affects the expression of ACIN1 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Ackr2
|
atypical chemokine receptor 2
|
affects expression
|
EXP
|
Cocaine affects the expression of ACKR2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:130,438,703...130,451,106
Ensembl chr 8:130,384,559...130,464,393
|
|
| G
|
Aco2
|
aconitase 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of ACO2 protein modified form
|
CTD |
PMID:24096156 |
|
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
|
|
| G
|
Acod1
|
aconitate decarboxylase 1
|
|
EXP
|
[cocaine cotreated with recombinant HIV Tat protein] increases expression of Acod1 mRNA in primary motor cortex neuronal cultures
|
RGD |
PMID:38884890 |
RGD:596948411 |
NCBI chr15:86,286,531...86,295,803
Ensembl chr15:86,286,579...86,295,687
|
|
| G
|
Acsl5
|
acyl-CoA synthetase long-chain family member 5
|
affects expression
|
EXP
|
Cocaine affects the expression of ACSL5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
|
|
| G
|
Acss1
|
acyl-CoA synthetase short-chain family member 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ACSS1 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ACTG2 mRNA
|
CTD |
PMID:20948987 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Actn2
|
actinin alpha 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of ACTN2 mRNA
|
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552
|
|
| G
|
Acvr1c
|
activin A receptor type 1C
|
increases expression
|
EXP
|
Cocaine results in increased expression of ACVR1C mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:63,227,559...63,301,205
|
|
| G
|
Acy3
|
aminoacylase 3
|
affects expression
|
EXP
|
Cocaine affects the expression of ACY3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:210,709,238...210,715,258
Ensembl chr 1:210,709,294...210,715,633
|
|
| G
|
Adam19
|
ADAM metallopeptidase domain 19
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ADAM19 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455
|
|
| G
|
Adam1a
|
ADAM metallopeptidase domain 1a
|
multiple interactions
|
ISO
|
HDAC5 affects the reaction [Cocaine affects the expression of ADAM1A mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr12:40,674,460...40,680,988
Ensembl chr12:40,676,918...40,684,619
|
|
| G
|
Adamts19
|
ADAM metallopeptidase with thrombospondin type 1 motif, 19
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ADAMTS19 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr18:54,545,357...54,729,184
Ensembl chr18:54,545,357...54,729,181
|
|
| G
|
Adat2
|
adenosine deaminase, tRNA-specific 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ADAT2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:9,774,680...9,795,376
Ensembl chr 1:9,774,680...9,795,376
|
|
| G
|
Adcy2
|
adenylate cyclase 2
|
affects expression
|
EXP
|
Cocaine affects the expression of ADCY2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
|
|
| G
|
Adcy8
|
adenylate cyclase 8
|
affects expression
|
EXP
|
Cocaine affects the expression of ADCY8 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038
|
|
| G
|
Adcyap1
|
adenylate cyclase activating polypeptide 1
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of ADCYAP1 mRNA ADCYAP1 protein modified form affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; ADCYAP1 protein modified form affects the reaction [Cocaine results in increased expression of BAX protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]
|
CTD |
PMID:29673861 |
|
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383
|
|
| G
|
Adcyap1r1
|
ADCYAP receptor type I
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of ADCYAP1R1 mRNA alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]
|
CTD |
PMID:29673861 |
|
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973
|
|
| G
|
Adgra1
|
adhesion G protein-coupled receptor A1
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in increased expression of ADGRA1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869
|
|
| G
|
Adgre1
|
adhesion G protein-coupled receptor E1
|
affects expression
|
EXP
|
Cocaine affects the expression of ADGRE1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959
|
|
| G
|
Adgrf1
|
adhesion G protein-coupled receptor F1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ADGRF1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 9:25,158,198...25,210,744
Ensembl chr 9:25,147,588...25,208,916
|
|
| G
|
Adgrl1
|
adhesion G protein-coupled receptor L1
|
affects expression
|
EXP
|
Cocaine affects the expression of ADGRL1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr19:41,107,162...41,148,752
Ensembl chr19:41,109,117...41,148,896
|
|
| G
|
Adgrl3
|
adhesion G protein-coupled receptor L3
|
affects expression
|
EXP
|
Cocaine affects the expression of ADGRL3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,722,194...27,280,418
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
affects expression affects response to substance
|
EXP ISO
|
Cocaine affects the expression of ADORA1 mRNA; Cocaine affects the expression of ADORA1 protein ADORA1 affects the susceptibility to Cocaine
|
CTD |
PMID:12358776 PMID:19092996 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
increases response to substance increases expression
|
ISO
|
ADORA2A results in increased susceptibility to Cocaine Cocaine deficiency results in increased expression of ADORA2A mRNA
|
CTD |
PMID:16123743 PMID:27126842 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
affects expression
|
EXP
|
Cocaine affects the expression of ADORA2B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adra1b
|
adrenoceptor alpha 1B
|
increases response to substance
|
ISO
|
ADRA1B gene results in increased susceptibility to Cocaine
|
CTD |
PMID:14556232 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
multiple interactions affects expression
|
EXP
|
Betaxolol affects the reaction [Cocaine affects the expression of ADRB1 protein]; Betaxolol inhibits the reaction [Cocaine affects the expression of ADRB1 protein]
|
CTD |
PMID:17513029 PMID:18596687 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Aff4
|
ALF transcription elongation factor 4
|
increases expression
|
EXP
|
Cocaine results in increased expression of AFF4 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580
|
|
| G
|
Afmid
|
arylformamidase
|
increases expression
|
EXP
|
Cocaine results in increased expression of AFMID mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:103,544,822...103,560,408
Ensembl chr10:103,544,841...103,560,408
|
|
| G
|
Afp
|
alpha-fetoprotein
|
increases expression
|
EXP
|
Cocaine results in increased expression of AFP mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
| G
|
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
affects expression
|
EXP
|
Cocaine affects the expression of AGAP2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:64,782,618...64,799,624
Ensembl chr 7:64,782,612...64,799,640
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
multiple interactions affects response to substance
|
ISO
|
AGO2 protein affects the reaction [Cocaine results in increased expression of MIR130A mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR136 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR137 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR138-1 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR148B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR154 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR181A1 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR186 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR301B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR324 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR337 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR369 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR376A mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR376C mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR380 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR384 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR467B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR488 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR500 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR544 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR665 mRNA] AGO2 protein affects the susceptibility to Cocaine
|
CTD |
PMID:20643829 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Aif1l
|
allograft inflammatory factor 1-like
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of AIF1L mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
affects expression increases expression
|
ISO
|
Cocaine affects the expression of AIFM1 mRNA Cocaine results in increased expression of AIFM1 mRNA
|
CTD |
PMID:15681117 PMID:18000554 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aifm2
|
AIF family member 2
|
affects expression
|
ISO
|
Cocaine affects the expression of AIFM2 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957
|
|
| G
|
Ak1
|
adenylate kinase 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of AK1 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak3
|
adenylate kinase 3
|
affects expression
|
EXP
|
Cocaine affects the expression of AK3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
|
|
| G
|
Akr1d1
|
aldo-keto reductase family 1, member D1
|
affects expression
|
EXP
|
Cocaine affects the expression of AKR1D1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
|
|
| G
|
Akr1e2
|
aldo-keto reductase family 1, member E2
|
affects expression
|
EXP
|
Cocaine affects the expression of AKR1E1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:70,645,835...70,660,366
Ensembl chr17:70,645,869...70,660,360
|
|
| G
|
Akr7a3
|
aldo-keto reductase family 7 member A3
|
affects expression
|
EXP
|
Cocaine affects the expression of AKR7A3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
affects expression multiple interactions increases phosphorylation
|
EXP ISO
|
Cocaine affects the expression of AKT1 mRNA [Cocaine co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased phosphorylation of AKT1 protein Cocaine results in increased phosphorylation of AKT1 protein Cocaine affects the reaction [ILK protein affects the phosphorylation of AKT1 protein]
|
CTD |
PMID:18702665 PMID:20187946 PMID:25933444 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
increases expression
|
EXP
|
Cocaine results in increased expression of ALCAM mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
multiple interactions
|
EXP
|
[[CVT-10216 results in decreased activity of ALDH2 protein] which results in increased abundance of Tetrahydropapaveroline] inhibits the reaction [Cocaine results in increased abundance of and results in increased secretion of Dopamine]; [ALDH2 protein affects the abundance of Tetrahydropapaveroline] which affects the susceptibility to Cocaine; ALDH2 protein affects the reaction [Cocaine results in increased abundance of Dopamine]
|
CTD |
PMID:20729865 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Ambra1
|
autophagy and beclin 1 regulator 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of AMBRA1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:98,156,626...98,345,876
Ensembl chr 3:98,156,652...98,345,872
|
|
| G
|
Amh
|
anti-Mullerian hormone
|
increases expression
|
EXP
|
Cocaine results in increased expression of AMH mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867
|
|
| G
|
Amigo1
|
adhesion molecule with Ig like domain 1
|
affects expression
|
EXP
|
Cocaine affects the expression of AMIGO1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 2:198,511,285...198,516,744
Ensembl chr 2:198,511,039...198,521,146
|
|
| G
|
Amigo3
|
adhesion molecule with Ig like domain 3
|
affects expression
|
EXP
|
Cocaine affects the expression of AMIGO3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:117,620,499...117,622,025
Ensembl chr 8:117,616,629...117,626,577
|
|
| G
|
Amn1
|
antagonist of mitotic exit network 1 homolog
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of AMN1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 4:183,886,469...183,913,411
Ensembl chr 4:183,886,474...183,913,411
|
|
| G
|
Ankrd54
|
ankyrin repeat domain 54
|
affects expression
|
EXP
|
Cocaine affects the expression of ANKRD54 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:112,495,396...112,508,186
Ensembl chr 7:112,495,462...112,508,128
|
|
| G
|
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ANKS1B mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:26,201,240...27,364,943
|
|
| G
|
Anxa7
|
annexin A7
|
affects expression
|
EXP
|
Cocaine affects the expression of ANXA7 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891
|
|
| G
|
Ap1ar
|
adaptor-related protein complex 1 associated regulatory protein
|
increases expression
|
EXP
|
Cocaine results in increased expression of AP1AR mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:218,951,104...218,983,495
Ensembl chr 2:218,927,373...218,983,752
|
|
| G
|
Ap2b1
|
adaptor related protein complex 2 subunit beta 1
|
affects expression
|
EXP
|
Cocaine affects the expression of AP2B1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539
|
|
| G
|
Ap2m1
|
adaptor related protein complex 2 subunit mu 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of AP2M1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480
|
|
| G
|
Ap2s1
|
adaptor related protein complex 2 subunit sigma 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of AP2S1 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:86,545,350...86,557,009
|
|
| G
|
Ap5m1
|
adaptor related protein complex 5 subunit mu 1
|
affects expression
|
EXP
|
Cocaine affects the expression of AP5M1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr15:24,835,122...24,864,854
Ensembl chr15:24,835,100...24,862,606
|
|
| G
|
Apcs
|
amyloid P component, serum
|
increases expression
|
ISO
|
Cocaine results in increased expression of APCS protein
|
CTD |
PMID:12714198 |
|
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824
|
|
| G
|
Aph1a
|
aph-1 homolog A, gamma secretase subunit
|
affects expression
|
EXP
|
Cocaine affects the expression of APH1A mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 2:186,123,023...186,130,886
Ensembl chr 2:186,127,323...186,132,045
|
|
| G
|
Aplnr
|
apelin receptor
|
increases expression
|
EXP
|
Cocaine results in increased expression of APLNR mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908
|
|
| G
|
Apol11a
|
apolipoprotein L11a
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of APOL11A mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 7:111,118,668...111,142,866
|
|
| G
|
Apol2
|
apolipoprotein L2
|
increases expression
|
ISO
|
Cocaine results in increased expression of APOL2 mRNA
|
CTD |
PMID:17205118 |
|
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223
|
|
| G
|
Apold1
|
apolipoprotein L domain containing 1
|
affects expression
|
EXP
|
Cocaine affects the expression of APOLD1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176
|
|
| G
|
Apoo
|
apolipoprotein O
|
increases expression
|
EXP
|
Cocaine results in increased expression of APOO protein
|
CTD |
PMID:25100957 |
|
NCBI chr X:63,151,736...63,256,696
Ensembl chr X:63,151,814...63,256,690
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases expression increases expression
|
EXP ISO
|
Cocaine results in decreased expression of APP mRNA Cocaine results in increased expression of APP mRNA
|
CTD |
PMID:15009677 PMID:16710320 PMID:17898221 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Appl1
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of APPL1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,125,234...2,173,421
|
|
| G
|
Arc
|
activity-regulated cytoskeleton-associated protein
|
affects expression multiple interactions increases expression
|
EXP ISO
|
Cocaine affects the expression of ARC mRNA cocaine co treated with anisomycin decreases expression of Arc protein in dorsal striatum and shell of nucleus accumbens Cocaine increases expression of Arc protein in dorsal striatum and shell of nucleus accumbens Cocaine results in increased expression of ARC mRNA; Cocaine results in increased expression of ARC protein Reserpine inhibits the reaction [Cocaine results in increased expression of ARC mRNA]
|
CTD RGD |
PMID:7722525 PMID:12117546 PMID:15254092 PMID:17851536 PMID:18311559 PMID:18361437 PMID:20187946 PMID:24810662 PMID:27567310 PMID:27567310 More...
|
RGD:401901591, RGD:401901591 |
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220
|
|
| G
|
Arf4
|
ARF GTPase 4
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ARF4 protein
|
CTD |
PMID:25100957 |
|
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011
|
|
| G
|
Arhgap1
|
Rho GTPase activating protein 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of ARHGAP1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154
|
|
| G
|
Arhgap29
|
Rho GTPase activating protein 29
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ARHGAP29 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729
|
|
| G
|
Arhgap30
|
Rho GTPase activating protein 30
|
increases expression
|
EXP
|
Cocaine results in increased expression of ARHGAP30 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:86,354,448...86,376,552
Ensembl chr13:86,354,547...86,376,888
|
|
| G
|
Arhgap44
|
Rho GTPase activating protein 44
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ARHGAP44 protein
|
CTD |
PMID:25100957 |
|
NCBI chr10:50,154,724...50,322,027
Ensembl chr10:50,154,724...50,321,897
|
|
| G
|
Arhgap5
|
Rho GTPase activating protein 5
|
increases expression
|
EXP
|
Cocaine results in increased expression of ARHGAP5 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636
|
|
| G
|
Arhgap9
|
Rho GTPase activating protein 9
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ARHGAP9 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336
|
|
| G
|
Arhgef1
|
Rho guanine nucleotide exchange factor 1
|
affects expression
|
EXP
|
Cocaine affects the expression of ARHGEF1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:89,626,884...89,648,823
Ensembl chr 1:89,628,266...89,649,067
|
|
| G
|
Arhgef7
|
Rho guanine nucleotide exchange factor 7
|
affects expression
|
EXP
|
Cocaine affects the expression of ARHGEF7 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr16:84,373,123...84,484,759
Ensembl chr16:84,373,123...84,484,597
|
|
| G
|
Armcx6
|
armadillo repeat containing, X-linked 6
|
affects expression
|
EXP
|
Cocaine affects the expression of ARMCX6 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr X:102,222,288...102,229,871
Ensembl chr X:102,222,220...102,240,052
|
|
| G
|
Arpc1a
|
actin related protein 2/3 complex, subunit 1A
|
increases expression
|
EXP
|
Cocaine results in increased expression of ARPC1A protein
|
CTD |
PMID:25100957 |
|
NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052
|
|
| G
|
Arpp19
|
cAMP-regulated phosphoprotein 19
|
multiple interactions
|
EXP
|
Cocaine inhibits the reaction [SK&F 81297 results in increased phosphorylation of ARPP19 protein]
|
CTD |
PMID:11268215 |
|
NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385 Ensembl chr 8:119,691,942...119,692,385
|
|
| G
|
Arpp21
|
cAMP regulated phosphoprotein 21
|
multiple interactions increases expression
|
EXP ISO
|
Cocaine inhibits the reaction [SK&F 81297 results in increased phosphorylation of ARPP21 protein] Cocaine deficiency results in increased expression of ARPP21 mRNA
|
CTD |
PMID:11268215 PMID:27126842 |
|
NCBI chr 8:120,912,964...121,077,586
Ensembl chr 8:120,912,970...121,031,357
|
|
| G
|
Art5
|
ADP-ribosyltransferase 5
|
increases expression
|
EXP
|
Cocaine results in increased expression of ART5 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306
|
|
| G
|
As3mt
|
arsenite methyltransferase
|
affects expression
|
EXP
|
Cocaine affects the expression of AS3MT mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
|
|
| G
|
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ASAP1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:97,675,354...97,982,523
Ensembl chr 7:97,675,354...97,982,024
|
|
| G
|
Atad1
|
ATPase family, AAA domain containing 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of ATAD1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822
|
|
| G
|
Atad5
|
ATPase family, AAA domain containing 5
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ATAD5 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376
|
|
| G
|
Ate1
|
arginyltransferase 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of ATE1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:194,391,843...194,511,348
|
|
| G
|
Atf3
|
activating transcription factor 3
|
increases expression decreases expression
|
EXP
|
Cocaine results in increased expression of ATF3 mRNA Cocaine results in decreased expression of ATF3 mRNA
|
CTD |
PMID:23644055 PMID:27899881 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
EXP
|
Cocaine results in increased expression of ATF4; Cocaine results in increased expression of ATF4 mRNA
|
CTD |
PMID:18593214 PMID:23644055 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf6
|
activating transcription factor 6
|
affects expression
|
EXP
|
Cocaine affects the expression of ATF6 mRNA
|
CTD |
PMID:23644055 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atf7
|
activating transcription factor 7
|
affects expression
|
ISO
|
Cocaine affects the expression of ATF7 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 7:135,537,351...135,649,188
Ensembl chr 7:135,542,111...135,599,899
|
|
| G
|
Atg2b
|
autophagy related 2B
|
affects expression
|
EXP
|
Cocaine affects the expression of ATG2B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109
|
|
| G
|
Atg4b
|
autophagy related 4B, cysteine peptidase
|
affects expression
|
EXP
|
Cocaine affects the expression of ATG4B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 9:101,729,772...101,761,456
Ensembl chr 9:101,726,782...101,761,622
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
multiple interactions increases expression
|
ISO
|
EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA]
|
CTD |
PMID:20056891 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atp10a
|
ATPase phospholipid transporting 10A (putative)
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ATP10A mRNA
|
CTD |
PMID:17898221 PMID:27899881 |
|
NCBI chr 1:118,692,456...118,866,117
Ensembl chr 1:118,692,478...118,866,114
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
affects expression
|
ISO
|
Cocaine affects the expression of ATP1A1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3
|
increases expression affects expression
|
EXP
|
Cocaine results in increased expression of ATP1A3 mRNA Cocaine affects the expression of ATP1A3 mRNA
|
CTD |
PMID:16076954 PMID:20187946 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
|
|
| G
|
Atp1b2
|
ATPase Na+/K+ transporting subunit beta 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of ATP1B2 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708
|
|
| G
|
Atp1b3
|
ATPase Na+/K+ transporting subunit beta 3
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of ATP1B3 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP1B3 mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304 Ensembl chr 8:65,253,361...65,254,304
|
|
| G
|
Atp5f1a
|
ATP synthase F1 subunit alpha
|
affects expression
|
ISO
|
Cocaine affects the expression of ATP5F1A protein
|
CTD |
PMID:19393250 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ATP5F1B protein
|
CTD |
PMID:17075605 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Atp5f1e
|
ATP synthase F1 subunit epsilon
|
affects expression
|
EXP
|
Cocaine affects the expression of ATP5F1E mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214
|
|
| G
|
Atp5mc3
|
ATP synthase membrane subunit c locus 3
|
decreases expression affects expression
|
ISO EXP
|
Cocaine results in decreased expression of ATP5MC3 mRNA Cocaine affects the expression of ATP5MC3 mRNA
|
CTD |
PMID:12629581 PMID:20187946 |
|
NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:79,218,014...79,220,664
|
|
| G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
affects expression
|
EXP
|
Cocaine affects the expression of ATP5PB mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387
|
|
| G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
affects expression
|
EXP
|
Cocaine affects the expression of ATP5PD mRNA
|
CTD |
PMID:12358776 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
| G
|
Atp6v1d
|
ATPase H+ transporting V1 subunit D
|
affects expression
|
EXP
|
Cocaine affects the expression of ATP6V1D mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
|
|
| G
|
Atp8b2
|
ATPase phospholipid transporting 8B2
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of ATP8B2 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP8B2 mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575
|
|
| G
|
Atp9b
|
ATPase phospholipid transporting 9B (putative)
|
affects response to substance
|
ISO
|
ATP9B gene SNP affects the susceptibility to Cocaine
|
CTD |
PMID:18438686 |
|
NCBI chr18:76,451,821...76,643,931
Ensembl chr18:76,451,821...76,643,893
|
|
| G
|
Atpaf1
|
ATP synthase mitochondrial F1 complex assembly factor 1
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 5:134,503,164...134,530,323
Ensembl chr 5:134,499,687...134,530,321
|
|
| G
|
Atrx
|
ATRX, chromatin remodeler
|
increases expression
|
EXP
|
Cocaine results in increased expression of ATRX mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
|
|
| G
|
Atxn1
|
ataxin 1
|
affects expression
|
EXP
|
Cocaine affects the expression of ATXN1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:19,208,200...19,356,790
|
|
| G
|
Atxn3
|
ataxin 3
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ATXN3 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:126,839,327...126,872,781
|
|
| G
|
Avp
|
arginine vasopressin
|
increases expression
|
EXP
|
Cocaine increases expression of Avp mRNA in paraventricular nucleus of hypothalamus Cocaine increases expression of Avp protein in the nucleus accumbens
|
RGD |
PMID:21677651 PMID:19596360 |
RGD:408418732, RGD:408426004 |
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522
|
|
| G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of AZGP1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020
|
|
| G
|
Baalc
|
BAALC binder of MAP3K1 and KLF4
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of BAALC mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 7:71,803,640...71,877,608
Ensembl chr 7:71,774,898...71,879,261
|
|
| G
|
Bach1
|
BTB domain and CNC homolog 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of BACH1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277
|
|
| G
|
Bach2
|
BTB domain and CNC homolog 2
|
affects expression
|
ISO
|
Cocaine affects the expression of BACH2 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
affects expression
|
ISO
|
Cocaine affects the expression of BAD mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
affects expression
|
ISO
|
Cocaine affects the expression of BAG1 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
affects expression increases expression
|
ISO EXP
|
Cocaine affects the expression of BAG3 mRNA Cocaine results in increased expression of BAG3 mRNA
|
CTD |
PMID:15681117 PMID:27899881 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bambi
|
BMP and activin membrane-bound inhibitor
|
affects expression
|
EXP
|
Cocaine affects the expression of BAMBI mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247
|
|
| G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of BASP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions increases activity affects expression
|
ISO EXP
|
Cocaine results in increased expression of BAX mRNA ADCYAP1 protein modified form affects the reaction [Cocaine results in increased expression of BAX protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [Cocaine results in increased expression of BAX protein]; IL6 protein affects the reaction [Cocaine results in increased expression of BAX protein]; TNF protein affects the reaction [Cocaine results in increased expression of BAX protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of BAX protein]] Cocaine results in increased activity of BAX protein Cocaine affects the expression of BAX mRNA
|
CTD |
PMID:11392460 PMID:15681117 PMID:15685203 PMID:17084983 PMID:17635674 PMID:18974856 PMID:20948987 PMID:29673861 PMID:30393195 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz1b
|
bromodomain adjacent to zinc finger domain, 1B
|
multiple interactions increases expression
|
ISO
|
[SMARCA5 protein co-treated with BAZ1B protein] results in increased susceptibility to Cocaine; Cocaine promotes the reaction [BAZ1B protein binds to SPHKAP gene]; Cocaine results in increased expression of and affects the activity of BAZ1B protein Cocaine results in increased expression of BAZ1B mRNA
|
CTD |
PMID:27053203 |
|
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511
|
|
| G
|
Baz2b
|
bromodomain adjacent to zinc finger domain, 2B
|
increases expression
|
EXP
|
Cocaine results in increased expression of BAZ2B mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781
|
|
| G
|
Bcap31
|
B-cell receptor-associated protein 31
|
affects expression
|
EXP
|
Cocaine affects the expression of BCAP31 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr X:156,548,911...156,581,002
Ensembl chr X:156,548,911...156,579,371
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
affects expression
|
EXP
|
Cocaine affects the expression of BCAT1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bche
|
butyrylcholinesterase
|
affects metabolic processing multiple interactions increases hydrolysis increases metabolic processing decreases response to substance affects hydrolysis decreases metabolic processing affects degradation
|
ISO
|
BCHE protein affects the metabolism of Cocaine [BCHE protein mutant form results in increased metabolism of Cocaine] which results in increased chemical synthesis of Benzoic Acid; [BCHE protein mutant form results in increased metabolism of Cocaine] which results in increased chemical synthesis of ecgonine methyl ester [BCHE protein mutant form results in increased hydrolysis of Cocaine] which results in increased abundance of Benzoic Acid; [BCHE protein mutant form results in increased hydrolysis of Cocaine] which results in increased abundance of ecgonine methyl ester BCHE protein mutant form results in increased metabolism of Cocaine; BCHE protein results in increased metabolism of Cocaine BCHE protein mutant form results in decreased susceptibility to Cocaine BCHE protein modified form results in increased hydrolysis of Cocaine; BCHE protein mutant form results in increased hydrolysis of Cocaine BCHE protein affects the hydrolysis of Cocaine BCHE protein mutant form results in decreased metabolism of Cocaine BCHE protein mutant form affects the degradation of Cocaine
|
CTD |
PMID:572161 PMID:16275916 PMID:17989928 PMID:18514178 PMID:18514640 PMID:19067679 PMID:20060817 PMID:20219449 PMID:20971807 PMID:22917637 PMID:22960160 PMID:24582612 PMID:25814464 PMID:27154495 PMID:30080993 More...
|
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl11b
|
BCL11 transcription factor B
|
increases expression
|
ISO
|
Cocaine deficiency results in increased expression of BCL11B mRNA
|
CTD |
PMID:27126842 |
|
NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
affects expression multiple interactions decreases expression increases phosphorylation increases expression
|
ISO EXP
|
Cocaine affects the expression of BCL2 mRNA IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; PRKCD protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; rottlerin inhibits the reaction [Cocaine results in decreased expression of BCL2 protein]; TNF protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]] Cocaine results in increased phosphorylation of BCL2 protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] Cocaine results in decreased expression of BCL2 mRNA; Cocaine results in decreased expression of BCL2 protein Cocaine results in increased expression of BCL2 protein
|
CTD |
PMID:11392460 PMID:15365088 PMID:15681117 PMID:15685203 PMID:17084983 PMID:18974856 PMID:19183502 PMID:19879923 PMID:29673861 PMID:30393195 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Cocaine results in increased expression of BCL2L1 mRNA; Cocaine results in increased expression of BCL2L1 mRNA alternative form Cocaine results in decreased expression of BCL2L1 protein IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; PRKCD protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; rottlerin inhibits the reaction [Cocaine results in decreased expression of BCL2L1 protein]; TNF protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]]
|
CTD |
PMID:16076954 PMID:29673861 PMID:30393195 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
increases expression
|
EXP
|
Cocaine results in increased expression of BCL2L11 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
decreases response to substance increases expression decreases activity affects expression multiple interactions decreases expression increases response to substance
|
ISO EXP
|
BDNF mRNA results in decreased susceptibility to Cocaine; BDNF protein results in decreased susceptibility to Cocaine Cocaine results in increased expression of BDNF mRNA Cocaine results in decreased activity of BDNF protein Cocaine results in increased expression of BDNF protein Cocaine affects the expression of BDNF exon; Cocaine affects the expression of BDNF mRNA; Cocaine affects the expression of BDNF protein BDNF protein inhibits the reaction [Cocaine results in increased abundance of Amino Acids, Peptides, and Proteins]; Cocaine affects the activity of and affects the expression of BDNF protein; Cocaine affects the reaction [CREB1 modified form binds to BDNF promoter]; Cocaine affects the reaction [MECP2 protein affects the expression of BDNF protein]; Cocaine affects the reaction [MECP2 protein binds to and results in decreased activity of BDNF promoter]; Cocaine affects the reaction [MIR212 protein affects the expression of BDNF protein] BDNF mRNA results in decreased susceptibility to Cocaine; BDNF protein results in decreased susceptibility to Cocaine; BDNF results in decreased susceptibility to Cocaine (+)-JQ1 compound inhibits the reaction [Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]]; (+)-JQ1 compound inhibits the reaction [Cocaine results in increased expression of BDNF mRNA]; Cocaine inhibits the reaction [CREB1 protein binds to BDNF promoter]; Cocaine inhibits the reaction [MECP2 protein binds to BDNF promoter]; Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of BDNF mRNA]; Haloperidol inhibits the reaction [Cocaine results in decreased expression of BDNF protein] Cocaine results in decreased expression of BDNF mRNA; Cocaine results in decreased expression of BDNF protein BDNF results in increased susceptibility to Cocaine
|
CTD |
PMID:12099907 PMID:14973246 PMID:16423334 PMID:17194538 PMID:17618281 PMID:18311559 PMID:18355967 PMID:19321768 PMID:20554863 PMID:20711185 PMID:20810894 PMID:20826313 PMID:24358339 PMID:26558777 More...
|
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Begain
|
brain-enriched guanylate kinase-associated
|
affects expression
|
EXP
|
Cocaine affects the expression of BEGAIN mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:133,708,010...133,744,264
Ensembl chr 6:133,708,007...133,744,526
|
|
| G
|
Bhlhe22
|
basic helix-loop-helix family, member e22
|
increases expression
|
EXP
|
Cocaine results in increased expression of BHLHE22 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:102,402,622...102,405,732
Ensembl chr 2:102,400,164...102,420,508
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
affects expression
|
EXP
|
Cocaine affects the expression of BHLHE40 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
affects expression
|
ISO
|
Cocaine affects the expression of BID mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bik
|
BCL2-interacting killer
|
affects expression
|
ISO
|
Cocaine affects the expression of BIK mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
|
|
| G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of BMAL1 mRNA
|
CTD |
PMID:15994025 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
| G
|
Bmp2k
|
BMP-2 inducible kinase
|
affects expression
|
EXP
|
Cocaine affects the expression of BMP2K mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657
|
|
| G
|
Bmpr2
|
bone morphogenetic protein receptor type 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of BMPR2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350
|
|
| G
|
Bnip2
|
BCL2 interacting protein 2
|
affects expression
|
ISO
|
Cocaine affects the expression of BNIP2 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
affects expression
|
ISO
|
Cocaine affects the expression of BNIP3 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
affects expression
|
ISO
|
Cocaine affects the expression of BNIP3L mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Brd4
|
bromodomain containing 4
|
multiple interactions increases expression
|
ISO EXP
|
(+)-JQ1 compound inhibits the reaction [Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]]; Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter] Cocaine results in increased expression of BRD4 protein
|
CTD |
PMID:26558777 |
|
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
|
|
| G
|
Bscl2
|
BSCL2 lipid droplet biogenesis associated, seipin
|
affects expression
|
EXP
|
Cocaine affects the expression of BSCL2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536
|
|
| G
|
Bst1
|
bone marrow stromal cell antigen 1
|
affects expression
|
EXP
|
Cocaine affects the expression of BST1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647
|
|
| G
|
Btbd9
|
BTB domain containing 9
|
increases expression
|
EXP
|
Cocaine results in increased expression of BTBD9 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr20:8,287,813...8,645,437
Ensembl chr20:8,290,456...8,641,292
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
affects expression
|
EXP
|
Cocaine affects the expression of BTG2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
Btk
|
Bruton tyrosine kinase
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of BTK mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143
|
|
| G
|
C1qbp
|
complement C1q binding protein
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of C1QBP protein
|
CTD |
PMID:25100957 |
|
NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235
|
|
| G
|
C1qtnf1
|
C1q and TNF related 1
|
affects expression
|
EXP
|
Cocaine affects the expression of C1QTNF1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:104,159,021...104,180,253
Ensembl chr10:104,158,886...104,180,251
|
|
| G
|
C1qtnf4
|
C1q and TNF related 4
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of C1QTNF4 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587
|
|
| G
|
C2cd3
|
C2 domain containing 3 centriole elongation regulator
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of C2CD3 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:164,127,304...164,225,088
Ensembl chr 1:164,127,281...164,225,086
|
|
| G
|
C2cd4d
|
C2 calcium-dependent domain containing 4D
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of C2CD4D mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:184,688,815...184,690,978
Ensembl chr 2:184,677,258...184,691,381
|
|
| G
|
C3h11orf96
|
similar to human chromosome 11 open reading frame 96
|
increases expression
|
EXP
|
Cocaine results in increased expression of C3H11ORF96 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 3:100,375,474...100,376,717
Ensembl chr 3:100,351,199...100,378,346
|
|
| G
|
Ca4
|
carbonic anhydrase 4
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CAR4 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916
|
|
| G
|
Cab39l
|
calcium binding protein 39-like
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CAB39L mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742
|
|
| G
|
Cacna1d
|
calcium voltage-gated channel subunit alpha1 D
|
affects response to substance
|
ISO
|
CACNA1D polymorphism affects the susceptibility to Cocaine
|
CTD |
PMID:28194001 |
|
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
|
|
| G
|
Cacnb3
|
calcium voltage-gated channel auxiliary subunit beta 3
|
affects expression
|
EXP
|
Cocaine affects the expression of CACNB3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085
|
|
| G
|
Cald1
|
caldesmon 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CALD1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
| G
|
Calm1
|
calmodulin 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CALM1 mRNA
|
CTD |
PMID:17205118 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Calm2
|
calmodulin 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CALM2 mRNA
|
CTD |
PMID:17205118 |
|
NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657 Ensembl chr 6:64,519,554...64,520,657
|
|
| G
|
Calr
|
calreticulin
|
decreases expression multiple interactions affects expression
|
ISO EXP
|
Cocaine results in decreased expression of CALR mRNA FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of CALR mRNA] Cocaine affects the expression of CALR mRNA
|
CTD |
PMID:18355967 PMID:20187946 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Caly
|
calcyon neuron-specific vesicular protein
|
increases expression
|
EXP
|
Cocaine results in increased expression of CALY mRNA
|
CTD |
PMID:20171207 |
|
NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196
|
|
| G
|
Camk1g
|
calcium/calmodulin-dependent protein kinase IG
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CAMK1G mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr13:107,406,583...107,430,332
Ensembl chr13:107,406,584...107,430,230
|
|
| G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
affects response to substance multiple interactions increases expression
|
ISO EXP
|
CAMK2A affects the susceptibility to Cocaine Cocaine results in increased expression of and results in increased phosphorylation of CAMK2A protein; Nifedipine inhibits the reaction [Cocaine results in increased expression of and results in increased phosphorylation of CAMK2A protein] Cocaine results in increased expression of CAMK2A protein 7-chlorokynurenic acid inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]; Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]; Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein; KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]]; Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]
|
CTD |
PMID:14725635 PMID:17609678 PMID:19217379 PMID:28194001 |
|
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
decreases expression affects expression
|
ISO EXP
|
Cocaine results in decreased expression of CAMK2B mRNA Cocaine affects the expression of CAMK2B mRNA
|
CTD |
PMID:17205118 PMID:20187946 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camk4
|
calcium/calmodulin-dependent protein kinase IV
|
increases response to substance decreases response to substance
|
ISO
|
CAMK4 promoter SNP results in increased susceptibility to Cocaine CAMK4 protein results in decreased susceptibility to Cocaine
|
CTD |
PMID:19001277 |
|
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193
|
|
| G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
affects expression
|
EXP
|
Cocaine affects the expression of CAP2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563
|
|
| G
|
Capzb
|
capping actin protein of muscle Z-line subunit beta
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CAPZB mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619
|
|
| G
|
Card11
|
caspase recruitment domain family, member 11
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CARD11 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr12:18,735,088...18,872,045
Ensembl chr12:18,735,088...18,872,045
|
|
| G
|
Carm1
|
coactivator-associated arginine methyltransferase 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CARM1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:28,373,362...28,418,056
|
|
| G
|
Carnmt1
|
carnosine N-methyltransferase 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CARNMT1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:225,520,345...225,549,971
Ensembl chr 1:225,520,151...225,550,232
|
|
| G
|
Cartpt
|
CART prepropeptide
|
increases expression affects expression
|
ISO EXP
|
Cocaine results in increased expression of CARTPT mRNA Cocaine affects the expression of CARTPT mRNA
|
CTD |
PMID:15009677 PMID:17851536 PMID:20187946 |
|
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712
|
|
| G
|
Casp2
|
caspase 2
|
increases activity increases expression
|
EXP
|
Cocaine results in increased activity of CASP2 protein Cocaine results in increased expression of CASP2 mRNA
|
CTD |
PMID:16076954 PMID:16638611 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
| G
|
Casp3
|
caspase 3
|
increases expression increases cleavage multiple interactions increases activity affects expression
|
ISO EXP
|
Cocaine results in increased expression of CASP3 protein Cocaine results in increased cleavage of CASP3 protein ADCYAP1 protein modified form affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; GPX1 affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; IL6 protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; PRKCD protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; rottlerin inhibits the reaction [Cocaine results in increased cleavage of CASP3 protein]; TNF protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]] Cocaine results in increased activity of CASP3 protein Cocaine affects the expression of CASP3 protein [Heroin co-treated with Cocaine] results in increased activity of CASP3 protein; Cocaine results in increased cleavage of and results in increased activity of CASP3 protein; Heroin promotes the reaction [Cocaine results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP3 protein] Cocaine affects the expression of CASP3 mRNA
|
CTD |
PMID:10604926 PMID:11392460 PMID:12639677 PMID:14741756 PMID:15365088 PMID:15681117 PMID:16179556 PMID:16638611 PMID:16686379 PMID:17084983 PMID:17635674 PMID:18974856 PMID:19183502 PMID:20600547 PMID:29673861 PMID:30027653 PMID:30393195 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
affects expression decreases expression
|
ISO
|
Cocaine affects the expression of CASP4 mRNA Cocaine results in decreased expression of CASP4 mRNA
|
CTD |
PMID:12629581 PMID:15681117 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp8
|
caspase 8
|
affects expression increases activity
|
ISO EXP
|
Cocaine affects the expression of CASP8 mRNA Cocaine results in increased activity of CASP8 protein
|
CTD |
PMID:11392460 PMID:15681117 PMID:18974856 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
affects expression increases activity multiple interactions increases expression
|
ISO EXP
|
Cocaine affects the expression of CASP9 mRNA Cocaine results in increased activity of CASP9 protein SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] Cocaine affects the expression of CASP9 protein Cocaine results in increased expression of CASP9 protein
|
CTD |
PMID:10604926 PMID:11392460 PMID:12639677 PMID:15365088 PMID:15681117 PMID:16179556 PMID:16638611 PMID:16686379 PMID:17084983 PMID:17635674 PMID:18974856 More...
|
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Castor1
|
cytosolic arginine sensor for mTORC1 subunit 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CASTOR1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:83,309,710...83,314,123
Ensembl chr14:83,309,504...83,314,127
|
|
| G
|
Cat
|
catalase
|
decreases activity increases activity increases expression
|
ISO EXP
|
Cocaine results in decreased activity of CAT protein Cocaine results in increased activity of CAT protein Cocaine results in increased expression of CAT protein
|
CTD |
PMID:14576513 PMID:16085363 PMID:29475069 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Catsper2
|
cation channel, sperm associated 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of CATSPER2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:128,822,387...128,842,501
Ensembl chr 3:128,822,391...128,842,261
|
|
| G
|
Cbln1
|
cerebellin 1 precursor
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CBLN1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr19:35,782,151...35,785,960
Ensembl chr19:35,781,952...35,785,960
|
|
| G
|
Ccdc127
|
coiled-coil domain containing 127
|
increases expression
|
EXP
|
Cocaine results in increased expression of CCDC127 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:30,757,010...30,764,473
Ensembl chr 1:30,757,010...30,764,473
|
|
| G
|
Ccdc174
|
coiled-coil domain containing 174
|
affects expression
|
EXP
|
Cocaine affects the expression of CCDC174 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:125,949,203...125,976,179
Ensembl chr 4:125,949,420...125,976,178
|
|
| G
|
Ccdc73
|
coiled-coil domain containing 73
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CCDC73 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:111,737,771...111,879,588
Ensembl chr 3:111,737,730...111,880,105
|
|
| G
|
Ccdc88a
|
coiled coil domain containing 88A
|
increases expression
|
EXP
|
Cocaine results in increased expression of CCDC88A mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr14:107,304,654...107,456,104
Ensembl chr14:107,305,199...107,453,285
|
|
| G
|
Ccdc93
|
coiled-coil domain containing 93
|
increases expression
|
EXP
|
Cocaine results in increased expression of CCDC93 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:35,160,354...35,233,877
Ensembl chr13:35,160,363...35,233,875
|
|
| G
|
Cckbr
|
cholecystokinin B receptor
|
decreases expression increases response to substance
|
ISO
|
Cocaine results in decreased expression of CCKBR mRNA CCKBR protein results in increased susceptibility to Cocaine
|
CTD |
PMID:11403953 PMID:18000554 |
|
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases secretion increases expression multiple interactions
|
ISO EXP
|
Cocaine results in increased secretion of CCL2 protein Cocaine results in increased expression of CCL2 mRNA; Cocaine results in increased expression of CCL2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; AG 1879 inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; Cocaine promotes the reaction [RELA protein binds to CCL2 promoter]; methyl-beta-cyclodextrin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; pyrazolanthrone inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; RELA mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; SC 514 inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; SIGMAR1 mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; U 0126 inhibits the reaction [Cocaine results in increased expression of CCL2 protein]
|
CTD |
PMID:10065903 PMID:20354174 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
increases secretion
|
ISO
|
Cocaine results in increased secretion of CCL3 protein
|
CTD |
PMID:10065903 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CCN2 mRNA; Cocaine results in decreased expression of CCN2 protein
|
CTD |
PMID:18000554 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccn3
|
cellular communication network factor 3
|
increases expression
|
EXP
|
Cocaine results in increased expression of CCN3 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581
|
|
| G
|
Ccna2
|
cyclin A2
|
decreases expression
|
ISO EXP
|
Cocaine results in decreased expression of CCNA2 mRNA
|
CTD |
PMID:18593214 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnd1
|
cyclin D1
|
affects expression
|
EXP
|
Cocaine affects the expression of CCND1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd3
|
cyclin D3
|
affects expression
|
EXP
|
Cocaine affects the expression of CCND3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033
|
|
| G
|
Ccnl1
|
cyclin L1
|
increases expression
|
EXP
|
Cocaine results in increased expression of CCNL1 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
affects expression increases response to substance
|
EXP ISO
|
Cocaine affects the expression of CCR2 mRNA CCR2 results in increased susceptibility to Cocaine
|
CTD |
PMID:20187946 PMID:20354174 |
|
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
increases expression
|
ISO
|
Cocaine results in increased expression of CCR5 protein
|
CTD |
PMID:16204638 |
|
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Ccser1
|
coiled-coil serine-rich protein 1
|
affects response to substance
|
ISO
|
CCSER1 gene SNP affects the susceptibility to Cocaine
|
CTD |
PMID:18438686 |
|
NCBI chr 4:91,483,896...92,720,439
Ensembl chr 4:91,483,770...92,718,789
|
|
| G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
affects expression
|
EXP
|
Cocaine affects the expression of CCT2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
| G
|
Ccz1
|
CCZ1 homolog, vacuolar protein trafficking and biogenesis associated
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CCZ1 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr12:15,714,768...15,738,273
Ensembl chr12:15,714,748...15,738,268
|
|
| G
|
Cd180
|
CD180 molecule
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CD180 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:35,589,451...35,603,982
|
|
| G
|
Cd276
|
Cd276 molecule
|
affects expression
|
EXP
|
Cocaine affects the expression of CD276 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505
|
|
| G
|
Cd4
|
Cd4 molecule
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of CD4 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461
|
|
| G
|
Cd44
|
CD44 molecule
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CD44 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd47
|
Cd47 molecule
|
affects expression
|
EXP
|
Cocaine affects the expression of CD47 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
|
|
| G
|
Cd74
|
CD74 molecule
|
affects expression
|
EXP
|
Cocaine affects the expression of CD74 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
|
|
| G
|
Cd81
|
Cd81 molecule
|
increases response to substance increases expression affects response to substance
|
ISO EXP
|
CD81 protein results in increased susceptibility to Cocaine Cocaine results in increased expression of CD81 mRNA CD81 protein affects the susceptibility to Cocaine
|
CTD |
PMID:11178868 PMID:12113778 PMID:15715673 |
|
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
|
|
| G
|
Cd93
|
CD93 molecule
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CD93 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
|
|
| G
|
Cdc14b
|
cell division cycle 14B
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CDC14B mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164
|
|
| G
|
Cdc25a
|
cell division cycle 25A
|
increases expression
|
EXP
|
Cocaine results in increased expression of CDC25A mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
|
|
| G
|
Cdh1
|
cadherin 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CDH1 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh16
|
cadherin 16
|
affects expression
|
EXP
|
Cocaine affects the expression of CDH16 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934
|
|
| G
|
Cdh17
|
cadherin 17
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CDH17 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226
|
|
| G
|
Cdk18
|
cyclin-dependent kinase 18
|
affects expression
|
EXP
|
Cocaine affects the expression of CDK18 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr13:46,107,763...46,140,705
Ensembl chr13:46,108,911...46,140,865
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
affects expression
|
ISO
|
Cocaine affects the expression of CDK4 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
affects expression increases expression decreases expression
|
EXP
|
Cocaine affects the expression of CDK5 mRNA; Cocaine affects the expression of CDK5 protein Cocaine results in increased expression of CDK5 mRNA; Cocaine results in increased expression of CDK5 protein Cocaine results in decreased expression of CDK5 protein
|
CTD |
PMID:11268215 PMID:12787079 PMID:16263094 PMID:17339080 PMID:17680995 PMID:20187946 More...
|
|
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
CDK5R1 protein inhibits the reaction [Cocaine affects the expression of FOS mRNA]; CDK5R1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K2 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAPK1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAPK3 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein] Cocaine results in increased expression of CDK5R1 mRNA; Cocaine results in increased expression of CDK5R1 protein Cocaine results in decreased expression of CDK5R1 protein
|
CTD |
PMID:11268215 PMID:15665076 PMID:16263094 |
|
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
EXP
|
Cocaine results in increased expression of CDKN1A mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Ceacam9
|
CEA cell adhesion molecule 9
|
affects expression
|
EXP
|
Cocaine affects the expression of CEACAM3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:86,533,724...86,538,259
Ensembl chr 1:86,533,724...86,538,260
|
|
| G
|
Cel
|
carboxyl ester lipase
|
increases expression
|
EXP
|
Cocaine results in increased expression of CEL mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:32,281,518...32,289,019
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
multiple interactions increases hydrolysis affects binding
|
ISO
|
CES1 protein results in increased metabolism of [Cocaine co-treated with Ethanol]; Cocaine inhibits the reaction [CES1 protein results in increased chemical synthesis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-methylumbelliferyl acetate]; Cocaine inhibits the reaction [CES1 protein results in increased hydrolysis of Heroin] CES1 protein results in increased hydrolysis of Cocaine Cocaine binds to CES1 protein
|
CTD |
PMID:8930175 PMID:9311626 PMID:12679808 PMID:12773168 PMID:25445008 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Ces2h
|
carboxylesterase 2H
|
multiple interactions decreases expression increases hydrolysis
|
ISO
|
Cocaine inhibits the reaction [CES2 protein results in increased chemical synthesis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES2 protein results in increased chemical synthesis of Morphine]; Cocaine inhibits the reaction [CES2 protein results in increased hydrolysis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES2 protein results in increased hydrolysis of Heroin] Cocaine results in decreased expression of CES2 mRNA CES2 protein results in increased hydrolysis of Cocaine
|
CTD |
PMID:8930175 PMID:9169443 PMID:12629581 |
|
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752
|
|
| G
|
Cfh
|
complement factor H
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CFH mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
affects expression
|
ISO
|
Cocaine affects the expression of CFLAR mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
increases expression
|
ISO
|
Cocaine results in increased expression of CHAT protein
|
CTD |
PMID:35597300 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Chfr
|
checkpoint with forkhead and ring finger domains
|
affects expression
|
EXP
|
Cocaine affects the expression of CHFR mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:52,164,214...52,197,860
Ensembl chr12:52,164,217...52,197,703
|
|
| G
|
Chn1
|
chimerin 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CHN1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:78,917,329...79,084,040
Ensembl chr 3:78,917,329...79,084,197
|
|
| G
|
Chrm1
|
cholinergic receptor, muscarinic 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of CHRM1 protein
|
CTD |
PMID:35597300 |
|
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
|
|
| G
|
Chrm3
|
cholinergic receptor, muscarinic 3
|
increases expression
|
ISO
|
Cocaine results in increased expression of CHRM3 protein
|
CTD |
PMID:35597300 |
|
NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304
|
|
| G
|
Chrm4
|
cholinergic receptor, muscarinic 4
|
affects expression
|
EXP
|
Cocaine affects the expression of CHRM4 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771
|
|
| G
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
decreases response to substance increases expression
|
EXP ISO
|
CHRM5 mutant form results in decreased susceptibility to Cocaine Cocaine results in increased expression of CHRM5 protein
|
CTD |
PMID:20393457 PMID:35597300 |
|
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:119,735,975...119,792,166
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
multiple interactions
|
EXP
|
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]
|
CTD |
PMID:10336510 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]
|
CTD |
PMID:10336510 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna5
|
cholinergic receptor nicotinic alpha 5 subunit
|
decreases response to substance
|
ISO
|
CHRNA5 gene polymorphism results in decreased susceptibility to Cocaine
|
CTD |
PMID:18519132 |
|
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:64,265,879...64,294,233
|
|
| G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
multiple interactions increases response to substance
|
EXP ISO
|
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] CHRNB2 protein results in increased susceptibility to Cocaine
|
CTD |
PMID:10336510 PMID:11282258 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
increases expression
|
EXP
|
Cocaine results in increased expression of CHRNE mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chtf8
|
chromosome transmission fidelity factor 8
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CHTF8 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr19:51,691,776...51,702,076
Ensembl chr19:51,678,543...51,707,144
|
|
| G
|
Churc1
|
churchill domain containing 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CHURC1 mRNA
|
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr 6:101,203,778...101,218,364
Ensembl chr 6:101,203,841...101,237,748
|
|
| G
|
Ciao1
|
cytosolic iron-sulfur assembly component 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CIAO1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:134,913,639...134,919,244
Ensembl chr 3:134,913,172...134,979,255
|
|
| G
|
Cidea
|
cell death-inducing DFFA-like effector a
|
affects expression
|
ISO
|
Cocaine affects the expression of CIDEA mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382
|
|
| G
|
Cideb
|
cell death-inducing DFFA-like effector b
|
affects expression
|
ISO
|
Cocaine affects the expression of CIDEB mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr15:33,222,135...33,226,407
Ensembl chr15:33,221,824...33,226,688
|
|
| G
|
Cisd1
|
CDGSH iron sulfur domain 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of CISD1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042
|
|
| G
|
Cisd2
|
CDGSH iron sulfur domain 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of CISD2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:226,502,517...226,527,325
Ensembl chr 2:226,502,517...226,540,080
|
|
| G
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CITED4 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361
|
|
| G
|
Ckb
|
creatine kinase B
|
multiple interactions
|
ISO
|
Cocaine results in increased secretion of [CKB protein binds to CKM protein]
|
CTD |
PMID:12359538 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
multiple interactions
|
ISO
|
Cocaine results in increased secretion of [CKB protein binds to CKM protein]
|
CTD |
PMID:12359538 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Ckmt1
|
creatine kinase, mitochondrial 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CKMT1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483
|
|
| G
|
Clcn7
|
chloride voltage-gated channel 7
|
affects expression
|
EXP
|
Cocaine affects the expression of CLCN7 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:14,656,261...14,681,632
Ensembl chr10:14,656,245...14,681,631
|
|
| G
|
Cldn11
|
claudin 11
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CLDN11 mRNA
|
CTD |
PMID:18357522 |
|
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539
|
|
| G
|
Clec4f
|
C-type lectin domain family 4, member F
|
affects expression
|
EXP
|
Cocaine affects the expression of CLEC4F mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438
|
|
| G
|
Clic1
|
chloride intracellular channel 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CLIC1 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367
|
|
| G
|
Clip1
|
CAP-GLY domain containing linker protein 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of CLIP1 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr12:38,571,533...38,678,779
Ensembl chr12:38,571,834...38,678,779
|
|
| G
|
Clk1
|
CDC-like kinase 1
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of CLK1 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CLK1 mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187
|
|
| G
|
Clk4
|
CDC-like kinase 4
|
increases expression
|
ISO
|
Cocaine results in increased expression of CLK4 mRNA
|
CTD |
PMID:20056891 |
|
NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372
|
|
| G
|
Clock
|
clock circadian regulator
|
increases expression
|
ISO
|
Cocaine results in increased expression of CLOCK mRNA
|
CTD |
PMID:15994025 |
|
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872
|
|
| G
|
Cltb
|
clathrin, light chain B
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CLTB mRNA
|
CTD |
PMID:12629581 PMID:15009677 |
|
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
|
|
| G
|
Clybl
|
citramalyl-CoA lyase
|
increases expression
|
EXP
|
Cocaine results in increased expression of CLYBL protein
|
CTD |
PMID:25100957 |
|
NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345
|
|
| G
|
Cnbd2
|
cyclic nucleotide binding domain containing 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of CNBD2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:165,279,157...165,357,582
Ensembl chr 3:165,279,204...165,361,688
|
|
| G
|
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of CNKSR2 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr X:40,722,843...40,971,730
Ensembl chr X:40,722,996...40,965,604
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
affects response to substance increases activity decreases response to substance multiple interactions
|
ISO
|
CNR1 gene polymorphism affects the susceptibility to Cocaine; CNR1 gene SNP affects the susceptibility to Cocaine; CNR1 polymorphism affects the susceptibility to Cocaine Cocaine results in increased activity of CNR1 protein CNR1 mutant form results in decreased susceptibility to Cocaine CNR1 gene mutant form inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased expression of FOS protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:9106242 PMID:16314880 PMID:17596442 PMID:19052543 PMID:20554863 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cnr2
|
cannabinoid receptor 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of CNR2 mRNA
|
CTD |
PMID:18286196 |
|
NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961
|
|
| G
|
Cobll1
|
cordon-bleu WH2 repeat protein-like 1
|
increases expression increases expression
|
ISO
|
Cocaine results in increased expression of COBLL1 mRNA cocaine increases expression of Colbl1 mRNA in nucleus accumbens
|
CTD RGD |
PMID:27506785 PMID:27506785 |
RGD:11561325 |
NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460
|
|
| G
|
Coil
|
coilin
|
affects expression
|
EXP
|
Cocaine affects the expression of COIL mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:74,286,279...74,307,597
Ensembl chr10:74,286,840...74,307,595
|
|
| G
|
Col15a1
|
collagen type XV alpha 1 chain
|
affects expression
|
EXP
|
Cocaine affects the expression of COL15A1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression
|
EXP
|
Cocaine results in increased expression of COL1A1 mRNA
|
CTD |
PMID:9455993 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
increases expression
|
EXP
|
Cocaine results in increased expression of COL3A1 mRNA
|
CTD |
PMID:9455993 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Coq6
|
coenzyme Q6 monooxygenase
|
affects expression
|
EXP
|
Cocaine affects the expression of COQ6 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310
|
|
| G
|
Coro7
|
coronin 7
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of CORO7 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr10:11,386,683...11,447,422
Ensembl chr10:11,391,613...11,447,866
|
|
| G
|
Cox20
|
cytochrome c oxidase assembly factor COX20
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of COX20 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:92,592,260...92,604,129
Ensembl chr14:6,872,315...6,872,638
|
|
| G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
affects expression
|
EXP
|
Cocaine affects the expression of COX5A mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
| G
|
Cox6a1
|
cytochrome c oxidase subunit 6A1
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of COX6A1 mRNA Cocaine results in increased expression of COX6A1 protein
|
CTD |
PMID:20187946 PMID:25100957 |
|
NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768
|
|
| G
|
Cox6c
|
cytochrome c oxidase subunit 6C
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of COX6C mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166
|
|
| G
|
Cox7b
|
cytochrome c oxidase subunit 7B
|
affects expression
|
EXP
|
Cocaine affects the expression of COX7B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr X:75,149,036...75,155,285
Ensembl chr X:75,148,996...75,155,284
|
|
| G
|
Cox8a
|
cytochrome c oxidase subunit 8A
|
affects expression
|
EXP
|
Cocaine affects the expression of COX8A mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623
|
|
| G
|
Cplx1
|
complexin 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CPLX1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:1,329,073...1,360,781
Ensembl chr14:1,329,032...1,360,769
|
|
| G
|
Cpne8
|
copine 8
|
increases expression
|
EXP
|
Cocaine results in increased expression of CPNE8 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
affects expression increases phosphorylation multiple interactions affects phosphorylation increases expression
|
EXP ISO
|
Cocaine affects the expression of CREB1 mRNA cocaine increases phosphorylation of Creb1 protein in nucleus accumbens Cocaine results in increased phosphorylation of CREB1 protein CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; Cocaine inhibits the reaction [CREB1 protein binds to BDNF promoter]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of CREB1 protein]; RPS6KA3 gene mutant form inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein] Cocaine affects the phosphorylation of CREB1 protein Betaxolol affects the reaction [Cocaine affects the phosphorylation of CREB1 protein]; Cocaine affects the reaction [CREB1 modified form binds to BDNF promoter]; Cocaine promotes the reaction [RPS6KA1 protein binds to CREB1 protein]; Cocaine results in increased phosphorylation of and results in increased activity of CREB1 protein; U 0126 inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]
|
CTD RGD |
PMID:12595601 PMID:15470197 PMID:15665076 PMID:16219028 PMID:16339038 PMID:16710312 PMID:18596687 PMID:20187946 PMID:20810894 PMID:24358339 PMID:27664298 More...
|
RGD:401900166 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crebbp
|
CREB binding protein
|
increases expression
|
EXP
|
Cocaine results in increased expression of CREBBP mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Crebrf
|
CREB3 regulatory factor
|
increases expression
|
EXP
|
Cocaine results in increased expression of CREBRF mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
affects expression increases expression
|
ISO EXP
|
Cocaine affects the expression of CREM mRNA Cocaine results in increased expression of CREM mRNA
|
CTD |
PMID:18355967 PMID:27899881 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Crh
|
corticotropin releasing hormone
|
multiple interactions affects expression
|
EXP
|
Betaxolol affects the reaction [Cocaine affects the expression of CRH mRNA]; Cocaine affects the reaction [CRH protein affects the secretion of Excitatory Amino Acid Agents]; SCH 23390 affects the reaction [Cocaine affects the expression of CRH mRNA] Cocaine affects the expression of CRH mRNA; Cocaine affects the expression of CRH protein
|
CTD |
PMID:7796157 PMID:11597771 PMID:12782395 PMID:15930388 PMID:18596687 |
|
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
|
|
| G
|
Crhbp
|
corticotropin releasing hormone binding protein
|
increases expression
|
EXP
|
Cocaine results in increased expression of CRHBP mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:28,427,139...28,439,446
Ensembl chr 2:28,427,139...28,439,446
|
|
| G
|
Crhr1
|
corticotropin releasing hormone receptor 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of CRHR1 protein
|
CTD |
PMID:17079348 |
|
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
|
|
| G
|
Crip2
|
cysteine-rich protein 2
|
affects expression
|
EXP
|
Cocaine affects the expression of CRIP2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120
|
|
| G
|
Crispld1
|
cysteine-rich secretory protein LCCL domain containing 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CRISPLD1 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:6,050,970...6,098,265
Ensembl chr 5:6,051,891...6,098,265
|
|
| G
|
Crp
|
C-reactive protein
|
increases expression
|
ISO
|
Cocaine results in increased expression of CRP protein
|
CTD |
PMID:11988210 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Crtac1
|
cartilage acidic protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CRTAC1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:251,040,963...251,182,920
Ensembl chr 1:251,028,143...251,182,689
|
|
| G
|
Crtc1
|
CREB regulated transcription coactivator 1
|
multiple interactions
|
EXP
|
[[Cocaine results in increased expression of MIR212 mRNA] which results in increased activity of RAF1 protein] which results in increased expression of CRTC1 protein
|
CTD |
PMID:20613834 |
|
NCBI chr16:19,022,171...19,080,880
Ensembl chr16:19,022,005...19,080,880
|
|
| G
|
Cry1
|
cryptochrome circadian regulator 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CRY1 mRNA
|
CTD |
PMID:15994025 |
|
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
|
|
| G
|
Cry2
|
cryptochrome circadian regulator 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CRY2 mRNA
|
CTD |
PMID:15994025 |
|
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447
|
|
| G
|
Cryab
|
crystallin, alpha B
|
decreases expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of CRYAB mRNA Cocaine results in increased expression of CRYAB mRNA
|
CTD |
PMID:15009677 PMID:27899881 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Crybb2
|
crystallin, beta B2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CRYBB2 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr12:49,230,192...49,240,116
Ensembl chr12:49,230,192...49,240,116
|
|
| G
|
Csad
|
cysteine sulfinic acid decarboxylase
|
affects expression decreases expression
|
EXP
|
Cocaine affects the expression of CSAD mRNA Cocaine results in decreased expression of CSAD protein
|
CTD |
PMID:20187946 PMID:25100957 |
|
NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581
|
|
| G
|
Csf2ra
|
colony stimulating factor 2 receptor subunit alpha
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CSF2RA mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr14:113,219...118,808
Ensembl chr14:113,225...118,117
|
|
| G
|
Csn3
|
casein kappa
|
affects expression
|
EXP
|
Cocaine affects the expression of CSN3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:20,433,277...20,439,830
Ensembl chr14:20,433,277...20,439,832
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CSNK2A1 mRNA
|
CTD |
PMID:12117546 |
|
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Cspg5
|
chondroitin sulfate proteoglycan 5
|
affects expression
|
EXP
|
Cocaine affects the expression of CSPG5 mRNA; Cocaine affects the expression of CSPG5 protein
|
CTD |
PMID:12358776 |
|
NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907
|
|
| G
|
Csrp2
|
cysteine and glycine-rich protein 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CSRP2 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238
|
|
| G
|
Ctdnep1
|
CTD nuclear envelope phosphatase 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CTDNEP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
affects expression multiple interactions
|
EXP
|
Cocaine affects the expression of CTNNB1 mRNA Cocaine deficiency promotes the reaction [SMARCA4 protein binds to CTNNB1 promoter]
|
CTD |
PMID:20187946 PMID:27422367 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctnnbip1
|
catenin, beta-interacting protein 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CTNNBIP1 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 5:165,245,019...165,293,994
Ensembl chr 5:165,245,098...165,293,991
|
|
| G
|
Ctnnd2
|
catenin delta 2
|
decreases expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of CTNND2 mRNA Cocaine results in increased expression of CTNND2 mRNA
|
CTD |
PMID:12629581 PMID:16076954 |
|
NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409
|
|
| G
|
Ctrl
|
chymotrypsin-like
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of CTRL mRNA Cocaine results in increased expression of CTRL mRNA
|
CTD |
PMID:20187946 PMID:27899881 |
|
NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979
|
|
| G
|
Ctsb
|
cathepsin B
|
affects expression multiple interactions increases expression
|
ISO
|
Cocaine affects the expression of CTSB mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CTSB mRNA]
|
CTD |
PMID:15681117 PMID:18355967 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsd
|
cathepsin D
|
affects expression increases expression
|
ISO EXP
|
Cocaine affects the expression of CTSD mRNA Cocaine results in increased expression of CTSD protein
|
CTD |
PMID:15681117 PMID:25100957 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
| G
|
Cuedc1
|
CUE domain containing 1
|
multiple interactions
|
ISO
|
HDAC5 affects the reaction [Cocaine affects the expression of CUEDC1 mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr10:73,389,798...73,484,914
Ensembl chr10:73,389,841...73,483,749
|
|
| G
|
Cul4b
|
cullin 4B
|
increases expression
|
ISO
|
Cocaine results in increased expression of CUL4B mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr X:122,154,332...122,192,299
Ensembl chr X:122,154,332...122,192,299
|
|
| G
|
Cwf19l2
|
CWF19 like cell cycle control factor 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of CWF19L2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 6:6,036,158...6,102,686
Ensembl chr 6:6,026,861...6,102,635
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of CX3CL1 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
increases secretion
|
ISO
|
Cocaine results in increased secretion of CXCL10 protein
|
CTD |
PMID:10065903 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CXCL9 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
increases expression
|
ISO
|
Cocaine results in increased expression of CXCR4 protein
|
CTD |
PMID:16204638 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cxxc5
|
CXXC finger protein 5
|
affects expression
|
EXP
|
Cocaine affects the expression of CXXC5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
increases expression
|
ISO
|
Cocaine results in increased expression of CYBA protein
|
CTD |
PMID:18952886 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
increases expression increases response to substance
|
ISO
|
Cocaine results in increased expression of CYBB protein CYBB results in increased susceptibility to Cocaine
|
CTD |
PMID:18952886 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyc1
|
cytochrome c-1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CYC1 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions affects expression
|
EXP ISO
|
Minocycline inhibits the reaction [Cocaine results in increased secretion of CYCS protein] Cocaine affects the expression of CYCS mRNA
|
CTD |
PMID:15681117 PMID:21424555 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cygb
|
cytoglobin
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CYGB protein
|
CTD |
PMID:25100957 |
|
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CYP19A1 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP1A1 protein]; Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP1A1 protein]
|
CTD |
PMID:11856816 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CYP26A1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
|
|
| G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
decreases response to substance
|
EXP
|
CYP26B1 protein results in decreased susceptibility to Cocaine
|
CTD |
PMID:27899881 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
| G
|
Cyp2c79
|
cytochrome P450, family 2, subfamily c, polypeptide 79
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CYP2C8 mRNA; Cocaine results in decreased expression of CYP2C8 protein
|
CTD |
PMID:16188404 |
|
|
|
| G
|
Cyp2j10
|
cytochrome P450, family 2, subfamily j, polypeptide 10
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of CYP2J10 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:116,076,012...116,110,914
Ensembl chr 5:116,023,198...116,110,897
|
|
| G
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of CYP2J2 protein Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein]; Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein]
|
CTD |
PMID:11856816 |
|
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
affects expression
|
EXP
|
Cocaine affects the expression of CYP3A23-3A1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Cyp51
|
cytochrome P450, family 51
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of CYP51 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
|
|
| G
|
Cyss
|
cystatin S
|
affects expression
|
EXP
|
Cocaine affects the expression of CYSS mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:157,892,660...157,897,265
Ensembl chr 3:157,892,660...157,897,265
|
|
| G
|
Dab2ip
|
DAB2 interacting protein
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of DAB2IP mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730
|
|
| G
|
Dazap1
|
DAZ associated protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of DAZAP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:10,074,342...10,098,810
Ensembl chr 7:10,074,849...10,095,599
|
|
| G
|
Dbh
|
dopamine beta-hydroxylase
|
increases response to substance decreases response to substance
|
ISO
|
DBH gene polymorphism results in increased susceptibility to Cocaine DBH gene mutant form results in decreased susceptibility to Cocaine
|
CTD |
PMID:10673769 PMID:12555232 PMID:18083142 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316
|
|
| G
|
Dbn1
|
drebrin 1
|
multiple interactions
|
EXP
|
Cocaine deficiency promotes the reaction [SMARCA4 protein binds to DBN1 promoter]
|
CTD |
PMID:27422367 |
|
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122
|
|
| G
|
Dcaf8
|
DDB1 and CUL4 associated factor 8
|
affects expression
|
EXP
|
Cocaine affects the expression of DCAF8 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr13:87,141,940...87,199,859
Ensembl chr13:87,142,525...87,202,099
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
affects expression increases expression
|
ISO EXP
|
Cocaine affects the expression of DDIT3 mRNA Cocaine results in increased expression of DDIT3 mRNA
|
CTD |
PMID:15681117 PMID:20187946 PMID:23644055 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddr2
|
discoidin domain receptor tyrosine kinase 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of DDR2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288
|
|
| G
|
Ddx41
|
DEAD-box helicase 41
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of DDX41 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,108,074...9,113,561
|
|
| G
|
Ddx50
|
DExD-box helicase 50
|
affects expression
|
EXP
|
Cocaine affects the expression of DDX50 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr20:31,104,354...31,133,652
Ensembl chr20:31,104,354...31,133,652
|
|
| G
|
Ddx6
|
DEAD-box helicase 6
|
increases expression
|
EXP
|
Cocaine results in increased expression of DDX6 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977
|
|
| G
|
Deaf1
|
DEAF1 transcription factor
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of DEAF1 mRNA
|
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr 1:205,831,428...205,865,106
Ensembl chr 1:205,831,336...205,865,106
|
|
| G
|
Dhh
|
desert hedgehog signaling molecule
|
affects expression
|
EXP
|
Cocaine affects the expression of DHH mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352
|
|
| G
|
Dhx30
|
DExH-box helicase 30
|
affects expression
|
EXP
|
Cocaine affects the expression of DHX30 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:118,943,186...118,975,319
Ensembl chr 8:118,943,187...118,975,592
|
|
| G
|
Dipk1b
|
divergent protein kinase domain 1B
|
affects expression
|
EXP
|
Cocaine affects the expression of DIPK1B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255
|
|
| G
|
Dlg2
|
discs large MAGUK scaffold protein 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of DLG2 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 1:153,864,545...155,916,238
Ensembl chr 1:153,865,299...155,916,215
|
|
| G
|
Dlg4
|
discs large MAGUK scaffold protein 4
|
affects expression increases expression multiple interactions decreases response to substance decreases expression
|
EXP ISO
|
Cocaine affects the expression of DLG4 mRNA; Cocaine affects the expression of DLG4 protein Cocaine results in increased expression of DLG4 protein ILK mutant form inhibits the reaction [Cocaine results in increased expression of DLG4 protein] DLG4 protein results in decreased susceptibility to Cocaine Cocaine results in decreased expression of DLG4 mRNA
|
CTD |
PMID:14980210 PMID:19629758 PMID:20187946 PMID:20534846 PMID:20600170 |
|
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
|
|
| G
|
Dlk2
|
delta like non-canonical Notch ligand 2
|
decreases expression multiple interactions
|
ISO
|
Cocaine results in decreased expression of DLK2 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of DLK2 mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149
|
|
| G
|
Dnah8
|
dynein, axonemal, heavy chain 8
|
affects response to substance
|
ISO
|
DNAH8 gene SNP affects the susceptibility to Cocaine
|
CTD |
PMID:18438686 |
|
NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,694,398...8,948,849
|
|
| G
|
Dnm1
|
dynamin 1
|
affects expression
|
EXP
|
Cocaine affects the expression of DNM1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
multiple interactions increases phosphorylation
|
EXP ISO
|
[Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to DNM1L promoter] Cocaine results in increased phosphorylation of DNM1L protein
|
CTD |
PMID:30158054 PMID:31494168 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Dnm2
|
dynamin 2
|
affects expression
|
EXP
|
Cocaine affects the expression of DNM2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295
|
|
| G
|
Dnm3
|
dynamin 3
|
affects expression
|
EXP
|
Cocaine affects the expression of DNM3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350
|
|
| G
|
Dnmbp
|
dynamin binding protein
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of DNMBP mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688
|
|
| G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
decreases expression multiple interactions
|
ISO
|
Cocaine results in decreased expression of DNMT3B mRNA; Cocaine results in decreased expression of DNMT3B protein Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B mRNA]; Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B protein]
|
CTD |
PMID:22438930 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313
|
|
| G
|
Dnph1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of DNPH1 mRNA
|
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631
|
|
| G
|
Dpf2
|
double PHD fingers 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of DPF2 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 1:212,612,986...212,628,376
Ensembl chr 1:212,612,986...212,628,289
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
multiple interactions
|
EXP
|
[Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of DPYSL2 protein
|
CTD |
PMID:19457111 |
|
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Dpysl3
|
dihydropyrimidinase-like 3
|
affects expression
|
EXP
|
Cocaine affects the expression of DPYSL3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152
|
|
| G
|
Drd1
|
dopamine receptor D1
|
multiple interactions affects expression increases expression decreases expression affects response to substance increases response to substance decreases response to substance
|
ISO EXP
|
1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; 1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; [Cocaine binds to SIGMAR1 protein] affects the folding of [SIGMAR1 protein binds to DRD1 protein]; Cocaine affects the localization of [DRD1 protein binds to SIGMAR1 protein]; Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Cocaine promotes the reaction [DRD1 protein binds to SIGMAR1 protein]; SCH 23390 inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; SCH 23390 inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]] Cocaine affects the expression of DRD1 protein Cocaine deficiency results in increased expression of DRD1 mRNA Cocaine results in decreased expression of DRD1 protein DRD1 protein affects the susceptibility to Cocaine DRD1 results in increased susceptibility to Cocaine DRD1 gene mutant form results in decreased susceptibility to Cocaine Cocaine promotes the reaction [DRD1 protein results in increased expression of FOS protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of NEO1 protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of PDYN protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of SYT7 protein]; Cocaine promotes the reaction [DRD1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Cocaine promotes the reaction [DRD1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; DRD1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; DRD1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] [anhydroecgonine methyl ester co-treated with Cocaine] results in decreased expression of DRD1 protein; [SCH 23390 binds to and results in decreased activity of DRD1 protein] inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine affects the reaction [SCH 23390 binds to DRD1 protein]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein alternative form]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein]
|
CTD |
PMID:2213551 PMID:8001143 PMID:11421588 PMID:11602327 PMID:15049517 PMID:15056714 PMID:16674926 PMID:17161392 PMID:20435100 PMID:20456009 PMID:20956312 PMID:27126842 PMID:27129946 PMID:35597300 More...
|
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
|
|
| G
|
Drd2
|
dopamine receptor D2
|
decreases expression increases expression affects response to substance increases activity multiple interactions affects expression decreases response to substance increases response to substance
|
ISO EXP
|
Cocaine results in decreased expression of DRD2 mRNA; Cocaine results in decreased expression of DRD2 protein Cocaine deficiency results in increased expression of DRD2 mRNA; Cocaine results in increased expression of DRD2 protein DRD2 protein affects the susceptibility to Cocaine Cocaine results in increased activity of DRD2 protein Cocaine results in increased expression of DRD2 mRNA; Cocaine results in increased expression of DRD2 protein Cocaine affects the reaction [Spiperone binds to DRD2 protein]; Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]; Methadone affects the reaction [Cocaine affects the expression of DRD2 mRNA]; Spiperone inhibits the reaction [Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]] Cocaine affects the expression of DRD2; Cocaine affects the expression of DRD2 mRNA; Cocaine affects the expression of DRD2 protein DRD2 protein results in decreased susceptibility to Cocaine PDYN protein affects the reaction [Cocaine affects the expression of DRD2 protein] DRD2 results in increased susceptibility to Cocaine DRD2 polymorphism results in increased susceptibility to Cocaine Cocaine affects the reaction [Raclopride binds to DRD2]
|
CTD |
PMID:2213551 PMID:9892293 PMID:11126397 PMID:11602327 PMID:11790512 PMID:11923462 PMID:12892653 PMID:15010698 PMID:15042275 PMID:15049517 PMID:17161392 PMID:17532787 PMID:17544385 PMID:17671965 PMID:18000554 PMID:18305460 PMID:18990547 PMID:19046384 PMID:19723785 PMID:20435100 PMID:20729865 PMID:27126842 PMID:35597300 More...
|
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Drd3
|
dopamine receptor D3
|
decreases expression decreases response to substance increases expression increases activity affects expression affects activity multiple interactions affects response to substance
|
ISO EXP
|
Cocaine results in decreased expression of DRD3 protein DRD3 results in decreased susceptibility to Cocaine Cocaine results in increased expression of DRD3 mRNA Cocaine results in increased activity of DRD3 protein Cocaine affects the expression of DRD3 protein Cocaine affects the activity of DRD3 protein DRD3 protein results in decreased susceptibility to Cocaine 7-hydroxy-2-N,N-dipropylaminotetralin inhibits the reaction [Cocaine affects the activity of DRD3 protein]; Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]; KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]] DRD3 affects the susceptibility to Cocaine [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD3 protein] which results in decreased susceptibility to Cocaine; [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol co-treated with Cocaine] affects the localization of DRD3 protein; Cocaine promotes the reaction [DRD3 protein results in decreased expression of FOS protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of NEO1 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of PDYN protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of SYT7 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; DRD3 protein affects the reaction [Cocaine results in increased expression of NTS mRNA]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of PDYN protein]; SB 277011 inhibits the reaction [[3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD3 protein] which results in decreased susceptibility to Cocaine]
|
CTD |
PMID:10523822 PMID:10943692 PMID:11120399 PMID:12099907 PMID:15056714 PMID:15100700 PMID:16026479 PMID:18566292 PMID:19046384 PMID:19217379 PMID:19723785 PMID:20435100 PMID:20456009 More...
|
|
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760
|
|
| G
|
Drd4
|
dopamine receptor D4
|
increases response to substance affects expression
|
ISO EXP
|
DRD4 polymorphism results in increased susceptibility to Cocaine Cocaine affects the expression of DRD4 mRNA
|
CTD |
PMID:17671965 PMID:20187946 |
|
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458
|
|
| G
|
Drd5
|
dopamine receptor D5
|
affects expression
|
EXP
|
Cocaine affects the expression of DRD5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr14:76,700,244...76,703,344
Ensembl chr14:76,700,241...76,703,466
|
|
| G
|
Drp2
|
dystrophin related protein 2
|
affects expression
|
ISO
|
Cocaine affects the expression of DRP2 protein
|
CTD |
PMID:19393250 |
|
NCBI chr X:101,900,743...101,951,403
Ensembl chr X:101,901,011...101,951,403
|
|
| G
|
Dsp
|
desmoplakin
|
increases expression
|
ISO
|
Cocaine results in increased expression of DSP protein
|
CTD |
PMID:17075605 |
|
NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
affects expression increases phosphorylation
|
EXP
|
Cocaine affects the expression of DUSP1 mRNA Cocaine results in increased phosphorylation of DUSP1 protein
|
CTD |
PMID:18822274 PMID:20187946 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp5
|
dual specificity phosphatase 5
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of CPG21 mRNA Cocaine results in increased expression of DUSP5 mRNA
|
CTD |
PMID:20187946 PMID:27899881 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
|
|
| G
|
Dusp8
|
dual specificity phosphatase 8
|
multiple interactions increases expression
|
EXP
|
5,7-Dihydroxytryptamine inhibits the reaction [Cocaine results in increased expression of DUSP8 mRNA]
|
CTD |
PMID:9813294 |
|
NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441
|
|
| G
|
Dvl1
|
dishevelled segment polarity protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of DVL1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966
|
|
| G
|
Dync1i1
|
dynein cytoplasmic 1 intermediate chain 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of DYNC1I1 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 4:34,819,313...35,132,647
Ensembl chr 4:34,819,430...35,142,319
|
|
| G
|
Dync1li2
|
dynein, cytoplasmic 1 light intermediate chain 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of DYNC1LI2 protein
|
CTD |
PMID:25100957 |
|
NCBI chr19:538,207...561,110
Ensembl chr19:538,211...561,107
|
|
| G
|
Dynll1
|
dynein light chain LC8-type 1
|
affects expression
|
EXP
|
Cocaine affects the expression of DYNLL1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
|
|
| G
|
Eci2
|
enoyl-CoA delta isomerase 2
|
affects expression
|
EXP
|
Cocaine affects the expression of ECI2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161
|
|
| G
|
Edn1
|
endothelin 1
|
increases expression
|
EXP ISO
|
Cocaine results in increased expression of EDN1 protein
|
CTD |
PMID:9714087 PMID:11948058 PMID:17420087 PMID:18813882 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Ednra
|
endothelin receptor type A
|
increases expression
|
ISO EXP
|
Cocaine results in increased expression of EDNRA protein
|
CTD |
PMID:17420087 PMID:18813882 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
affects expression
|
EXP
|
Cocaine affects the expression of EDNRB mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
affects expression
|
EXP
|
Cocaine affects the expression of EEF1A1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
| G
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2
|
affects expression
|
EXP
|
Cocaine affects the expression of EEF1A2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712
|
|
| G
|
Eef1g
|
eukaryotic translation elongation factor 1 gamma
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of EEF1G mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479
|
|
| G
|
Efcab3
|
EF-hand calcium binding domain 3
|
affects expression decreases expression
|
EXP
|
Cocaine affects the expression of EFCAB3 mRNA Cocaine results in decreased expression of EFCAB3 mRNA
|
CTD |
PMID:17898221 PMID:20187946 |
|
NCBI chr10:90,084,495...90,577,145
Ensembl chr10:90,084,397...90,577,144
|
|
| G
|
Efna1
|
ephrin A1
|
affects expression
|
EXP
|
Cocaine affects the expression of EFNA1 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
|
|
| G
|
Efna2
|
ephrin A2
|
affects expression
|
EXP
|
Cocaine affects the expression of EFNA2 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 7:10,167,091...10,177,719
Ensembl chr 7:10,167,091...10,177,719
|
|
| G
|
Efna3
|
ephrin A3
|
affects expression
|
EXP
|
Cocaine affects the expression of EFNA3 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843
|
|
| G
|
Efna4
|
ephrin A4
|
affects expression
|
EXP
|
Cocaine affects the expression of EFNA4 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 2:177,046,463...177,050,713
Ensembl chr 2:177,046,463...177,050,713
|
|
| G
|
Efna5
|
ephrin A5
|
increases expression
|
EXP
|
Cocaine results in increased expression of EFNA5 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348
|
|
| G
|
Efnb1
|
ephrin B1
|
increases expression
|
EXP
|
Cocaine results in increased expression of EFNB1 mRNA
|
CTD |
PMID:15691709 PMID:17898221 |
|
NCBI chr X:68,297,529...68,310,335
Ensembl chr X:68,297,492...68,349,546
|
|
| G
|
Efnb2
|
ephrin B2
|
increases expression
|
EXP
|
Cocaine results in increased expression of EFNB2 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
|
|
| G
|
Efnb3
|
ephrin B3
|
increases expression
|
EXP
|
Cocaine results in increased expression of EFNB3 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Eftud2
|
elongation factor Tu GTP binding domain containing 2
|
affects expression
|
EXP
|
Cocaine affects the expression of EFTUD2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:88,304,992...88,352,229
Ensembl chr10:88,304,992...88,346,299
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of EGFR mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
affects expression decreases expression increases expression multiple interactions increases response to substance
|
ISO EXP
|
Cocaine affects the expression of EGR1 mRNA Cocaine deficiency results in decreased expression of EGR1 mRNA Cocaine results in increased expression of EGR1 protein NPPC protein inhibits the reaction [Cocaine results in increased expression of EGR1 mRNA] Cocaine results in increased expression of EGR1 mRNA; Cocaine results in increased expression of EGR1 protein EGR1 results in increased susceptibility to Cocaine [Cocaine co-treated with Caffeine] results in increased expression of EGR1 mRNA; Cocaine promotes the reaction [Caffeine results in increased expression of EGR1 mRNA]
|
CTD |
PMID:1347779 PMID:7905595 PMID:9890435 PMID:10971643 PMID:11860464 PMID:16339038 PMID:16459018 PMID:16738229 PMID:17851536 PMID:18311559 PMID:18355967 PMID:20187946 PMID:27126842 More...
|
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr2
|
early growth response 2
|
increases expression affects expression
|
ISO EXP
|
Cocaine results in increased expression of EGR2 mRNA Cocaine affects the expression of EGR2 mRNA
|
CTD |
PMID:20056891 PMID:20187946 PMID:27899881 |
|
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
| G
|
Egr3
|
early growth response 3
|
affects expression decreases expression multiple interactions increases expression
|
EXP ISO
|
Cocaine affects the expression of EGR3 mRNA Cocaine deficiency results in decreased expression of EGR3 mRNA [Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to EGR3 promoter] Cocaine results in increased expression of EGR3 mRNA
|
CTD |
PMID:16459018 PMID:20187946 PMID:27126842 PMID:30158054 |
|
NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712
|
|
| G
|
Egr4
|
early growth response 4
|
increases expression
|
EXP
|
Cocaine results in increased expression of EGR4 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368
|
|
| G
|
Ehd2
|
EH-domain containing 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of EHD2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943
|
|
| G
|
Ehmt1
|
euchromatic histone lysine methyltransferase 1
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of EHMT1 mRNA
|
CTD |
PMID:20056891 |
|
NCBI chr 3:27,978,888...28,127,178
Ensembl chr 3:27,978,888...28,127,349
|
|
| G
|
Ehmt2
|
euchromatic histone lysine methyltransferase 2
|
multiple interactions decreases response to substance decreases expression
|
ISO
|
Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TGFBR1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of USP9X mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of WNK3 mRNA]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA] EHMT2 results in decreased susceptibility to Cocaine Cocaine results in decreased expression of EHMT2 mRNA; Cocaine results in decreased expression of EHMT2 protein
|
CTD |
PMID:20056891 |
|
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,924,263...3,941,384
|
|
| G
|
Eif1a
|
eukaryotic translation initiation factor 1A
|
increases expression
|
EXP
|
Cocaine results in increased expression of EIF1A mRNA; Cocaine results in increased expression of EIF1AY mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr18:41,512,298...41,524,645
Ensembl chr18:41,503,180...41,549,696
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases expression multiple interactions
|
EXP
|
Cocaine results in increased expression of EIF2AK3 protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]
|
CTD |
PMID:17303341 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases phosphorylation
|
EXP
|
Cocaine results in increased phosphorylation of EIF2S1
|
CTD |
PMID:18593214 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
increases expression
|
EXP
|
Cocaine results in increased expression of EIF3A mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3b
|
eukaryotic translation initiation factor 3, subunit B
|
affects expression
|
EXP
|
Cocaine affects the expression of EIF3B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
|
|
| G
|
Eif3c
|
eukaryotic translation initiation factor 3, subunit C
|
increases expression
|
EXP
|
Cocaine results in increased expression of EIF3C mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
|
|
| G
|
Eif3e
|
eukaryotic translation initiation factor 3 subunit E
|
affects expression
|
EXP
|
Cocaine affects the expression of EIF3E mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:76,224,567...76,257,346
Ensembl chr 7:76,224,568...76,257,785
|
|
| G
|
Eif4b
|
eukaryotic translation initiation factor 4B
|
multiple interactions increases expression
|
ISO
|
FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of EIF4B mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
|
|
| G
|
Eif5a
|
eukaryotic translation initiation factor 5A
|
decreases expression affects expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of EIF5A mRNA Cocaine affects the expression of EIF5A mRNA Cocaine results in increased expression of EIF5A mRNA
|
CTD |
PMID:15009677 PMID:16710320 PMID:20187946 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
|
|
| G
|
Eif5b
|
eukaryotic translation initiation factor 5B
|
increases expression
|
EXP
|
Cocaine results in increased expression of EIF5B mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583
|
|
| G
|
Eif5b-ps1
|
eukaryotic translation initiation factor 5B, pseudogene 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of EIF5B-PS1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr19:52,297,623...52,301,730
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
multiple interactions
|
ISO
|
[Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to ELANE protein]] which results in decreased activity of ELANE protein; Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to ELANE protein]
|
CTD |
PMID:18438818 |
|
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Elmo1
|
engulfment and cell motility 1
|
multiple interactions increases expression
|
ISO
|
EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA]
|
CTD |
PMID:20056891 |
|
NCBI chr17:48,982,188...49,518,525
Ensembl chr17:48,982,188...49,518,159
|
|
| G
|
Emc9
|
ER membrane protein complex subunit 9
|
affects expression
|
EXP
|
Cocaine affects the expression of EMC9 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr15:33,041,840...33,046,056
Ensembl chr15:33,041,842...33,046,102
|
|
| G
|
Enah
|
ENAH, actin regulator
|
increases expression
|
EXP
|
Cocaine results in increased expression of ENAH mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:96,149,437...96,269,841
Ensembl chr13:96,149,437...96,269,796
|
|
| G
|
Enc1
|
ectodermal-neural cortex 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of ENC1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
|
|
| G
|
Enho
|
energy homeostasis associated
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of ENHO mRNA
|
CTD |
PMID:16710320 |
|
NCBI chr 5:61,596,860...61,598,657
Ensembl chr 5:61,596,860...61,598,657
|
|
| G
|
Eno2
|
enolase 2
|
decreases expression increases expression
|
ISO
|
Cocaine results in decreased expression of ENO2 mRNA Cocaine results in increased expression of ENO2 protein
|
CTD |
PMID:12629581 PMID:17075605 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Enpp5
|
ectonucleotide pyrophosphatase/phosphodiesterase family member 5
|
increases expression
|
ISO
|
Cocaine results in increased expression of ENPP5 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 9:24,407,574...24,415,029
Ensembl chr 9:24,408,218...24,414,867
|
|
| G
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ENTPD2 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:28,611,772...28,618,184
|
|
| G
|
Entpd3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ENTPD3 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252
|
|
| G
|
Epha1
|
Eph receptor A1
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA1 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
| G
|
Epha2
|
Eph receptor A2
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA2 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
|
|
| G
|
Epha3
|
Eph receptor A3
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA3 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425
|
|
| G
|
Epha4
|
Eph receptor A4
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of EPHA4 mRNA Cocaine results in increased expression of EPHA4 mRNA
|
CTD |
PMID:15691709 PMID:17898221 |
|
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755
|
|
| G
|
Epha5
|
EPH receptor A5
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA5 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr14:24,007,400...24,374,854
Ensembl chr14:24,008,122...24,374,848
|
|
| G
|
Epha7
|
Eph receptor A7
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA7 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:47,771,865...47,925,058
|
|
| G
|
Epha8
|
Eph receptor A8
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHA8 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 5:154,449,566...154,476,966
Ensembl chr 5:154,449,566...154,476,966
|
|
| G
|
Ephb1
|
Eph receptor B1
|
increases expression
|
ISO EXP
|
Cocaine results in increased expression of EPHB1 protein Cocaine results in increased expression of EPHB1 mRNA
|
CTD |
PMID:11146119 PMID:15691709 |
|
NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759
|
|
| G
|
Ephb2
|
Eph receptor B2
|
increases expression
|
EXP
|
Cocaine results in increased expression of EPHB2 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615
|
|
| G
|
Ephb3
|
Eph receptor B3
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHB3 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr11:93,345,098...93,363,775
Ensembl chr11:93,345,098...93,363,775
|
|
| G
|
Ephb4
|
EPH receptor B4
|
decreases expression affects expression
|
ISO EXP
|
Cocaine results in decreased expression of EPHB4 mRNA Cocaine affects the expression of EPHB4 mRNA
|
CTD |
PMID:15691709 PMID:18000554 |
|
NCBI chr12:24,963,174...24,988,473
Ensembl chr12:24,963,174...24,988,388
|
|
| G
|
Ephb6
|
Eph receptor B6
|
affects expression
|
EXP
|
Cocaine affects the expression of EPHB6 mRNA
|
CTD |
PMID:15691709 |
|
NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659
|
|
| G
|
Erbin
|
erbb2 interacting protein
|
multiple interactions
|
ISO
|
HDAC5 affects the reaction [Cocaine affects the expression of ERBIN mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr 2:36,660,399...36,762,584
Ensembl chr 2:36,660,399...36,762,153
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions increases expression
|
EXP
|
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of ERN1 protein]
|
CTD |
PMID:17303341 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Ess2
|
ess-2 splicing factor homolog
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of ESS2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr11:96,580,185...96,596,673
Ensembl chr11:96,580,169...96,590,146
|
|
| G
|
Etf1
|
eukaryotic translation termination factor 1
|
affects expression
|
EXP
|
Cocaine affects the expression of ETF1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613
|
|
| G
|
Etfa
|
electron transfer flavoprotein subunit alpha
|
affects expression
|
EXP
|
Cocaine affects the expression of ETFA mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080
|
|
| G
|
Exoc2
|
exocyst complex component 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of EXOC2 protein
|
CTD |
PMID:25100957 |
|
NCBI chr17:33,714,949...33,906,901
Ensembl chr17:33,715,008...33,901,944
|
|
| G
|
Eya1
|
EYA transcriptional coactivator and phosphatase 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of EYA1 mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 5:9,646,599...9,884,609
Ensembl chr 5:9,646,591...9,884,614
|
|
| G
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2
|
affects expression
|
EXP
|
Cocaine affects the expression of EYA2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034
|
|
| G
|
Ezr
|
ezrin
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of EZR mRNA
|
CTD |
PMID:20948987 |
|
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
|
|
| G
|
Fadd
|
Fas associated via death domain
|
affects expression multiple interactions decreases expression
|
EXP
|
Cocaine affects the expression of FADD mRNA Raclopride affects the reaction [Cocaine affects the expression of FADD protein] Cocaine results in decreased expression of FADD protein modified form
|
CTD |
PMID:18580876 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fahd1
|
fumarylacetoacetate hydrolase domain containing 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of FAHD1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr10:14,378,058...14,379,497
Ensembl chr10:14,378,120...14,379,867
|
|
| G
|
Fahd2a
|
fumarylacetoacetate hydrolase domain containing 2A
|
affects expression
|
ISO
|
Cocaine affects the expression of FAHD2A protein
|
CTD |
PMID:19393250 |
|
NCBI chr 3:135,110,480...135,118,653
Ensembl chr 3:135,109,482...135,118,853
|
|
| G
|
Faim
|
Fas apoptotic inhibitory molecule
|
affects expression
|
ISO
|
Cocaine affects the expression of FAIM mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151
|
|
| G
|
Faim2
|
Fas apoptotic inhibitory molecule 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of FAIM2 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 7:132,512,095...132,539,192
Ensembl chr 7:132,512,210...132,538,026
|
|
| G
|
Fam184b
|
family with sequence similarity 184, member B
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FAM184B mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922
|
|
| G
|
Fam20c
|
FAM20C, golgi associated secretory pathway kinase
|
affects expression
|
EXP
|
Cocaine affects the expression of FAM20C mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:20,940,654...20,999,072
Ensembl chr12:20,940,654...20,998,318
|
|
| G
|
Fam78b
|
family with sequence similarity 78, member B
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FAM78B mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784
|
|
| G
|
Fam89b
|
family with sequence similarity 89, member B
|
affects expression
|
EXP
|
Cocaine affects the expression of MTVR2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:212,445,101...212,447,164
Ensembl chr 1:212,445,102...212,446,738
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
ISO
|
Cocaine results in increased expression of FAS mRNA
|
CTD |
PMID:16710320 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fbxl3
|
F-box and leucine-rich repeat protein 3
|
increases expression
|
EXP
|
Cocaine results in increased expression of FBXL3 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr15:86,321,504...86,341,387
Ensembl chr15:86,321,504...86,341,387
|
|
| G
|
Fbxo46
|
F-box protein 46
|
affects expression
|
EXP
|
Cocaine affects the expression of FBXO46 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:87,898,029...87,914,615
Ensembl chr 1:87,897,888...87,926,021
|
|
| G
|
Fcgr2b
|
Fc gamma receptor 2B
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FCGR2B mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of FDFT1 mRNA
|
CTD |
PMID:17205118 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fev
|
FEV transcription factor, ETS family member
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FEV mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 9:83,887,844...83,891,718
Ensembl chr 9:83,887,844...83,891,737
|
|
| G
|
Fgd5
|
FYVE, RhoGEF and PH domain containing 5
|
increases expression
|
EXP
|
Cocaine results in increased expression of FGD5 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 4:126,054,201...126,151,698
Ensembl chr 4:126,054,210...126,151,697
|
|
| G
|
Fgf12
|
fibroblast growth factor 12
|
affects expression
|
EXP
|
Cocaine affects the expression of FGF12 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of FGF2 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of FGFR1 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fh
|
fumarate hydratase
|
affects expression
|
ISO
|
Cocaine affects the expression of FH1 protein
|
CTD |
PMID:19393250 |
|
NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of FIS1 mRNA
|
CTD |
PMID:31494168 |
|
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Fkbp1b
|
FKBP prolyl isomerase 1B
|
affects expression
|
EXP
|
Cocaine affects the expression of FKBP1B mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129
|
|
| G
|
Fkbp5
|
FKBP prolyl isomerase 5
|
increases expression
|
EXP
|
cocaine increases expression of Fkbp5 mRNA in bed nucleus of the stria terminalis, central amygdala and paraventricular nucleus
|
RGD |
PMID:31029877 |
RGD:401976486 |
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
|
|
| G
|
Fkbpl
|
FKBP prolyl isomerase like
|
affects expression
|
EXP
|
Cocaine affects the expression of FKBPL mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr20:4,104,457...4,105,927
Ensembl chr20:4,104,019...4,105,615
|
|
| G
|
Flrt3
|
fibronectin leucine rich transmembrane protein 3
|
increases expression
|
ISO
|
Cocaine results in increased expression of FLRT3 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650
|
|
| G
|
Flywch1
|
FLYWCH-type zinc finger 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FLYWCH1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925
|
|
| G
|
Fmr1
|
fragile X messenger ribonucleoprotein 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FMR1 mRNA
|
CTD |
PMID:24810662 |
|
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675
|
|
| G
|
Fndc1
|
fibronectin type III domain containing 1
|
multiple interactions
|
ISO
|
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of FNDC1 mRNA
|
CTD |
PMID:18355967 |
|
NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263
|
|
| G
|
Fndc5
|
fibronectin type III domain containing 5
|
affects expression
|
EXP
|
Cocaine affects the expression of FNDC5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression affects expression increases phosphorylation decreases response to substance increases activity decreases expression
|
ISO EXP
|
[Cocaine co-treated with SLC6A3 protein] results in increased expression of FOS protein; Cocaine inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; Cocaine inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein] Cocaine results in increased expression of FOS mRNA; Cocaine results in increased expression of FOS protein Cocaine affects the expression of FOS mRNA; Cocaine affects the expression of FOS protein Cocaine results in increased phosphorylation of FOS protein [Morphine co-treated with Cocaine] affects the expression of FOS; [SCH 23390 binds to and results in decreased activity of DRD1 protein] inhibits the reaction [Cocaine results in increased expression of FOS protein]; Alcohols promotes the reaction [Cocaine results in increased expression of FOS protein]; Baclofen inhibits the reaction [Cocaine results in increased expression of FOS protein]; Chloral Hydrate inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine promotes the reaction [[SK&F 81297 co-treated with Quinpirole] results in increased expression of FOS protein]; Cocaine promotes the reaction [Cocaine results in increased expression of FOS mRNA]; Cocaine promotes the reaction [Ethanol results in increased expression of FOS protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of FOS protein]; ecopipam inhibits the reaction [Cocaine results in increased expression of FOS protein]; Ethanol promotes the reaction [Cocaine results in increased expression of FOS protein]; Muscimol inhibits the reaction [Cocaine results in increased expression of FOS protein]; NPPC protein inhibits the reaction [Cocaine results in increased expression of FOS mRNA]; Reserpine inhibits the reaction [Cocaine results in increased expression of FOS protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOS protein]; Urethane inhibits the reaction [Cocaine results in increased expression of FOS protein]; volinanserin inhibits the reaction [Cocaine results in increased expression of FOS protein] FOS protein mutant form results in decreased susceptibility to Cocaine Cocaine results in increased activity of FOS protein Cocaine deficiency results in decreased expression of FOS protein; Cocaine results in decreased expression of FOS protein [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of NEO1 protein; [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of PDYN protein; [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of SYT7 protein; [Cocaine co-treated with Caffeine] results in increased expression of FOS mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of CD4 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of CORO7 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ENTPD3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of FNDC1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ITPR1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of NEXN mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PBX2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PER1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PINX1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PKNOX2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PLPP1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PRKCZ mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of SHANK3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of SYT9 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of THRA mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of ADGRA1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CAB39L mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CAMK1G mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CBLN1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of GRIP1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of INA mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of LARGE1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of NRIP3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of SATB2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of SORCS3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of TENM4 mRNA; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOS protein; Baclofen inhibits the reaction [Cocaine results in increased expression of FOS protein]; CDK5R1 protein inhibits the reaction [Cocaine affects the expression of FOS mRNA]; CDK5R1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine promotes the reaction [Caffeine results in increased expression of FOS mRNA]; Cocaine promotes the reaction [DRD1 protein results in increased expression of FOS protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of FOS protein]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Cocaine results in increased expression of FOS protein]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of BDNF mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of CALR mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of DLK2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of HOMER2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of HS3ST2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of MAPK11 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NCALD mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NPTXR mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NRN1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of PRKCA mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SATB1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SEZ6L mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP1B3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP8B2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CLK1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CTSB mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of EIF4B mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of GPC5 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of KCNT1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of KDM3A mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of LIN7B mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of LZTS3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of MEPCE mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NIT2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NOS3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PBX3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PPP1R7 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PRPF18 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PTPRV mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SBSN mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SYNE1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SYT2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of TSPOAP1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ZFPM1 mRNA]; GPX1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of FOS protein]; N-methyl-3-(bis(4'-fluorophenyl)methoxy)tropane inhibits the reaction [Cocaine results in increased expression of FOS protein]; NTRK2 protein affects the reaction [Cocaine affects the expression of FOS protein]; prolinedithiocarbamate inhibits the reaction [Cocaine results in increased expression of FOS protein]; RPS6KA3 affects the reaction [Cocaine results in increased phosphorylation of FOS protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOS protein]; SL 327 inhibits the reaction [Cocaine results in increased activity of FOS protein]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOS mRNA]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOS protein]
|
CTD |
PMID:1498673 PMID:2118661 PMID:7905595 PMID:10415707 PMID:10521585 PMID:10632609 PMID:10814832 PMID:10904129 PMID:10943692 PMID:10971643 PMID:11160452 PMID:11172061 PMID:11403691 PMID:11421588 PMID:11716816 PMID:11739600 PMID:11860464 PMID:11882344 PMID:12112414 PMID:12122080 PMID:12128156 PMID:12379259 PMID:12419516 PMID:12581847 PMID:12670717 PMID:12699766 PMID:12786985 PMID:12821175 PMID:14644470 PMID:14741756 PMID:15056714 PMID:15219685 PMID:15254092 PMID:15295023 PMID:15665076 PMID:15814102 PMID:16179556 PMID:16263220 PMID:16300424 PMID:16339038 PMID:16395306 PMID:16459018 PMID:16710312 PMID:16930414 PMID:16962079 PMID:17276011 PMID:17596442 PMID:17851536 PMID:18164822 PMID:18311559 PMID:18355967 PMID:18396266 PMID:18479823 PMID:18822274 PMID:18991842 PMID:19169671 PMID:19606084 PMID:19620976 PMID:20187946 PMID:20633205 PMID:20947769 PMID:25933444 PMID:27126842 PMID:27899881 PMID:31059705 More...
|
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit
|
increases expression increases expression multiple interactions affects expression
|
ISO EXP
|
Cocaine results in increased expression of FOSB protein cocaine increases expression of Fosb protein in dorsal striatum and nucelus accumbens Cocaine increases expression of Fosb mRNA and protein in Nucleus Accumbens and Caudate Putamen Cocaine increases expression of Fosb protein in Nucleus Accumbens and Caudate putamen Cocaine increases expression of Fosb protein in caudate���putamen Cocaine increases expression of Fosb protein in brain cocaine increases expression of Fosb protein in Brain cocaine increases expression of Fosb protein in Nucleus Accumbens and Caudate Putamen DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein alternative form]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOSB protein] Cocaine results in increased expression of FOSB mRNA; Cocaine results in increased expression of FOSB protein; Cocaine results in increased expression of FOSB protein alternative form Cocaine affects the expression of FOSB mRNA; Cocaine affects the expression of FOSB protein [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSB protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSB protein; [JUND protein results in decreased activity of FOSB protein] which results in decreased susceptibility to Cocaine; Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form]; PPP1R1B gene mutant form inhibits the reaction [Cocaine results in increased expression of FOSB protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSB protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSB protein]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form]
|
CTD RGD |
PMID:10103106 PMID:11391778 PMID:11739600 PMID:12417638 PMID:15056714 PMID:15814102 PMID:15926929 PMID:16263220 PMID:16674926 PMID:16710312 PMID:17898221 PMID:18293355 PMID:18355967 PMID:18822274 PMID:20056891 PMID:20633205 PMID:27899881 PMID:27380261 PMID:20633205 PMID:27664298 PMID:17572394 PMID:22403532 PMID:23665060 PMID:25522720 More...
|
RGD:401901287, RGD:401900126, RGD:401900166, RGD:401900302, RGD:401851084, RGD:401851078, RGD:401851063 |
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
affects expression decreases expression
|
EXP ISO
|
Cocaine affects the expression of FOSL1 mRNA Cocaine results in decreased expression of FOSL1 mRNA
|
CTD |
PMID:12117546 PMID:12629581 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
multiple interactions decreases expression
|
ISO
|
Cocaine promotes the reaction [JUN protein binds to FOSL2 protein] [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSL2 protein; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSL2 protein] Cocaine results in decreased expression of FOSL2 protein
|
CTD |
PMID:15056714 PMID:15814102 |
|
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406
|
|
| G
|
Foxc2
|
forkhead box C2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FOXC2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977
|
|
| G
|
Foxo1
|
forkhead box O1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FOXO1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxp1
|
forkhead box P1
|
increases expression
|
ISO
|
Cocaine deficiency results in increased expression of FOXP1 mRNA
|
CTD |
PMID:27126842 |
|
NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272
|
|
| G
|
Fras1
|
Fraser extracellular matrix complex subunit 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of FRAS1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr14:13,095,370...13,506,895
Ensembl chr14:13,095,370...13,504,664
|
|
| G
|
Frem2
|
FRAS1 related extracellular matrix 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FREM2 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:139,753,055...139,891,046
Ensembl chr 2:139,753,055...139,891,046
|
|
| G
|
Frmd5
|
FERM domain containing 5
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of FRMD5 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 3:128,945,812...129,217,134
Ensembl chr 3:128,927,671...129,217,074
|
|
| G
|
Frs3
|
fibroblast growth factor receptor substrate 3
|
affects expression
|
EXP
|
Cocaine affects the expression of FRS3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 9:20,786,096...20,800,905
Ensembl chr 9:20,786,096...20,794,761
|
|
| G
|
Fryl
|
FRY like transcription coactivator
|
increases expression
|
ISO
|
cocaine increases expression of Fryl mRNA in nucleus accumbens
|
RGD |
PMID:27506785 |
RGD:11561325 |
NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147
|
|
| G
|
Fubp1
|
far upstream element binding protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of FUBP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428
|
|
| G
|
Fut8
|
fucosyltransferase 8
|
affects expression
|
EXP
|
Cocaine affects the expression of FUT8 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775
|
|
| G
|
Fzd6
|
frizzled class receptor 6
|
affects expression
|
EXP
|
Cocaine affects the expression of FZD6 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
increases expression
|
EXP
|
Cocaine results in increased expression of G6PD protein
|
CTD |
PMID:25100957 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1
|
affects expression increases expression decreases expression
|
EXP
|
Cocaine affects the expression of GABBR1 mRNA Cocaine results in increased expression of GABBR1 mRNA Cocaine results in decreased expression of GABBR1 mRNA
|
CTD |
PMID:11793422 PMID:16076954 PMID:20187946 |
|
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607
|
|
| G
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2
|
decreases phosphorylation
|
EXP
|
Cocaine results in decreased phosphorylation of GABBR2 protein
|
CTD |
PMID:12716959 |
|
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
|
|
| G
|
Gabra1
|
gamma-aminobutyric acid type A receptor subunit alpha 1
|
affects expression multiple interactions
|
EXP ISO
|
Cocaine affects the expression of GABRA1 protein Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] 1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]
|
CTD |
PMID:20826313 PMID:23266428 PMID:32209479 |
|
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
|
|
| G
|
Gabrb1
|
gamma-aminobutyric acid type A receptor subunit beta1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GABRB1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
multiple interactions
|
ISO EXP
|
1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:23266428 PMID:32209479 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrb3
|
gamma-aminobutyric acid type A receptor subunit beta 3
|
affects expression multiple interactions
|
EXP
|
Cocaine affects the expression of GABRB3 mRNA Cocaine affects the phosphorylation of and affects the expression of GABRB3 protein
|
CTD |
PMID:20187946 PMID:20826313 |
|
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725
|
|
| G
|
Gabrg2
|
gamma-aminobutyric acid type A receptor subunit gamma 2
|
multiple interactions increases expression
|
ISO EXP
|
1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] Cocaine deficiency results in increased expression of GABRG2 mRNA Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:23266428 PMID:27126842 PMID:32209479 |
|
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
decreases expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of GAD1 mRNA Cocaine results in increased expression of GAD1 protein
|
CTD |
PMID:12629581 PMID:15295023 PMID:18611417 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
multiple interactions
|
ISO
|
GAL protein inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; GAL protein inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:19099295 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Galk1
|
galactokinase 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GALK1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
|
|
| G
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GALNT1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
|
|
| G
|
Galnt16
|
polypeptide N-acetylgalactosaminyltransferase 16
|
affects expression
|
EXP
|
Cocaine affects the expression of GALNT16 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350
|
|
| G
|
Gap43
|
growth associated protein 43
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of GAP43 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gas2
|
growth arrest-specific 2
|
affects expression
|
ISO
|
Cocaine affects the expression of GAS2 mRNA
|
CTD |
PMID:15681117 |
|
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:110,717,312...110,718,541
|
|
| G
|
Gcc1
|
GRIP and coiled-coil domain containing 1
|
increases expression
|
ISO
|
Cocaine results in increased expression of GCC1 mRNA
|
CTD |
PMID:17205118 |
|
NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,996,267...58,002,185
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of GCLC mRNA PRKCD protein affects the reaction [Cocaine results in increased expression of GCLC mRNA]; rottlerin promotes the reaction [Cocaine results in increased expression of GCLC mRNA]
|
CTD |
PMID:30393195 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
affects expression increases expression multiple interactions
|
EXP ISO
|
Cocaine affects the expression of GCLM mRNA Cocaine results in increased expression of GCLM mRNA PRKCD protein affects the reaction [Cocaine results in increased expression of GCLM mRNA]; rottlerin promotes the reaction [Cocaine results in increased expression of GCLM mRNA]
|
CTD |
PMID:20187946 PMID:30393195 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2
|
increases expression
|
ISO
|
Cocaine deficiency results in increased expression of GCNT2 mRNA
|
CTD |
PMID:27126842 |
|
NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989
|
|
| G
|
Gdap1
|
ganglioside-induced differentiation-associated-protein 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GDAP1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 5:6,715,935...6,735,013
Ensembl chr 5:6,715,935...6,735,313
|
|
| G
|
Gdap1l1
|
ganglioside-induced differentiation-associated protein 1-like 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GDAP1L1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GDNF mRNA
|
CTD |
PMID:14622243 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gem
|
GTP binding protein overexpressed in skeletal muscle
|
increases expression
|
ISO
|
Cocaine results in increased expression of GEM mRNA
|
CTD |
PMID:15009677 |
|
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression decreases expression affects expression
|
ISO EXP
|
Cocaine results in increased expression of GFAP protein Cocaine results in decreased expression of GFAP protein Cocaine affects the expression of GFAP mRNA; Cocaine affects the expression of GFAP protein
|
CTD |
PMID:11391778 PMID:11882367 PMID:12670315 PMID:15814102 PMID:20187946 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfra2
|
GDNF family receptor alpha 2
|
affects expression
|
EXP
|
Cocaine affects the expression of GFRA2 mRNA
|
CTD |
PMID:12358776 |
|
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
|
|
| G
|
Gh1
|
growth hormone 1
|
multiple interactions
|
ISO EXP
|
Cocaine inhibits the reaction [4-hydroxybutyric acid results in increased secretion of GH1 protein]; Cocaine inhibits the reaction [Sodium Oxybate results in increased expression of GH1 protein] Cocaine inhibits the reaction [Clonidine results in increased secretion of GH1 protein]
|
CTD |
PMID:9413023 PMID:10657535 PMID:15099682 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Gid8
|
GID complex subunit 8 homolog
|
affects expression
|
EXP
|
Cocaine affects the expression of GID8 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 3:188,203,571...188,214,324
Ensembl chr 3:188,203,619...188,212,270
|
|
| G
|
Gimap1
|
GTPase, IMAP family member 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GIMAP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:79,018,473...79,022,360
Ensembl chr 4:79,018,202...79,022,525
|
|
| G
|
Gimap5
|
GTPase, IMAP family member 5
|
affects expression
|
EXP
|
Cocaine affects the expression of GIMAP5 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:79,025,151...79,031,917
Ensembl chr 4:79,024,304...79,039,030
|
|
| G
|
Gins3
|
GINS complex subunit 3
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GINS3 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679
|
|
| G
|
Gipc1
|
GIPC PDZ domain containing family, member 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GIPC1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr19:41,380,125...41,392,078
Ensembl chr19:41,380,125...41,391,725
|
|
| G
|
Gja5
|
gap junction protein, alpha 5
|
increases expression
|
EXP
|
Cocaine results in increased expression of GJA5 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512
|
|
| G
|
Gjb1
|
gap junction protein, beta 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GJB1 mRNA; Cocaine affects the expression of GJB1 protein
|
CTD |
PMID:10510198 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of GJB2 mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Gjb5
|
gap junction protein, beta 5
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GJB5 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:144,965,133...144,968,051
Ensembl chr 5:144,964,751...144,984,021
|
|
| G
|
Gjd2
|
gap junction protein, delta 2
|
affects expression
|
EXP
|
Cocaine affects the expression of GJD2 mRNA; Cocaine affects the expression of GJD2 protein
|
CTD |
PMID:16138316 |
|
NCBI chr 3:121,226,372...121,229,367
Ensembl chr 3:121,226,368...121,230,603
|
|
| G
|
Gli2
|
GLI family zinc finger 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GLI2 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418
|
|
| G
|
Glp2r
|
glucagon-like peptide 2 receptor
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GLP2R mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr10:52,901,707...52,964,961
Ensembl chr10:52,900,706...52,964,961
|
|
| G
|
Glra1
|
glycine receptor, alpha 1
|
multiple interactions
|
EXP
|
Cocaine inhibits the reaction [Glycine results in increased activity of GLRA1 protein]; Dronabinol inhibits the reaction [Cocaine inhibits the reaction [Glycine results in increased activity of GLRA1 protein]]
|
CTD |
PMID:32209479 |
|
NCBI chr10:40,128,284...40,228,612
Ensembl chr10:40,130,121...40,227,815
|
|
| G
|
Glrx3
|
glutaredoxin 3
|
affects expression
|
EXP
|
Cocaine affects the expression of GLRX3 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717
|
|
| G
|
Gnao1
|
G protein subunit alpha o1
|
decreases expression multiple interactions
|
ISO EXP
|
Cocaine results in decreased expression of GNAO1 mRNA [Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of GNAO1 protein alternative form
|
CTD |
PMID:12629581 PMID:19457111 |
|
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437
|
|
| G
|
Gnat1
|
G protein subunit alpha transducin 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GNAT1 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:117,229,575...117,234,311
|
|
| G
|
Gnb1
|
G protein subunit beta 1
|
decreases expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of GNB1 mRNA Cocaine results in increased expression of GNB1 mRNA
|
CTD |
PMID:12629581 PMID:16076954 |
|
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488
|
|
| G
|
Gnb2
|
G protein subunit beta 2
|
affects expression
|
EXP
|
Cocaine affects the expression of GNB2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr12:24,795,505...24,800,796
Ensembl chr12:24,795,827...24,800,796
|
|
| G
|
Gnb4
|
G protein subunit beta 4
|
multiple interactions
|
ISO
|
HDAC5 affects the reaction [Cocaine affects the expression of GNB4 mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr 2:117,289,112...117,329,050
Ensembl chr 2:117,293,284...117,328,945
|
|
| G
|
Gng12
|
G protein subunit gamma 12
|
affects expression
|
EXP
|
Cocaine affects the expression of GNG12 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
|
|
| G
|
Gnrh1
|
gonadotropin releasing hormone 1
|
decreases expression multiple interactions
|
ISO
|
Cocaine results in decreased expression of GNRH1 protein GPX1 protein inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein]; prolinedithiocarbamate inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein]
|
CTD |
PMID:31059705 |
|
NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977 Ensembl chr15:46,148,301...46,148,977
|
|
| G
|
Gp2
|
glycoprotein 2
|
affects expression
|
EXP
|
Cocaine affects the expression of GP2 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 1:183,228,395...183,243,954
Ensembl chr 1:183,228,395...183,243,954
|
|
| G
|
Gpc5
|
glypican 5
|
increases expression multiple interactions
|
ISO
|
Cocaine results in increased expression of GPC5 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of GPC5 mRNA]
|
CTD |
PMID:18355967 |
|
NCBI chr15:98,614,499...100,051,285
Ensembl chr15:98,646,340...100,051,514
|
|
| G
|
Gper1
|
G protein-coupled estrogen receptor 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GPER1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144
|
|
| G
|
Gphn
|
gephyrin
|
increases phosphorylation multiple interactions
|
EXP
|
Cocaine results in increased phosphorylation of GPHN protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Cocaine results in increased phosphorylation of GPHN protein]
|
CTD |
PMID:32312805 |
|
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:102,687,423...103,216,674
|
|
| G
|
Gpm6a
|
glycoprotein m6a
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of GPM6A mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr16:43,374,385...43,706,461
Ensembl chr16:43,374,385...43,706,705
|
|
| G
|
Gpm6b
|
glycoprotein m6b
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of GPM6B mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr X:31,689,485...31,836,199
Ensembl chr X:31,690,359...31,733,272
|
|
| G
|
Gpr157
|
G protein-coupled receptor 157
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GPR157 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:165,833,651...165,849,376
Ensembl chr 5:165,833,673...165,851,280
|
|
| G
|
Gpr3
|
G protein-coupled receptor 3
|
increases expression
|
EXP
|
Cocaine results in increased expression of GPR3 mRNA
|
CTD |
PMID:27899881 |
|
NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:150,695,251...150,706,529
|
|
| G
|
Gpr88
|
G-protein coupled receptor 88
|
affects expression increases expression
|
EXP ISO
|
Cocaine affects the expression of GPR88 mRNA Cocaine deficiency results in increased expression of GPR88 mRNA
|
CTD |
PMID:20187946 PMID:27126842 |
|
NCBI chr 2:206,876,373...206,885,034
Ensembl chr 2:206,868,585...206,884,945
|
|
| G
|
Gprasp1
|
G protein-coupled receptor associated sorting protein 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GPRASP1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr X:103,556,493...103,564,275
Ensembl chr X:103,501,377...103,565,649
|
|
| G
|
Gpsm1
|
G-protein signaling modulator 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GPSM1 protein
|
CTD |
PMID:15091342 |
|
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:29,526,802...29,565,920
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases activity
|
ISO
|
PRKCD protein affects the reaction [Cocaine results in increased activity of GPT protein]; rottlerin inhibits the reaction [Cocaine results in increased activity of GPT protein]
|
CTD |
PMID:30393195 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
increases expression affects response to substance multiple interactions
|
ISO
|
Cocaine results in increased expression of GPX1 protein GPX1 protein affects the susceptibility to Cocaine GPX1 affects the reaction [Cocaine results in increased activity of SOD1 protein]; GPX1 affects the reaction [Cocaine results in increased activity of SOD2 protein]; GPX1 affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; GPX1 affects the reaction [Cocaine results in increased cleavage of PRKCD protein]; GPX1 protein affects the susceptibility to [Cocaine co-treated with prolinedithiocarbamate]; GPX1 protein inhibits the reaction [Cocaine affects the localization of RELA protein]; GPX1 protein inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein]; GPX1 protein inhibits the reaction [Cocaine results in increased activity of and affects the localization of RELA protein]; GPX1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; prolinedithiocarbamate promotes the reaction [Cocaine results in increased expression of GPX1 protein]
|
CTD |
PMID:30027653 PMID:31059705 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Grb2
|
growth factor receptor bound protein 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of GRB2 protein
|
CTD |
PMID:25100957 |
|
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
decreases response to substance increases expression increases phosphorylation decreases expression affects response to substance increases response to substance decreases phosphorylation multiple interactions affects expression
|
ISO EXP
|
GRIA1 results in decreased susceptibility to Cocaine Cocaine increases expression of Gria1 protein in the nucleus accumbens Cocaine increases phosphorylation of Gria1 protein in prefrontal cortex, nucleus accumbens Cocaine increases expression of Gria1 protein on nucleus accumbens cell surface Cocaine increases phosphorylation of Gria1 protein in the shell of nucleus accumbens Cocaine increases phosphorylation of Gria1 protein in the prefrontal cortex, premotor cortex Cocaine decreases expression of Gria1 protein in the nucleus accumbens Cocaine increases phosphorylation of Gria1 protein in the dorsal striatum Cocaine increases phosphorylation of Gria1 protein in the hippocampal formation Cocaine increases expression of Gria1 protein in the ventral tegmental area Cocaine increases expression of Gria1 mRNA in the nucleus accumbens Cocaine results in decreased expression of GRIA1 mRNA; Cocaine results in decreased expression of GRIA1 protein Cocaine results in increased phosphorylation of GRIA1 protein GRIA1 protein affects the susceptibility to Cocaine GRIA1 protein results in increased susceptibility to Cocaine GRIA1 protein mutant form results in decreased susceptibility to Cocaine; GRIA1 results in decreased susceptibility to Cocaine Cocaine results in increased expression of GRIA1 mRNA; Cocaine results in increased expression of GRIA1 protein Cocaine results in decreased phosphorylation of GRIA1 protein 6-methyl-2-(phenylethynyl)pyridine affects the reaction [Cocaine affects the phosphorylation of GRIA1 protein]; Cocaine affects the phosphorylation of and affects the expression of GRIA1 protein; Cocaine results in increased phosphorylation of and results in increased transport of GRIA1 protein; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of GRIA1 protein]; ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIA1 protein]; ILK mutant form inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; Ondansetron inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; roscovitine inhibits the reaction [Cocaine results in decreased phosphorylation of GRIA1 protein]; U 0126 inhibits the reaction [Cocaine results in increased expression of GRIA1 protein] Cocaine affects the expression of GRIA1 mRNA; Cocaine affects the expression of GRIA1 protein Cocaine results in increased expression of and results in increased phosphorylation of GRIA1 protein; Nifedipine inhibits the reaction [Cocaine results in increased expression of and results in increased phosphorylation of GRIA1 protein]; resveratrol promotes the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]
|
CTD RGD |
PMID:9886066 PMID:11268215 PMID:11801363 PMID:12511956 PMID:12787079 PMID:14684464 PMID:15140200 PMID:16473939 PMID:16794574 PMID:17680995 PMID:17898221 PMID:18278040 PMID:18430032 PMID:18701074 PMID:19070590 PMID:19105975 PMID:19457111 PMID:19474322 PMID:19629758 PMID:20187946 PMID:20600170 PMID:23499958 PMID:24810662 PMID:28194001 PMID:22127928 PMID:16794574 PMID:16207873 PMID:29317777 PMID:28495973 PMID:17439498 PMID:11801363 PMID:22197517 PMID:23352852 PMID:18554320 PMID:29196318 PMID:15548228 More...
|
RGD:405820210, RGD:405820206, RGD:405818274, RGD:405650685, RGD:405650670, RGD:405650586, RGD:405650201, RGD:405650197, RGD:405649862, RGD:405649734, RGD:405649733, RGD:405096667 |
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
increases expression increases abundance decreases response to substance multiple interactions affects expression
|
ISO EXP
|
Cocaine results in increased expression of GRIA2 protein cocaine increases abundance of Gria2 Q subunit transcripts in nucleus accumbens shell GRIA2 results in decreased susceptibility to Cocaine Cocaine results in increased phosphorylation of and affects the localization of GRIA2 protein Cocaine results in increased expression of GRIA2 mRNA Cocaine affects the expression of GRIA2 mRNA; Cocaine affects the expression of GRIA2 protein
|
CTD RGD |
PMID:9886066 PMID:12511956 PMID:12787079 PMID:15140200 PMID:16363995 PMID:18945913 PMID:19105975 PMID:20187946 PMID:20534846 PMID:25349168 More...
|
RGD:11528441 |
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3
|
decreases expression affects expression increases expression
|
ISO EXP
|
Cocaine results in decreased expression of GRIA3 mRNA Cocaine affects the expression of GRIA3 protein Cocaine results in increased expression of GRIA3 protein
|
CTD |
PMID:9886066 PMID:12511956 PMID:15140200 PMID:16363995 |
|
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:125,103,782...125,369,679
|
|
| G
|
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4
|
affects expression
|
ISO EXP
|
Cocaine affects the expression of GRIA4 mRNA Cocaine affects the expression of GRIA4 protein
|
CTD |
PMID:9886066 PMID:15140200 |
|
NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881
|
|
| G
|
Grik1
|
glutamate ionotropic receptor kainate type subunit 1
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIK1 mRNA; Cocaine affects the expression of GRIK1 protein
|
CTD |
PMID:12358776 PMID:15140200 |
|
NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517
|
|
| G
|
Grik2
|
glutamate ionotropic receptor kainate type subunit 2
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIK2 protein
|
CTD |
PMID:15140200 |
|
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
|
|
| G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIK3 protein
|
CTD |
PMID:15140200 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
| G
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIK5 protein
|
CTD |
PMID:15140200 |
|
NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:89,733,741...89,794,962
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
multiple interactions affects response to substance increases expression affects phosphorylation affects expression decreases expression
|
EXP ISO
|
6-methyl-2-(phenylethynyl)pyridine affects the reaction [Cocaine affects the phosphorylation of GRIN1 protein]; Cocaine affects the phosphorylation of and affects the expression of GRIN1 protein; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of GRIN1 protein]; ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIN1 protein] GRIN1 protein affects the susceptibility to Cocaine Cocaine results in increased expression of GRIN1 mRNA; Cocaine results in increased expression of GRIN1 protein Cocaine affects the expression of GRIN1 mRNA; Cocaine affects the expression of GRIN1 protein Cocaine results in decreased expression of GRIN1 mRNA
|
CTD |
PMID:9886066 PMID:11032893 PMID:11801363 PMID:12457264 PMID:12670717 PMID:12787079 PMID:15140200 PMID:16363995 PMID:17680995 PMID:19474322 PMID:20187946 PMID:20600170 More...
|
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
multiple interactions increases expression affects expression
|
ISO EXP
|
HDAC5 affects the reaction [Cocaine affects the expression of GRIN2A mRNA] ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIN2A protein] Cocaine results in increased expression of GRIN2A mRNA; Cocaine results in increased expression of GRIN2A protein Cocaine affects the expression of GRIN2A mRNA; Cocaine affects the expression of GRIN2A protein
|
CTD |
PMID:17898221 PMID:17988634 PMID:19105975 PMID:19306440 PMID:19474322 PMID:20187946 More...
|
|
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
increases expression affects response to substance multiple interactions affects expression decreases phosphorylation
|
EXP
|
Cocaine results in increased expression of GRIN2B protein GRIN2B protein affects the susceptibility to Cocaine Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of GRIN2B protein]; ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIN2B protein]; Ondansetron inhibits the reaction [Cocaine results in decreased phosphorylation of GRIN2B protein]; Ondansetron inhibits the reaction [Cocaine results in increased expression of GRIN2B protein] Cocaine affects the expression of GRIN2B mRNA; Cocaine affects the expression of GRIN2B protein
|
CTD |
PMID:11032893 PMID:11801363 PMID:15140200 PMID:16794574 PMID:19105975 PMID:19306440 PMID:19474322 PMID:20187946 More...
|
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Grin2c
|
glutamate ionotropic receptor NMDA type subunit 2C
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIN2C mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,987,513...101,005,409
|
|
| G
|
Grin2d
|
glutamate ionotropic receptor NMDA type subunit 2D
|
increases expression affects expression
|
EXP
|
Cocaine results in increased expression of GRIN2D mRNA Cocaine affects the expression of GRIN2D mRNA
|
CTD |
PMID:16076954 PMID:20187946 |
|
NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:105,444,813...105,481,236
|
|
| G
|
Grin3a
|
glutamate ionotropic receptor NMDA type subunit 3A
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIN3A protein
|
CTD |
PMID:15140200 |
|
NCBI chr 5:68,802,333...69,001,880
Ensembl chr 5:68,804,970...69,001,558
|
|
| G
|
Grin3b
|
glutamate ionotropic receptor NMDA type subunit 3B
|
affects expression
|
EXP
|
Cocaine affects the expression of GRIN3B protein
|
CTD |
PMID:15140200 |
|
NCBI chr 7:10,381,495...10,387,817
Ensembl chr 7:10,381,496...10,387,817
|
|
| G
|
Grina
|
glutamate ionotropic receptor NMDA type subunit associated protein 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GRINA mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
|
|
| G
|
Grip1
|
glutamate receptor interacting protein 1
|
increases phosphorylation multiple interactions
|
EXP ISO
|
Cocaine results in increased phosphorylation of GRIP1 protein [Cocaine co-treated with FOS protein mutant form] results in increased expression of GRIP1 mRNA
|
CTD |
PMID:18355967 PMID:19439608 |
|
NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417
|
|
| G
|
Grip2
|
glutamate receptor interacting protein 2
|
increases expression
|
EXP
|
Cocaine results in increased expression of GRIP2 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 4:125,828,609...125,913,693
Ensembl chr 4:125,828,609...125,913,750
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of GRK2 mRNA Cocaine results in increased expression of GRK2 mRNA
|
CTD |
PMID:16076954 PMID:20187946 |
|
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Grk6
|
G protein-coupled receptor kinase 6
|
affects expression
|
EXP
|
Cocaine affects the expression of GRK6 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954
|
|
| G
|
Grm1
|
glutamate metabotropic receptor 1
|
affects response to substance
|
ISO
|
GRM1 affects the susceptibility to Cocaine
|
CTD |
PMID:19597494 |
|
NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443
|
|
| G
|
Grm2
|
glutamate metabotropic receptor 2
|
increases activity affects expression decreases activity
|
EXP
|
Cocaine results in increased activity of GRM2 protein Cocaine affects the expression of GRM2 protein Cocaine results in decreased activity of GRM2 protein
|
CTD |
PMID:18673447 PMID:19105975 PMID:20416862 |
|
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857
|
|
| G
|
Grm3
|
glutamate metabotropic receptor 3
|
increases activity affects expression
|
EXP
|
Cocaine results in increased activity of GRM3 protein Cocaine affects the expression of GRM3 protein
|
CTD |
PMID:19105975 PMID:20416862 |
|
NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764
|
|
| G
|
Grm5
|
glutamate metabotropic receptor 5
|
affects expression increases expression multiple interactions affects localization decreases response to substance
|
ISO EXP
|
Cocaine affects the expression of GRM5 mRNA Cocaine deficiency results in increased expression of GRM5 mRNA Cocaine results in decreased expression of and results in decreased activity of GRM5 protein Cocaine results in increased expression of GRM5 mRNA Cocaine affects the expression of GRM5 protein Cocaine affects the localization of GRM5 protein GRM5 mutant form results in decreased susceptibility to Cocaine
|
CTD |
PMID:9886066 PMID:15295029 PMID:17898221 PMID:19105975 PMID:19118598 PMID:20416862 PMID:20534846 PMID:20826661 PMID:24810662 PMID:27126842 More...
|
|
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:150,733,678...151,296,649
|
|
| G
|
Grm7
|
glutamate metabotropic receptor 7
|
increases expression
|
EXP
|
Cocaine results in increased expression of GRM7 mRNA
|
CTD |
PMID:16076954 |
|
NCBI chr 4:145,286,714...146,169,099
Ensembl chr 4:145,286,924...146,169,201
|
|
| G
|
Grpr
|
gastrin releasing peptide receptor
|
affects expression
|
EXP
|
Cocaine affects the expression of GRPR mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr X:34,630,238...34,670,245
Ensembl chr X:34,630,229...34,670,245
|
|
| G
|
Gsk3a
|
glycogen synthase kinase 3 alpha
|
affects expression
|
EXP
|
Cocaine affects the expression of GSK3A mRNA
|
CTD |
PMID:12117546 |
|
NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions increases activity
|
ISO
|
Cocaine results in decreased phosphorylation of and results in increased activity of GSK3B protein Cocaine results in increased activity of GSK3B protein
|
CTD |
PMID:19328817 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsn
|
gelsolin
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of GSN mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
increases expression
|
EXP
|
Cocaine deficiency results in increased expression of GSR mRNA
|
CTD |
PMID:22860061 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
affects expression
|
ISO
|
Cocaine affects the expression of GSTO1 protein
|
CTD |
PMID:19393250 |
|
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
affects response to substance
|
ISO
|
GSTP1 polymorphism affects the susceptibility to Cocaine
|
CTD |
PMID:16272961 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GUCY1A1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
Gucy1b1
|
guanylate cyclase 1 soluble subunit beta 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of GUCY1B1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987
|
|
| G
|
Gyg1
|
glycogenin 1
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of GYG1 protein
|
CTD |
PMID:25100957 |
|
NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818
|
|
| G
|
Gzmm
|
granzyme M
|
affects expression
|
EXP
|
Cocaine affects the expression of GZMM mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:10,661,683...10,667,448
Ensembl chr 7:10,661,684...10,667,504
|
|
| G
|
Hand1
|
heart and neural crest derivatives expressed 1
|
affects expression
|
EXP
|
Cocaine affects the expression of HAND1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr10:42,507,117...42,509,684
Ensembl chr10:42,507,122...42,509,684
|
|
| G
|
Hbb-b2
|
hemoglobin, beta adult minor chain
|
increases expression
|
ISO
|
Cocaine results in increased expression of HBB-B2 protein modified form
|
CTD |
PMID:24096156 |
|
NCBI chr 1:167,655,583...167,656,963
|
|
| G
|
Hcn2
|
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
|
increases expression
|
ISO
|
Cocaine results in increased expression of HCN2 mRNA
|
CTD |
PMID:18000554 |
|
NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457
|
|
| G
|
Hcrt
|
hypocretin neuropeptide precursor
|
affects expression multiple interactions
|
EXP
|
Cocaine affects the expression of HCRT mRNA Methadone affects the reaction [Cocaine affects the expression of HCRT mRNA]
|
CTD |
PMID:18990547 |
|
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524
|
|
| G
|
Hcrtr2
|
hypocretin receptor 2
|
affects expression
|
EXP
|
Cocaine affects the expression of HCRTR2 protein
|
CTD |
PMID:17623047 |
|
NCBI chr 8:85,870,279...85,986,405
Ensembl chr 8:85,870,279...85,986,405
|
|
| G
|
Hdac10
|
histone deacetylase 10
|
affects expression
|
EXP
|
Cocaine affects the expression of HDAC10 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr 7:122,078,768...122,084,457
Ensembl chr 7:122,078,768...122,083,870
|
|
| G
|
Hdac5
|
histone deacetylase 5
|
decreases activity decreases response to substance multiple interactions
|
ISO
|
Cocaine results in decreased activity of HDAC5 protein HDAC5 results in decreased susceptibility to Cocaine Cocaine results in increased phosphorylation of and results in increased localization of HDAC5 protein; HDAC5 affects the reaction [Cocaine affects the expression of ABCA5 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of ADAM1A mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of CUEDC1 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of ERBIN mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of GNB4 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of GRIN2A mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of KCNK4 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of KCNQ5 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of PRM1 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of RAPGEF6 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of RGS20 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of SUV39H1 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of TACR1 mRNA]; HDAC5 affects the reaction [Cocaine affects the expression of WNT5A mRNA]
|
CTD |
PMID:17988634 |
|
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
|
|
| G
|
Hdac6
|
histone deacetylase 6
|
multiple interactions decreases expression
|
EXP
|
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Cocaine results in decreased expression of HDAC6 protein]
|
CTD |
PMID:32312805 |
|
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
|
|
| G
|
Hdc
|
histidine decarboxylase
|
affects response to substance
|
ISO
|
HDC gene mutant form affects the susceptibility to Cocaine
|
CTD |
PMID:17072589 |
|
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
|
|
| G
|
Hecw2
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of HECW2 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:62,859,645...63,074,758
|
|
| G
|
Herc1
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of HERC1 mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347
|
|
| G
|
Hhip
|
Hedgehog-interacting protein
|
decreases expression
|
EXP
|
Cocaine results in decreased expression of HHIP mRNA
|
CTD |
PMID:17898221 |
|
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
decreases expression
|
ISO
|
Cocaine results in decreased expression of HIF1A mRNA
|
CTD |
PMID:12629581 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Higd1a
|
HIG1 hypoxia inducible domain family, member 1A
|
affects expression increases expression
|
EXP
|
Cocaine affects the expression of HIGD1A mRNA Cocaine results in increased expression of HIGD1A protein
|
CTD |
PMID:20187946 PMID:25100957 |
|
NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888
|
|
| G
|
Hmga1
|
high mobility group AT-hook 1
|
affects expression
|
EXP
|
Cocaine affects the expression of HMGA1 mRNA
|
CTD |
PMID:20187946 |
|
NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593
|
|
| G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
increases expression
|
EXP
|
Cocaine results in increased expression of HMGCS1 mRNA
|
CTD |
PMID:12117546 |
|
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
|
|
| G
|
Homer1
|
homer scaffold protein 1
|
increases response to substance increases expression affects expression multiple interactions decreases response to substance
|
ISO EXP
|
HOMER1 polymorphism results in increased susceptibility to Cocaine Cocaine results in increased expression of HOMER1 protein Cocaine affects the expression of HOMER1 mRNA; Cocaine affects the expression of HOMER1 protein Cocaine affects the expression of and affects the localization of HOMER1 protein HOMER1 protein results in decreased susceptibility to Cocaine Cocaine results in increased expression of HOMER1 mRNA
|
CTD |
PMID:15294147 PMID:16314758 PMID:18355967 PMID:19105975 PMID:19118598 PMID:19306440 PMID:20187946 PMID:20534846 More...
|
|
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657
|
|
| G
|
Homer2
|
home | |